Language selection

Search

Patent 2512536 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2512536
(54) English Title: BIOMARKERS AND METHODS FOR DETERMINING SENSITIVITY TO EPIDERMAL GROWTH FACTOR RECEPTOR MODULATORS
(54) French Title: BIOMARQUEURS ET METHODES DE DETERMINATION D'UNE SENSIBILITE AUX MODULATEURS DU FACTEUR DE CROISSANCE EPIDERMIQUE
Status: Dead
Bibliographic Data
(51) International Patent Classification (IPC):
  • G01N 33/48 (2006.01)
  • C12Q 1/68 (2006.01)
  • G01N 1/00 (2006.01)
(72) Inventors :
  • AMLER, LUKAS C. (United States of America)
  • JANUARIO, THOMAS (United States of America)
(73) Owners :
  • BRISTOL-MYERS SQUIBB COMPANY (United States of America)
(71) Applicants :
  • BRISTOL-MYERS SQUIBB COMPANY (United States of America)
(74) Agent: GOWLING LAFLEUR HENDERSON LLP
(74) Associate agent:
(45) Issued:
(86) PCT Filing Date: 2004-01-08
(87) Open to Public Inspection: 2004-07-29
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/US2004/000368
(87) International Publication Number: WO2004/063709
(85) National Entry: 2005-06-30

(30) Application Priority Data:
Application No. Country/Territory Date
60/438,735 United States of America 2003-01-08

Abstracts

English Abstract




EGFR biomakers useful in a method for identifying a mammal that will respond
therapeutically to a method of treating cancer comprising administering an
EGFR modulator, wherein the method comprises (a) exposing the mammal to the
EGFR modulator and (b) measuring in the mammal level of at least one biomaker,
wherein a difference in the level in at least one biomaker measured in (b)
compared to the level of the biomaker in a mammal that has not been exposed to
the EGFR modulator indicates that the mammal will respond therapeutically to
the method of treating cancer.


French Abstract

L'invention concerne des biomarqueurs EGFR utilisés dans une méthode d'identification d'un mammifère réagissant d'un point de vue thérapeutique à une méthode de traitement du cancer, consistant à administrer un modulateur EGFR. Ladite méthode consiste (a) à exposer le mammifère au modulateur EGFR, et (b) à mesurer chez le mammifère le niveau d'au moins un biomarqueur, une différence de niveau d'au moins un biomarqueur mesuré au cours de l'étape (b) par rapport au niveau d'un biomarqueur chez un mammifère n'ayant pas été exposé au modulateur EGFR indiquant que le mammifère réagit d'un point de vue thérapeutique à la méthode de traitement du cancer.

Claims

Note: Claims are shown in the official language in which they were submitted.




CLAIMS:


What is claimed is:

1. A method for identifying a mammal that will respond therapeutically to a
method of treating cancer comprising administering an EGFR modulator, wherein
the
method comprises:
(a) measuring in the mammal the level of at least one biomarker selected from
the biomarkers of Table 4;
(b) exposing the mammal to the EGFR modulator;
(c) following the exposing of step (b), measuring in the mammal the level of
the at least one biomarker,
wherein a difference in the level of the at least one biomarker measured in
step
(c) compared to the level of the at least one biomarker measured in step (a)
indicates
that the mammal will respond therapeutically to said method of treating
cancer.

2. The method of claim 1 wherein the at least one biomarker is selected from
the biomarkers of Table 5.

3. The method of claim 1 wherein the method is an in vitro method, and
wherein the at least one biomarker is measured in at least one mammalian
biological
sample from the mammal.

4. A method for identifying a mammal that will respond therapeutically to a
method of treating cancer comprising administering an EGFR modulator, wherein
the
method comprises:
(a) exposing the mammal to the EGFR modulator;
(b) following the exposing of step (a), measuring in the mammal the level of
the at least one biomarker selected from the biomarkers of Table 4,
wherein a difference in the level of the at least one biomarker measured in
step
(b), compared to the level of the biomarker in a mammal that has not been
exposed to
said EGFR modulator, indicates that the mammal will respond therapeutically to
said
method of treating cancer.



-76-

Description

Note: Descriptions are shown in the official language in which they were submitted.





DEMANDE OU BREVET VOLUMINEUX
LA PRESENTE PARTIE DE CETTE DEMANDE OU CE BREVET COMPREND
PLUS D'UN TOME.
CECI EST LE TOME 1 DE 2
CONTENANT LES PAGES 1 A 281
NOTE : Pour les tomes additionels, veuillez contacter le Bureau canadien des
brevets
JUMBO APPLICATIONS/PATENTS
THIS SECTION OF THE APPLICATION/PATENT CONTAINS MORE THAN ONE
VOLUME
THIS IS VOLUME 1 OF 2
CONTAINING PAGES 1 TO 281
NOTE: For additional volumes, please contact the Canadian Patent Office
NOM DU FICHIER / FILE NAME
NOTE POUR LE TOME / VOLUME NOTE:



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
BIOMARKERS AND METHODS FOR DETERMINING SENSITIVITY TO
EPIDERMAL GROWTH FACTOR RECEPTOR MODULATORS
FIELD OF THE INVENTION
The present invention relates generally to the field of pharmacogenomics, and
more specifically to methods and procedures to determine sensitivity in
patients to
allow the development of individualized genetic profiles which aid in treating
diseases and disorders based on patient response at a molecular level.
BACKGROUND OF THE INVENTION:
Cancer is a disease with extensive histoclinical heterogeneity. Although
conventional histological and clinical features have been correlated to
prognosis, the
same apparent prognostic type of tumors varies widely in its responsiveness to
therapy and consequent survival of the patient.
New prognostic and predictive markers, which would facilitate an
individualization of therapy for each patient, are needed to accurately
predict patient
response to treatments, such as small molecule or biological molecule drugs,
in the
clinic. The problem may be solved by the identification of new parameters that
could
better predict the patient's sensitivity to treatment. The classification of
patient
samples is a crucial aspect of cancer diagnosis and treatment. The association
of a
patient's response to a treatment with molecular and genetic markers can open
up new
opportunities for treatment development in non-responding patients, or
distinguish a
treatment's indication among other treatment choices because of higher
confidence in
the efficacy. Further, the pre-selection of patients who are likely to respond
well to a
medicine, drug, or combination therapy may reduce the number of patients
needed in
a clinical study or accelerate the time needed to complete a clinical
development
program (M. Cockett et al., 2000, Current Opinion ifz Biotechnology, 11:602-
609).
The ability to predict drug sensitivity in patients is particularly
challenging
because drug responses reflect not only properties intrinsic to the target
cells, but also
a host's metabolic properties. Efforts to use genetic information to predict
drug
sensitivity have primarily focused on individual genes that have broad
effects, such as
the multidrug resistance genes, ~2drl and fnfpl (P. Sonneveld, 2000, J.
Intef°n. Med.,
247:521-534).



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
The development of microarray technologies for large scale characterization
of gene mRNA expression pattern has made it possible to systematically search
for
molecular markers and to categorize cancers into distinct subgroups not
evident by
traditional histopathological methods (J. Khan et al., 1998, Cancer Res.,
58:5009-
5013; A.A. Alizadeh et al., 2000, Natui°e, 403:503-511; M. Bittner et
al., 2000,
Nature, 406:536-540; J. Khan et al., 2001, Nature Medicine, 7(6):673-679; and
T.R.
Golub et al., 1999, Science, 286:531-537; U. Alon et al., 1999, Proc. Natl.
Acad. Sci.
USA, 96:6745-6750). Such technologies and molecular tools have made it
possible to
monitor the expression level of a large number of transcripts within a cell
population
at any given time (see, e.g., Schena et al., 1995, Science, 270:467-470;
Lockhart et al.,
1996 Nature Biotechnology, 14:1675-1680; Blanchard et al., 1996,
Natuf°e
Biotechnology, 14:1649; U.S. Patent No. 5,569,588 to Ashby et al.).
Recent studies demonstrate that gene expression information generated by
microarray analysis of human tumors can predict clinical outcome (L.J. van't
Veer et
al., 2002, Nature, 415:530-536; M. West et al., 2001, Proc. Natl. Acad. Sci.
USA,
98:11462-11467; T. Sorlie et al., 2001, Proc. Natl. Acad. Sci. USA, 98:10869-
10874;
M. Shipp et al., 2002, Nature Medicine, 8(1):68-74). These findings bring hope
that
cancer treatment will be vastly improved by better predicting the response of
individual tumors to therapy.
Needed are new and alternative methods and procedures to determine drug
sensitivity in patients to allow the development of individualized genetic
profiles
which are necessary to treat diseases and disorders based on patient response
at a
molecular level.
SUMMARY OF THE INVENTION:
The invention provides methods and procedures for determining patient
sensitivity to one or more Epidermal Growth Factor Receptor (EGFR) modulators.
The invention also provides methods of determining or predicting whether an
individual requiring therapy for a disease state such as cancer will or will
not respond
to treatment, prior to administration of the treatment, wherein the treatment
comprises
one or more EGFR modulators. The one or more EGFR modulators are compounds
that can be selected from, for example, one or more EGFR specific ligands, one
or
_2_



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
more small molecule EGFR inhibitors, or one or more EGFR binding monoclonal
antibodies.
In one aspect, the invention provides a method for identifying a mammal that
will respond therapeutically to a method of treating cancer comprising
administering
an EGFR modulator, wherein the method comprises: (a) measuring in the mammal
the level of at least one biomarker selected from the biomarkers of Table 4;
(b)
exposing the mammal to the EGFR modulator; (c) following the exposing of step
(b),
measuring in the mammal the level of the at least one biomarker, wherein a
difference
in the level of the at least one biomarker measured in step (c) compared to
the level of
the at least one biomarker measured in step (a) indicates that the mammal will
respond therapeutically to said method of treating cancer.
As used herein, respond therapeutically refers to the alleviation or
abrogation
of the cancer. This means that the life expectancy of an individual affected
with the
cancer will be increased or that one or more of the symptoms of the cancer
will be
reduced or ameliorated. The term encompasses a reduction in cancerous cell
growth
or tumor volume. Whether a mammal responds therapeutically can be measured by
many methods well known in the art, such as PET imaging.
The at least one biomarker can also be selected from the biomarkers of Table
5. The mammal can be, for example, a human, rat, mouse, dog rabbit, pig sheep,
cow,
horse, cat, primate, or monkey.
The method of the invention can be, for example, an in vitro method and
wherein the at least one biornarker is measured in at least one mammalian
biological
sample from the mammal. The biological sample can comprise, for example, at
least
one of whole fresh blood, peripheral blood mononuclear cells, frozen whole
blood,
fresh plasma, frozen plasma, urine, saliva, skin, hair follicle, or tumor
tissue.
In another aspect, the invention provides a method for identifying a mammal
that will respond therapeutically to a method of treating cancer comprising
administering an EGFR modulator, wherein the method comprises: (a) exposing
the
mammal to the EGFR modulator; (b) following the exposing of step (a),
measuring in
the mammal the level of the at least one biomarker selected from the
biomarkers of
Table 4, wherein a difference in the level of the at least one biomarker
measured in
step (b), compared to the level of the biomarker in a mammal that has not been
-3-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
exposed to said EGFR modulator, indicates that the mammal will respond
therapeutically to said method of treating cancer.
In yet another aspect, the invention provides a method for testing or
predicting
whether a mammal will respond therapeutically to a method of treating cancer
comprising administering an EGFR modulator, wherein the method comprises: (a)
measuring in the mammal the level of at least one biomarker selected from the
biomarkers of Table 4; (b) exposing the mammal to the EGFR modulator; (c)
following the exposing of step (b), measuring in the mammal the level of the
at least
one biomarker, wherein a difference in the level of the at least one biomarker
measured in step (c) compared to the level of the at least one biomarker
measured in
step (a) indicates that the mammal will respond therapeutically to said method
of
treating cancer.
In another aspect, the invention provides a method for determining whether a
compound inhibits EGFR activity in a mammal, comprising: (a) exposing the
mammal to the compound; and (b) following the exposing of step (a), measuring
in
the mammal the level of at least one biomarker selected from the biomarkers of
Table
4, wherein a difference in the level of said biomarker measured in step (b),
compared
to the level of the biomarker in a mammal that has not been exposed to said
compound, indicates that the compound inhibits EGFR activity in the mammal.
In yet another aspect, the invention provides a method for determining
whether a mammal has been exposed to a compound that inhibits EGFR activity,
comprising (a) exposing the mammal to the compound; and (b) following the
exposing of step (a), measuring in the mammal the level of at least one
biomarker
selected from the biomarkers of Table 4, wherein a difference in the level of
said
biomarker measured in step (b), compared to the level of the biomarker in a
mammal
that has not been exposed to said compound, indicates that the mammal has been
exposed to a compound that inhibits EGFR activity.
In another aspect, the invention provides a method for determining whether a
mammal is responding to a compound that inhibits EGFR activity, comprising (a)
exposing the mammal to the compound; and (b) following the exposing of step
(a),
measuring in the mammal the level of at least one biomarker selected from the
biomaxkers of Table 4, wherein a difference in the level of said biomarker
measured
-4-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
in step (b), compared to the level of the biomarker in a mammal that has not
been
exposed to said compound, indicates that the mammal is responding to the
compound
that inhibits EGFR activity.
As used herein, "responding" encompasses responding by way of a biological
and cellular response, as well as a clinical response (such as improved
symptoms, a
therapeutic effect, or an adverse event), in a mammal
The invention also provides an isolated biomarker selected from the
biomarkers of Table 4. The biomarkers of the invention comprise sequences
selected
from the nucleotide and amino acid sequences provided in Table 4 and the
Sequence
Listing, as well as fragments and variants thereof.
The invention also provides a biomarker set comprising two or more
biomarkers selected from the biomarkers of Table 4.
The invention also provides kits for determining or predicting whether a
patient would be susceptible or resistant to a treatment that comprises one or
more
EGFR modulators. The patient may have a cancer or tumor such as, for example,
a
colon cancer or tumor.
In one aspect, the kit comprises a suitable container that comprises one or
more specialized microarrays of the invention, one or more EGFR modulators for
use
in testing cells from patient tissue specimens or patient samples, and
instructions for
use. The kit may further comprise reagents or materials for monitoring the
expression
of a biomarker set at the level of mRNA or protein.
In another aspect, the invention provides a kit comprising two or more
biomarkers selected from the biomarkers of Table 4.
In yet another aspect, the invention provides a kit comprising at least one of
an
antibody and a nucleic acid for detecting the presence of at least one of the
biomarkers selected from the biomarkers of Table 4. In one aspect, the kit
further
comprises instructions for determining whether or not a mammal will respond
therapeutically to a method of treating cancer comprising administering a
compound
that inhibits EGFR activity. In another aspect, the instructions comprise the
steps of
(a) measuring in the mammal the level of at least one biomarker selected from
the
biomarkers of Table 4, (b) exposing the mammal to the compound, (c) following
the
exposing of step (b), measuring in the mammal the level of the at least one
biomarker,
_5_



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
wherein a difference in the level of the at least one biomarker measured in
step (c)
compared to the level of the at least one biomarker measured in step (a)
indicates that
the mammal will respond therapeutically to said method of treating cancer.
The invention also provides screening assays for determining if a patient will
be susceptible or resistant to treatment with one or more EGFR modulators.
The invention also provides a method of monitoring the treatment of a patient
having a disease treatable by one or more EGFR modulators.
The invention also provides individualized genetic profiles which are
necessary to treat diseases and disorders based on patient response at a
molecular
level.
The invention also provides specialized microarrays, e.g., oligonucleotide
microarrays or cDNA microarrays, comprising one or more biomarkers having
expression profiles that correlate with either sensitivity or resistance to
one or more
EGFR modulators.
The invention also provides antibodies, including polyclonal or monoclonal,
directed against one or more biomarkers of the invention.
The invention will be better understood upon a reading of the detailed
description of the invention when considered in connection with the
accompanying
figures.
BRIEF DESCRIPTION OF THE FIGURES:
FIG. 1 illustrates a EGFR biomarker identification and prioritization
strategy.
FIG. 2A illustrates the RT-PCR results for EGFR in thirty one colon cancer
cell lines to identify cell lines which do not have significant mRNA
expression of
EGFR.
FIG. 2B illustrates the ICSO profile for twenty two colon cancer cell lines
with
an EGFR inhibitor compound, and determination of sensitive and resistant cell
lines.
-6-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
DETAILED DESCRIPTION OF THE INVENTION:
The invention provides biomarkers that respond to the modulation of a
specific signal transduction pathway and also correlate with EGFR modulator
sensitivity or resistance. These biomarkers can be employed for predicting
response
to one or more EGFR modulators. In one aspect, the biomarkers of the invention
are
those provided in Table 4 and the Sequence Listing, including both
polynucleotide
and polypeptide sequences.
The biomarkers were determined by an in vit~°o assay employing
microarray
technology to monitor simultaneously the expression pattern of thousands of
discrete
genes in untreated cells, whose response to the modulation of a signal
transduction
pathway, in particular the EGFR pathway, was tested on untreated cells whose
sensitivity to EGFR modulators was tested. The biomarkers have expression
levels in
the cells that are dependent on the activity of the EFGR signal transduction
pathway
and that are also highly correlated with EGFR modulator sensitivity exhibited
by the
cells. Biomarkers serve as useful molecular tools for predicting a response to
EGFR
modulators, preferably biological molecules, small molecules, and the like
that affect
EGFR kinase activity via direct or indirect inhibition or antagonism of EGFR
kinase
function or activity.
EGFR MODULATORS
As used herein, the term "EGFR modulator" is intended to mean a compound
or drug that is a biological molecule or a small molecule that directly or
indirectly
modulates EGFR activity or the EGFR signal transduction pathway. Thus,
compounds or drugs as used herein is intended to include both small molecules
and
biological molecules. Direct or indirect modulation includes activation or
inhibition
of EGFR activity or the EGFR signal transduction pathway. In one aspect,
inhibition
refers to inhibition of the binding of EGFR to an EGFR ligand such as, for
example,
EGF. In another aspect, inhibition refers to inhibition of the kinase activity
of EGFR.
EGFR modulators include, for example, EGFR specific ligands, small
molecule EGFR inhibitors, and EGFR monoclonal antibodies.. In one aspect, the
EGFR modulator inhibits EGFR activity and/or inhibits the EGFR signal
transduction
7_



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
pathway. Tn another aspect, the EGFR modulator is an EGFR antibody that
inhibits
EGFR activity and/or inhibits the EGFR signal transduction pathway.
EGFR modulators include biological molecules or small molecules.
Biological molecules include all lipids and polymers of monosaccharides, amino
acids, and nucleotides having a molecular weight greater than 450. Thus,
biological
molecules include, for example, oligosaccharides and polysaccharides;
oligopeptides,
polypeptides, peptides, and proteins; and oligonucleotides and
polynucleotides.
Oligonucleotides and polynucleotides include, for example, DNA and RNA.
Biological molecules further include derivatives of any of the molecules
described above. For example, derivatives of biological molecules include
lipid and
glycosylation derivatives of oligopeptides, polypeptides, peptides, and
proteins.
Derivatives of biological molecules further include lipid derivatives of
oligosaccharides and polysaccharides, e.g., lipopolysaccharides. Most
typically,
biological molecules are antibodies, or functional equivalents of antibodies.
Functional equivalents of antibodies have binding characteristics comparable
to those
of antibodies, and inhibit the growth of cells that express EGFR. Such
functional
equivalents include, for example, chimerized, humanized, and single chain
antibodies
as well as fragments thereof.
Functional equivalents of antibodies also include polypeptides with amino
acid sequences substantially the same as the amino acid sequence of the
variable or
hypervariable regions of the antibodies. An amino acid sequence that is
substantially
the same as another sequence, but that differs from the other sequence by
means of
one or more substitutions, additions, and/or deletions, is considered to be an
equivalent sequence. Preferably, less than 50%, more preferably less than 25%,
and
still more preferably less than 10%, of the number of amino acid residues in a
sequence are substituted for, added to, or deleted from the protein.
The functional equivalent of an antibody is preferably a chimerized or
humanized antibody. A chimerized antibody comprises the variable region of a
non-
human antibody and the constant region of a human antibody. A humanized
antibody
comprises the hypervariable region (CDRs) of a non-human antibody. The
variable
region other than the hypervariable region, e.g., the framework variable
region, and
the constant region of a humanized antibody are those of a human antibody.
_g_



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
Suitable variable and hypervariable regions of non-human antibodies may be
derived from antibodies produced by any non-human mammal in which monoclonal
antibodies are made. Suitable examples of mammals other than humans include,
for
example, rabbits, rats, mice, horses, goats, or primates.
Functional equivalents further include fragments of antibodies that have
binding characteristics that are the same as, or are comparable to, those of
the whole
antibody. Suitable fragments of the antibody include any fragment that
comprises a
sufficient portion of the hypervariable (i.e., complementarity determining)
region to
bind specifically, and with sufficient affinity, to EGFR tyrosine kinase to
inhibit
growth of cells that express such receptors.
Such fragments may, for example, contain one or both Fab fragments or the
F(ab')2 fragment. Preferably, the antibody fragments contain all six
complementarity
determining regions of the whole antibody, although functional fragments
containing
fewer than all of such regions, such as three, four, or five CDRs, are also
included.
In one aspect, the fragments are single chain antibodies, or Fv fragments.
Single chain antibodies are polypeptides that comprise at least the variable
region of
the heavy chain of the antibody linked to the vaxiable region of the light
chain, with or
without an interconnecting linker. Thus, Fv fragment comprises the entire
antibody
combining site. These chains may be produced in bacteria or in eukaryotic
cells.
The antibodies and functional equivalents may be members of any class of
immunoglobulins, such as IgG, IgM, IgA, IgD, or IgE, and the subclasses
thereof.
In one aspect, the antibodies are members of the IgGl subclass. The functional
equivalents may also be equivalents of combinations of any of the above
classes and
subclasses.
In one aspect, EGFR antibodies can be selected from chimerized, humanized,
fully human, and single chain antibodies derived from the marine antibody 225
described in U.S. Patent No. 4,943,533 to Mendelsohn et al. In one aspect, the
225
derived antibodies have the following hypervariable (CDR) regions of the light
and
heavy chain, wherein the amino acid sequences are indicated below the
nucleotide
sequences:
HEAVY CHAIN HYPERVARIABLE REGIONS (VH):
-9-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
CDRl
AACTATGGTGTACAC (SEQ ID NO: 179)
N Y G V H (SEQ ID NO: 180)
CDR2
GTGATATGGAGTGGTGGAAACACAGACTATAATACACCTTTCACATCC
(SEQ ID NO: 181)
VIWSGGNTDYNTPFTS(SEQIDN0:182)
CDR3
GCCCTCACCTACTATGATTACGAGTTTGCTTAC (SEQ ID NO: 183)
ALTYYDYEFAY(SEQIDN0:184)
LIGHT CHAIN HYPERVARIABLE REGIONS (VL):
CDRl
AGGGCCAGTCAGAGTATTGGCACAAACATACAC (SEQ ID NO: 185)
RASQSIGTNIH(SEQIDN0:186)
CDR2
GCTTCTGAGTCTATCTCT (SEQ ID NO: 187)
A S E S I S (SEQ ID NO: 188)
CDR3
CAACAAAATAATAACTGGCCAACCACG (SEQ ID NO: 189)
Q Q N N N W P T T (SEQ ID NO: 190)
In another aspect, the EGFR antibody can be selected from the antibodies
described in
U.S. Patent No. 6,235,883 to Jakobovits et al., U.S. Patent No. 5,558,864 to
Bendi et
al., and U.S. Patent No. 5,891,996 to Mateo de Acosta del Rio et al.
In addition to the biological molecules discussed above, the EGFR modulators
useful in the invention may also be small molecules. Any molecule that is not
a
biological molecule is considered herein to be a small molecule. Some examples
of
small molecules include organic compounds, organometallic compounds, salts of
organic and organometallic compounds, saccharides, amino acids, and
nucleotides.
Small molecules further include molecules that would otherwise be considered
biological molecules, except their molecular weight is not greater than 450.
Thus,
-10-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
small molecules may be lipids, oligosaccharides, oligopeptides, and
oligonucleotides
and their derivatives, having a molecular weight of 450 or less.
It is emphasized that small molecules can have any molecular weight. They
are merely called small molecules because they typically have molecular
weights less
than 450. Small molecules include compounds that are found in nature as well
as
synthetic compounds. In one embodiment, the EGFR modulator is a small molecule
that inhibits the growth of tumor cells that express EGFR. In another
embodiment,
the EGFR modulator is a small molecule that inhibits the growth of refractory
tumor
cells that express EGFR.
Numerous small molecules have been described as being useful to inhibit
EGFR. For example, U.S. Patent No. 5,656,655 to Spada et al. discloses styryl
substituted heteroaryl compounds that inhibit EGFR. The heteroaryl group is a
monocyclic ring with one or two heteroatoms, or a bicyclic ring with 1 to
about 4
heteroatoms, the compound being optionally substituted or polysubstituted.
U.S. Patent No. 5,646,153 to Spada et al. discloses bis mono and/or bicyclic
aryl heteroaryl, carbocyclic, and heterocarbocyclic compounds that inhibit
EGFR.
U.S. Patent No. 5,679,683 to Bridges et al. discloses tricyclic pyrimidine
compounds that inhibit the EGFR. The compounds are fused heterocyclic
pyrimidine
derivatives described at column 3, line 35 to column 5, line 6.
U.S. Patent No. 5,616,582 to Barker discloses quinazoline derivatives that
have receptor tyrosine kinase inhibitory activity.
Fry et al., Science 265, 1093-1095 (1994) in Figure 1 discloses a compound
having a structure that inhibits EGFR.
Osherov et al. disclose tyrphostins that inhibit EGFR/HERl and HER 2,
particularly those in Tables I, II, III, and IV.
U.S. Patent No. 5,196,446 to Levitzki et al. discloses heteroarylethenediyl or
heteroarylethendeiylaryl compounds that inhibit EGFR, particularly from column
2,
line 42 to column 3, line 40.
Panek et al., Journal of Pharmacology and Experimental Therapeutics 283,
1433-1444 (1997) discloses a compound identified as PD166285 that inhibits the
EGFR, PDGFR, and FGFR families of receptors. PD166285 is identified as 6-(2,6-
-11-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
dichlorophenyl)-2-(4-(2-diethylamirioethyoxy)phenylamino)-8-methyl-8H-
pyrido(2,3-d)pyrimidin-7-one having the structure shown in Figure 1 on page
1436.
BIOMARI~ERS AND BIOMARI~ER SETS
The invention includes individual biomarkers and biomarker sets having both
diagnostic and prognostic value in disease areas in which signaling through
EGFR or
the EGFR pathway is of importance, e.g., in cancers or tumors, in
ixnmunological
disorders, conditions or dysfunction, or in disease states in which cell
signaling and/or
cellular proliferation controls are abnormal or aberrant. The biomarker sets
comprise
a plurality of biomarkers such as, for example, a plurality of the biomarkers
provided
in Table 4 below, that highly correlate with resistance or sensitivity to one
or more
EGFR modulators.
The biomarker sets of the invention enable one to predict or reasonably
foretell the likely effect of one or more EGFR modulators in different
biological
systems or for cellular responses. The biomarker sets can be used in i~ vitro
assays of
EGFR modulator response by test cells to predict ifs vivo outcome. In
accordance
with the invention, the various biomarker sets described herein, or the
combination of
these biomarker sets with other biomarkers or markers, can be used, for
example, to
predict how patients with cancer might respond to therapeutic intervention
with one or
more EGFR modulators.
A biomarker set of cellular gene expression patterns correlating with
sensitivity or resistance of cells following exposure of the cells to one or
more EGFR
modulators provides a useful tool for screening one or tumor samples before
treatment
with the EGFR modulator. The screening allows a prediction of cells of a tumor
sample exposed to one or more EGFR modulators, based on the expression results
of
the biomarker set, as to whether or not the tumor, and hence a patient
harboring the
' tumor, will or will not respond to treatment with the EGFR modulator.
The biomarker or biomarker set can also be used as described herein for
monitoring the progress of disease treatment or therapy in those patients
undergoing
treatment for a disease involving an EGFR modulator.
The biomarkers serve as targets for the development of therapies for disease
treatment. Such targets may be particularly applicable to treatment of breast
disease,
-12-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
such as breast cancers or tumors. Indeed, because these biomarkers are
differentially
expressed in sensitive and resistant cells, their expression patterns are
correlated with
relative intrinsic sensitivity of cells to treatment with EGFR modulators.
Accordingly, the biomarkers highly expressed in resistant cells may serve as
targets
for the development of new therapies for the tumors which are resistant to
EGFR
modulators, particularly EGFR inhibitors.
MICROARRAYS
The invention also includes specialized microarrays, e.g., oligonucleotide
microarrays or cDNA microarrays, comprising one or more biomarkers, showing
expression profiles that correlate with either sensitivity or resistance to
one or more
EGFR modulators. Such microarrays can be employed in in vitro assays for
assessing
the expression level of the biomarkers in the test cells from tumor biopsies,
and
determining whether these test cells are likely to be resistant or sensitive
to EGFR
modulators. For example, a specialized microarray can be prepared using all
the
biomarkers, or subsets thereof, as described herein and shown in Table 4.
Cells from
a tissue or organ biopsy can be isolated and exposed to one or more of the
EGFR
modulators. Following application of nucleic acids isolated from both
untreated and
treated cells to one or more of the specialized microarrays, the pattern of
gene
expression of the tested cells can be determined and compared with that of the
biomarker pattern from the control panel of cells used to create the biomarker
set on
the microarray. Based upon the gene expression pattern results from the cells
that
underwent testing, it can be determined if the cells show a resistant or a
sensitive
profile of gene expression. Whether or not the tested cells from a tissue or
organ
biopsy will respond to one or more of the EGFR modulators and the course of
treatment or therapy can then be determined or evaluated based on the
information
gleaned from the results of the specialized microarray analysis.
ANTIBODIES
The invention also includes antibodies, including polyclonal or monoclonal,
directed against one or more of the polypeptide biomarkers. Such antibodies
can be
used in a variety of ways, for example, to purify, detect, and target the
biomarkers of
-13-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
the invention, including both i~ vitro and ih vivo diagnostic, detection,
screening,
andlor therapeutic methods.
FITS
The invention also includes kits for determining or predicting whether a
patient would be susceptible or resistant to a treatment that comprises one or
more
EGFR modulators. The patient may have a cancer or tumor such as, for example,
a
breast cancer or tumor. Such kits would be useful in a clinical setting for
use in
testing a patient's biopsied tumor or cancer samples, for example, to
determine or
predict if the patient's tumor or cancer will be resistant or sensitive to a
given
treatment or therapy with an EGFR modulator. The kit comprises a suitable
container
that comprises: one or more microarrays, e.g., oligonucleotide microarrays or
cDNA
microarrays, that comprise those biomarkers that correlate with resistance and
sensitivity to EGFR modulators, particularly EGFR inhibitors; one or more EGFR
modulators for use in testing cells from patient tissue specimens or patient
samples;
and instructions for use. In addition, kits contemplated by the invention can
further
include, for example, reagents or materials for monitoring the expression of
biomarkers of the invention at the level of mRNA or protein, using other
techniques
and systems practiced in the art such as, for example, RT-PCR assays, which
employ
primers designed on the basis of one or more of the biomarkers described
herein,
immunoassays, such as enzyme linked immunosorbent assays (ELISAs),
immunoblotting, e.g., Western blots, or ifz situ hybridization, and the like,
as further
described herein.
APPLICATION OF BIOMARI~ERS AND BIOMARI~ER SETS
The biomarkers and biomarker sets may be used in different applications.
Biomarker sets can be built from any combination of biomarkers listed in Table
4 to
make predictions about the likely effect of any EGFR modulator in different
biological systems. The various biomarkers and biomarker sets described herein
can
be used, for example, as diagnostic or prognostic indicators in disease
management, to
predict how patients with cancer might respond to therapeutic intervention
with
compounds that modulate the EGFR, and to predict how patients might respond to
-14-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
therapeutic intervention that modulates signaling through the entire EGFR
regulatory
pathway.
While the data described herein were generated in cell lines that are
routinely
used to screen and identify compounds that have potential utility for cancer
therapy,
the biomarkers have both diagnostic and prognostic value in other diseases
areas in
which signaling through EGFR or the EGFR pathway is of importance, e.g., in
immunology, or in cancers or tumors in which cell signaling and/or
proliferation
controls have gone awry.
In the examples described below, the sensitivity and resistance
classifications
in the twenty two colon cell lines were similar for the two EGFR modulators
tested.
Therefore, the biomarkers of the invention are expected to have both
diagnostic and
prognostic value for other compounds that modulate EGFR or the EGFR signaling
pathways.
Those having skill in the pertinent art will appreciate that the EGFR
signaling
pathway is used and functional in cell types other than cell lines of colon
tissue.
Therefore, the described biomarkers are expected to have utility for
predicting drug
sensitivity or resistance to compounds that interact with or inhibit the EGFR
activity
in cells from other tissues or organs associated with a disease state, or
cancers or
tumors derived from other tissue types. Non-limiting examples of such cells,
tissues
and organs include breast, colon, lung, prostate, testes, ovaries, cervix,
esophagus,
pancreas, spleen, liver, kidney, stomach, lymphocytic and brain, thereby
providing a
broad and advantageous applicability to the biomarkers described herein. Cells
for
analysis can be obtained by conventional procedures as known in the art, for
example,
tissue biopsy, aspiration, sloughed cells, e.g., colonocytes, clinical
or.medical tissue or
cell sampling procedures.
In accordance with the invention, cells from a patient tissue sample, e.g., a
tumor or cancer biopsy, can be assayed to determine the expression pattern of
one or
more biomarkers prior to treatment with one or more EGFR modulators. Success
or
failure of a treatment can be determined based on the biomaxker expression
pattern of
the cells from the test tissue (test cells), e.g., tumor or cancer biopsy, as
being
relatively similar or different from the expression pattern of a control set
of the one or
more biomarkers. Thus, if the test cells show a biomarker expression profile
which
-15-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
corresponds to that of the biomarkers in the control panel of cells which are
sensitive
to the EGFR modulator, it is highly likely or predicted that the individual's
cancer or
tumor will respond favorably to treatment with the EGFR modulator. By
contrast, if
the test cells show a biomarker expression pattern corresponding to that of
the
biomarkers of the control panel of cells which are resistant to the EGFR
modulator, it
is highly likely or predicted that the individual's cancer or tumor will not
respond to
treatment with the EGFR modulator.
The invention also provides a method of monitoring the treatment of a patient
having a disease treatable by one or more EGFR modulators. The isolated test
cells
from the patient's tissue sample, e.g., a tumor biopsy or tumor sample, can be
assayed
to determine the expression pattern of one or more biomarkers before and after
exposure to an EGFR modulator wherein, preferably, the EGFR modulator is an
EGFR inhibitor. The resulting biomarker expression profile of the test cells
before
and after treatment is compared with that of one or more biomarkers as
described and
shown herein to be highly expressed in the control panel of cells that are
either
resistant or sensitive to an EGFR modulator. Thus, if a patient's response is
sensitive
to treatment by an EGFR modulator, based on correlation of the expression
profile of
the one or biomarkers, the patient's treatment prognosis can be qualified as
favorable
and treatment can continue. Also, if, after treatment with an EGFR modulator,
the
test cells don't show a change in the biomarker expression profile
corresponding to the
control panel of cells that are sensitive to the EGFR modulator, it can serve
as an
indicator that the current treatment should be modified, changed, or even
discontinued. Tlus monitoring process can indicate success or failure of a
patient's
treatment with an EGFR modulator and such monitoring processes can be repeated
as
necessary or desired.
The biomarkers of the invention can be used to predict an outcome prior to
having any knowledge about a biological system. Essentially, a biomarker can
be
considered to be a statistical tool. Biomarkers are useful primarily in
predicting the
phenotype that is used to classify the biological system. In an embodiment of
the
invention, the goal of the prediction is to classify cancer cells as having an
active or
inactive EGFR pathway. Cancer cells with an inactive EGFR pathway can be
considered resistant to treatment with an EGFR modulator. An inactive EGFR
-16-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
pathway is defined herein as a non-significant expression of the EGFR or by a
classification as "resistant" or "sensitive" based on the ICSO value of each
colon cell
line to a compound (EGFR inhibitor compound BMS-461453) exemplified herein.
A number of the biomarker described herein are known to be regulated by
EGFR, e.g., mucin 2 (J Biol Chem. 2002 Aug 30;277(35):32258-67). Another
biomarker, betacellulin, is know to be an EGFR ligand (Biochem Biophys Res
Commun. 2002 Jun 28;294(5):1040-6). A functional relationship of the top
biomarkers to the EGFR is expected, since biomarkers that contribute to high
biomarker accuracy are likely to play a functional role in the pathway that is
being
modulated. For example, Perception therapy (i.e., antibody that binds to the
Her2
receptor and prevents function via internalization) is indicated when the Her2
gene is
overexpressed. It is unlikely that a therapy will have any therapeutic effect
if the
target enzyme is not expressed.
However, although the complete function of all of the biomarkers are not
currently known, some of the biomarkers are likely to be directly or
indirectly
involved in the EGFR signaling pathway. In addition, some of the biomarkers
may
function in the metabolic or other resistance pathways specific to the EGFR
modulators tested. Notwithstanding, knowledge about the function of the
biomarkers
is not a requisite for determining the accuracy of a biomarker according to
the practice
of the invention.
DISCOVERY OF BIOMARKERS
An approach has been discovered in which biomarkers were identified whose
expression patterns, in a subset of cell lines, correlated to and can be used
as an ih
vitro marker of cellular response to treatment or therapy with one compound,
or with
a combination or series of compounds, that are known to inhibit or activate
the
function of a protein, enzyme, or molecule (e.g., a receptor) that is directly
or
indirectly involved in cell proliferation, cell responses to external stimuli,
(such as
ligand binding), or signal transduction, e.g., a receptor tyrosine kinase.
Preferred are
antagonists or inhibitors of the function of a given protein, e.g., a receptor
tyrosine
kinase.
-17-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
Two analytical strategies were deployed to discover biomarkers useful for
predicting the sensitivity or resistance of cancer cells to treatment with one
or more
EGFR modulators. FIG. 1 illustrates the EGFR biomarker identification and
prioritization strategy. In one strategy, the mRNA expression level of EGFR
was
used to identify six colon cancer cell lines with, inferred from the mRNA
expression
level, no significant presence of the EGFR protein and hence no significant
activity of
the EGFR pathway (FIG. 2A). In subsequent analyses, biomarkers were identified
that had no significant mRNA expression level in the six cell lines and no
inferred
presence of the EGFR protein. Further, it was required that these biomarkers
would
have a significant mRNA expression level in at least six other cell lines.
In a second strategy, an EGFR specific tyrosine kinase inhibitor compound
was used to determine compound sensitivity in a panel of twenty two colon
cancer
cell lines following exposure of the cells to the compound. Some of the cell
lines
were determined to be resistant to treatment with the inhibitor compound,
while
others were determined to be sensitive to the inhibitor (FIG. 2B). A subset of
the cell
lines examined provided an expression pattern or profile of biomarkers that
correlated
to a response by the cells to the EGFR inhibitor compound as well as the
absence of
significant EGFR expression as thus could serve as biomarkers.
By combining the use of EGFR co-regulation studies in tumor cells with
experimental studies in cultured cells as a model of i~ vivo effects, the
invention
advantageously focuses on cell-intrinsic properties that are exposed in cell
culture to
identify biomarkers that predict compound sensitivity and resistance. The
discovery
and identification of biomaxkers in tumor cells and cell lines assayed i~
vitr°o can be
used to predict responses to one or more EGFR modulators i~ vivo and, thus,
can be
extended to clinical situations in which the same biomarkers axe used to
predict
patients' responses to one or more EGFR modulators and treatments comprising
one
or more EGFR modulators.
As described in the examples below, oligonucleotide microarrays were used to
measure the expression levels of over 44,792 probe sets in a panel of thirty
one
untreated colon cancer cell lines for which the expression status of the EGFR
and the
drug sensitivity to EGFR inhibitor compounds was determined. This analysis was
performed to determine whether the gene expression signatures of untreated
cells
-l~-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
were sufficient for the prediction of sensitivity of the disease to inhibition
of the
EGFR by small molecule or biological molecule compounds. Through data
analysis,
biomarkers were identified whose expression levels were found to be highly
counter-
correlated with the status of the EGFR and correlated with the drug
sensitivity. In
addition, the treatment of cells with a small molecule EGFR inhibitor also
provided
gene expression signatures predictive of sensitivity to the compound.
The means of performing the gene expression and biomarker identification
analyses embraced by the invention is described in further detail and without
limitation below.
ICSO Determination and Phenotype Classification Based on Sensitivity of Twenty-
two
Colon Cancer Cell lines to EGFR Inhibitor Compounds
Twenty two colon cell lines were treated with a small molecule EGFR
inhibitor (BMS-461453) to determine the individual ICSO value. The ICSO for
each cell
line was assessed by MTS assays. The average ICSO values along with standard
deviations were calculated from two to five individual determinations for each
cell
line. As shown in FIG. 2B, a 4-fold variation in the ICSO values was observed
for the
small molecule EGFR inhibitor among the 22 colon cancer cell lines. The ICSO
unit is
~M.
All cell lines with at least a 1.75 fold lower ICSO than the most resistant
cell
lines were considered to be sensitive to treatment with the small molecule
EGFR
inhibitor. FIG. 2B represents the resistance/sensitivity classifications of
the twenty-
two colon cell lines to the small molecule EGFR inhibitor. Five cell lines
were
classified as sensitive and seventeen cell lines as resistant.
Description of the Strategy for Identifying Biomarkers
Biomarkers were discovered based on two criteria: (i) the correlation of their
mRNA expression level to the expression of EGFR in cell lines with
insignificant
EGFR expression and (ii) the correlation of the ICSO values for the small
molecule
EGFR inhibitor BMS-461453 with gene expression levels.
For each of these two biomarker selection strategies, two independent
"discovery" probe set lists were established by using statistical filters with
different
-19-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
stringency levels to identify genes whose expression correlated with either
EGFR
status or ICSO value. These statistical methods are described below and
resulted in
four discovery probe set lists: EGFR-A and EGFR-B (correlation with no
significant
EGFR expression) and IC-50-A, IC-50-B (correlation with ICSO expression), the
A-
lists containing probe sets selected by more stringent conditions. To then
establish
two biomarker probe set lists, probe sets that appeared in both EGFR-A and IC-
50 B
were selected (Biomarker Probe Set List A, Table 2) and probe sets that
appeared in
both EGFR-B and IC-50-A were selected (Biomarker Probe Set List B, Table 3).
Identifying Genes that Significantly Correlate with EGFR status classification
RT-PCR expression data for EGFR were obtained from thirty one colon
cancer cell lines and six cell lines with a significantly lower expression
level of EGFR
compared to the other cell lines were identified as described in Example 1
below.
(FIG. 2A). Expression profiling data of 44,792 probe sets represented on the
HG-
U133 array set for all thirty one untreated colon cancer cell lines were
obtained and
analyzed for the identification of probe sets which would be correlated with
the above
described six cell lines with no significant mRNA expression of EGFR. For the
discovery probe set list EGFR-A, all probe sets which were judged to be absent
by the
Affymetrix Mas 5.0 software in six of the six colon cancer cell lines with
significantly
lower expression of EGFR were identified. Second, it was required that these
probe
sets would be judged to be present in at least six cell lines of the twenty
five cell lines
classified as having significant mRNA expression of the EGFR. This analytical
strategy resulted in the identification of 280 probe sets that could be
analyzed in
comparison to the discovery probe set list IC-50-B.
The discovery probe set list EGFR-B was generated by selecting all probe sets
which were judged to be absent by the Affymetrix Mas 5.0 software in five of
the six
colon cancer cell lines with significantly lower expression of EGFR and which
would
be present in at least six cell lines of the twenty five cell lines classified
as having
significant mRNA expression of the EGFR. Discovery probe set list EGR-B
contains
1,852 probe sets (LJ133A: 876; U133B: 976).
-20-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
Identifying Genes that Significantly Correlate with Drug
Resistance/Sensitivity
Classification
Expression profiling data of 44,792 probe sets represented on the HG-U133
array set far twenty two untreated colon cell lines were obtained and
preprocessed as
described in Example 1 below. These data were analyzed using the Student's
TTEST
to identify genes whose expression patterns were strongly correlated with the
drug
resistance/sensitivity classification. Table 1 provides the
resistance/sensitivity
phenotype classification of the twenty two colon cell lines for the EGFR
antagonist
BMS-461453 based on the ICSO results. The mean ICSO values along with standard
deviations (SD) were calculated from 2 to 5 individual determinations for each
cell
line as shown. The mean ICSO across the twenty two colon cell lines for BMS-
461453
was calculated and used to normalize the ICSO data for each cell line. A11
cell lines
with at least a 1.75 fold lower ICSO than the most resistant cell lines were
considered
to be sensitive to treatment with BMS-461453. The cell lines designated with
an
asterisk are defined as being sensitive to the drug treatment.
-21-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
TABLE 1 - Resistance/Sensitivity Phenotype Classification of Twenty Two Colon
Cell Lines
Cell lines ICso SD


CCD 33C0* 2 1.28


LOVO* 2.3 2.28


LSI 74T* 3.5 1.93


Caco2* 5.5 3.97


SW403 * 5.7 4.94


CCDIBCo 7.1 3.84


SW837 7.2 3.30


Sk-Co-1 9 2.02


MIP 9.7 0.52


SW1417 10 0.00


HT-29 10 0.00


T84 10 0.00


CX-1 10 0.00


Colo-205 10 0.00


Colo-201 10 0.00


Co1o320HSR 10 0.00


HCT8 10 0.00


Co1o320DM 10 0.00


SW480 10 0.00


HCT116 10 0.00


SW620 10 0.00


HCTl 165542 10 0.00


An "idealized expression pattern" corresponds to a gene that is uniformly high
in one
class (e.g., sensitive) and uniformly low in the other (e.g., resistant).
Initially, a
Student TTEST was performed in which a T value was obtained for each probe
set.
Once a T value was generated, its corresponding confidence value (P) was found
on a
standard table of significance. The confidence value is a measure of the
probability to
observe a certain mean expression difference between two groups by chance
alone
and is obtained using the following formula:
-22-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
T(g.C) _ (Xl - X2) / ( Varl/nl '+' Var2/n2)1l2
wherein,
T(g,c) represents the T value between expression for gene g and the
sensitivity/resistance classification c;
Xl represents mean gene expression level of samples in class 1;
X2 represents mean gene expression level of samples in class 2;
varl represents variance of gene expression for samples in class 1;
var,~ represents variance of gene expression for samples in class 2;
nl represents number of samples in class 1;
nz represents number of samples in class 2; and
corresponding confidence value (P) for T values are obtained from a standard
table of
significance.
To generate discovery probe set list IC-50-B, a confidence value of 0.05 or
lower was used as the cut off for probe sets to be included in the list.
Discovery probe
set list IC-50-B contains 5,050 probe sets (LT133A: 2,498; U133B: 2,552).
Discovery probe set list IC-50-A was generated using the Pearson correlation
coefficient (a dimensionless index that ranges from -1.0 to 1.0). This value
was
calculated by treating the IC50 data as continuous variables and by utilizing
a lineax
regression model to correlate gene expression levels with ICSO values for
twenty-two
colon cell lines. Probe sets with a correlation coefficient less than -0.5
were selected
(p <0.02), a total of 902 probe sets (LT133A: 467; U133B: 435).
Finally, two separate biomarker probe set lists were generated, biomarker
probe set lists A and B, by identifying probe sets which were present in EGFR-
A and
IC-50-B (Biomarker Probe Set List A) (Table 2) or were present in EGFR-B and
IC-
50-A (Biomarker Probe Set List B) (Table 3).
The biomarker probe set list A (Table 2) contains a total of 74 probe sets
(U133A: 43; U133B: 31) and provides the polynucleotides identified to be
biomarkers
of EGFR antagonist sensitivity employing strategy A. With strategy A,
polynucleotides were required to satisfy a stringent criteria for EGFR status
coregulation and a less stringent condition for correlation to IC$o values.
Namely, the
polynucleotides had to be called absent by the Affymetrix software in six out
of the
- 23 -



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
six cell lines with lowest expression of EGFR and be differentially expressed
in the
sensitive and resistance cell lines with a P value equal to or less than 0.05.
TABLE 2 - Biomarker Probe Set List A
Unigene TitleAffymetrix Description Affymetrix


robe set


hemoglobin, gb:BC005931.1 /DEF=Homo Sapiens, 211745 x
at


alpha 1 hemoglobin, alpha 2, clone MGC:14541,
mRNA,


complete cds. /FEA=mRNA


/PROD=hemoglobin, alpha 2


/DB XREF= 1:13543547 /FL= b:BC005931.1


dipeptidylpeptidagb:M80536.1 /DEF=H.sapiens dipeptidyl203716 s_at


se IV (CD26, peptidase IV (DPP4) mRNA, complete
cds.


adenosine /FEA=mRNA /GEN=DPP4 /PROD=dipeptidyl


deaminase peptidase IV /DB XREF=gi:181569


complexing /IJG=Hs.44926 dipeptidylpeptidase
IV (CD26,


protein 2) adenosine deaminase complexing protein
2)


/FL= b:M80536.1 gb:NM 001935.1


spondin 1, Consensus includes gb:AI885290 /FEA=EST213994~s
(f at


spondin) /DB XREF=gi:5590454


extracellular/DB XREF=est:w192a04.x1


matrix protein/CLONE=IMAGE:2432334 /UG=Hs.5378


spondin 1, (f spondin) extracellular
matrix


protein


3-hydroxy-3- gb:NM 005518.1 /DEF=Homo sapiens 204607 at
3-


methylglutaryl-hydroxy-3-methylglutaryl-Coenzyme
A synthase


Coenzyme A 2 (mitochondrial) (HMGCS2), mRNA.


synthase 2 /FEA=mRNA /GEN=HMGCS2 /PROD=3-


(mitochondrial)hydroxy-3-methylglutaryl-Coenzyme
A synthase


2(mitochondrial) /DB XREF=gi:5031750


/LTG=Hs.59889 3-hydroxy-3-methylglutaryl-


Coenzyme A synthase 2 (mitochondrial)


/FL= b:NM 005518.1


mucin 2, gb:NM 002457.1 /DEF=Homo sapiens 204673 at
mucin 2,


intestinal/tracheaintestinaltracheal (MUC2), mRNA.1FEA=mRNA


1 /GEN=MUC2 /PROD=mucin 2, intestinaltracheal


/DB XREF=gi:4505284 /LTG=Hs.315
mucin 2,


intestinaltracheallFL=gb:NM 002457.1


gb:L21998.1


cystic fibrosisgb:NM_000492.2 /DEF=Homo Sapiens 205043 at
cystic


transmembranefibrosis transmembrane conductance
regulator,


conductance ATP-binding cassette (sub-family
C, member 7)


regulator, (CFTR), mRNA. /FEA=mRNA /GEN=CFTR
ATP-


binding cassette/PROD=cystic fibrosis transmembrane


(sub-family conductanceregulator, ATP-binding
C, cassette (sub-


member 7) family C, member 7) /DB XRFF= 1:6995995


-24-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
/LTG=Hs.663 cystic fibrosis transmembrane


conductance regulator, ATP-binding
cassette


(sub-family C, member 7) /FL=gb:NM
000492.2


CUG triplet Consensus includes gb:N36839 /FEA=EST202156 s_at


repeat, RNA- lDB XRFF=gi:1157981
i


binding proteinXREF=est:yy35~7.s1
2 /DB


/CLONE=IMAGE:273253 /UG=Hs.211610
CUG


triplet repeat, RNA-binding protein
2


!FL=gb:U69546.1 gb:AF036956.1


gb:AF090694.1 b:NM 006561.1


nuclear receptorgb:NM_000901.1 /DEF=Homo Sapiens 205259 at
nuclear


subfamily receptor subfamily 3, group C, member
3, 2


group C, member(NR3C2), mRNA. /FEA=mRNA /GEN NR3C2


2 /PROD=nuclear receptor subfamily
3, group C,


member 2 !DB XREF=gi:4505198 /LJG=Hs.1790


nuclear receptor subfamily 3, group
C, member 2


/FL=gb:M16801.1 gb:NM 000901.1


cystic fibrosisConsensus includes gb:W60595 /FEA=EST215702~s
at


transmembrane/DB XREF=gi:1367354


conductance /DB XREF=est:zc91b04.s1


regulator, /CLONE=IMAGE:338479 /LTG=Hs.663
ATP- cystic


binding cassettefibrosis transmembrane conductance
regulator,


(sub-family ATP-binding cassette (sub-family
C, C, member 7)


member 7)


cytochrome gb:NM 000775.1 /DEF=Homo Sapiens 205073 at


P450, subfamilycytochrome P450, subfamily IIJ (arachidonicd
aci


IIJ (arachidonicepoxygenase) polypeptide 2 (CYP2J2),
mRNA.


acid /FEA=mRNA IGEN=CYP2J2


epoxygenase) /PROD=cytochrome P450, subfamily
IIJ


polypeptide (arachidonic acidepoxygenase) polypeptide
2 2


/DB XREF=gi:4503226 /UG=Hs.152096


cytochrome P450, subfamily IIJ (arachidonic
acid


epoxygenase) polypeptide 2 /FL=gb:U37143.1


b:NM 000775.1


cystatin S gb:NM 001899.1 /DEF=Homo Sapiens 206994 at
cystatin S


(CST4), mRNA. /FEA=mRNA /GEN=CST 4


/PROD=cystatin S /DB XREF=gi:4503108


/LTG=Hs.56319 cystatin S /FL=gb:NM
001899.1


spondin 1, Consensus includes gb:AI885290 /FEA=EST213993 at
(f


spondin) lDB_XREF=gi:5590454


extracellularlDB XREF=est:w192a04.x1


matrix protein/CLONE=IMAGE:2432334 /UG=Hs.5378


spondin 1, (f spondin) extracellular
matrix


rotein


fibroblast 022969.1 /DEF=Homo sapiens fibroblast203638 s_at
growth gb:NM


factor receptor_ d
2 growth factor receptor 2 (bacteria-expresse


(bacteria- kinase, keratinocyte growth factor
receptor,


ex ressed craniofacial dysostosis 1, Crouzon
kinase, syndrome,


-25-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
keratinocyte Pfeiffer syndrome, Jackson-Weiss
syndrome)


growth factor(FGFR2), transcript variant 2, mRNA.


receptor, /FEA=mRNA /GEN=FGFR2 /PROD=fibroblast


craniofacial growth factor receptor 2, isoform
2precursor


dysostosis lDB_XREF=gi:131862521LJG=Hs.278581
l,


Crouton fibroblast growth factor receptor
2 (bacteria-


syndrome, expressed kinase, keratinocyte growth
factor


Pfeiffer receptor, craniofacial dysostosis
1, Crouton


syndrome, syndrome, Pfeiffer syndrome, Jackson-Weiss


Jackson-Weisssyndrome) /FL=gb:NM 022969.1 gb:M97193.1


syndrome) gb:M80634.1


mucin 3B Consensus includes gb:AB038783.1 214898 x
lDEF=Homo at


sapiens MUC3B mRNA for intestinal
mucin,


partial cds. /FEA=mRNA /GEN=MUC3B


JPROD=intestinal mucin !DB XREF=gi:9929917


/LJG=Hs.129782 mucin 3A, intestinal


AA Consensus includes gb:AV728958 /FEA=EST212703 at


/DB_~REF=gi:10838379


/DB XREF=est:AV728958


/CLONE=HTCBYF04 /LJG=Hs.150443


KIAA0320 rotein


CUG triplet gb:NM 006561.1 /DEF=Homo Sapiens 202158 s_at
CUG


repeat, RNA- triplet repeat, RNA-binding protein
2 (CUGBP2),


binding proteinmRNA. /FEA=mRNA /GEN=CUGBP2
2


/PROD=CUG triplet repeat, RNA-binding
protein


2 /DB XREF=gi:5729815 /UG=Hs.211610
CUG


triplet repeat, RNA-binding protein
2


/FL=gb:U69546.1 gb:AF036956.1


gb:AF090694.1 gb:NM 006561.1


spondin 1, gb:AB051390.1 /DEF=Homo Sapiens 209437_s_at
(f mRNA for


spondin) VSGPF-spondin, complete cds. IFEA=mRNA


extracellular/PROD=VSGPF-spondin


matrix protein/DB XREF=gi:l 1320819 /LJG=Hs.5378
spondin


1, (f spondin) extracellular matrix
protein


/FL= b:AB051390.1


mucin 3B Consensus includes gb:AF113616 /DEF=Homo214676 x
at


sapiens intestinal mucin 3 (MUC3)
gene, partial


cds /FEA=mRNA /DB_XREF=gi:6466800


/UG=Hs.129782 mucin 3A, intestinal


EphAl gb:NM 005232.1 /DEF=Homo Sapiens 205977 s_at
EphAl


(EPHA1), mRNA. /FEA=mRNA /GEN=EPHAl


/PROD=EphAl /DB_~REF=gi:4885208


/LJG=Hs.89839 EphAl /FL=gb:M18391.1


b:NM 005232.1


matrilin 3 gb:NM_002381.2 /DEF=Homo Sapiens 206091 at
matrilin 3


(MATN3) precursor, mRNA. /FEA=mRNA


/GEN=MATN3 /PROD=matrilin 3 precursor


/DB ~~REF= 1:13518040 /LTG=Hs.278461


-26-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
matrilin 3 /FL=gb:NM 002381.2


bone 001200.1 /DEF=Homo sapiens bone 205290 s_at
gb:NM


morphogenetic_
morphogenetic protein 2 (BMP2),
mRNA.


protein 2 /FEA=mRNA /GEN=BMP2 /PROD=bone


morphogenetic protein 2 precursor


/DB XREF=gi:4557368 /UG=Hs.73853
bone


mo hogenetic rotein 2 /FL=gb:NM
001200.1


interferon Consensus includes gb:A1073984 /FEA=EST204057 at


consensus /DB_~~REF=gi:3400628


sequence binding/DB XREF=est:oy66cO5.x1


protein 1 /CLONE=IMAGE:1670792 lUG=Hs.14453


interferon consensus sequence binding
protein 1


/FL= b:M91196.1 gb:NM 002163.1


retinoic acidConsensus includes gb:AI669229 /FEA=EST221872~at


receptor /DB XREF=gi:4834003


responder /DB XREF=est:wc13e06.x1


(tazarotene /CLONE=IMAGE:2315074 /LTG=Hs.82547


induced) 1 retinoic acid receptor responder
(tazarotene


induced) 1


cystic fibrosisConsensus includes gb:W60595 /FEA=EST215703 at


transmembranelDB_XREF=gi:1367354


conductance /DB XREF=est:zc91b04.s1


regulator, /CLONE=IMAGE:338479 /LTG=Hs.663
ATP- cystic


binding cassettefibrosis transmembrane conductance
regulator,


(sub-family ATP-binding cassette (sub-family
C, C, member 7)


member 7)


fibroblast gb:M87771.1 IDEF=Human secreted 208228 s
growth fibroblast at


factor receptorgrowth factor receptor (K-sam-III)
2 mRNA,


(bacteria- complete cds. /FEA=mRNA /GEN=K-sam-III


expressed /PROD=fibroblast growth factor receptor
kinase,


keratinocyte fDB_XREF=gi:1867811UG=Hs.278581


growth factorfibroblast growth factor receptor
2 (bacteria-


receptor, expressed kinase, keratinocyte growth
factor


craw ofacial receptor, craniofacial dysostosis
1, Crouzon


dysostosis syndrome, Pfeiffer syndrome, Jackson-Weiss
1,


Crouzon syndrome) /FL=gb:NM 022970.1 gb:M87771.1


syndrome,


Pfeiffer


syndrome,


Jackson-Weiss


syndrome)


myosin, heavygb:NM_003802.1 /DEF=Homo sapiens 208208 at
myosin,


polypeptide heavy polypeptide 13, skeletal muscle
13, (MYH13),


skeletal musclemRNA. /FEA=mRNA /GEN=MYH13


/PROD=myosin, heavy polypeptide
13, skeletal


muscle /DB XREF=gi:11321578


/LTG=Hs.278488 myosin, heavy polypeptide
13,


skeletal muscle /FL= b:NM 003802.1


-27-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gb:AF 111782.2


ESTs, Weakly Consensus includes gb:AW675655 /FEA=EST222354 at


similar to /DB XREF=gi:7540890
138022


hypothetical /DB XREF=est:ba52e01.x1


protein /CLONE=IMAGE:2900184 /UG=Hs.314158


[H.sa iens ESTs


hypothetical gb:NM 017699.1 /DEF=Homo sapiens 219734 at


protein hypothetical protein FLJ20174 (FLJ20174),


FLJ20174 mRNA. /FEA=mRNA /GEN=FLJ20174


/PROD=hypothetical protein FLJ20174


/DB XREF=gi:8923170 /UG=Hs.114556


hypothetical protein FLJ20174


/FL=gb:NM 017699.1


PTPRF Consensus includes gb:AI692180 /FEA=EST212841 s_at


interacting /DB XREF=gi:4969520


protein, binding/DB XREF=est:Wd37fl76.x1


protein 2 /CLONE=IMAGE:2330339 /UG=Hs.12953
(liprin


beta 2) PTPRF interacting protein, binding
protein 2


(li rin beta 2)


ribonuclease,gb:NM 002933.1 IDEF=Homo sapiens 201785 at


RNase A family,ribonuclease, RNase A family, 1 )
(pancreatic


1 (pancreatic)(RNASE1), mRNA. /FEA=mRNA


/GEN=RNASE1 /PROD=ribonuclease,
RNase A


family, 1 (pancreatic) /DB XREF=gi:4506546


/LTG=Hs.78224 ribonuclease, RNase
A family, 1


(pancreatic) /FL=gb:BC005324.1


gb:NM 002933.1 gb:D26129.1


hairless (mouse)O18411.1 lDEF=Homo Sapiens hairless220163 s
gb:NM at


homolog _
protein (putative single zinc finger
transcription


factor protein, responsible for
autosomal


recessive universal congenital alopecia,
HR gene)


(HSA277165), mRNA. /FEA=mRNA


/GEN=HSA277165 /PROD=hairless protein


/DB XREF=gi:11036651 /UG=Hs.272367


hairless protein (putative single
zinc finger


transcription factor protein, responsible
for


autosomal recessive universal congenital


alopecia, HR ene) /FL=gb:NM 018411.1


nuclear receptorConsensus includes gb:AF228413.1 210174 at
/DEF=Homo


subfamily sapiens hepatocyte transcription
5, factor mRNA,


group A, 3UTR. /FEA=mRNA /DB XREF=gi:7677372


member 2 /UG=Hs.l 83123 nuclear receptor
subfamily 5,


group A, member 2 /FL=gb:U93553.1


b:AB019246.1 gb:AF124247.1


superoxide gb:NM 003102.1 /DEF=Homo Sapiens 205236 x
at


dismutase superoxide dismutase 3, extracellular
3, (SOD3),


extracellularmRNA. /FEA=mRNA /GEN=SOD3


/PROD=su eroxide dismutase 3, extracellular


-28-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
/DB XR.EF=gi:4507150 /UG=Hs.2420


superoxide dismutase 3, extracellular


/FL= b:J02947.1 b:NM 003102.1


zinc finger gb:NM 003438.1 /DEF=Homo sapiens 207394~at
zinc


protein 137 finger protein 137 (clone pHZ-30)
(ZNF137),


(clone pHZ-3 mRNA. /FEA=mRNA /GEN=ZNF 13 7
0)


/PROD=zinc finger protein 137 (clone
pHZ-30)


/DB XREF=gi:4507988 /LTG=Hs.151689
zinc


finger protein 137 (clone pHZ-30)


/FL=gb:NM 003438.1 gb:U09414.1


Homo Sapiens Consensus includes gb:AL049983.1 217288_at
/DEF=Homo


mRNA; cDNA sapiens mRNA; cDNA DKFZp564D042
(from


DKFZp564D042 clone DKFZp564D042). /FEA=mRNA


(from clone /DB XREF=gi:4884234 /UG=Hs.240136
Homo


DKFZp564D042 sapiens mRNA; cDNA DI~FZp564D042
(from


clone DI~FZ 564D042)


Hermansky- Consensus includes gb:AL022313 /DEF=Human217354 s
at
_


Pudlak syndromeDNA sequence from clone RPS-1119A7
on


chromosome 22q12.2-12.3 Contains
the TXN2


gene for mitochondria) thioredoxin,
a novel gene,


the EIF3S7 gene for eukaryotic translation


initiation factor 3 subunit 7 (zeta,
6667kD) (EIF3-


P66), the gene f... /FEA=CDS 3


/DB XREF=gi:4200326 /UG=Hs.272270
Human


DNA sequence from clone RPS-1119A7
on


chromosome 22q12.2-12.3 Contains
the TXN2


gene for mitochondria) thioredoxin,
a novel gene,


the EIF3S7 gene for eukaryotic translation


initiation factor 3 subunit 7 (zeta,
6667kD) (EIF3-


P66), the ene for a nov


peroxisomal 018441.1 /DEF=Homo sapiens 221142 s_at
gb:NM


traps 2-enoyl_
peroxisomal traps 2-enoyl CoA reductase;


CoA reductase;putative short chain alcohol dehydrogenase


putative short(HSA250303), mRNA. /FEA=mRNA


chain alcohol/GEN=HSA250303 /PROD~eroxisomal
traps 2-


dehydrogenaseenoyl CoA reductase;putative short
chain alcohol


dehydrogenase /DB XREF=gi:8923751


/UG=Hs.281680 peroxisomal traps
2-enoyl CoA


reductase; putative short chain
alcohol


dehydrogenase lFL=gb:NM 018441.1


BTG family gb:NM 006763.1 /DEF=Homo sapiens 201236 s
BTG at


, family, member 2 (BTG2), mRNA. /FEA=mRNA
member 2


/GEN=BTG2 (PROD=BTG family, member
2


/DB XREF=gi:5802987 /UG=Hs.75462
BTG


family, member 2 /FL=gb:U72649.1


gb:NM 006763.1


phosducin gb:M33478.1 /DEF=Human 33-kDa 211496 s_at


hototransducing rotein mRNA, com
lete cds.


_29_



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
/FEA=mRNA /DB_XREF=gi:177186


/UG=Hs.550 phosducin /FL=gb:NM 022577.1


gb:M33478.1 gb:AF076465.1


Rho GTPase gb:NM_015366.1 /DEF=Homo Sapiens 205980 s
Rho at


activating GTPase activating protein 8 (ARHGAPB),
protein


g mRNA. /FEA=mRNA 1GEN=ARHGAP8


/PROD=Rho GTPase activating protein
8


/DB XREF=gi:7656903 /UG=Hs.102336
Rho


GTPase activating protein 8


/FL= b:NM 015366.1


Homo sapiens Consensus includes gb:AW593996 /FEA=EST213256~at


clone 24707 /DB XREF=gi:7281254


mRNA sequence/DB XREF=est:hg41g06.x1


/CLONE=IMAGE:2948218 /UG=Hs.124969


Homo sa iens clone 24707 mRNA se
uence


caspase 10, gb:NM 001230.1 /DEF=Homo sapiens 205467 at
caspase


apoptosis-related10, apoptosis-related cysteine protease


cysteine protease(CASP 10), mRNA. /FEA=mRNA


/GEN=CASP10 /PROD=caspase 10, apoptosis-


related cysteine protease /DB XREF=gi:4502568


/LTG=Hs.5353 caspase 10, apoptosis-related


cysteine protease 1FL=gb:U60519.1


gb:NM 001230.1


KIA.A0690 Consensus includes gb:AK000238.1 216360 x
/DEF=Homo at


protein Sapiens cDNA FLI20231 fis, clone
COLF5511,


highly similar to AB014590 Homo
sapiens


mRNA for I~IAA0690 protein. /FEA=mRNA


/DB XREF=gi:7020188 !UG=Hs.60103


KIAA0690 protein


Homo sapiens ; Consensus includes gb:AW001287 227676 at
/FEA=EST


Similar to /DB XREF=gi:5848203


RII~EN cDNA /DB XREF=est:wu27e06.x1


1810037020 /CLONE=IMAGE:2521282 /LTG=Hs.61265


gene, clone ESTs, Weakly similar to G786_HUMAN


MGC:21481 PROTEIN GS3786 H.sapiens


IMAGE:385206


2, mRNA,


com lete cds


ESTs Consensus includes gb:AA581439 /FEA=EST244650 at
-


/DB XREF=gi:2359211


/DB XREF=est:nh13c10.s1


/CLONE=IMAGE:952242 /UG=Hs.152328


ESTs


ESTs Consensus includes gb:AI739241 /FEA=EST238984 at
-


/DB XREF=gi:5101222


/DB XREF=est:wi14h02.x1


(CLONE=IMAGE:2390259 /LTG=Hs.171480


ESTs


-30-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
hypothetical Consensus includes gb:AB046810.1 232083~at
/I7EF=Homo


protein Sapiens mRNA for I~IAA1590 protein,
partial


FLJ23045 cds. /FEA=mRNA /GEN=I~IA.A1590


/PROD=KIAA1590 protein


/DB XREF=gi:100472541UG=Hs.101774


h othetical rotein FLJ23045


regenerating gb:AY007243.1 /DEF=Homo sapiens 223447 at


gene type regenerating gene type IV mRNA,
IV complete cds.


/FEA=mRNA (PROD=regenerating gene
type IV


/DB XREF=gi:12621025 /LTG=Hs.105484
Homo


sapiens regenerating gene type IV
mRNA,


com fete cds lFL=gb:AY007243.1


ESTs Consensus includes gb:AI139990 /FEA=EST231022 at


/DB XREF=gi:3647447


/DB XREF=est:qa47d03.x1


/CLONE=IMAGE:1689893 /LTG=Hs.134586


ESTs


ESTs Consensus includes gb:AI733801 /FEA=EST237923 at


/DB XREF=gi:5054914


/DB XREF=est:qk39c04.x5


(CLONE=IMAGE:1871334 IIJG=Hs.146186


ESTs


hypothetical Consensus includes gb:AI~002203.1 226992 at
/DEF=Homo


protein sapiens cDNA FLJ11341 fis, clone


MGC20702 PLACE1010786. /FEA=mRNA


/DB XREF=gi:7023932 /LJG=Hs.10260
Homo


Sapiens cDNA FLJ11341 fis, clone


PLACEl010786


ESTs, Weakly Consensus includes gb:AI457984 /FEA=EST243729 at


similar to /DB XREF=gi:4312002


ALU1_HUMAN /DB XREF=estaj66a04.x1


ALU /CLONE=IMAGE:2146446 /UG=Hs.165900


SUBFAMILY ESTs, Weakly similar to ALUC_HUMAN
J ! ! ! !


SEQUENCE ALU CLASS C WARNING ENTRY ! ! !


CONTAMINAT H.sapiens


ION WARNING


ENTRY


[H.sa iens]


Homo Sapiens Consensus includes gb:T86159 /FEA=EST227724 at


cDNA: lDB_xR.EF=gi:714511


FLJ22063 fis,/DB XREF=est:yd84h07.s1


clone HEP10326/CLONE=IMAGE:114973 /UG=Hs.10450


Homo sapiens cDNA: FLJ22063 fis,
clone


HEP 103 26


ESTs Consensus includes gb:AI806131 /FEA=EST231148 at


/DB XREF=gi:5392697


/DB XREF=est:wf06c06.x1


/CLONE=IMAGE:2349802 /UG=Hs.99376


-31-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ESTs


_
anterior gradientConsensus includes gb:AI922323 /FEA=EST228969 at


2 (Xenepus lDB_~~REF=gi:5658287


laevis) homolog/DB XREF=est:wn90h03.x1


/CLONE=IMAGE:2453141 /UG=Hs.293380


ESTs


ESTs Consensus includes gb:AI493909 /FEA=EST235562 at


/DB XRFF=gi:4394912


!DB_~~REF=est:qz94e02.x1


/CLONE=IMAGE:2042234 /UG=Hs.6131
ESTs


hypothetical Consensus includes gb:AI339568 /FEA=EST222727 s
at


protein /DB_~~REF=gi:4076495


FLJ22233 /DB XREF=est:qk67e10.x1


/CLONE=IMAGE:1874058 /UG=Hs.286194


hypothetical protein FLJ22233


/FL=gb:NM 024959.1


GaINAc alpha-2,Consensus includes gb:Y11339.2 /DEF=Homo227725 at


6- sapiens mRNA for GaINAc alpha-2,
6-


sialyltransferasesialyltransferase I, long form.
/FEA=mRNA


I, long form /PROD=GaINAc alpha-2,6-sialyltransferase
I


/DB XREF=gi:75762751UG=Hs.105352


GaINAc al ha-2, 6-sialyltransferase
I, long form


ESTs Consensus includes gb:AI917390 /FEA=EST240964 at


/DB XREF=gi:5637245


IDB_XREF=estas79a05 .x 1


/CLONE=IMAGE:2237456 /UG=Hs.99415


ESTs


Homo Sapiens Consensus includes gb:AI~026404.1 232321 at
/DEF=Homo


cDNA: sapiens cDNA: FLJ22751 fis, clone
KAIA0483,


FLJ22751 fis,highly similar to AF016692 Homo
Sapiens small


clone intestinal mucin (MLTC3) mRNA. /FEA=mRNA


KAIA0483, /DB_~~REF=gi:10439257 /UG=Hs.271819
Homo


highly similarsapiens cDNA: FLJ22751 fis, clone
to I~AIA0483,


AF016692 Homohighly similar to AF016692 Homo
sapiens small


sapiens smallintestinal mucin (MUC3) mRNA


intestinal
mucin


(MLTC3) mRNA


Homo Sapiens Consensus includes gb:AK026984.1 229021 at
/DEF=Homo


cDNA: Sapiens cDNA: FLJ23331 fis, clone
HEP12664.


FLJ23331 fis,/FEA=mRNA /DB_XREF=gi:10439980


clone HEP12664/UG=Hs.50742 Homo Sapiens cDNA:
FLJ23331


fis, clone HEP 12664


ESTs Consensus includes gb:AA827649 /FEA=EST235515 at


/DB XR.EF=gi:2900090


/DB XREF=est:od01a12.s1


/CLONE=IMAGE:1357918 /UG=Hs.105317


ESTs


rostate cancerConsensus includes b:AA633076 /FEA=EST226167 at


-32-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
associated /DB XREF=gi:2556490


protein 7 /DB_~REF=est:nq38a06.s1


/CLONE=IMAGE:l 146130 /UG=Hs.27495


rostate cancer associated rotein
7


ESTs Consensus includes gb:N37023 /FEA=EST225407 at


/DB XREF=gi:1158165


/DB XREF=est:yy40d03.s1


(CLONE=IMAGE:273701 /UG=Hs.235883


ESTs


ESTs, Weakly Consensus includes gb:AI864053 /FEA=EST235678 at


similar to lDB XREF=gi:5528160
I38588


reverse /DB_XREF=est:wj S Shl0.x1


transcriptase/CLONE=IMAGE:2406787 /UG=Hs.39972


homolog ESTs, Weakly similar to I38588 reverse


[H.sa iens transcri tase homolog H.sa iens


ESTs, Weakly Consensus includes gb:AA557324 /FEA=EST227702 at


similar to /DB XREF=gi:2327801


JX03311aurate!DB XREF=est:n181a02.s1


omega- /CLONE=IMAGE:1057034 /UG=Hs.26040


hydroxylase ESTs, Weakly similar to fatty acid
omega-


[H.sa fens] hydroxylase H.sa iens


ESTs Consensus includes gb:BF594323 /FEA=EST238103 at


/DB X_RFF=gi:11686647


JDB XREF=est:7h79g07.x1


/CLONE=IMAGE:3322236 /LJG=Hs.158989


ESTs


ESTs, Weakly Consensus includes gb:AI827789 /FEA=EST228241 at


similar to /DB XREF=gi:5448449


JE0350 Anterior/DB XREF=est:wf33a07.x1


gradient-2 /CLONE=IMAGE:2357364 /UG=Hs.100686


[H.sapiens] ESTs, Weakly similar to JE0350 Anterior


adient-2 H.sa iens


ESTs Consensus includes gb:AI968097 /FEA=EST237835 at


/DB XREF=gi:5764915


/DB XREF=est:wu13a12.x1


/CLONE=IMAGE:2516830 /UG=Hs.131360


ESTs


ESTs Consensus includes gb:H05025 /FEA=EST241874 at


/DB XREF=gi:868577


/DB XREF=est:yl74g12.s1


/CLONE=IMAGE:43864 /UG=Hs.323767
ESTs


Homo sapiens,Consensus includes gb:AA524690 /FEA=EST226168 at


Similar to /DB XREF=gi:2265618


RII~EN cDNA /DB_~~REF=est:ng38e07.s1


1110060018 /CLONE=IMAGE:937092 /UG=Hs.294143


gene, clone ESTs, Weakly similar to predicted
using


MGC:17236 Genefinder C.elegans


IMAGE:3 86413


- 33 -



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
7, mRNA,


com fete cds


ESTs Consensus includes gb:AI300126 /FEA=EST240830 at


/DB XREF=gi:3959472


/DB XREF=est:qn54IU2.x1


/CLONE=IMAGE:1902075 /UG=Hs.257858


ESTs


Homo sapiens Consensus includes gb:AA129774 /FEA=EST227019~at


cDNA FLJ13137/DB XREF=gi:1690185


fis, clone /DB XREF=est:z116h09.s1


NT2RP3003150 /CLONE=IMAGE:502145 /UG=Hs.288905


Homo sapiens cDNA FLJ13137 fis,
clone


NT2RP3003150


ESTs Consensus includes gb:AW024656 /FEA=EST242358 at


!DB XREF=gi:5878186


/DB XREF=est:wu78hO5.x1


/CLONE=IMAGE:2526201 /UG=Hs.233382


ESTs, Moderately similar to AF119917
62


PR02822 H.sapiens


The biomarker probe set list B (Table 3) contains 95 probe sets (U133A: 47;
U133B 48). The biomarker probe set list B contains polynucleotides identified
to be
biomarkers of EGFR antagonist sensitivity employing strategy B. In strategy B,
polynucleotides were required to satisfy a stringent criteria for correlation
to IC$o
values and a less stringent condition for EGFR status coregulation. Namely,
the
polynucleotides had to have a Pearsons correlation of -0.5 or less with
respect to ICS
and be called absent by the Affymetrix software in 5 out of the 6 cell lines
with lowest
expression of EGFR.
TABLE 3 - Biomarker Probe Set List B
Unigene TitleAffymetrix Description Affymetrix


robe set


dopa Consensus includes gb:AW772056 /FEA=EST214347 s-at


decarboxylase/DB XREF=gi:7704118


(aromatic /DB XREF=est:hn64g06.x1
L-


amino acid /CLONE=IMAGE:3032698 JUG=Hs.150403


decarboxylase)dopa decarboxylase (aromatic L-amino
acid


decarboxylase)


cystic fibrosisgb:NM 000492.2 IDEF=Homo Sapiens 205043 at
cystic


transmembranefibrosis transmembrane conductance
regulator,


conductance ATP-binding cassette (sub-family
C, member 7)


regulator, (CFTR), mRNA. /FEA=mRNA /GEN=CFTR
ATP-


binding cassette/PROD=cystic fibrosis transmembrane


-34-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
(sub-family conductanceregulator, ATP-binding
C, cassette


member 7) (sub-family C, member 7)
~


/DB XREF=gi:6995995 /UG=Hs.663
cystic


fibrosis transmembrane conductance
regulator,


ATP-binding cassette (sub-family
C, member 7)


/FL=gb:NM 000492.2


carcinoembryoiugb:BC005008.1 /DEF=Homo sapiens, 203757 s
at


c antigen-relatedcarcinoembryonic antigen-related
cell adhesion


cell adhesionmolecule 6 (non-specific cross
reacting antigen),


molecule 6 clone MGC:10467, mRNA, complete
(non- cds.


specific cross/FEA=mRNA /PROD=carcinoembryonic


reacting antigen)antigen-related cell adhesionmolecule
6 (non-


specific cross reacting antigen)


/DB XRFF=gi:13477106 /UG=Hs.73848


carcinoembryonic antigen-related
cell adhesion


molecule 6 (non-specific cross
reacting antigen)


/FL=gb:BC005008.1 gb:M18216.1 gb:M29541.1


gb:NM 002483.1


hypothetical gb:NM 017655.1 /DEF=Homo sapiens 219970 at


protein hypothetical protein FLJ20075 (FLJ20075),


FLJ20075 mRNA. /FEA=mRNA /GEN=FLJ20075


/PROD=hypothetical protein FLJ20075


/DB XREF=gi:8923083 /UG=Hs.205058


hypothetical protein FLJ20075


/FL= b:NM 017655.1


ATPase, ClassConsensus includes gb:AW006935 214070 s
IFEA=EST at


V, type 10B /DB XREF=gi:5855713


/DB XREF=est:wt08b11.x1


/CLONE=IMAGE:2506845 /UG=Hs.109358


ATPase, Class V, type lOB


cystic fibrosisConsensus includes gb:W60595 IFEA=EST215702 s_at


transmembrane/DB XREF=gi:1367354


conductance /DB XREF=est:zc91b04.s1


regulator, /CLONE=IMAGE:338479 /UG=Hs.663
ATP- cystic


binding cassettefibrosis transmembrane conductance
regulator,


(sub-family ATP-binding cassette (sub-family
C, C, member 7)


member 7)


HERV-H LTR- gb:NM 007072.1 /DEF=Homo Sapiens 220812 s_at
HERV-


associating H LTR-associating 2 (HHLA2), mRNA.
2


/FEA=mRNA IGEN=HHLA2 /PROD=HERV-H


LTR-associating 2 /DB XREF=gi:5901963


/UG=Hs.252351 HERV-H LTR-associating
2


/FL=gb:AF126162.1 gb:NM 007072.1


AA Consensus includes gb:AV728958 212703 at
/FEA=EST


/DB XREF=gi:10838379


/DB XREF=est:AV728958


/CLONE=HTCBYF04 /UG=Hs.150443


KIAA0320 protein


-35-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
hemoglobin, Consensus includes gb:T50399 /FEA=EST214414 x
at


alpha 2 /DB XREF=gi:652259


/DB XREF=est: yb3 Ob 11. s 1


/CLONE=IMAGE:72669 /UG=Hs.251577


hemo lobin, al ha 1


spondin 1, Consensus includes gb:AI885290 213993 at
(f /FEA=EST


spondin) /DB XREF=gi:5590454


extracellular/DB XREF=est:w192a04.x1


matrix protein/CLONE=IMAGE:2432334 /UG=Hs.5378


spondin 1, (f spondin) extracellular
matrix


rotein


hemoglobin, gb:BC005931.1 /DEF=Homo sapiens, 211745 x
at


alpha 1 hemoglobin, alpha 2, clone MGC:14541,


mRNA, complete cds. /FEA=mRNA


/PROD=hemoglobin, alpha 2


/DB XREF= 1:13543547 /FL= b:BC005931.1


serine (or gb:NM_002639.1 /DEF=Homo Sapiens 204855 at
serine


cysteine) (or cysteine) proteinase inhibitor,
Glade B


proteinase (ovalbumin), member 5 (SERPINBS),
mRNA.


inhibitor, /FEA=mRNA /GEN=SERPINBS /PROD=serine
Glade B


(ovalbumin), (or cysteine) proteinase inhibitor,
cladeB


member 5 (ovalbumin), member 5 /DB XREF=gi:4505788


/LTG=Hs.55279 serine (or cysteine)
proteinase


inhibitor, Glade B (ovalbumin),
member 5


/FL=gb:NM 002639.1 gb:U04313.1


3-hydroxy-3- gb:NM 005518.1 /DEF=Homo sapiens 204607 at
3-


methylglutaryl-hydroxy-3-methylglutaryl-Coenzyme
A synthase


Coenzyme A 2 (mitochondrial) (HMGCS2), mRNA.


synthase 2 /FEA=mRNA /GEN=HMGCS2 /PROD=3-


(mitochondrial)hydroxy-3-methylglutaryl-Coenzyme
A synthase


2(mitochondrial) /DB XREF=gi:5031750


/LJG=Hs.59889 3-hydroxy-3-methylglutaryl-


Coenzyme A synthase 2 (mitochondrial)


/FL=gb:NM_005518.1


anterior gradientgb:AF088867.1 /DEF=Homo Sapiens 209173 at
putative


2 (Xenepus secreted protein XAG mRNA, complete
Gds.


laevis) homolog/FEA=mRNA /PROD~utative secreted
protein


XAG /DB XREF=gi:6652811 /LTG=Hs.91011


anterior gradient 2 (Xenepus laevis)
homolog


/FL=gb:AF007791.1 gb:AF038451.1


b:NM 006408.1 b:AF088867.1


FXYD domain- gb:BC005238.1 /DEF=Homo Sapiens, 202489 s
FXYD at


containing domain-containing ion transport
ion regulator 3,


transport clone MGC:12265, mRNA, complete
Gds.


regulator /FEA=mRNA /PROD=FXYD domain-
3


containing ion transport regulator3


/DB XREF=gi:13528881 /LTG=Hs.301350


FXYD domain-containin ion trans
ort regulator


-36-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
3 /FL= b:NM 005971.2 gb:BC005238.1


dipeptidylpeptidagb:M80536.1 /DEF=H.sapiens dipeptidyl203716 s_at


se IV (CD26, peptidase IV (DPP4) mRNA, complete
cds.


adenosine /FEA=mRNA /GEN=DPP4 /PROD=dipeptidyl


deaminase peptidase IV lDB_~iREF=gi:181569


complexiiig /LTG=Hs.44926 dipeptidylpeptidase
IV (CD26,


protein 2) adenosine deaminase complexing
protein 2)


lFL=gb:M80536.1 gb:NM_001935.1


cystic fibrosisConsensus includes gb:W60595 /FEA=EST215703 at


transmembrane/DB XREF=gi:1367354


conductance /DB XREF=est:zc91b04.s1


regulator, /CLONE=IMAGE:338479 IUG=Hs.663
ATP- cystic


binding cassettefibrosis transmembrane conductance
regulator,


(sub-family ATP-binding cassette (sub-family
C, C, member 7)


member 7)


EphAl gb:NM 005232.1 /DEF=Homo Sapiens 205977 s_at
EphAl


(EPHA 1 ), mRNA. /FEA=mRNA /GEN=EPHA1


/PROD=EphAl !DB XREF=gi:4885208


/LTG=Hs.89839 EphAl /FL=gb:M18391.1


b:NM 005232.1


spondin l, Consensus includes gb:AI885290 213994_s_at
(f /FEA=EST


spondin) /DB XREF=gi:5590454


extracellular/DB XREF=est:w192a04.x1


matrix protein/CLONE=IMAGE:2432334 /UG=Hs.5378


spondin 1, (f spondin) extracellular
matrix


protein


CUG triplet gb:NM 006561.1 /DEF=Homo sapiens 202158 s_at
CUG


repeat, RNA- triplet repeat, RNA-binding protein
2


binding protein(CUGBP2), mRNA. /FEA--mRNA
2


/GEN=CUGBP2 /PROD=CUG triplet repeat,


RNA-binding protein 2 /DB XREF=gi:5729815


/LJG=Hs.211610 CUG triplet repeat,
RNA-


binding protein 2 /FL=gb:U69546.1


gb:AF036956.1 gb:AF090694.1


gb:NM 006561.1


DKFZP434C091 Consensus includes gb:AL080170.1 215047 at


protein /DEF=Homo Sapiens mRNA; cDNA


DKFZp434C091 (from clone DKFZp434C091);


partial cds. /FEA=mRNA


IGEN=DKFZp434C091 (PROD=hypothetical


protein /DB XREF=gi:5262639 /UG=Hs.51692


DKFZP434C091 protein


mucin 3B Consensus includes gb:AF113616 214676_x_at
/DEF=Homo


Sapiens intestinal mucin 3 (MUC3)
gene, partial


cds /FEA=mRNA /DB XREF=gi:6466800


/UG=Hs.129782 mucin 3A, intestinal


potassium gb:U90065.1 /DEF=Human potassium 204678 s_at
channel


channel, KCNO1 mRNA, com fete cds. /FEA=mRNA


-37-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
subfamily /PROD=potassium channel KCNO1
K,


member 1 IDB XREF=gi:1916294 /UG=Hs.79351


(TWIK-1) potassium channel, subfamily K,
member 1


(TWIK-1) /FL=gb:U33632.1 gb:U90065.1


gb:U76996.1 gb:NM 002245.1


nuclear receptorgb:NM 000901.1 /DEF=Homo Sapiens 205259 at
nuclear


subfamily receptor subfamily 3, group C,
3, member 2


group C, member(NR3 C2), mRNA. /FEA=mRNA /GEN--NR3
C2


2 /PROD=nucleax receptor subfamily
3, group C,


member 2 /DB XREF=gi:4505198


/UG=Hs.1790 nuclear receptor subfamily
3,


group C, member 2 /FL=gb:M16801.1


gb:NM 000901.1


BTG family, gb:NM 006763.1 /DEF=Homo Sapiens 201236 s
BTG at


member 2 family, member 2 (BTG2), mRNA.


/FEA=mRNA IGEN=BTG2 /PROD=BTG


family, member 2 /DB XREF=gi:5802987


/IJG=Hs.75462 BTG family, member
2


/FL=gb:U72649.1 b:NM 006763.1


G protein- gb:AF062006.1 /DEF=Homo Sapiens 210393 at
orphan G


coupled receptorprotein-coupled receptor HG38 mRNA,


49 complete cds. /FEA=mRNA /PROD=orphan
G


protein-coupled receptor HG3 8


/DB XREF=gi:3366801 /UG=Hs.285529
G


protein-coupled receptor 49 /FL=gb:AF062006.1


b:AF061444.1 gb:NM 003667.1


hypothetical gb:NM 017640.1 IDEF=Homo Sapiens 219573lat


protein hypothetical protein FLJ20048 (FLJ20048),


FLJ20048 mRNA. /FEA=mRNA /GEN=FLJ20048


/PROD=hypothetical protein FLJ20048


!DB_~REF=gi:8923056 /L1G=Hs.116470


hypothetical protein FLJ20048


/FL=gb:NM 017640.1


cytochrome gb:NM 000775.1 /DEF=Homo Sapiens 205073 at


P450, subfamilycytochrome P450, subfamily IIJ
(arachidonic


IIJ (arachidonicacid epoxygenase) polypeptide 2
(CYP2J2),


acid mRNA. /FEA=mRNA /GEN=CYP2J2


epoxygenase) /PROD=cytochrome P450, subfamily
IIJ


polypeptide (arachidonic acidepoxygenase) polypeptide
2 2


/DB XREF=gi:4503226 /UG=Hs.152096


cytochrome P450, subfamily IIJ
(arachidonic


acid epoxygenase) polypeptide 2


lFL= b:U37143.1 gb:NM 000775.1


brain-specificgb:NM 007030.1 /DEF=Homo sapiens 206179 s_at
brain-


protein p25 specific protein p25 alpha (p25),
alpha mRNA.


IFEA=mRNA JGEN=p25 /PROD=brain-specific


protein p25 alpha /DB XREF=gi:5902017


ICTG=Hs.29353 brain-s ecific rotein
25 al ha


-38-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
/FL=gb:AB017016.1 gb:NM 007030.1


mucin 2, gb:NM 002457.1 /DEF=Homo Sapiens 204673 at
mucin 2,


intestinal/tracheaintestinaltracheal (MUC2), mRNA.


1 /FEA=mRNA /GEN=MUC2 /PROD=mucin
2,


intestinaltracheal /DB XREF=gi:4505284


/LTG=Hs.315 mucin 2, intestinaltracheal


/FL=gb:NM 002457.1 gb:L21998.1


hypothetical gb:NM 017699.1 /DEF=Homo Sapiens 219734 at


protein hypothetical protein FLJ20174 (FLJ20174),


FLJ20174 mRNA. /FEA~nRNA /GEN=FLJ20174


(PROD=hypothetical protein FLJ20174


/DB XREF=gi:8923170 /LTG=Hs.114556


hypothetical protein FLJ20174


/FL=gb:NM 017699.1


metastasis- gb:NM 004739.1 lDEF=Homo sapiens 203444 s
at


associated metastasis-associated 1-like 1
1-like (MTA1L1),


1 mRNA. /FEA--mRNA /GEN=MTA 1 L 1


/PROD=metastasis-associated 1-like
1


/DB XR.EF=gi:4758739 /LJG=Hs.173043


metastasis-associated 1-like 1


/FL=gb:AB016591.1 gb:NM 004739.1


b:AF295807.1


bone gb:NM_001200.1 /DEF=Homo Sapiens 205290 s_at
bone


morphogeneticmorphogenetic protein 2 (BMP2),
mRNA.


protein 2 /FEA=mRNA /GEN=BMP2 /PROD=bone


morphogenetic protein 2 precursor


/DB XREF=gi:4557368 IIJG=Hs.73853
bane


morpho enetic protein 2 /FL=gb:NM
001200.1


heparanase gb:NM 006665.1 /DEF=Homo Sapiens 219403 s_at


heparanase (HPSE), mRNA. /FEA=mRNA


/GEN=HPSE /PROD=heparanase


/DB XREF=gi:5729872 /LTG=Hs.44227


heparanase /FL=gb:AF165154.1 gb:AF152376.1


gb:NM 006665.1 gb:AF084467.1


gb:AF155510.1


tumor necrosisgb:BC002794.1 IDEF=Homo Sapiens, 209354 at
tumor


factor receptornecrosis factor receptor superfamily,4
member 1


superfamily, (herpesvirus entry mediator), clone
MGC:3753,


member 14 mRNA, complete cds. /FEA=mRNA


(herpesvirus /PROD=tumor necrosis factor receptor


entry mediator)superfamily,member 14 (herpesvirus
entry


mediator) /DB XREF=gi:12803894


iUG=Hs.279899 tumor necrosis factor
receptor


superfamily, member 14 (herpesvirus
entry


mediator) /FL=gb:BC002794.1 gb:U70321.1


gb:U81232.1 gb:NM 003820.1 b:AF153978.1


CUG triplet Consensus includes gb:N36839 /FEA=EST202156 s_at


re eat, RNA- /DB ~~REF= 1:1157981


-39-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
binding protein/DB XREF=est:yy35f07.s1
2


/CLONE=IMAGE:273253 /UG=Hs.211610


CUG triplet repeat, RNA-binding
protein 2


/FL=gb:U69546.1 gb:AF036956.1


~gb:AF090694.1 gb:NM 006561.1


ESTs, Consensus includes gb:R06655 /FEA=EST217546 at


Moderately /DB XREF=gi:757275


similar to /DB XREF=est:yf10e02.r1


AF0788441 /CLONE=IMAGE:126458 /LTG=Hs.188518


hqp0376 proteinESTs, Moderately similar to AF078844
1


[H.sa iens h 0376 rotein H.sa iens


hairless (mouse)018411.1 /DEF=Homo sapiens hairless220163 s_at
gb:NM


homolog _
protein (putative single zinc finger
transcription


factor protein, responsible for
autosomal


recessive universal congenital
alopecia, HR


gene) (HSA277165), mRNA. /FEA=mRNA


/GEN=HSA277165 /PROD=hairless protein


lDB_XREF=gi:1103 6651 ILTG=Hs.2723
67


hairless protein (putative single
zinc finger


transcription factor protein, responsible
for


autosomal recessive universal congenital


alo ecia, HR ene) /FL=gb:NM 018411.1


branched chainConsensus includes gb:NM_005504.1 214452 at


aminotransferase/DEF=Homo Sapiens branched chain


1, cytosolic aminotransferase l, cytosolic (BCATl),
mRNA.


/FEA=CDS /GEN=BCATl /PROD=branched


chain aminotransferase 1, cytosolic


!DB XI2EF=gi:5031606 lLJG=Hs.157205


branched chain aminotransferase
1, cytosolic


/FL= b:U21551.1 b:NM 005504.1


pancreas- gb:NM 016341.1 /DEF=Homo Sapiens 205112 at


enriched pancreas-enriched phospholipase
C


phospholipase(LOC51196), mRNA. /FEA=mRNA
C


/GEN=LOC51196 IPROD~ancreas-enriched


phospholipase C /DB XREF=gi:7705940


/UG=Hs.6733 pancreas-enriched phospholipase


C /FL=gb:AF190642.2 gb:AF117948.1


b:NM 016341.1


prostaglandin-gb:NM 000963.1 /DEF=Homo Sapiens 204748 at


endoperoxide prostaglandin-endoperoxide synthase
2


synthase 2 (prostaglandin GH synthase and


(prostaglandincyclooxygenase) (PTGS2), mRNA.


G/H synthase /FEA=mRNA /GEN=PTGS2


and /PROD=prostaglandin-endoperoxide
synthase


cyclooxygenase)2(prostaglandin GH synthase and


cyclooxygenase) /DB XREF=gi:4506264


/UG=Hs.196384 prostaglandin-endoperoxide


synthase 2 ( rostaglandin GH synthase
and


-40-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
cyclooxygenase) /FL=gb:M90100.1


gb:L15326.1 gb:NM 00096
3.1


phosphatase _ 204054 at
and 000314.1 /DEF=Homo Sapiens
gb:NM


tensin homolog_
phosphatase and tensin homolog
(mutated in


(mutated in multiple advanced cancers 1) (PTEN),
mRNA.


multiple /FEA=mRNA /GEN=PTEN


advanced cancers/PROD=phosphatase and tensin homolog


1) (mutated inmultiple advanced cancers
1)


/DB XREF=gi:4506248 /UG=Hs.10712


phosphatase and tensin homolog
(mutated in


multiple advanced cancers 1) lFL=gb:U92436.1


gb:U93051.1 gb:U96180.1 gb:NM 000314.1


retinoic acidConsensus includes gb:AI669229 221872 at
/FEA=EST


receptor /DB XREF=gi:4834003


responder /DB XREF=est:WC13e06.x1


(tazarotene /CLONE=IMAGE:2315074 /UG=Hs.82547


induced) 1 retinoic acid receptor responder
(tazarotene


induced) 1


protease inhibitorgb:NM 002638.1 /DEF=Homo sapiens 203691 at
protease


3, skin-derivedinhibitor 3, skin-derived (SI~ALP)
(PI3), mRNA.


(SKALP) /FEA=mRNA /GEN=PI3 /PROD~rotease


inhibitor 3, skin-derived (SI~ALP)


/DB XREF=gi:4505786 /LTG=Hs.112341


protease inhibitor 3, skin-derived
(SKALP)


/FL= b:NM 002638.1


zinc finger gb:NM 003438.1 /DEF=Homo Sapiens 207394 at
zinc


protein 137 finger protein 137 (clone pHZ-30)
(ZNF137),


(clone pHZ-30)mRNA. /FEA=mRNA /GEN=ZNF137


/PROD=zinc finger protein 137 (clone
pHZ-30)


/DB XREF=gi:4507988 ILTG=Hs.151689
zinc


finger protein 137 (clone pHZ-30)


/FL=gb:NM_003438.1 gb:U09414.1


myosin, lightgb:NM 002477.1 /DEF=Homo sapiens 205145 s_at
myosin,


polypeptide light polypeptide 5, regulatory
5, (MYLS), mRNA.


regulatory /FEA=mRNA /GEN=MYLS /PROD=myosin,


light polypeptide 5, regulatory


JDB_XREF=gi:4505304 lUG=Hs.170482


myosin, light polypeptide 5, regulatory


/FL=gb:L03785.1 gb:NM 002477.1


tumor necrosis000043.1 /DEF=Homo sapiens tumor 204781 s
gb:NM at


factor receptor_ 6
necrosis factor receptor superfamily,
member


superfamily, (TNFRSF6), mRNA. /FEA=mRNA


member 6 /GEN=TNFRSF6 /PROD=apoptosis (APO-1)


antigen 1 /DB XREF=gi:4507582


/LTG=Hs.82359 tumor necrosis factor
receptor


superfamily, member 6 /FL=gb:M67454.1


gb:NM 000043.1


h othetical Consensus includes b:AI339568 /FEA=EST222727 s
at


-41-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
protein /DB XREF=gi:4076495


FLJ22233 /DB XREF=est:qk67e10.x1


/CLONE=IMAGE:1874058 lUG=Hs.286194


hypothetical protein FLJ22233


/FL=gb:NM 024959.1


regenerating gb:AY007243.1 /DEF=Homo Sapiens 223447 at


gene type regenerating gene type IV mRNA,
IV complete


cds. /FEA=mRNA /PROD=regenerating
gene


type IV /DB XREF=gi:12621025


/UG=Hs.105484 Homo sapiens regenerating


gene type IV mRNA, complete cds


/FL=gb:AY007243.1


Homo Sapiens Consensus includes gb:AK025615.1 225285 at


cDNA: /DEF=Homo sapiens cDNA: FLJ21962
fis,


FLJ21962 fis,clone HEP05564. IFEA=nlRNA


clone HEP05564/DB XREF=gi:10438186 /UG=Hs.7567
Homo


sa iens cDNA: FLJ21962 fis, clone
HEP05564


phosphoproteinConsensus includes gb:AK000680.1 225626 at


associated /DEF=Homo Sapiens cDNA FLJ20673
With fis,


glycosphingolipiclone KAIA4464. /FEA=mRNA


d-enriched /DB XREF=gi:7020924 lLTG=Hs.266175


microdomains phosphoprotein associated with
GEMs


/FL=gb:AF240634.1 gb:NM 018440.1


hypothetical Consensus includes gb:BF111925 226171 at
iFEA=EST


protein /DB XREF=gi:10941704


FLJ20209 /DB XREF=est:7138gO5.x1


/CLONE=IMAGE:3523784 lUG=Hs.3685


hypothetical protein FLJ20209


Homo sapiens Consensus includes gb:AA532640 226484 at
/FEA=EST


mRNA for /DB XREF=gi:2276894


KIAA1190 lDB_XREF=est:nj 17c04.s1


protein, partial/CLONE=IMAGE:986598 /LJG=Hs.206259


cds Homo sapiens mRNA for KIAA1190
protein,


artial cds


KIAA1543 Consensus includes gb:AB040976.1 226494 at


protein /DEF=Homo sapiens mRNA for KIAA1543


protein, partial cds. JFEA~mRNA


/GEN=KIAA1543 /PROD=KIAA1543 protein


/DB XREF=gi:7959352 /LTG=Hs.17686


KIAAl543 rotein


hypothetical Consensus includes gb:AW138767 227180 at
/FEA=EST


protein /DB XREF=gi:6143085 /DB XREF=est:UI-H-


FLJ23563 BI1-aep-a-12-0-ULsl


/CLONE=IMAGE:2719799 /UG=Hs.274256


hypothetical rotein FLJ23563


ESTs Consensus includes gb:AW264333 227320 at
/FEA=EST


/DB XREF=gi:6641075


/DB XREF=est:x 98e01.x1


-42-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
/CLONE=IMAGE:2758680 /UG=Hs.21835


ESTs


ESTs Consensus includes gb:BF589359 227354 at
/FEA=EST


/DB _X_RFF=gi:11681683


/DB XREF=est:nab25dOl.x1


/CLONE=IMAGE:3266737 /UG=Hs.13256


ESTs


Homo Sapiens,Consensus includes gb:AW001287 227676_at
/FEA=EST


Similar to /DB XREF=gi:5848203


RIKEN cDNA /DB XREF=est:wu27e06.x1


1810037020 /CLONE=IMAGE:2521282 /UG=Hs.61265


gene, clone ESTs, Weakly similar to G786_HCTMAN


MGC:21481 PROTEIN GS3786 H.sapiens


IMAGE:385206


2, mRNA,


com fete cds


Homo sapiens Consensus includes gb:T86159 /FEA=EST227724 at


cDNA: /DB XR.EF=gi:714511


FLJ22063 fis,/DB XREF=est:yd84h07.s1


clone HEP10326/CLONE=IMAGE:114973 /UG=Hs.10450


Homo sapiens cDNA: FLJ22063 fis,
clone


HEP 10326


ESTs Consensus includes gb:AI700341 228653 at
/FEA=EST


/DB XREF=gi:4988241


/DB XREF=est:wd06e1O.x1


/CLONE=IMAGE:2327370 /UG=Hs.110406


ESTs


ESTs Consensus includes gb:BG494007 228716 at
/FEA=EST


/DB XREF=gi:13455521


/DB XREF=est:602542289F1


!CLONE=IMAGE:4673182 /UG=Hs.203213


ESTs


ESTs Consensus includes gb:AI559300 229331 at
/FEA=EST


/DB XRFF=gi:4509505


/DB XREF=estaq43d03.,x1


/CLONE=IMAGE:2211557 /UG=Hs.294140


ESTs


hypothetical Consensus includes gb:AI830823 229439 s
/FEA=EST at


protein /DB XREF=gi:5451416


lDB_~R.EF=est:wj52b06.x1


/CLONE=IMAGE:2406419 /UG=Hs.95549


by othetical rotein


ESTs Consensus includes gb:BF431989 229657 at
/FEA=EST


IDB_XREF=gi:11444103


/DB XREF=est:nab84a05.x1


/CLONE=IMAGE:3274280 /UG=Hs.203213


ESTs


ESTs Consensus includes gb:BF589413 229893 at
/FEA=EST


- 43 -



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
/DB XREF=gi:11681737


lDB_XREF=est:nab26b11.x1


/CLONE=IMAGE:3267020 /UG=Hs.55501


ESTs


brain-specificConsensus includes gb:BG055052 230104 s_at
/FEA=EST


protein p25 /DB XREF=gi:12512386
alpha


/DB XREF=est:nac94g06.x1


/CLONE=IMAGE:3441995 /UG=Hs.29353


brain-s ecific rotein 25 al ha


ESTs, Weakly Consensus includes gb:BF110588 230645 at
/FEA=EST


similar to /DB XREF=gi:10940278


MMHUE4 fDB_XREF=est:7n39e12.x1


erythrocyte /CLONE=IMAGE:3567071 /UG=Hs.150478


membrane ESTs, Weakly similar to KIAA0987
protein


protein 4.1, H.sapiens


parent splice


form [H.sa
iens


ESTs Consensus includes gb:BF592062 230760 at
/FEA=EST


/DB XREF=gi:11684386


/DB XREF=est:7n98h06.x1


/CLONE=IMAGE:3 572962 ILJG=Hs.23
3 890


ESTs


hepatocyte Consensus includes gb:AI032108 230914 at
/FEA=EST


nuclear factor/DB_~~REF=gi:3250320
4,


alpha /DB XREF=est:ow92dll.xl


/CLONE=IMAGE:1654293 /UG=Hs.54424


hepatocyte nuclear factor 4, alpha


ESTs Consensus includes gb:AW203959 230944 at
/FEA=EST


/DB XREF=gi:6503431 /DB XREF=est:UI-H-


BI 1-aeu-b-12-0-UI. s 1


!CLONE=IMAGE:2720590 /UG=Hs.149532


ESTs


ESTs Consensus includes gb:AI139990 231022~at
/FEA=EST


/DB XREF=gi:3647447


/DB XREF=est:qa47d03.x1


/CLONE=IMAGE:1689893 /UG=Hs.134586


ESTs


ESTs Consensus includes gb:AI806131 231148 at
/FEA=EST


/DB XREF=gi:5392697


lDB XREF=est:wf06c06.x1


/CLONE=IMAGE:2349802 /UG=Hs.99376


ESTs


hypothetical Consensus includes gb:AB046810.1 232083 at


protein /DEF=Homo Sapiens mRNA for KIAA1590


FLJ23045 protein, partial cds. /FEA=mRNA


/GEN=KIAA1590 /PROD=KIAA1590 protein


/DB_~REF=gi:10047254 /LTG=Hs.141774


by othetical rotein FLJ23045


-44-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
Homo Sapiens Consensus includes gb:AC004908 232641 at
/DEF=Homo


PAC clone Sapiens PAC clone RPS-855D21 /FEA=CDS
RPS- 3


855D2 1 /DB XREF=gi:4156179 /UG=Hs.249181


Homo sa iens PAC clone RPS-855D21


putative Consensus includes gb:AJ251708.1 234669 x
at


microtubule- /DEF=Homo Sapiens partial mRNA
for putative


binding proteinmicrotubule-binding protein. /FEA--mRNA


/PROD=putative microtubule-binding
protein


/DB XREF=gi:6491740 /UG=Hs.326544


utative microtubule-binding rotein


ESTs Consensus includes gb:AI741469 234970 at
/FEA=EST


/DB XREF=gi:5109757


/DB_~~REF=est:wgl lbOl.x1


/CLONE=IMAGE:2364745 /LJG=Hs.57787


ESTs


ESTs Consensus includes gb:AI417897 235444 at
/FEA=EST


/DB XRFF=gi:4261401


/DB XREF=estag55b06.x1


/CLONE=IMAGE:2112659 lUG=Hs.235860


ESTs


ESTs Consensus includes gb:AI493909 235562 at
/FEA=EST


/DB XR.EF=gi:4394912


/DB XREF=est:qz94e02.x1


/CLONE=IMAGE:2042234 /UG=Hs.6131


ESTs


ESTs Consensus includes gb:AV741130 235651 at
/FEA=EST


/DB XREF=gi:10858711
~


/DB
XREF=est:AV741130


/CLONE=CBCATB06 /UG=Hs.173704 ESTs,


Moderately similar to ALUB_HUMAN
ALU


SUBFAMILY SX SEQUENCE


CONTAMINATION WARNING ENTRY


H.sapiens


ESTs Consensus includes gb:AW339510 235866 at
/FEA=EST


/DB XREF=gi:6836136


/DB XREF=est:xz91h08.x1


/CLONE=IMAGE:2871615 /UG=Hs.42722


ESTs


ESTs Consensus includes gb:AI076192 236422 at
/FEA=EST


/DB XREF=gi:3405370


/DB XREF=est:oz01g07.x1


/CLONE=IMAGE:1674108 /UG=Hs.131933


ESTs


ESTs Consensus includes gb:AL044570 236548 at
/FEA=EST


/DB XREF=gi:5432785


/DB XREF=est:DKFZp434L082_s1


/CLONE=DKFZp434L082 fUG=Hs.147975


ESTs


- 45 -



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ESTs Consensus includes gb:AI733801 /FEA=EST237923 at


/DB XREF=gi:5054914


/DB XREF=est:qk39c04.x5


/CLONE=IMAGE:1871334 /UG=Hs.146186


ESTs


Homo Sapiens,Consensus includes gb:T69015 /FEA=EST238422 at


clone /DB XREF=gi:680163


MGC:16402 /DB XREF=est:yc31f04.s1


IMAGE:394036 /CLONE=IMAGE:82303 /UG=Hs.192728


0, mRNA, ESTs


com lete cds


ESTs Consensus includes gb:AA502384 /FEA=EST238956 at
_


/DB XREF=gi:2237351


/DB XREF=est:ne27fll.sl


/CLONE=IMAGE:898605 /UG=Hs.151.529


ESTs


ESTs Consensus includes gb:AI739241 /FEA=EST238984 at
_


/DB XREF=gi:5101222


/DB XREF=est:wi14h02.x1


/CLONE=IMAGE:2390259 /UG=Hs.171480


ESTs


ESTs Consensus includes gb:AA088446 /FEA=EST239065 at
_


/DB XREF=gi:1633958


/DB XREF=est:z189f04.s1


/CLONE=IMAGE:511807 /UG=Hs.170298


ESTs


ESTs Consensus includes gb:AI493046 /FEA=EST239148 at
_


/DB XREF=gi:4394049


/DB XREF=est:qz49b04.x1


/CLONE=IMAGE:2030191 /UG=Hs.146133


ESTs


ESTs Consensus includes gb:AI243098 /FEA=EST239966 at


/DB XREF=gi:3838495


/DB XREF=est:qh26e03.x1


/CLONE=IMAGE:1845820 /UG=Hs.178398


ESTs


Weakly Consensus includes gb:AI633523 /FEA=EST240106 at
ESTs, _


similar to /DB XREF=gi:4684853


A49175 Motch /DB XREF=estah68b11.x1
B


protein - (CLONE=IMAGE:2123805 /LJG=Hs.44705
mouse


M.musculus] ESTs


betacellulin Consensus includes gb:AI620677 /FEA=EST241412 at
_


/DB XREF=gi:4629803


lDB_XREF=estau85e09.x1


/CLONE=IMAGE:2257864 /UG=Hs.154191


ESTs


ESTs Consensus includes gb:BF696216 /FEA=EST242626 at
_


/DB XREF=gi:11981624


-46-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
/DB XREF=est:602124536F1


/CLONE=IMAGE:4281632 lUG=Hs.l 88724


ESTs


ESTs Consensus includes gb:N57929 /FEA=EST242978 x
at


lDB XRFF=gi:1201819


/DB XR.EF=est:yv61e06.s1


/CLONE=IMAGE:247234 /UG=Hs.48100


ESTs


ESTs, Weakly Consensus includes gb:AI457984 243729 at
/FEA=EST


similar to /DB XREF=gi:4312002


ALUl_HUMAN /DB XREF=estaj66a04.x1


ALU /CLONE=IMAGE:2146446 /UG=Hs.165900


SUBFAMILY ESTs, Weakly similar to ALUC_HUMAN
J ! ! ! !


SEQUENCE ALU CLASS C WARNING ENTRY ! ! !


CONTAMINAT H.sapiens


ION WARNING


ENTRY


[H.sapiens)


ESTs Consensus includes gb:AA581439 244650 at
/FEA=EST


/DB XREF=gi:2359211


/DB XREF=est:nh13c10.s1


/CLONE=IMAGE:952242 lUG=Hs.152328


ESTs


The two biomarker probe sets A and B were then combined, a total of 161
different probe sets, and the redundant polynucleotides were removed,
representing
125 unique polynucleotides which are provided below in Table 4. The Table 4
polynucleotides are biomarkers of the invention.
TABLE 4 - Biomarkers
Unigene Title Affymetrix Description Affymetrix


And SEQ ID robe set
NO:


3-hydroxy-3- gb:NM 005518.1 /DEF=Homo sapiens204607
3- at


methylglutaryl- hydroxy-3-methylglutaryl-Coenzyme~
A


Coenzyme A synthase 2 (mitochondrial) (HMGCS2),


synthase 2 mRNA. /FEA=mRNA /GEN=HMGCS2


(mitochondrial) /PROD=3-hydroxy-3-methylglutaryl-


Coenzyme A synthase 2(mitochondrial)


SEQ ID NOS: /DB XREF=gi:5031750 /UG=Hs.59889
1 3-


(DNA) and 126 hydroxy-3-methylglutaryl-Coenzyme
A


(amino acid) synthase 2 (mitochondrial)


/FL=gb:NM 005518.1


ATPase, Class Consensus includes gb:AW006935 214070 s at
V,


type lOB /FEA=EST /DB XREF=gi:5855713


/DB XREF=est:wt08bll.xl


_47_



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
SEQ ID NO: 2 /CLONE=IMAGE:2506845 /UG=Hs.109358


(DNA) ATPase, Class V, a lOB


bone morphogeneticgb:NM 001200.1 /DEF=Homo sapiens 205290 s_at
bone


protein 2 morphogenetic protein 2 (BMP2),
mRNA.


/FEA=mRNA IGEN=BMP2 /PROD=bone


SEQ ID NOS: 3 morphogenetic protein 2 precursor


(DNA) and 127 /DB XREF=gi:4557368 /UG=Hs.73853
bone


(amino acid) morphogenetic protein 2


lFL=gb:NM 001200.1


brain-specific gb:NM 007030.1 /DEF=Homo sapiens 206179 s at
protein brain-


p25 alpha specific protein p25 alpha (p25),
mRNA.


IFEA=mRNA /GEN~25 !PROD=brain-


SEQ ID NOS: 4 specific protein p25 alpha


(DNA) and 128 /DB XREF=gi:5902017 /LTG=Hs.29353


(amino acid) brain-specific protein p25 alpha


/FL=gb:AB017016.1 gb:NM 007030.1


branched chain Consensus includes gb:NM 005504.1214452_at


aminotransferase/DEF=Homo sapiens branched chain
1,


cytosolic aminotransferase 1, cytosolic
(BCAT1),


mRNA. /FEA=CDS /GEN=BCAT1


SEQ ID NOS: 5 /PROD=branched chain aminotransferase
1,


(DNA) and 129 cytosolic /DB XREF=gi:5031606


(amino acid) /LJG=Hs.157205 branched chain


aminotransferase l, cytosolic


/FL=gb:U21551.1 b:NM 005504.1


BTG family, membergb:NM 006763.1 /DEF=Homo Sapiens 201236 s_at
BTG


2 family, member 2 (BTG2), mRNA.


/FEA=mRNA /GEN=BTG21PROD=BTG


SEQ ID NOS: 6 family, member 2 /DB XREF=gi:5802987


(DNA) and 130 /UG=Hs.75462 BTG family, member
2


(amino acid) /FL=gb:U72649.1 gb:NM 006763.1


Carcinoembryonicgb:BC005008.1 /DEF=Homo sapiens, 203757 s_at


antigen-related carcinoembryonic antigen-related
cell cel1


adhesion moleculeadhesion molecule 6 (non-specific
6 cross


(non-specific reacting antigen), clone MGC:10467,
cross mRNA,


reacting antigen)complete cds. /FEA=inRNA


/PROD=carcinoembryonic antigen-related


SEQ ID NOS: 7 cell adhesionmolecule 6 (non-specific
cross


(DNA) and 131 reacting antigen) /DB XREF=gi:13477106


(amino acid) /LTG=Hs.73848 carcinoembryonic
antigen-


related cell adhesion molecule
6 (non-specific


cross reacting antigen) /FL=gb:BC005008.1


gb:M18216.1 gb:M29541.1 gb:NM
002483.1


caspase 10, apoptosis-gb:NM 001230.1 /DEF=Homo sapiens 205467 at


related cysteinecaspase 10, apoptosis-related
cysteine


protease protease (CASP 10), mRNA. /FEA=mRNA


/GEN=CASP 10 /PROD=caspase 10,


SEQ ID NOS: 8 a o tosis-related cysteine protease


-48-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
(DNA) and 132 /DB XREF=gi:4502568 /UG=Hs.5353


(amino acid) caspase 10, apoptosis-related
cysteine


rotease /FL=gb:U60519.1 gb:NM
001230.1


CUG triplet repeat,gb:NM 006561.1 /DEF=Homo sapiens202158 s at
CUG


RNA-binding proteintriplet repeat, RNA-binding protein2


2 (CUGBP2), mRNA. /FEA=mRNA


/GEN=CUGBP2 /PROD=CUG triplet
repeat,


SEQ ID NOS: 9 RNA-binding protein 2


(DNA) and 133 /DB XREF=gi:5729815 lUG=Hs.211610


(amino acid) CUG triplet repeat, RNA-binding
protein 2


/FL=gb:U69546.1 gb:AF036956.1


gb:AF090694.1 gb:NM 006561.1


cystatin S gb:NM 001899.1 /DEF=Homo sapiens206994 at


cystatin S (CST4), mRNA. /FEA=mRNA


SEQ ID NOS: 10 /GEN=CST4 /PROD=cystatin S


(DNA) and 134 /DB XREF=gi:4503108 /LJG=Hs.56319


(amino acid) cystatin S /FL=gb:NM 001899.1


cystic fibrosis gb:NM 000492.2 JDEF=Homo sapiens205043 at
cystic


transmembrane fibrosis transmembrane conductance


conductance regulator, ATP-binding cassette
(sub-family


regulator, ATP- C, member 7) (CFTR), mRNA.


binding cassette/FEA=mRNA /GEN=CFTR /PROD=cystic
(sub-


family C, memberfibrosis transmembrane conductanceregulator,
7)


ATP-binding cassette (sub-family
C, member


SEQ ID NOS: 11 7) /DB XREF=gi:6995995 /UG=Hs.663


(DNA) and 135 cystic fibrosis transmembrane
conductance


(amino acid) regulator, ATP-binding cassette
(sub-family


C, member 7) /FL=gb:NM 000492.2


cytochrome P450,gb:NM 000775.1 /DEF=Homo sapiens205073 at


subfamily IIJ cytochrome P450, subfamily IIJ
(arachidonic


(arachidonic acid epoxygenase) polypeptide
acid 2 (CYP2J2),


epoxygenase) mRNA. /FEA=mRNA /GEN=CYP2J2


polypeptide 2 /PROD=cytochrome P450, subfamily
IIJ


(arachidonic acidepoxygenase)
polypeptide 2


SEQ ID NOS: 12 /DB XREF=gi:4503226 /LTG=Hs.152096


(DNA) and 136 cytochrome P450, subfamily IIJ
(arachidonic


(amino acid) acid epoxygenase) polypeptide
2


/FL=gb:U37143.1 b:NM 000775.1


dipeptidylpeptidasegb:M80536.1 /DEF=H.sapiens dipeptidyl203716 s at


IV (CD26, adenosinepeptidase IV (DPP4) mRNA, complete
cds.


deaminase /FEA=mRNA /GEN=DPP4


complexing protein/PROD=dipeptidyl peptidase IV
2)


IDB_XREF=gi:181569 iLTG=Hs.44926


SEQ ID NOS 13 dipeptidylpeptidase IV (CD26,
adenosine


(DNA) and 137 deaminase complexing protein
2)


(amino acid) /FL=gb:M80536.1 gb:NM 001935.1


DI~FZP434C091 Consensus includes gb:AL080170.1215047 at


rotein /DEF=Homo sa iens mRNA; cDNA


-49-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
DKFZp434C091 (from clone


SEQ ID NO: 14 DKFZp434C091); partial cds. /FEA=mRNA


(DNA) /GEN=DKFZp434C091 /PROD=hypothetical


protein /DB XREF=gi:5262639


/UG=Hs.51692 DKFZP434C091 rotein


dopa decarboxylaseConsensus includes gb:AW772056 214347 s at


(aromatic L-amino/FEA=EST /DB XREF=gi:7704118


acid decarboxylase)/DB XREF=est:hn64g06.x1


/CLONE=IMAGE:3032698 /LTG=Hs.150403


SEQ ID NO: 15 dopa decarboxylase (aromatic
L-amino acid


(DNA) decarboxylase)


EphAl gb:NM 005232.1 /DEF=Homo Sapiens205977 s_at


EphA 1 (EPHA 1 ), mRNA. /FEA=mRNA


SEQ ID NOS: 16 /GEN=EPHAl /PROD=EphAl


(DNA) and 138 /DB XREF=gi:4885208 /LTG=Hs.89839


(amino acid) E hAl /FL=gb:M18391.1 gb:NM 005232.1


ESTs, ModeratelyConsensus includes gb:R06655 217546_at
/FEA=EST


similar to AF078844/DB XREF=gi:757275


1 hqp0376 protein/DB XREF=est:yf10e02.r1


[H.sapiens] /CLONE=IMAGE:126458 /UG=Hs.188518


ESTs, Moderately similar to AF078844
1


SEQ ID NO: 17 hqp0376 protein H.sapiens


(DNA)


ESTs, Weakly Consensus includes gb:AW675655 222354 at
similar


to I38022 /FEA=EST /DB XREF=gi:7540890


hypothetical /DB XREF=est:ba52e01.x1
protein


[H. sapiens] /CLONE=IMAGE:2900184 lUG=Hs.31415
8


ESTs


SEQ ID NO: 18


(DNA)


fibroblast growthgb:NM 022969.1 lDEF=Homo Sapiens203638 s at


factor receptor fibroblast growth factor receptor
2 2 (bacteria-


(bacteria-expressedexpressed kinase, keratinocyte
growth factor


kinase, keratinocytereceptor, craniofacial dysostosis
1, Crouzon~


growth factor syndrome, Pfeiffer syndrome,
Jackson-Weiss


receptor, craniofacialsyndrome) (FGFR2), transcript
variant 2,


dysostosis 1, mRNA. JFEA=mRNA IGEN=FGFR2
Crouzon


syndrome, Pfeiffer/PROD=fibroblast growth factor
receptor 2,


syndxome, Jackson-isoform 2precursor /DB XREF=gi:13186252


Weiss syndrome) /UG=Hs.278581 fibroblast growth
factor


receptor 2 (bacteria-expressed
kinase,


SEQ ID NOS: 19 keratinocyte growth factor receptor,


(DNA) and 139 craniofacial dysostosis 1, Crouzon
syndrome,


(amino acid) Pfeiffer syndrome, Jackson-Weiss
syndrome)


/FL=gb:NM 022969.1 gb:M97193.1


gb:M80634.1


FXYD domain- gb:BC005238.1 /DEF=Homo Sapiens,202489 s_at
FXYD


containing ion domain-containing ion trans ort
regulator 3,


-50-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
transport regulatorclone MGC:12265, mRNA, complete
3 cds.


/FEA=mRNA /PROD=FXYD domain-


SEQ ID NOS: 20 containing ion transport regulator3


(DNA) and 140 /DB XREF=gi:13528881 /UG=Hs.301350


(amino acid) FXYD domain-containing ion transport


regulator 3 /FL=gb:NM 005971.2


b:BC005238.1


G protein-coupledgb:AF062006.1 /DEF=Homo sapiens 210393 at
orphan


receptor 49 G protein-coupled receptor HG38
mRNA,


complete cds. /FEA=mRNA /PROD=orphan


SEQ ID NOS: 21 G protein-coupled receptor HG38


(DNA) and 141 /DB XREF=gi:3366801 /UG=Hs.285529
G


(amino acid) protein-coupled receptor 49


/FL=gb:AF062006.1 gb:AF061444.1


gb:NM 003667.1


hairless (mouse)gb:NM 018411.1 /DEF=Homo Sapiens 220163 s at


homolog hairless protein (putative single
zinc finger


transcription factor protein,
responsible for


SEQ ID NOS: 22 autosomal recessive universal
congenital


(DNA) and 142 alopecia, HR gene) (HSA277165),
mRNA.


(amino acid) /FEA=mRNA /GEN=HSA277165


/PROD=hairless protein


/DB XREF=gi:11036651 /UG=Hs.272367


hairless protein (putative single
zinc finger


transcription factor protein,
responsible for


autosomal recessive universal
congenital


alo ecia, HR gene) /FL= b:NM 018411.1


hemoglobin, alphagb:BC005931.1 /DEF=Homo Sapiens, 211745 x at
1


hemoglobin, alpha 2, clone MGC:14541,


SEQ ID NOS: 23 mRNA, complete cds. /FEA=mRNA


(DNA) and 143 /PROD=hemoglobin, alpha 2


(amino acid) /DB XRFF=gi:13543547


/FL= b:BC005931.1


hemoglobin, alphaConsensus includes gb:T50399 /FEA=EST.214414 x at
2


/DB XREF=gi:652259


SEQ ID NO: 24 /DB XREF=est:yb30b1 l.sl


(DNA) l CLONE=IMAGE:72669 I UG=Hs.251577


hemo lobin, al ha 1


heparanase gb:NM_006665.1 /DEF=Homo Sapiens 219403 s_at


heparanase (HPSE), mRNA. /FEA=mRNA


SEQ ID NOS: 25 /GEN=HPSE /PROD=heparanase


(DNA) and 144 /DB XREF=gi:5729872 /UG=Hs.44227


(amino acid) heparanase /FL=gb:AF165154.1


gb:AF152376.1 gb:NM_OQ6665.1


gb:AF084467.1 gb:AF155510.1


Pudlak Consensus includes gb:AL022313 217354 s at
Hermansky- _


syndrome /DEF=Human DNA sequence from clone


RPS-1119A7 an chromosome 22 12.2-12.3


-51-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
SEQ ID NOS: 26 Contains the TXN2 gene for mitochondria)


(DNA) and 145 thioredoxin, a novel gene, the
EIF3S7 gene


(amino acid) for eukaryotic translation initiation
factor 3


subunit 7 (zeta, 6667kD) (EIF3-P66),
the


gene f... /FEA=CDS_3


/DB XREF=gi:4200326 /UG=Hs.272270


Human DNA sequence from clone
RP5-


1119A7 on chromosome 22q12.2-12.3


Contains the TXN2 gene for mitochondria)


thioredoxin, a novel gene, the
EIF3S7 gene


for eukaryotic translation initiation
factor 3


subunit 7 (zeta, 6667kD) (EIF3-P66),
the


gene for a nov


HERV-H LTR- gb:NM 007072.1 /DEF=Homo Sapiens 220812 s_at


associating 2 HERV-H LTR-associating 2 (HHLA2),


mRNA. /FEA=mRNA /GEN=HHLA2


SEQ ID NOS: 27 /PROD=HERV-H LTR-associating 2


(DNA) and 146 /DB XREF=gi:5901963 /LTG=Hs.252351


(amino acid) HERV-H LTR-associating 2


/FL=gb:AF126162.1 b:NM 007072.1


Homo Sapiens Consensus includes gb:AW593996 213256 at
clone


24707 mRNA /FEA=EST /DB X_RFF=gi:7281254


sequence /DB XREF=est:hg41g06.x1


/CLONE=IMAGE:2948218 /UG=Hs.124969


SEQ ID NO: 28 Homo Sapiens clone 24707 mRNA
sequence


(DNA)


Homo sapiens Consensus includes gb:AL049983.1 217288 at


mRNA; cDNA /DEF=Homo sapiens mRNA; cDNA


DI~FZp564D042 DI~FZp564D042 (from clone


(from clone DI~.FZp564D042). /FEA=mRNA


DI~F'Zp564D042) !DB_~~REF=gi:4884234 /UG=Hs.244136


Homo Sapiens mRNA; cDNA


SEQ ID NO: 29 DKFZp564D042 (from clone


(DNA) DKFZp564D042)


hypothetical gb:NM 017640.1 /DEF=Homo Sapiens 219573 at
protein


FLJ20048 hypothetical protein FLJ20048
(FLJ20048),


mRNA. /FEA=mRNA /GEN=FLJ20048


SEQ ID NOS: 30 /PROD=hypothetical protein FLJ20048


(DNA) and 147 /DB XREF=gi:8923056 /UG=Hs.116470


(amino acid) hypothetical protein FLJ20048


/FL=gb:NM 017640.1


hypothetical gb:NM 017655.1 /DEF=Homo Sapiens 219970 at
protein


FLJ20075 hypothetical protein FLJ20075
(FLJ20075),


mRNA. /FEA=mRNA /GEN=FLJ20075


SEQ ID NOS: 31 /PROD=hypothetical protein FLJ20075


(DNA) and 148 /DB XREF=gi:8923083 lUG=Hs.205058


(amino acid) hypothetical protein FLJ20075


/FL=gb:NM 017655.1


-52-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
interferon consensusConsensus includes gb:AI073984 204057 at
/FEA=EST


sequence bindingIDB_XREF=gi:3400628


protein 1 /DB XREF=est:oy66cO5.x1


/CLONE=IMAGE:1670792 /UG=Hs.14453


SEQ ID NO: 32 interferon consensus.sequence
binding protein


(DNA) 1 /FL=gb:M91196.1 gb:NM 002163.1


KIAA0690 proteinConsensus includes gb:AK000238.1216360 x at


/DEF=Homo Sapiens cDNA FLJ20231
fis,


SEQ ID NO: 33 clone COLF5511, highly similar
to


(DNA) AB014590 Homo sapiens mRNA for


I~IAA0690 protein. /FEA=mRNA


/DB_~REF=gi:7020188 /L1G=Hs.60103


I~IAA0690 protein


matrilin 3 . gb:NM_002381.2 /DEF=Homo Sapiens206091 at


matrilin 3 (MATN3) precursor,
mRNA.


SEQ ID NOS: 34 /FEA~nRNA /GEN=MATN3


(DNA) and 149 /PROD=matrilin 3 precursor


(aanino acid) !DB ~~REF=gi:13518040 !UG=Hs.278461


matrilin 3 /FL=gb:NM 002381.2


metastasis-associatedgb:NM 004739.1 /DEF=Homo Sapiens203444 s at


1-like 1 metastasis-associated 1-like
1 (MTA1L1),


mRNA. /FEA=mRNA /GEN=MTA 1 L
1


SEQ ID NOS: 35 /PROD=metastasis-associated 1-like
1


(DNA) and 150 /DB XREF=gi:4758739 /LTG=Hs.173043


(amino acid) metastasis-associated 1-like
1


/FL=gb:AB016591.1 gb:NM 004739.1


gb:AF295807.1


mucin 2, gb:NM 002457.1 /DEF=Homo Sapiens204673 at
mucin


intestinal/tracheal2, intestinaltracheal (MUC2),
mRNA.


/FEA=mRNA /GEN=MUC2 /PROD=mucin


SEQ ID NOS: 36 2, intestinaltracheal /DB XREF=gi:4505284


(DNA) and 151 /UG=Hs.315 mucin 2, intestinaltracheal


(amino acid) /FL=gb:NM 002457.1 gb:L21998.1


mucin 3B Consensus includes gb:AB038783.1214898 x at


/DEF=Homo sapiens MUC3B mRNA
for


SEQ ID NOS: 37 intestinal mucin, partial cds.
/FEA=mRNA


(DNA) and 152 /GEN=MUC3B /PROD=intestinal mucin


(amino acid) /DB XREF=gi:9929917 /UG=Hs.129782


mucin 3A, intestinal


myosin, heavy gb:NM_003802.1 /DEF=Homo sapiens208208 at


polypeptide 13, myosin, heavy polypeptide 13,
skeletal


skeletal muscle muscle (MYH13), mRNA. /FEA=mRNA


/GEN=MYH13 /PROD=myosin, heavy


SEQ ID NOS: 38 polypeptide 13, skeletal muscle


(DNA) and 153 /DB XREF=gi:11321578 /UG=Hs.278488


(amino acid) myosin, heavy polypeptide 13,
skeletal


muscle /FL=gb:NM 003802.1


b:AF111782.2


- 53 -



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
myosin, light gb:NM 002477.1 /DEF=Homo Sapiens 205145 s
at


polypeptide 5, myosin, light polypeptide 5, regulatory


regulatory (MYLS), mRNA. /FEA=mRNA


/GEN=MYLS /PROD=myosin, light


SEQ ID NOS: 39 polypeptide 5, regulatory ,


(DNA) and 154 /DB XREF=gi:4505304 /UG=Hs.170482


(amino acid) myosin, light polypeptide 5, regulatory


lFL=gb:L03785.1 gb:NM 002477.1


nuclear receptorgb:NM_000901.1 /DEF=Homo sapiens 205259 at


subfamily 3, nuclear receptor subfamily 3,
group C, group C,


member 2 member 2 (NR3C2), mRNA. /FEA=mRNA


/GEN NR3C2 /PROD=nuclear receptor


SEQ ID NOS: 40 subfamily 3, group C, member 2


(DNA) and 155 /DB XREF=gi:4505198 lUG=Hs.1790


(amino acid) nuclear receptor subfamily 3,
group C,


member 2 /FL=gb:M16801.1


gb:NM 000901.1


nuclear receptorConsensus includes gb:AF228413.1 210174 at


subfamily 5, /DEF=Homo Sapiens hepatocyte transcription
group A,


member 2 factor mRNA, 3UTR. /FEA=mRNA


lDB_XREF=gi:7677372 /LTG=Hs.183123


SEQ ID NOS: 41 nuclear receptor subfamily 5,
group A,


(DNA) and 156 member 2 /FL=gb:U93553.1 gb:AB019246.1


(amino acid) gb:AF124247.1


pancreas-enrichedgb:NM 016341.1 /DEF=Homo sapiens 205112 at


phospholipase pancreas-enriched phospholipase
C C


(LOC51196), mRNA. IFEA=mRNA


SEQ ID NOS: 42 /GEN=LOC51196 /PROD=pancreas-enriched


(DNA) and 157 phospholipase C /DB XREF=gi:7705940


(amino acid) /UG=Hs.6733 pancreas-enriched


phospholipase C /FL=gb:AF190642.2


gb:AF117948.1 gb:NM 016341.1


peroxisomal trapsgb:NM_018441.1 /DEF=Homo sapiens 221142 s_at
2-


enoyl CoA reductase;peroxisomal traps 2-enoyl CoA
reductase;


putative short putative short chain alcohol dehydrogenase
chain


alcohol (HSA250303), mRNA. /FEA=mRNA


dehydrogenase /GEN=HSA250303 !PROD=peroxisomal


traps 2-enoyl CoA reductase;putative
short


SEQ ID NOS: 43 chain alcohol dehydrogenase


(DNA) and 158 /DB XREF=gi:8923751 !UG=Hs.281680


(amino acid) peroxisomal traps 2-enoyl CoA
reductase;


putative short chain alcohol dehydrogenase


/FL=gb:NM 018441.1


phosducin gb:M33478.1 /DEF=Human 33-kDa 211496 s_at


phototransducing protein mRNA,
complete


SEQ ID NOS: 44 cds. IFEA=mRNA /DB XREF=gi:1771.86


(DNA) and 159 /LTG=Hs.550 phosducin


(amino acid) /FL= b:NM 022577.1 b:M33478.1


-54-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
b:AF076465.1


phosphatase and gb:NM 000314.1 /DEF=Homo sapiens204054 at


tensin homolog phosphatase and tensin homolog
(mutated in


(mutated in multiplemultiple advanced cancers 1)
(PTEN),


advanced cancersmRNA. /FEA=mRNA IGEN=PTEN
1)


/PROD=phosphatase and tensin
homolog


SEQ ID NOS: 45 (mutated inmultiple advanced
cancers 1)


(DNA) and 160 lDB XREF=gi:4506248 lUG=Hs.10712


(amino acid) phosphatase and tensin homolog
(mutated in


multiple advanced cancers 1)


/FL=gb:U92436.1 gb:U93051.1 gb:U96180.1


gb:NM 000314.1


potassium channel,gb:U90065.1 /DEF=Human potassium204678 s at


subfamily K, channel KCNO1 mRNA, complete
member cds.


1 (TWIK-1) /FEA=mRNA /PROD=potassium channel


KCNOl /DB XREF=gi:1916294


SEQ ID NOS: 46 /UG=Hs.79351 potassium channel,
subfamily


(DNA) and 161 K, member 1 (TWIK-1) /FL=gb:U33632.1


amino acid) b:U90065.1 b:U76996.1 b:NM_002245.1


prostaglandin- gb:NM 000963.1 /DEF=Homo sapiens204748 at


endoperoxide prostaglandin-endoperoxide synthase2


synthase 2 (prostaglandin GH synthase and


(prostaglandin cyclooxygenase) (PTGS2), mRNA.
G/H


synthase and /FEA=mRNA IGEN=PTGS2


cyclooxygenase) /PROD=prostaglandin-endoperoxide
synthase


2(prostaglandin GH synthase and


SEQ ID NOS: 47 cyclooxygenase) /DB XREF=gi:4506264


(DNA) and 162 /UG=Hs.196384 prostaglandin-endoperoxide


(amino acid) synthase 2 (prostaglandin GH
synthase and


cyclooxygenase) /FL=gb:M90100.1


gb:L15326.1 gb:NM 000963.1


protease inhibitorgb:NM 002638.1 /DEF=Homo Sapiens203691 at
3,


skin-derived protease inhibitor 3, skin-derived
(SKALP)


(SKALP) (PI3), mRNA. IFEA=mRNA lGEN=PI3


/PROD~rotease inhibitor 3, skin-derived


SEQ ID NOS: 48 (SKALP) /DB XREF=gi:4505786


(DNA} and 163 /UG=Hs.112341 protease inhibitor
3, skin-


(amino acid) derived (SKALP) /FL=gb:NM 002638.1


PTPRF interactingConsensus includes gb:AI692180 212841 s_at
/FEA=EST


protein, binding/DB XREF=gi:4969520


protein 2 (liprin/DB XREF=est:wd37f06.x1
beta


2) /CLONE=IMAGE:2330339 /LTG=Hs.12953


PTPRF interacting protein, binding
protein 2


SEQ ID NO: 49 (liprin beta 2)


(DNA)


retinoic acid Consensus includes gb:AI669229 221872 at
receptor IFEA=EST


responder (tazarotene/DB XREF=gi:4834003


induced) 1 /DB XREF=est:wc13e06.x1


-55-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
/CLONE=IMAGE:2315074 /UG=Hs.82547


SEQ TD NO: 50 retinoic acid receptor responder
(tazarotene


(DNA) induced) 1


Rho GTPase 015366.1 /DEF=Homo sapiens Rho 205980 s
gb:NM at


activating protein_
8 GTPase activating protein 8 (ARHGAPB),


mRNA. IFEA=mRNA /GEN=ARHGAP8


SEQ ID NOS: 51 /PROD=Rho GTPase activating protein
8


(DNA) and 164 /DB XREF=gi:7656903 /UG=Hs.102336


(amino acid) Rho GTPase activating protein
8


/FL= b:NM 015366.1


ribonuclease, gb:NM 002933.1 /DEF=Homo sapiens 201785 at
RNase


A family, 1 ribonuclease, RNase A family, )
1 (pancreatic


(pancreatic) (RNASE 1 ), mRNA. /FEA=mRNA


/GEN=RNASEl /PROD=ribonuclease,


SEQ ID NOS: 52 RNase A family, 1 (pancreatic)


(DNA) and 165 /DB XREF=gi:4506546 /UG=Hs.78224


(amino acid) ribonuclease, RNase A family,
1 (pancreatic)


/FL=gb:BC005324.1 gb:NM 002933.1


gb:D26129.1


serine (or cysteine)gb:NM 002639.1 /DEF=Homo Sapiens 204855 at
serine


proteinase inhibitor,(or cysteine) proteinase inhibitor,B
Glade


Glade B (ovalbumin),(ovalbumin), member 5 (SERPINBS),


member 5 mRNA. /FEA=mRNA /GEN=SERP1NB5


/PROD=serine (or cysteine) proteinase


SEQ ID NOS: 53 inhibitor, cladeB (ovalbuxnin),
member 5


(DNA) and 166 /DB XREF=gi:4505788 /UG=Hs.55279


(amino acid) serine (or cysteine) proteinase
inhibitor, Glade


B (ovalbumin), member 5


/FL=gb:NM 002639.1 gb:U04313.1


spondin 1, (f Consensus includes gb:AI885290 213994 s
spondin) /FEA=EST at


extracellular /DB XREF=gi:5590454
matrix


protein /DB XREF=est:w192a04.x1


/CLONE=IMAGE:2432334 /UG=Hs.5378


SEQ ID NO: 54 spondin l, (f spondin) extracellular
matrix


(DNA) rotein


superoxide dismutasegb:NM 003102.1 /DEF=Homo sapiens 205236 x
at


3, extracellularsuperoxide dismutase 3, extracellular
(SOD3),


mRNA. /FEA=mRNA /GEN=SODS


SEQ ID NOS: 55 /PROD=superoxide dismutase 3,
extracellular


(DNA) and 167 lDB_XREF=gi:4507150 /UG=Hs.2420


(amino acid) superoxide dismutase 3, extracellular


/FL=gb:J02947.1 gb:NM 003102.1


tumor necrosis gb:BC002794.1 /DEF=Homo Sapiens, 209354 at
factor tumor


receptor superfamily,necrosis factor receptor superfamily,
member


member 14 14 (herpesvirus entry mediator),
clone


(herpesvirus MGC:3753, mRNA, complete Gds.
entry


mediator) lFEA=mRNA /PROD=tumor necrosis
factor


rece for su erfamily,member 14
(he esvirus


-56-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
SEQ ID NOS: 56 entry mediator) /DB XREF=gi:12803894


(DNA) and 168 !UG=Hs.279899 tumor necrosis
factor


(amino acid) receptor superfamily, member
14 (herpesvirus


entry mediator) /FL=gb:BC002794.1


gb:U70321.1 gb:U81232.1 gb:NM
003820.1


gb:AF153978.1


tumor necrosis gb:NM 000043.1 /DEF=Homo Sapiens204781 s at
factor tumor


receptor superfamily,necrosis factor receptor superfamily,
member


member 6 6 (TNFRSF6), mRNA. /FEA=mRNA


/GEN=TNFRSF6 /PROD=apoptosis
(APO-1)


SEQ ID NOS: 57 antigen 1 /DB XREF=gi:4507582


(DNA) and 169 /LJG=Hs.82359 tumor necrosis
factor receptor


(amino acid) superfamily, member 6 /FL=gb:M67454.1


b:NM 000043.1


zinc finger proteingb:NM 003438.1 /DEF=Homo sapiens20?394 at
zinc


137 (clone pHZ-30)finger protein 137 (clone pHZ-30)
(ZNF137),


mRNA. /FEA=mRNA /GEN=ZNF 13 7


SEQ ID NOS: 58 /PROD=zinc finger protein 137
(clone pHZ-


(DNA) and 170 30) /DB XREF=gi:4507988 /LTG=Hs.151689


(amino acid) zinc finger protein 137 (clone
pHZ-30)


/FL=gb:NM 003438.1 gb:U09414.1


hypothetical Consensus includes gb:AI339568 222727 s_at
protein /FEA=EST


FLJ22233 /DB XREF=gi:4076495


/DB XREF=est:qk67e10.x1


SEQ ID NO: 59 /CLONE=IMAGE:1874058 /UG=Hs.286194


(DNA) hypothetical protein FLJ22233


/FL= b:NM 024959.1


regenerating gb:AY007243.1 /DEF=Homo Sapiens 223447 at
gene


type IV regenerating gene type IV mRNA,
complete


cds. /FEA=mRNA /PROD=regenerating
gene


SEQ ID NOS: 60 type IV /DB XREF=gi:12621025


(DNA) and 171 /LTG=Hs.105484 Homo Sapiens regenerating


(amino acid) gene type IV mRNA, complete cds


!FL=gb:AY007243.1


Homo sapiens Consensus includes gb:AK025615.1225285 at
cDNA:


FLJ21962 fis, /DEF=Homo Sapiens cDNA: FLJ21962
clone fis,


HEP05564 clone HEP05564. /FEA=mRNA


/DB XREF=gi:10438186 /UG=Hs.7567


SEQ ID NO: 61 Homo sapiens cDNA: FLJ21962 fis,
clone


(DNA) HEP05564


ESTs Consensus includes gb:N37023 225407 at
IFEA=EST


/DB XREF=gi:1158165


SEQ ID NO: 62 1DB XREF=est:yy40d03.s1


(DNA) /CLONE=IMAGE:273701 /UG=Hs.235883


ESTs


phosphoprotein Consensus includes gb:AI~000680.1225626 at


associated with /DEF=Homo sapiens cDNA FLJ20673
fis,


lycos hin oli clone I~AAIA4464. /FEA=mRNA
id-


-57-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
enriched /DB XREF=gi:7020924 /UG=Hs.266175


microdomains phosphoprotein associated with
GEMS


/FL=gb:AF240634.1 gb:NM_018440.1


SEQ ID NOS: 63


(DNA) and 172


(amino acid)


prostate cancer Consensus includes gb:AA633076 226167 at
/FEA=EST


associated proteinlDB_XREF=gi:2556490
7


/DB XREF=est:nq38a06.s1


SEQ ID NO: 64 /CLONE=IMAGE:1146130 /UG=Hs.27495


(DNA) rostate cancer associated rotein
7


Homo Sapiens, Consensus includes gb:AA524690 226168 at
/FEA=EST


Similar to RIKEN/DB XREF=gi:2265618


cDNA 1110060018 /DB XREF=est:ng38e07.s1


gene, clone /CLONE=IMAGE:937092 /UG=Hs.294143


MGC:17236 ESTs, Weakly similar to predicted
using


IMAGE:3864137, Genefinder C.elegans


mRNA, complete
cds


SEQ ID NO: 65


(DNA)


hypothetical Consensus includes gb:BF111925 226171 at
protein /FEA=EST


FLJ20209 /DB XREF=gi:10941704


/DB XREF=est:7138gO5.x1


SEQ ID NO: 66 /CLONE=IMAGE:3523784 /UG=Hs.3685


(DNA) h othetical rotein FLJ20209


Homo sapiens Consensus includes gb:AA532640 226484 at
mRNA /FEA=EST


for KIAA1190 /DB XREF=gi:2276894 .


protein, partial/DB XREF=est:nj 17c04.s1
cds


/CLONE=IMAGE:986598 /UG=Hs.206259


SEQ ID NOS: 67 Homo Sapiens mRNA for KIAA1190
protein,


(DNA) and 173 partial cds


(amino acid)


KIAA1543 proteinConsensus includes gb:AB040976.1226494 at


/DEF=Homo sapiens mRNA for KIAA1543


SEQ ID NOS: 68 protein, partial cds. /FEA=mRNA


(DNA) and 174 /GEN=KIAA1543 /PROD=KIAA1543


(amino acid) protein lDB_XREF=gi:7959352


/UG=Hs.17686 KIAA1543 protein


hypothetical Consensus includes gb:AK002203.1226992_at
protein


MGC20702 /DEF=Homo Sapiens cDNA FLJ11341
fis,


clone PLACE1010786. /FEA=mRNA


SEQ ID NO: 69 /DB XREF=gi:7023932 /UG=Hs.10260


(DNA) Homo sapiens cDNA FLJ11341 fis,
clone


PLACE1010786


Homo Sapiens Consensus includes gb:AA129774 227019 at
cDNA /FEA=EST


FLJ13137 fis, /DB XREF=gi:1690185
clone


NT2RP3003150 /DB XREF=est:z116h09.s1


-58-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
/CLONE=IMAGE:502145 /UG=Hs.288905


SEQ ID NO: 70 Homo sapiens cDNA FLJ13137 fis,
clone


(DNA) NT2RP3003150


hypothetical Consensus includes gb:AW138767 227180 at
protein


FLJ23563 /FEA=EST /DB XREF=gi:6143085


/DB_XREF=est:UI-H-BI1-aep-a-12-0-UI.
s 1


SEQ ID NO: 71 /CLONE=IMAGE:2719799 /UG=Hs.274256


(DNA) h othetical protein FLJ23563


ESTs Consensus includes gb:AW264333 227320 at


/FEA=EST /DB _X_RFF=gi:6641075


SEQ ID NO: 72 /DB XREF=est:xq98e01.x1


(DNA) !CLONE=IMAGE:2758680 !UG=Hs.21835


ESTs


ESTs Consensus includes gb:BF589359 227354 at
/FEA=EST


/DB XREF=gi:11681683


SEQ ID NO: 73 /DB XREF=est:nab25dOl.xl


(DNA) /CLONE=IMAGE:3266737 /UG=Hs.13256


ESTs


Homo sapiens, Consensus includes gb:AW001287 227676 at


Similar to RII~EN/FEA=EST /DB XREF=gi:5848203


cDNA 1810037020 lDB_XREF=est:wu27e06.x1


gene, clone /CLONE=IMAGE:2521282 /UG=Hs.61265


MGC:21481 ESTs, Weakly similar to G786_HUMAN


IMAGE:3852062, PROTEIN GS3786 H.sapiens


mRNA, complete
cds


SEQ ID NO: 74


(DNA)


ESTs, Weakly Consensus includes gb:AA557324 227702 at
similar /FEA=EST


to JX0331 laurate/DB XREF=gi:2327801


omega-hydroxylase/DB XREF=est:n181a02.s1


[H.sapiens] /CLONE=IMAGE:1057034 /UG=Hs.26040


ESTs, Weakly similar to fatty
acid omega-


SEQ ID NO: 75 hydroxylase H.sapiens


(DNA)


Homo Sapiens Consensus includes gb:T86159 227724 at
cDNA: /FEA=EST


FLJ22063 fis, /DB XREF=gi:714511
clone


HEP10326 /DB XREF=est:yd84h07.s1


/CLONE=IMAGE:114973 /UG=Hs.10450


SEQ ID NO: 76 Homo Sapiens cDNA: FLJ22063 fis,
clone


(DNA) HEP 10326


GalNAc alpha-2, Consensus includes gb:Y11339.2 227725 at
6-


sialyltransferase/DEF=Homo Sapiens mRNA for GalNAc
I,


long form alpha-2, 6-sialyltransferase
I, long form.


/FEA=mRNA /PROD=GaINAc alpha-2,6-


SEQ ID NOS: 77 sialyltransferase I /DB XREF=gi:7576275


(DNA) and 175 1UG=Hs.105352 GaINAc alpha-2,
6-


(amino acid) sialyltransferase I, long form


-59-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ESTs, Weakly Consensus includes gb:AI827789 228241 at
similar /FEA=EST


to JE0350 Anterior!DB XREF=gi:5448449


gradient-2 /DB XREF=est:wf33a07.x1


[H.sapiens] /CLONE=IMAGE:2357364 /LTG=Hs.100686


ESTs, Weakly similar to JE0350
Anterior


SEQ ID NO: 78 gradient-2 H.sapiens


(DNA)


ESTs Consensus includes gb:AI700341 228653 at
/FEA=EST


/DS ~~REF=gi:4988241


SEQ ID NO: 79 /DB XREF=est:wd06e10.x1


(DNA) /CLONE=IMAGE:2327370 /UG=Hs.110406


ESTs


ESTs Consensus includes gb:BG494007 228716 at
/FEA=EST


/DB XREF=gi:13455521


SEQ ID NO: 80 /DB XREF=est:602542289F1


(DNA) , /CLONE=IMAGE:4673182 /LTG=Hs.203213


ESTs


anterior gradientConsensus includes gb:AI922323 228969 at
2 /FEA=EST


(Xenepus laevis)/DB XREF=gi:5658287


homolog /DB XREF=est:wn90h03.x1


/CLONE=IMAGE:2453141 !UG=Hs.293380


SEQ ID NO: 81 ESTs


(DNA)


Homo sapiens Consensus includes gb:AK026984.1229021 at
cDNA:


FLJ23331 fis, /DEF=Homo sapiens cDNA: FLJ23331
clone fis,


HEP 12664 clone HEP 12664. /FEA=mRNA


/DB XREF=gi:10439980 /UG=Hs.50742


SEQ ID N0: 82 Homo Sapiens cDNA: FLJ23331 fis,
clone


(DNA) HEP 12664


ESTs Consensus includes gb:AI559300 229331 at
IFEA=EST


/DB XREF=gi:4509545


SEQ ID N0: 83 /DB XREF=estaq43d03.x1


(DNA) /CLONE=IMAGE:2211557 /UG=Hs.294140


ESTs


hypothetical Consensus includes gb:AI830823 229439 s at
protein /FEA=EST


/DB XREF=gi:5451416


SEQ ID NO: 84 !DB XREF=est:wj52b06.x1


(DNA) /CLONE=IMAGE:2406419 /UG=Hs.95549


by othetical rotein


ESTs Consensus includes gb:BF431989 229657 at
/FEA=EST


/DB XREF=gi:11444103


SEQ ID N0: 85 /DB XREF=est:nab84a05.x1


(DNA) /CLONE=IMAGE:3274280 ILTG=Hs.203213


ESTs


ESTs Consensus includes gb:BF589413 229893 at
/FEA=EST


/DB XREF=gi:11681737


SEQ ID NO: 86 /DB XREF=est:nab26b11.x1


(DNA) /CLONE=IMAGE:3267020 /UG=Hs.55501


-60-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ESTs


brain-specific Consensus includes gb:BG055052 230104_s_at
protein /FEA=EST


p25 alpha /DB XREF=gi:12512386


/DB XREF=est:nac94g06.x1


SEQ ID NO: 87 /CLONE=IMAGE:3441995 /UG=Hs.29353


(DNA) brain-s ecific rotein 25 al ha


Weakly similar Consensus includes gb:BF110588 230645 at
ESTs /FEA=EST
,


to MMHUE4 /DB XREF=gi:10940278


erythrocyte /DB XREF=est:7n39e12.x1


membrane protein/CLONE=IMAGE:3567071 /UG=Hs.150478


4.1, parent spliceESTs, Weakly similar to KIAA0987
protein


form [H.sapiens]H.sapiens


SEQ ID NO: 88


(DNA)


ESTs Consensus includes gb:BF592062 230760 at
/FEA=EST _


/DB XREF=gi:11684386


SEQ ID NO: 89 /DB XREF=est:7n98h06.x1


(DNA) /CLONE=IMAGE:3572962 /UG=Hs.233890


ESTs


nuclear Consensus includes gb:AI032108 230914 at
hepatocyte /FEA=EST _


factor 4, alpha /DB XREF=gi:3250320


/DB XREF=est:ow92dll.xl


SEQ D~ NO: 90 (CLONE=IMAGE:1654293 lUG=Hs.54424


(DNA) hepatocyte nuclear factor 4, alpha


ESTs Consensus includes gb:AW203959 230944 at


/FEA=EST /DB XREF=gi:6503431


SEQ ID NO: 91 /DB_XREF=est:UI-H-BI1-aeu-b-12-0-ULsl


(DNA) /CLONE=IMAGE:2720590 /UG=Hs.149532


ESTs


ESTs Consensus includes gb:AI139990 231022 at
/FEA=EST _


/DB ~~REF=gi:3647447


SEQ ID NO: 92 /DB XREF=est:qa47d03.x1


(DNA) /CLONE=IMAGE:1689893 /UG=Hs.134586


ESTs


ESTs Consensus includes gb:AI806131 231148 at
/FEA=EST _


/DB XREF=gi:5392697


SEQ ID NO: 93 /DB XREF=est:wf06c06.x1


(DNA) /CLONE=IMAGE:2349802 /UG=Hs.99376


ESTs


hypothetical Consensus includes gb:AB046810.1 232083 at
protein


FLJ23045 /DEF=Homo sapiens mRNA for KIAA1590


protein, partial cds. /FEA=mRNA


SEQ ID NO: 94 /GEN=KIAA1590 /PROD=KIAA1590


(DNA) protein /DB XREF=gi:10047254


/UG=Hs.101774 hypothetical protein


FLJ23045


Homo sa iens Consensus includes gb:AK026404.1 232321 at
cDNA:


-61-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
FLJ22751 fis, /DEF=Homo sapiens cDNA: FLJ22751
clone fis,


I~AIA0483, highlyclone KAIA0483, highly similar
to AF016692


similar to AF016692Homo sapiens small intestinal
mucin (MUC3)


Homo sapiens mRNA. /FEA~nRNA
small


intestinal mucin/DB XREF=gi:10439257 /LJG=Hs.271819


(MLTC3) mRNA Homo sapiens cDNA: FLJ22751 fis,
clone


I~AIA0483, highly similar to
AF016692


SEQ ID NO: 95 Homo sapiens small intestinal
mucin (MUC3)


(DNA) mRNA


Homo Sapiens Consensus includes gb:AC004908 232641 at
PAC


clone RP5-855D21/DEF=Homo Sapiens PAC clone RP5-


855D21 /FEA=CDS_3


SEQ ID NOS: 96 /DB XREF=gi:4156179 /LJG=Hs.249181


(DNA), 176 (aminoHomo Sapiens PAC clone RP5-855D21


acid), 177 (amino


acid), and 178
(amino


acid)


putative microtubule-Consensus includes gb:AJ251708.1234669 x at


binding protein /DEF=Homo Sapiens partial mRNA
for


putative microtubule-binding
protein.


SEQ ID NO: 97 /FEA=mRNA /PROD=putative microtubule-


(DNA) binding protein /DB XREF=gi:6491740


/UG=Hs.326544 putative microtubule-binding


rotein


ESTs Consensus includes gb:AI741469 234970 at
/FEA=EST


/DB XREF=gi:5109757


SEQ ID NO: 98 /DB XREF=est:wgllbOl.x1


(DNA) /CLONE=IMAGE:2364745 /UG=Hs.57787


ESTs


ESTs Consensus includes gb:AI417897 235444 at
IFEA=EST


/DB XREF=gi:4261401


SEQ ID NO: 99 /DB XREF=estag55b06.x1


(DNA) /CLONE=IMAGE:2112659 /UG=Hs.235860


ESTs


ESTs Consensus includes gb:AA827649 235515 at
/FEA=EST


/DB XREF=gi:2900090


SEQ ID NO: 100 !DB_~~REF=est:odOla12.s1


(DNA) /CLONE=IMAGE:1357918 /UG=Hs.105317


ESTs


ESTs Consensus includes gb:AI493909 235562 at
/FEA=EST


/DB _X_RFF=gi:4394912


SEQ ID NO: 101 /DB XREF=est:qz94e02.x1


(DNA) /CLONE=IMAGE:2042234 /UG=Hs.6131


ESTs


ESTs Consensus includes gb:AV741130 235651 at
/FEA=EST


/DB XREF=gi:10858711


SEQ ID NO: 102 /DB XREF=est:AV741130


(DNA) /CLONE=CBCATB06 /UG=Hs.173704


-62-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ESTs, Moderately similar to ALU8_HUMAN


ALU SUBFAMILY SX SEQUENCE


CONTAMINATION WARNING ENTRY


H.sa iens


ESTs, Weakly Consensus includes gb:AI864053 235678_at
similar /FEA=EST


to I38588 reverselDB_XREF=gi:5528160


transcriptase /DB XREF=est:wj55h10.x1
homolog


[H. sapiens] /CLONE=IMAGE:2406787 IUG=Hs.3
9972


ESTs, Weakly similar to I38588
reverse


SEQ ID NO: 103 transcriptase homolog H.sapiens


(DNA)


ESTs Consensus includes gb:AW339510 235866 at


/FEA=EST /DB XREF=gi:6836136


SEQ ID NO: 104 /DB XREF=est:xz91h08.x1


(DNA) /CLONE=IMAGE:2871615 /UG=Hs.42722


ESTs


ESTs Consensus includes gb:AI076192 236422 at
/FEA=EST


/DB XREF=gi:3405370


SEQ ID NO: 105 /DB XREF=est:oz01g07.x1


(DNA) /CLONE=IMAGE:1674108 /UG=Hs.131933


ESTs


ESTs Consensus includes gb:AL044570 236548 at
/FEA=EST


/DB XREF=gi:5432785


SEQ ID NO: 106 /DB XREF=est:DKFZp434L082_sl


(DNA) /CLONE=DI~FZp434L082 /LJG=Hs.147975


ESTs


ESTs Consensus includes gb:AI968097 237835 at
/FEA=EST


/DB XREF=gi:5764915


SEQ ID NO: 107 /DB XREF=est:wu13a12.x1


(DNA) /CLONE=IMAGE:2516830 /UG=Hs.131360


ESTs


ESTs Consensus includes gb:AI733801 237923 at
/FEA=EST


/DB XREF=gi:5054914


SEQ ID NO: 108 lDB_XREF=est:qk39c04.x5


(DNA) /CLONE=IMAGE:1871334 lUG=Hs.146186


ESTs


ESTs Consensus includes gb:BF594323 238103 at
/FEA=EST .


/DB XREF=gi:11686647


SEQ ID NO: 109 /DB XREF=est:7h79g07.x1


(DNA) /CLONE=IMAGE:3322236 /UG=Hs.158989


ESTs


Homo Sapiens, Consensus includes gb:T69015 /FEA=EST238422 at
clone


MGC:16402 /DB XREF=gi:684163


IMAGE:3940360, /DB XREF=est:yc31~4.s1


mRNA, complete /CLONE=IMAGE:82303 /LJG=Hs.192728
cds


ESTs


SEQ ID NO: 110


(DNA)


- 63 -



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ESTs Consensus includes gb:AA502384 238956 at
/FEA=EST


/DB_XKEF=gi:2237351


SEQ ID NO: 111 /DB XREF=est:ne27f1l.sl


(DNA) /CLONE=IMAGE:898605 /UG=Hs.151529


ESTs


ESTs Consensus includes gb:AI739241 238984 at
/FEA=EST


/DB XREF=gi:5101222


SEQ ID NO: 112 /DB XREF=est:wi14h02.x1


(DNA) /CLONE=IMAGE:2390259 fUG=Hs.171480


ESTs


ESTs Consensus includes gb:AA088446 239065 at
/FEA=EST


/DB XRFF=gi:1633958


SEQ ID NO: 113 /DB_XREF=est:z189f04.s1


(DNA) /CLONE=IMAGE:511807 /UG=Hs.170298


ESTs


ESTs Consensus includes gb:AI493046 239148 at
/FEA=EST


/DB XRFF=gi:4394049


SEQ ID NO: 114 /DB XREF=est:qz49b04.x1


(DNA) /CLONE=IMAGE:2030191 /LTG=Hs.146133


ESTs


ESTs Consensus includes gb:AI243098 239966 at
/FEA=EST


/DB XREF=gi:3838495


SEQ ID NO: 115 /DB XREF=est:qh26e03.x1


(DNA) /CLONE=IMAGE:1845820 lUG=Hs.178398


ESTs


ESTs, Weakly Consensus includes gb:AI633523 240106 at
similar /FEA=EST


to A49175 Motch /DB XREF=gi:4684853
B


protein - mouse /DB XREF=estah68b1 l.xl


[M.musculus] /CLONE=IMAGE:2123805 /LTG=Hs.44705


ESTs


SEQ ID NO: 116


(DNA)


ESTs Consensus includes gb:AI300126 240830 at
/FEA=EST


/DB XREF=gi:3959472


SEQ ID NO: 117 /DB XREF=est:qn54f02.x1


(DNA) /CLONE=IMAGE:1902075 lUG=Hs.257858


ESTs


ESTs Consensus includes gb:AI917390 240964 at
/FEA=EST


/DB~XR.EF=gi: 563 7245


SEQ ID NO: 118 /DB XREF=estas79a05.x1


(DNA) /CLONE=IMAGE:2237456 /UG=Hs.99415


ESTs


betacellulin Consensus includes gb:AI620677 241412iat
/FEA=EST


/DB XREF=gi:4629803


SEQ ID NO: 119 /DB XREF=estau85e09.x1


(DNA) /CLONE=IMAGE:2257864 /UG=Hs.154191


ESTs


ESTs Consensus includes gb:H05025 /FEA=EST241874 at


-64-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
/DB _X_RFF=gi:868577


SEQ ID NO: 120 /DB XREF=est:y174g12.s1


(DNA) /CLONE=IMAGE:43864 /UG=Hs.323767


ESTs


ESTs Consensus includes gb:AW024656 242358 at


/FEA=EST /DB XREF=gi:5878186


SEQ ID NO: 121 /DB XREF=est:wu78hO5.xl


(DNA) /CLONE=IMAGE:2526201 /UG=Hs.233382


ESTs, Moderately similar to AF119917
62


PR02822 H.sa iens


ESTs Consensus includes gb:BF696216 242626 at
/FEA=EST


/DB XREF=gi:11981624


SEQ ID NO: 122 /DB XREF=est:602124536F1


(DNA) /CLONE=IMAGE:4281632 /UG=Hs.188724


ESTs


ESTs Consensus includes gb:N57929 242978 x at
/FEA=EST


/DB XRFF=gi:1201819


SEQ ID NO: 123 /DB XREF=est:yv61e06.s1


(DNA) /CLONE=IMAGE:247234 /UG=Hs.48100


ESTs


ESTs, Weakly similarConsensus includes gb:AI457984 243729
/FEA=EST at


to ALU1_HUMAN /DB XREF=gi:4312002 _


ALU SUBFAMILY /DB XREF=estaj66a04.x1
J


SEQUENCE /CLONE=IMAGE:2146446 !UG=Hs.165900


CONTAMINATION ESTs, Weakly similar to ALUC_HLJMAN


WARNING ENTRY ! ! ! ! ALU CLAS S C WARNING
ENTRY ! ! !


[H.sapiens] H.sapiens


SEQ ID NO: 124


(DNA)


ESTs Consensus includes gb:AA581439 244650 at
lFEA=EST


/DB _X_RFF=gi:2359211


SEQ ID NO: 125 /DB XREF=est:nh13c10.s1


(DNA) /CLONE=IMAGE:952242 !UG=Hs.152328


ESTs


Biological Validation of Biomarker Candidates: Modulation of Expression by
Treatment with Ligands for EGFR or by Treatment with Inhibitors for EGFR
To validate the significance of the biomarker candidates to predict the
activity
of the EGFR pathway and thereby the sensitivity of cancer cell to inhibition
of EGFR
by therapy, genes that would be regulated by the EGFR pathway were identified.
Demonstration of that property for the EGFR biomaxker candidates described
above
would add additional credibility as it would link these genes functionally to
the EGFR
pathway. Colon cancer and a lung cancer cell lines were treated with epidermal
-65-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
growth factor, in the absence of serum or, in the presence of serum with the
EGFR
modulator BMS-461453 or the EGFR modulator cetuximab (also known as C225, a
chimeric monoclonal EGFR antibody). To identify genes induced by epidermal
growth factor, serum starved cells were treated with 20ng/ml EGF for 0.5, 6,
and 1 ~
hours. Control cells were treated with media alone. The expression profiling
was
performed, and data was analyzed using GeneChip~ Expression Analysis software
MAS 5.0 (Affymetrix, Santa Clara, California).
Genes inhibited by EGFR antagonists were identified by treating cells in the
presence of 10% serum with 0.5uM of BMS-461453 or lug/ml or 5ug/ml of C225 for
6 and 24 hours. Cells exposed to 0.05% DMSO were used as the experimental
control. Expression profiling was performed, and data were analyzed using
GeneChip~ Expression Analysis software MAS 5Ø
The gene expression of the inhibitor or EGFR treated cell lines was compared
pair-wise to the untreated controls. Polynucleotides from the biomarker list,
in which
expression was increased two fold with EGFR exposure or decreased two fold
with
EGFR inhibitor treatment compared to the untreated controls, were considered
to be
modulated by EGFR. These biomarkers are provided in Table 4. Examples of the
biomarkers include EphAl, B-cell translocation gene 2, prostaglandin-
endoperoxide
synthase 2 and serine (or cysteine) proteinase inhibitor (clade B), which are
highly
expressed in sensitive cells and up regulated by treatment with EGFR. On the
other
hand, spondin 1, talin 2 and nuclear receptor subfamily 3 are genes whose
expression
levels correlate with sensitivity or resistance of colon cancer cell lines and
are
consistently down regulated by treatment with EGFR inhibitors BMS-461453 and
C225. It appears that these biomarkers are likely to be directly or indirectly
involved
in the EGFR signaling pathway, based on their expression modulation by EGF or
EGFR inhibitor treatment.
Identification of Top Biomarkers
In an attempt to further prioritize biomarkers for use in predicting response
of
cancer cells to treatment with one or more EGFR modulators, the following
filter
criteria were used on the Table 4 biomarkers to identify a total of fourteen
biomaxkers
(Table 5) as the top biomarkers:
-66-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
(1) results from the highly significant correlation of gene expression with
ICSO:
A p-value < 0.01 in the student TTEST or a Pearson value < - 0.6 described
above;
(2) results from the modulation of expression by EGFR ligand and/or EGFR
inhibitor treatment described above; and
(3) biomarkers supported by literature revealing a direct relationship between
the EGFR pathway and the biomarkers.
TABLE 5 - Top Fourteen Biomarkers
Biomarker Name Literature SupportInduced by EGFI


Citation Inhibited by EGFR antagonist


mucin 2, J Biol Chem. 2002 Expression inhibited 2 fold
Aug by EGFR


intestinal/tracheal30;277(35):32258-67antagonist in GEO colon
cancer cell


MLTC2) line


intestinal mucinNo Expression inhibited 2 fold
3 by EGFR


(MLTC3) antagonist in GEO colon
cancer cell


line


Homo Sapiens No Expression stimulated 2
cystic fold by


fibrosis EGFR in H292 lung cancer
cell line


transmembrane


conductance


regulator


ATP-binding


cassette (sub-family


C, member 7)


(CFTR)


f spondin ~ No Expression inhibited 2 fold
by EGFR


(KIAA0762) protein antagonist in LOVO colon
cancer cell


line


3-hydroxy-3- J Invest Dermatol.Expression stimulated 3
2000 fold by


methylglutaryl-Jan;l 14(1):83-7 EGFR in H292 lung cancer
cell line


Coenzyme A


synthase 2


serine (or cysteine)Electrophoresis. Expression stimulated 2
2001 fold by


proteinase inhibitor,Aug;22(14):3001-8.EGFR in H292 lung cancer
cell line


Glade B


(ovalbumin),


member 5


(SERPINBS


BTG family, No Expression stimulated 2
fold by


member 2 (BTG2) EGFR in H292 lung cancer
cell line


talin 2 (TLN2) No Expression inhibited 2 fold
by EGFR


antagonist in GEO colon
cancer cell


line


arachidonic J Biol Chem. 1994 no
acid Aug


-67-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
a oxygenase 26;269(34):21786-92.


prostaglandin 3 Biol Chem. 1994Expression stimulated 6
G/H Aug fold by


synthase and 26;269(34):21786-92.EGFR in H292 lung cancer
cell line


cyclooxy enase


EphAl (EPHA1) No Expression stimulated 2
fold by


EGFR in CAC02 colon cancer
cell


line


hemoglobin, alphaNo Expression inhibited 2 fold
1 by EGFR


(HBA1) antagonist in GEO colon
cancer cell


line


bone morphogeneticDevelopment 2000 no


rotein 2 Nov;127(22):4993-5005


betacellulin Biochem Biophys no
(BTC)* Res


Commun. 2002 Jun


28;294(5):1040-6


*The gene betacellulin showed counter regulation with EGFR expression as
defined
for the EGFR-A list but had just a p value of 0.04 in the Student's TTest for
correlation with ICSO. It was still selected as a top biomarker for the strong
literature
support, as betacellulin is one of the published ligands of EGFR.
Utility of Biomarkers
Polynucleotides that correlate to a specific property of a biological system
can
be used to make predictions about that biological system and other biological
systems.
To show the predictive utility of biomarkers that correlate to EGFR modulator
sensitivity and resistance, these polynucleotides were tested for their
ability to predict
the response of twenty two colon cancer cell lines to a small molecule EGFR
modulator.
The invention includes single biomarkers including, for example, the fourteen
top biomarkers which were tested in a voting scheme. For that purpose, the
mean
expression value was calculated for all fourteen biomarkers. Colon cancer cell
lines
which showed an expression level above the mean were then voted to be
sensitive,
and colon cancer cell lines with expression levels below the mean were voted
to be
resistant. After this procedure, the voting was compared to the actual
sensitivity/resistance status according to the definition based on ICSQ (see
above) and
an error rate was calculated. The error rates of the fourteen top biomarkers
are shown
in Table 6.
TABLE 6 - Error Rates of Fourteen Top Biomarkers
~ Biomarker Name ~ Pearsons value ~ TTEST P value ~ Prediction error rate
mucin 2, -0.531 0.0083 20%
-68-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
intestinal/tracheal


(MUC2)


intestinal mucin-0.639 0.0004 11.72%
3


(MUC3)


Homo sapiens -0.646 9E-OS 5.9%
cystic


fibrosis


transmembrane


conductance


regulator


ATP-binding


cassette (sub-family


C, member 7)


(CFTR)


f spondin -0.622 0.0004 12.8%
.


(KIAA0762) protein


3-hydroxy-3- -0.575 0.0029 21.75%


methylglutaryl-


Coenzyme A


synthase 2


serine (or cysteine)-0.62 0.0028 21.75%


proteinase inhibitor,


Glade B


(ovalbumin),


member 5


(SERPINBS


BTG family, -0.544 0.0042 20.5%


member 2 (BTG2)


talin 2 (TLN2) -0.874 3E-OS 8.8%


E hAl (EPHAl) -0.647 0.0021 22%


hemoglobin, -0.744 8E-OS 20%
alpha 1


(HBAl)


bone morphogenetic-0.555 0.0091 31.8%


protein 2


betacellulin -0.536 0.047 43.5%
(BTC)


The biomarkers talin, the Cystic fibrosis conductance regulator (CFTR), and
mucin 3
were the best single biomarkers with error rates below 12%.
EXAMPLES
EXAMPLE 1 - METHODS
IC50 determination--in vitro cytotoxicity assay
A small molecule EGFR inhibitor, erlotinib HCl (BMS-461453), was tested
for cytoxicity in vitro against a panel of twenty-two human colon cancer cell
lines
-69-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
available from the American Type Culture Collection. Cytotoxicity was assessed
in
cells by MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carbaxymethoxyphenyl)-2-(4-
sulphenyl)-2H-tetrazolium, inner salt) assay (T.L. Riss et al., 1992, Mol.
Biol. Cell, 3
(Suppl.):184a).
To carry out the assays, the colon cells were plated at 4,000 cell/well in 96
well microtiter plates and 24 hours later serial diluted drugs were added. The
concentration range for the EGFR inhibitor was from 5 ~,g/ml to 0.0016 ~,g/ml
(roughly 10 ~,M to 0.0032 qM). The cells were incubated at 37 °C for 72
hours at
which time the tetrazolium dye MTS (333 ~.g/ml final concentration) in
combination
with the electron coupling agent phenazine methosulfate (25 ~M final
concentration)
was added. A dehydrogenase enzyme in live cells reduces the MTS to a form that
absorbs light at 492 nm that can be quantified spectrophotometrically. The
greater the
absorbency, the greater the number of live cells. The results were expressed
as an
ICSQ, which is the drug concentration required to inlubit cell proliferation
(i.e.,
absorbance at 450 nm) to 50% of that of untreated control cells. The mean ICSQ
and
standard deviation (SD) from multiple tests for each cell line were
calculated.
Resistant/sensitive classification
The cell lines with ICSO below 6 ~M were defined as sensitive to the EGFR
inhibitor, whereas those with ICSO above 6 ~,M were considered to be
resistant. The
resistant/sensitive classification are shown above in Table 1, with five cell
lines
classified as sensitive and seventeen cell lines classified as resistant.
Gene expression profiling
The colon cells were grown using standard cell culture conditions: RPMI
1640 supplemented to contain 10% fetal bovine serum, 100 IU/ml penicillin, 100
mg/ml streptomycin, 2 mM L-glutamine and 10 mM Hepes (all from GibcoBRL,
Rockville, Maryland). RNA was isolated from 50-70% confluent cells or drug-
treated
cells using the RNeasyT"" kits commercially available from Qiagen (Valencia,
California). Quality of the RNA was checked by measuring the 28s:18s ribosomal
RNA ratio using Agilent 2100 bioanalyzer (Agilent, Technologies, Rockville,
Maryland). Concentration of total RNA was determined spectrophotometrically.
10
-70-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
~,g of total RNA from each cell line was used to prepare biotinylated probe
according
to the Af~'ymetrix Genechip~ Expression Analysis Technical Manual, 2001.
Targets
were hybridized to AfFymetrix high density oligonucleotide array human HG-U133
set chips (Affymetrix, Santa Clara, California). Arrays were then washed, and
stained
using the GeneChip Fluidics station according to the manufacture's
instructions. The
HG-U133 set consisting of two GeneChip~ arrays contains nearly 45,000 probe
sets
representing more than 39,000 transcripts derived from approximately 33,000
well-
substantiated human genes.
Preprocessing of microarray data for selecting biomarkers
Scanned image files were visually inspected for artifacts and analyzed with
GeneGhip~ Expression Analysis software MAS 5.0 (Affymetrix, Santa Clara,
California). The "Detection Call" (see Affymetrix manual) was used to
determine
whether a transcript was detected within one sample, as well as the "Signal"
(see
Affymetrix Genechip° Expression Analysis Technical Manual, 2001)
which
measured the relative abundance of a transcript. The trimmed mean intensity
for each
chip was scaled to 1,500 (see Affymetrix manual) in order to account for any
minor
difFerences in global chip intensity, so that the overall expression level for
each cell
line is comparable. Affymetrix control sequences were removed prior to
analysis.
Induction Studies of colon and breast cell lines with EGFR inhibitors or EGFR
ligand
and selection of genes modulated by the inductions
The five colon cell lines and one lung cell line indicated with asterisks in
Table 1 were used in the drug induction study. Three of the colon cell lines
express
EGFR and are sensitive to the EGFR inhibitor BMS-461453. The SW480 cell line,
while expressing EGFR, is insensitive to the EGFR inhibitor, and the COL0320
DM
does not express EGFR and is EGFR inhibitor resistant. The lung cancer cell
line
H292 expresses EGFR, but its sensitivity status is unknown. Cells were seeded
in a
10 cm2 culture plate with the medium described above and cultured for 24
hours.
For the EGF induction studies, the colon cell line CAC02 and the lung cancer
H292 cell line were washed 2X PBS, and the media was changed to RPMI without
serum. The next day the cells were treated with 20 ng/ml EGF, and eventually
lysed
-71 _



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
i
for RNA isolation 0.5, 6 and 18 hours post treatment. Gene expression was
profiled
as described below.
EGFR inhibition studies were conducted on the colon cell lines GEO, CCD33-
CO, SW480 and COL0320DM. The expression profiling was performed as
described above and data was analyzed using GeneChip~ Expression Analysis
software MAS 5Ø The expression data of EGFR inhibitor treated cell lines
were
compared pair-wise to that of untreated same cell line. A change was
considered
significant if a two fold difference in expression was demonstrated between
the
treated and the untreated control. Analysis was done for all four cell lines
to compare
the gene expression with or without EGFR inhibitor treatment.
EXAMPLE 2 - RT-PCR EXPRESSION PROFILING
RNA quantification was performed using the SYBR Green real-time PCR.
The SYBR Green real-time PCR assay is one of the most precise methods for
assaying the concentration of nucleic acid templates.
RNA can be prepared using standard methods, preferably, employing the
RNeasy Kit commercially available from Qiagen (Valencia, California). cDNA
template for real-time PCR can be generated using the SuperscriptTM Fixst
Strand
Synthesis system for RT-PCR. SYBR Green real-time PCR reactions are prepared
as
follows: the reaction mix contains 20 ng first strand cDNA; 50 nM Forward
Primer;
50 nM Reverse Primer; 0.75X SYBR Green I (Sigma); 1X SYBR Green PCR Buffer
(SOmMTris-HCl pH 8.3, 75 mM KCl); 10% DMSO; 3 mM MgCl2; 300 ~M each
dATP, dGTP, dTTP, dCTP; 1 U Platinum~ Taq DNA Polymerase High Fidelity
(Cat# 11304-029; Life Technologies; Rockville, Maryland). Real-time PCR is
performed using an Applied Biosystems 5700 Sequence Detection System.
Conditions are 95 °C for 10 minutes (denaturation and activation of
Platinum~ Taq
DNA Polymerase), 40 cycles of PCR (95 °C for 15 seconds, 60 °C
for 1 minute).
PCR products are analyzed for uniform melting using an analysis algorithm
built into
the 5700 Sequence Detection System.
cDNA quantification used in the normalization of template quantity is
performed using SYBR Green real-time PCR. Expression of EGFR is normalized to
GAPDH expression as described below.
_72_



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
The sequences for the GAPDH oligonucleotides used in the SYBR Green real-
time PCR reactions are:
GAPDH-F: 5'-AGCCGAGCCACATCGCT-3' (SEQ ID NO: 191)
GAPDH-R: 5'-GTGACCAGGCGCCCAATAC-3' (SEQ ID NO: 192)
The sequences for the EGFR oligonucleotides used in the SYBR Green real-
time PCR reactions axe:
EGFR-F: 5'- GCGTCTCTTGCCGGAATGT-3' (SEQ ID NO: 193)
EGFR-R: 5'- AGCCGAGGCAGGGAATGCGTG-3' (SEQ ID NO: 194)
The Sequence Detection System generates a Ct (threshold cycle) value that is
used to calculate a concentration for each input cDNA template. cDNA levels
for
each gene of interest are normalized to GAPDH cDNA levels to compensate for
variations in total cDNA quantity in the input sample. This is done by
generating
GAPDH Ct values for each cell line. Ct values for the gene of interest and
GAPDH
are inserted into a modified version of the ~BCt equation (Applied Biosystems
Prism~ 5700 Sequence Detection System User Manual) which is used to calculate
a
GAPDH normalized relative cDNA level for each specific cDNA. The ~BCt equation
is: relative quantity of nucleic acid template =2ssct = 2~scta-sctb~~ where
BCta = Ct
target - Ct GAPDH, and BCtb = Ct reference - Ct GAPDH.
EXAMPLE 3 - PRODUCTION OF ANTIBODIES AGAINST THE BIOMARI~ERS
Antibodies against the biomarkers can be prepared by a variety of methods.
For example, cells expressing an biomarker polypeptide can be administered to
an
animal to induce the production of sera containing polyclonal antibodies
directed to
the expressed polypeptides. In one aspect, the biomarker protein is prepared
and
isolated or otherwise purified to render it substantially free of natural
contaminants,
using teclniiques commonly practiced in the art. Such a preparation is then
introduced
into an animal in order to produce polyclonal antisera of greater specific
activity for
the expressed and isolated polypeptide.
In one aspect, the antibodies of the invention are monoclonal antibodies (or
protein binding fragments thereof). Cells expressing the biomarker polypeptide
can
be cultured in any suitable tissue culture medium, however, it is preferable
to culture
cells in Earle's modified Eagle's medium supplemented to contain 10% fetal
bovine
-73-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
serum (inactivated at about 56 °C), and supplemented to contain about
10 g/1
nonessential amino acids, about 1,00 U/ml penicillin, and about 100 p,g/ml
streptomycin.
The splenocytes of immunized (and boosted) mice can be extracted and fused
with a suitable myeloma cell line. Any suitable myeloma cell line can be
employed in
accordance with the invention, however, it is preferable to employ the parent
myeloma cell line (SP2/0), available from the ATCC. After fusion, the
resulting
hybridoma cells are selectively maintained in HAT medium, and then cloned by
limiting dilution as described by Wands et al. (1981, Gastr-oenterology,
80:225-232).
The hybridoma cells obtained through such a selection are then assayed to
identify
those cell clones that secrete antibodies capable of binding to the
polypeptide
immunogen, or a portion thereof.
Alternatively, additional antibodies capable of binding to the biomarker
polypeptide can be produced in a two-step procedure using anti-idiotypic
antibodies.
Such a method makes use of the fact that antibodies are themselves antigens
and,
therefore, it is possible to obtain an antibody that binds to a second
antibody. In
accordance with this method, protein specific antibodies can' be used to
immunize an
animal, preferably a mouse. The splenocytes of such an immunized animal are
then
used to produce hybridoma cells, and the hybridoma cells are screened to
identify
clones that produce an antibody whose ability to bind to the protein-specific
antibody
can be blocked by the polypeptide. Such antibodies comprise anti-idiotypic
antibodies to the protein-specific antibody and can be used to immunize an
animal to
induce the formation of further protein-specific antibodies.
EXAMPLE 4 - IMMUNOFLUORESCENCE ASSAYS
The following immunofluorescence protocol may be used, for example, to
verify EGFR biomarker protein expression on cells or, for example, to check
for the
presence of one or more antibodies that bind EGFR biomarkers expressed on the
surface of cells. Briefly, Lab-Tek II chamber slides are coated overnight at 4
°C with
10 micrograms/milliliter (p.g/ml) of bovine collagen Type II in DPBS
containing
calcium and magnesium (DPBS++). The slides are then washed twice with cold
DPBS++ and seeded with 8000 CHO-CCRS or CHO pC4 transfected cells in a total
-74-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
volume of 125 p,l and incubated at 37 °C in the presence of 95% oxygen
/ 5% carbon
dioxide.
The culture medium is gently removed by aspiration and the adherent cells are
washed twice with DPBS++ at ambient temperature. The slides are blocked with
DPBS++ containing 0.2% BSA (blocker) at 0-4 °C for one hour. The
blocking
solution is gently removed by aspiration, and 125 p,l of antibody containing
solution
(an antibody containing solution may be, for example, a hybridoma culture
supernatant which is usually used undiluted, or serum/plasma which is usually
diluted, e.g., a dilution of about 1/100 dilution). The slides are incubated
for 1 hour at
0-4 °C. Antibody solutions are then gently removed by aspiration and
the cells are
washed five times with 400 ~l of ice cold blocking solution. Next, 125 ~1 of 1
~g/ml
rhodamine labeled secondary antibody (e.g., anti-human IgG) in blocker
solution is
added to the cells. Again, cells are incubated for 1 hour at 0-4 °C.
The secondary antibody solution is then gently removed by aspiration and the
cells are washed three times with 400 p,l of ice cold blocking solution, and
five times
with cold DPBS++, The cells are then fixed with 125 p,l of 3.7% formaldehyde
in
DPBS++ for 15 minutes at ambient temperature. Thereafter, the cells are washed
five
times with 400 pl of DPBS++ at ambient temperature. Finally, the cells are
mounted
in 50% aqueous glycerol and viewed in a fluorescence microscope using
rhodamine
filters.
-75-



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
SEQUENCE LISTING
<l10> Amler, Lukas C.
Januario, Thomas
<120> BIOMARKERS AND METHODS FOR DETERMINING SENSITIVITY TO EPIDERMAL
GROWTH FACTOR RECEPTOR MODULATORS
<130> D0304 PCT
<150> US 60/438,735
<151> 2003-01-08
<160> 194
<170> PatentIn version 3.2
<210> 1
<211> 2058
<2l2> DNA
<213> Human '
<400> 1
cggtttctgc tgggtttctg aactgctggg tttctgcttg ctcctctgga gatgcagcgt 60
ctgttgactc cagtgaagcg cattctgcaa ctgacaagag cggtgcagga aacctccctc 120
acacctgctc gcctgctccc agtagcccac caaaggtttt ctacagcctc tgctgtcccc 180
ctggccaaaa cagatacttg gccaaaggac gtgggcatcc tggccctgga ggtctacttc 240
ccagcccaatatgtggaccaaactgacctggagaagtataacaatgtggaagcaggaaag300


tatacagtgggcttgggccagacccgtatgggcttctgctcagtccaagaggacatcaac360


tccctgtgcctgacggtggtgcaacggctgatggagcgcatacagctcccatgggactct420


gtgggcaggctggaagtaggcactgagaccatcattgacaagtccaaagctgtcaaaaca480


gtgctcatggaactcttccaggattcaggcaatactgatattgagggcatagataccacc540


aatgcctgctacggtggtactgcctccctcttcaatgctgccaactggatggagtccagt600


tcctgggatggtcgttatgccatggtggtctgtggagacattgccgtctatcccagtggt660


aatgctcgtcccacaggtggggccggagctgtggctatgctgattggcccaaaggcccct720


ctggccctggagcgagggctgaggggaacccatatggagaatgtgtatgacttctacaaa780


ccaaatttggcctcggagtacccaatagtggatgggaagctttccatccagtgctacttg840


cgggccttggatcgatgttacacatcataccgtaaaaaaatccagaatcagtggaagcaa900


gctggcagcgatcgacccttcacccttgacgatttacagtatatgatctttcatacaccc960


ttttgcaagatggtccagaagtctctggctcgcctgatgttcaatgacttcctgtcagcc1020


agcagtgaca cacaaaccag cttatataag gggctggagg ctttcggggg gctaaagctg 1080
1/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gaagacacct acaccaacaa ggacctggat aaagcacttc taaaggcctc tcaggacatg 1140
ttcgacaaga aaaccaaggc ttccctttac ctctccactc acaatgggaa catgtacacc 1200
tcatccctgtacgggtgcctggcctcgcttctgtcccaccactctgcccaagaactggct1260


ggctccaggattggtgccttctcttatggctctggtttagcagcaagtttcttttcattt1320


cgagtatcccaggatgctgctccaggctctcccctggacaagttggtgtccagcacatca1380


gacctgccaaaacgcctagcctcccgaaagtgtgtgtctcctgaggagttcacagaaata1440


atgaaccaaagagagcaattctaccataaggtgaatttctccccacctggtgacacaaac1500


agccttttcccaggtacttggtacctggagcgagtggacgagcagcatcgccgaaagtat1560


gcccggcgtcccgtctaaaggtgttctgcagatccatggaaagcttcctgggaaacgtat1620


gctagcagagcttctccccgtgaatcatatttttaagatcccactcttagctggtaaatg1680


aatttgaatcgacatagtagccccataagcatcagccctgtagagtgaggagccatctct1740


agcgggcccttcattcctctccatgctgcaatcactgtcctgggcttatggtgcctatgg1800


actaggggtcctttgtgaaagagcaagatggagcaatggagagaagacctcttcctgaat1860


cactggactccagaaatgtgcatgcagatcagctgttgccttcaagatccagataaactt1920


tcctgtcatgtgttagaactttattattattaatattgttaaacttctgtgctgttcctg1980


tgaatctccaaattttgtaccttgttctaagctaatatatagcaattaaaaagagagaaa2040


gagaaaaaaa aaaaaaaa 2058
<210> 2
<211> 532
<212> DMA
<213> Human
<220>
<221> misc_feature
<222> (519)..(519)
<223> n is a, c, g, or t
<400> 2
taactatggaaaaccatgtttatttttaataaaggatgacatttccaatcagtaaaatat60


cataaaagtataaaaatgtactaagtacaatcattagcattatgttataggggaatagtg120


gttataacttttccctgtaagatggcacattggatggtcacagttggcttgatttacaga180


ggggcaagagtaggtgaccagttgtaccagttgctccagtttcctaggatttgggactct240


tgtaaaatgagaaagtcccaggcaaactgggacggttggtcctacaagaaaaagagcagc300


atcagagtgttggctatagtttggaacttaggaacaggatcagacattattttttaactt360


2/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ctccacctat tttcccttta gctgtgaaat aaaaatccct tttgttatta ctgagggtgt 420
tacagctttc agaggctttt ttaccactgg gtttcatgta attttgactt aatacctatg 480
tcaagcctgg gaagaaaggc agttctaatc aacttgcang tgtggcattc tg 532
<210>
3


<211>
1547


<212>
DNA


<213> n
Huma


<400>
3


ggggacttcttgaacttgcagggagaataacttgcgcaccccactttgcgccggtgcctt 60


tgccccagcggagcctgcttcgccatctccgagccccaccgcccctccactcctcggcct 120


tgcccgacactgagacgctgttcccagcgtgaaaagagagactgcgcggccggcacccgg 180


gagaaggaggaggcaaagaaaaggaacggacattcggtccttgcgccaggtcctttgacc 240


agagtttttccatgtggacgctctttcaatggacgtgtccccgcgtgcttcttagacgga 300


ctgcggtctcctaaaggtcgaccatggtggccgggacccgctgtcttctagcgttgctgc 360


ttccccaggtcctcctgggcggcgcggctggcctcgttccggagctgggccgcaggaagt 420


tcgcggcggcgtcgtcgggccgcccctcatcccagccctctgacgaggtcctgagcgagt 480


tcgagttgcggctgctcagcatgttcggcctgaaacagagacccacccccagcagggacg 540


ccgtggtgcccccctacatgctagacctgtatcgcaggcactcaggtcagccgggctcac 600


ccgccccagaccaccggttggagagggcagccagccgagccaacactgtgcgcagcttcc 660


accatgaagaatctttggaagaactaccagaaacgagtgggaaaacaacccggagattct 720


tctttaatttaagttctatccccacggaggagtttatcacctcagcagagcttcaggttt 780


tccgagaacagatgcaagatgctttaggaaacaatagcagtttccatcaccgaattaata 840


tttatgaaatcataaaacctgcaacagccaactcgaaattccccgtgaccagacttttgg 900


acaccaggttggtgaatcagaatgcaagcaggtgggaaagttttgatgtcacccccgctg 960


tgatgcggtggactgcacagggacacgccaaccatggattcgtggtggaagtggcccact 1020


tggaggagaaacaaggtgtctccaagagacatgttaggataagcaggtctttgcaccaag 1080


atgaacacagctggtcacagataaggccattgctagtaacttttggccatgatggaaaag 1140


ggcatcctctccacaaaagagaaaaacgtcaagccaaacacaaacagcggaaacgcctta 1200


agtccagctgtaagagacaccctttgtacgtggacttcagtgacgtggggtggaatgact 1260


ggattgtggctcccccggggtatcacgccttttactgccacggagaatgcccttttcctc 1320


tggctgatcatctgaactccactaatcatgccattgttcagacgttggtcaactctgtta 1380


3/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
actctaagat tcctaaggca tgctgtgtcc cgacagaact cagtgctatc tcgatgctgt 1440
accttgacga gaatgaaaag gttgtattaa agaactatca ggacatggtt gtggagggtt 1500
gtgggtgtcg ctagtacagc aaaattaaat acataaatat atatata 1547
<210> 4
<211> 5019
<212> DNA
<213> Human
<400> 4
gcctccgctg cagtcgctgc gtctccaagc aacatggctg acaaggccaa gcctgccaaa 60
gctgccaaca ggacgccccc caagtccccg ggggacccct cgaaggaccg ggcagccaag 120
aggctgtcgc tggaatcgga gggtgctggt gagggggcag ccgcatcccc tgagctcagt 180
gccctggaggaggccttccggcgctttgccgtgcacggggacgccagggccaccgggagg240


gagatgcacggcaagaactggtcgaagctgtgcaaggactgccaggtgatcgacggcagg300


aacgtgaccgtcactgacgtggacatcgtcttcagcaagatcaaagggaagtcttgccgg360


accatcacctttgagcagttccaggaggcgctggaggagctcgccaagaagcgattcaaa420


gacaagagcagcgaggaggccgttcgcgaggtgcacaggctcatcgagggcaaggcgccc480


atcatctcaggggtgacgaaagccatctcgtcgcccacagtgtcgaggctcacggacacc540


accaagttcacgggctcccacaaggagcgcttcgacccctctggcaagggcaagggcaag600


gctggccgcgtggatctggtggacgagtcaggctatgtgtccggctacaagcacgcaggc660


acctacgaccagaaggtgcaagggggcaagtagcccccgctccatgcctcgcggcactgc720


cggtgtccccagagcagggactctgtcacctcgcacttcattacattcctgtactaactg780


gggcagaactcagacgggtgccccagagggggctggggggcggccaggcccaggcctccc840


tcctgcccctcctcctaccggatgcccccagcactcccctctcaaaccaggtttgggccc900


cagttcgctgaccctcctaatacacctgcctcgtcctcagccatttccaaagtgtctcgc960


ggatcacaccacactgggcacgtggtttgcaggtcaaaggggcgttttaaagcagctggc1020


tgtcatggcaacaggaggctgtgctgacctcctgagcggcagacaccttccaggagccct1080


gagggtggcaggagctaaccccaaccagcaggcaactaacacggaattggccccacaccg1140


gacgtgggaggtgtctgtggggcccgaggcctgtcctgtgtgcagcggacaccacggggc1200


cttcctgctttcctgggcagagggcagagtgaggccacctggcgggggtgctgggcgcct1260


ggcacatgtgtggggaagccggtcacatggacacacctgtgcacacatgcctacaggcca1320


gctctgtgccaagggcaacctaggtaaaacgaaagccgtcaggggcagtgggcggcttcc1380


4/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
cggctgaccacagtggcttggactgtgagggtagagtaggctcgctttgctttcctgaga1440


agatgcggtggctgcctatgttctcagagcgggtctgggaagattcagaatgtccggtcc1500


ctgtggtgttgccaggcaagagacacgaagtgccgagacactcctcgcctcaccgcgtga1560


cagagcctctgcccggccctcccgttcgcccgtcctcactagctgcaccctgtttgctcg1620


cagacctcccattgccacagcccaagcaccttcttcaactctcccaaaatggctcagcct1680


aacctctcctggccaatcccccccgccggagagcaggacactagggaggacccccagtcc1740


tgcagtgtctgtgggggtttctctgccagcagggggctgagcagagcccatccaggacac1800


tccacactgccaggacacacccaggcggcccgcccttgcctgtctgcacctggggagaag1860


ccggcgctcctgctccctcctggggaggctgacgggtgtggccacccgctgtcacaatgg1920


cacactgccactgtcccttggcacgcacacagccacagccacacgtgtgacctgctgggc1980


cgtggttctggagtctacctgcggatgagcctgcggcagtcctggggaaacttttccaga2040


gcctgttagc'ccgtggctacggtcaggctctggccagggcagagggctgcccagggccag2100


gctcacagtacaggagggtggcgaggcccctccctcactggcacgcatgagcaccacccg2160


cctccccgactcccaagagtgcacctgctgcggccacagctccgtggaaggactccccct2220


acctgagcagagcagaagccccagggcggagctcccagccagcatggtccgctgagggct2280


ggggggcggtctccgaggcccctcaacagagaagcctccacctgaggatggggaggacct2340


ggcaggcagcttccacggcagggctgggaagttcagtgcctggaaataaagagcaaggaa2400


aaatggacctcaggcttcgtggctcctttaggatgtcacctcaccggcctggggaaggcg2460


gggggtgcccaagcccagccctgtgcccccgctgaacctggctggaccgcgtgtgaaagg2520


cagaactaacgtgcggaaacatttgaaaacaactctgaatgtgcggttcggaatcacccg2580


atcacagacgagcggtcaccggaatcgcccggtcacagacgagcagtcatcggactcacc2640


cgatcacagacgagcggtcaccggaatcgcccgatcacagacgagcggccaccggaatcg2700


cccaatcacagacaagcagtcatcggaatcacccgatcacagacgagcagtcatcggact2760


cacccgatcacagacgagcggtcaccagactcgcccgatcacagacgagcagtcatcgga2820


atcacccgatcacagacgagcagtcatcggactcacccgatcacagacgagcggtcacca2880


gaatcgcccgatcacagacgagcagtcatcggaatcacccgatcacagacgagtggccac2940


cggaatcacccgataacagcccatcacaactccaaagcccttgtgttgaaaaggccgagg3000


acgagtggtcaccaaacagggtggctccccaggtcccgaagcctgagacccggaaggccc3060


tggcacccttacaccctcggactcctgccctcctcggcctccctggccccagcgcggctc3120


caccctgggctgcgtctcctggtcacaggctgcgtttctcctttctgtccgtgggcagcc3180


5/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
cagtccccac agtcacggcc aagccacgca gaacgaacat gactccagag gacctcgccc 3240
tggagctgag cctggcgccg ggtcaggacg gagggaaggg cgggttgggg tccgcgggtc 3300
ctcacaccgc acggcaggca cagaggctcg ccaggccctg atccggtctg tggggacgag 3360
ggacactgag gagaggtgct gggcaccagg acgctgcctc ctggtccctg gttggcctca 3420
gacaagcacg gcctcgagaa aagagccaag cgcatcggga gcacaccaga aaccggccct 3480
gagcacgaga agagcctccg cccggcccgg gcaccacccg acctcgcagg gagcaggccc 3540
tgtcaccgac gggtcacctc gcccacacgg ccagcaccga ctcaccacag cccttcccag 3600
acctggctgg agtggccgga gcggcggggc tcatggctcc catcttggcc cctggaggtg 3660
agctcattca cagaagtggt cccttcactc tgagagagaa aatcgtggcg tgcatcccaa 3720
accctaggcc acgcctgtgg gtttcgtgaa tgagatcgag gctgctgtgg caccctgccc 3780
gtcctggcct ggagcaccct gggatcctgg agggagaggc cccacgcccc cactctccct 3840
ccacacttcc agggttggtg cccacgagtt agaggcacgg cctcccccag cggccctcag 3900
gcttttctca gacatgcggg agccaggaga gcacccttct ccactcagct ccaaagcgaa 3960
tctttgaaaa cacccactcg gctcccatct ctgtcaccta gccaggaggg gtagcaaaaa 4020
taaagtcacg aggacatagt ggtcaccact gtcagttaca acttgtctgt ggaatccgta 4080
attgcatctg tgtgccgcct ccgaacacag aacattgttt ggacggcagc cccactgcac 4140
ataacagacc cgtgcatctt cctcagtcag tttctgaata ttgtgaattc aggcaggtgt 4200
gtgttctctt ctgcatgttt ttatgcactg ccaattagct tctactaacc acggttcaac 4260
agaaaataaa tgtgtatttg tgaataacaa actgcacaac ctgcaaacca ggagagaggg 4320
acaggttctg tcaggggtga caccaggaca cagggacagg ttctgtcggg ggtgacacca 4380
ggacacaggg acaggttctg tcatgggtga cacgaggaca cagggacagg ttctatcatg 4440
ggtgacacca ggagagaggg acaggttctg ttgggggtga caagaggaga cagggacagg 4500
ttctgtcggg ggtgacacca ggagagaggg acaggttctg tcaggggtga caccaggaga 4560
gagggacagg ttctgttggg ggtgacacca ggacacagga ataggttctg tcgggaggac 4620
agtgctgatc gtgtctcagc atcaggaaag gagaaaggca gagggagagc gctgagaaga 4680
ctgttcacgc cagagtgctt atttattttt aatttactgc tataggataa gcaaccaggt 4740
agtgttccta acaattagcg ttaccaaaat taaagttcaa attatatgtt taaaatattg 4800
tagaagatat atatttatac tggactactt ttacaccttc taatatcctg tccaagtttg 4860
ggcgcagatg gtggagttgg gctggcatca tgtcctgtgg ccgccccact tgcctgttgg 4920
6/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tgccactcca tcccgggccc cagggatgcc agctcagggc tgaccacagc agccctgcgt 4980
gggcatcacc tcctacccca gcccccatcc tgggctgct 5019
<210> 5
<211> 1155
<212> DNA
<213> Human
<400>



atggattgcagtaacggatcggcagagtgtaccggagaaggaggatcaaaagaggtggtg60


gggacttttaaggctaaagacctaatagtcacaccagctaccattttaaaggaaaaacca120


gaccccaataatctggtttttggaactgtgttcacggatcatatgctgacggtggagtgg180


tcctcagagtttggatgggagaaacctcatatcaagcctcttcagaacctgtcattgcac240


cctggctcatcagctttgcactatgcagtggaattatttgaaggattgaaggcatttcga300


ggagtagataataaaattcgactgtttcagccaaacctcaacatggatagaatgtatcgc360


tctgctgtgagggcaactctgccggtatttgacaaagaagagctcttagagtgtattcaa420


cagcttgtgaaattggatcaagaatgggtcccatattcaacatctgctagtctgtatatt480


cgtcctgcattcattggaactgagccttctcttggagtcaagaagcctaccaaagccctg540


ctctttgtactcttgagcccagtgggaccttatttttcaagtggaacctttaatccagtg600


tccctgtgggccaatcccaagtatgtaagagcctggaaaggtggaactggggactgcaag660


atgggagggaattacggctcatctctttttgcccaatgtgaagacgtagataatgggtgt720


cagcaggtcctgtggctctatggcagagaccatcagatcactgaagtgggaactatgaat780


ctttttctttactggataaatgaagatggagaagaagaactggcaactcctccactagat840


ggcatcattcttccaggagtgacaaggcggtgcattctggacctggcacatcagtggggt900


gaatttaaggtgtcagagagatacctcaccatggatgacttgacaacagccctggagggg960


aacagagtgagagagatgtttagctctggtacagcctgtgttgtttgcccagtttctgat1020


atactgtacaaaggcgagacaatacacattccaactatggagaatggtcctaagctggca1080


agccgcatct tgagcaaatt aactgatatc cagtatggaa gagaagagag cgactggaca 1140
attgtgctat cctga 1155
<210> 6
<211> 2717
<212> DNA
<213> Human
<400> 6
cagggtaacg ctgtcttgtg gacccgcact tcccacccga gacctctcac tgagcccgag .60
7/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ccgcgcgcgacatgagccacgggaagggaaccgacatgctcccggagatcgccgccgccg120


tgggcttcctctccagcctcctgaggacccggggctgcgtgagcgagcagaggcttaagg180


tcttcagcggggcgctccaggaggcactcacagagcactacaaacaccactggtttcccg240


aaaagccgtccaagggctccggctaccgctgcattcgcatcaaccacaagatggacccca300


tcatcagcagggtggccagccagatcggactcagccagccccagctgcaccagctgctgc360


ccagcgagctgaccctgtgggtggacccctatgaggtgtcctaccgcattggggaggacg420


gctccatctgcgtcttgtacgaggaggccccactggccgcctcctgtgggctcctcacct480


gcaagaaccaagtgctgctgggccggagcagcccctccaagaactacgtgatggcagtct540


ccagctaggcccttccgcccccgccctgggcgccgccgtgctcatgctgccgtgacaaca600


ggccaccacatacctcaacctggggaactgtatttttaaatgaagagctatttatatata660


ttatttttttttaagaaaggaggaaaagaaaccaaaagttttttttaagaaaaaaaatcc720


ttcaagggagctgcttggaagtggcctccccaggtgcctttggagagaactgttgcgtgc780


ttgagtctgtgagccagtgtctgcctataggagggggagctgttagggggtagacctagc840


caaggagaagtgggagacgtttggctagcaccccaggaagatgtgagagggagcaagcaa900


ggttagcaactgtgaacagagaggtcgggatttgccctgggggaggaagagaggccaagt960


tcagagctctctgtctcccccagccagacacctgcatccctggctcctctattactcagg1020


ggcattcatgcctggacttaaacaatactatgttatcttttcttttatttttctaatgag1080


gtcctgggcagagagtgaaaaggcctctcctgattcctactgtcctaagctgcttttctt1140


gaaatcatgacttgtttctaattctaccctcaggggcctgtagatgttgctttccagcca1200


ggaatctaaagctttgggttttctgagggggggaggagggaactggaggttattggggtt1260


aggatggaagggaactctgcacaaaacctttgctttgctagtgctgctttgtgtgtatgt1320


gtggcaaataatttgggggtgatttgcaatgaaattttgggacccaaagagtatccactg1380


gggatgttttttggccaaaactcttccttttggaaccacatgaaagtcttgatgctgctg1440


ccatgatccctttgagaggtggctcaaaagctacagggaactccaggtcctttattactg1500


ccttcttttcaaaagcacaactctcctctaaccctcccctcccccttcccttctggtcgg1560


gtcatagagctaccgtattttctaggacaagagttctcagtcactgtgcaatatgccccc1620


tgggtcccaggagggtctggaggaaaactggctatcagaacctcctgatgccctggtggg1680


cttagggaaccatctctcctgctctccttgggatgatggctggctagtcagccttgcatg1740


tattccttggctgaatgggagagtgccccatgttctgcaagactacttggtattcttgta1800


8/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gggccgacac taaataaaag ccaaaccttg ggcactgttt tttctccctg gtgctcagag 1860
cacctgtggg aaaggttgct gtctgtctca gtacaatcca aatttgtcgt agacttgtgc 1920
aatatatact gttgtgggtt ggagaaaagt ggaaagctac actgggaaga aactcccttc 1980
cttcaatttc tcagtgacat tgatgagggg tcctcaaaag acctcgagtt tcccaaaccg 2040
aatcaccttaagaaggacagggctagggcatttggccaggatggccaccctcctgctgtt2100


gccccttagtgaggaatcttcaccccacttcctctacccccaggttctcctccccacagc2160


cagtcccctttcctggatttctaaactgctcaattttgactcaaaggtgctatttaccaa2220


acactctccctacccattcctgccagctctgcctccttttcaactctccacattttgtat2280


tgccttcccagacctgcttccagtctttattgctttaaagttcactttgggcccacagac2340


ccaagagctaattttctggtttgtgggttgaaacaaagctgtgaatcactgcaggctgtg2400


ttcttgcatcttgtctgcaaacaggtccctgcctttttagaagcagcctcatggtctcat2460


gcttaatcttgtctctcttctcttctttatgatgttcactttaaaaacaacaaaacccct2520


gagctggactgttgagcaggcctgtctctcctattaagtaaaaataaatagtagtagtat2580


gtttgtaagctattctgacagaaaagacaaaggttactaattgtatgatagtgtttttat2640


atggaagaatgtacagcttatggacaaatgtacacctttttgttactttaataaaaatgt2700


agtaggataaaaaaaaa 2717


<210> 7
<211> 2249
<212> DNA
<2l3> Human
<400>
7


ctcctctacaaagaggtggacagagaagacagcagagaccatgggacccccctcagcccc 60


tccctgcagattgcatgtcccctggaaggaggtcctgctcacagcctcacttctaacctt 120


ctggaacccacccaccactgccaagctcactattgaatccacgccattcaatgtcgcaga 180


ggggaaggaggttcttctactcgcccacaacctgccccagaatcgtattggttacagctg 240


gtacaaaggcgaaagagtggatggcaacagtctaattgtaggatatgtaataggaactca 300


acaagctaccccagggcccgcatacagtggtcgagagacaatataccccaatgcatccct 360


gctgatccagaacgtcacccagaatgacacaggattctataccctacaagtcataaagtc 420


agatcttgtgaatgaagaagcaaccggacagttccatgtatacccggagctgcccaagcc 480


ctccatctccagcaacaactccaaccccgtggaggacaaggatgctgtggccttcacctg 540


tgaacctgaggttcagaacacaacctacctgtggtgggtaaatggtcagagcctcccggt 600


9/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
cagtcccaggctgcagctgtccaatggcaacatgaccctcactctactcagcgtcaaaag660


gaacgatgcaggat'cctatgaatgtgaaatacagaacccagcgagtgccaaccgcagtga720


cccagtcaccctgaatgtcctctatggcccagatgtccccaccatttccccctcaaaggc780


caattaccgtccaggggaaaatctgaacctctcctgccacgcagcctctaacccacctgc840


acagtactcttggtttatcaatgggacgttccagcaatccacacaagagctctttatccc900


caacatcactgtgaataatagcggatcctatatgtgccaagcccataactcagccactgg960


cctcaataggaccacagtcacgatgatcacagtctctggaagtgctcctgtcctctcagc1020


tgtggccaccgtcggcatcacgattggagtgctggccagggtggctctgatatagcagcc1080


ctggtgtattttcgatatttcaggaagactggcagattggaccagaccctgaattcttct1140


agctcctccaatcccattttatcccatggaaccactaaaaacaaggtctgctctgctcct1200


gaagccctatatgctggagatggacaactcaatgaaaatttaaagggaaaaccctcaggc1260


ctgaggtgtgtgccactcag,agacttcacctaactagagacagtcaaactgcaaaccatg1320


gtgagaaattgacgacttcacactatggacagcttttcccaagatgtcaaaacaagactc1380


ctcatcatgataaggctcttacccccttttaatttgtccttgcttatgcctgcctctttc1440


gcttggcaggatgatgctgtcattagtatttcacaagaagtagcttcagagggtaactta1500


acagagtgtcagatctatcttgtcaatcccaacgttttacataaaataagagatccttta1560


gtgcacccagtgactgacattagcagcatctttaacacagccgtgtgttcaaatgtacag1620


tggtccttttcagagttggacttctagactcacctgttctcactccctgttttaattcaa1680


cccagccatgcaatgccaaataatagaattgctccctaccagctgaacagggaggagtct1740


gtgcagtttctgacacttgttgttgaacatggctaaatacaatgggtatcgctgagacta1800


agttgtagaaattaacaaatgtgctgcttggttaaaatggctacactcatctgactcatt1860


ctttattctattttagttggtttgtatcttgcctaaggtgcgtagtccaactcttggtat1920


taccctcctaatagtcatactagtagtcatactccctggtgtagtgtattctctaaaagc1980


tttaaatgtctgcatgcagccagccatcaaatagtgaatggtctctctttggctggaatt2040


acaaaactcagagaaatgtgtcatcaggagaacatcataacccatgaaggataaaagccc2100


caaatggtggtaactgataatagcactaatgctttaagatttggtcacactctcacctag2160


gtgagcgcattgagccagtggtgctaaatgctacatactccaactgaaatgttaaggaag2220


aagatagatccaaaaaaaaaaaaaaaaaa 2249


<210> 8
<211> 3583
10/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
<212> DNA
<213> Human
<400>
8


gcttctaaagtgaagattcagttttcacttaaacaaccagcaagtcttgaagtctcttcc60


caagcaaatgggagcttctttggaccttggagcacacagaggattctactttctttaaaa120


ctttgttttcaggcaatttccctgagaaccgtttacttccagaagattggtggagcttga180


tctgaaggctggccatgaaatctcaaggtcaacattggtattccagttcagataaaaact240


gtaaagtgagctttcgtgagaagcttctgattattgattcaaacctgggggtccaagatg300


tggagaacctcaagtttctctgcataggattggtccccaacaagaagctggagaagtcca360


gctcagcctcagatgtttttgaacatctcttggcagaggatctgctgagtgaggaagacc420


ctttcttcctggcagaactcctctatatcatacggcagaagaagctgctgcagcacctca480


actgtaccaaagaggaagtggagcgactgctgcccacccgacaaagggtttctctgttta540


gaaacctgctctacgaactgtcagaaggcattgactcagagaacttaaaggacatgatct600


tccttctgaaagactcgcttcccaaaactgaaatgacctccctaagtttcctggcatttc660


tagagaaacaaggtaaaatagatgaagataatctgacatgcctggaggacctctgcaaaa720


cagttgtacctaaacttttgagaaacatagagaaatacaaaagagagaaagctatccaga780


tagtgacacctcctgtagacaag(~aagccgagtcgtatcaaggagaggaagaactagttt840


cccaaacagatgttaagacattcttggaagccttaccgagggcagctgtgtacaggatga900


atcggaaccacagaggcctctgtgtcattgtcaacaaccacagctttacctccctgaagg960


acagacaaggaacccataaagatgctgagatcctgagtcatgtgttccagtggcttgggt1020


tcacagtgcatatacacaataatgtgacgaaagtggaaatggagatggtcctgcagaagc1080


agaagtgcaatccagcccatgccgacggggactgcttcgtgttctgtattctgacccatg1140


ggagatttggagctgtctactcttcggatgaggccctcattcccattcgggagatcatgt1200


ctcacttcacagccctgcagtgccctagactggctgaaaaacctaaactctttttcatcc1260


aggcctgccaaggtgaagagatacagccttccgtatccatcgaagcagatgctctgaacc1320


ctgagcaggcacccacttccctgcaggacagtattcctgccgaggctgacttcctacttg1380


gtctggccactgtcccaggctatgtatcctttcggcatgtggaggaaggcagctggtata1440


ttcagtctctgtgtaatcatctgaagaaattggtcccaagacatgaagacatcttatcca1500


tcctcactgctgtcaacgatgatgtgagtcgaagagtggacaaacagggaacaaagaaac1560


agatgccccagcctgctttcacactaaggaaaaaactagtattccctgtgcccctggatg1620


cactttcaatatagcagagagtttttgttggttcttagacctcaaacgaatcattgggta1680


11/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
taacctccagcctcctgcccagcacaggaatcggtggtctccacctgtcattctagaaac1740


aggaaacaccgtgttttctgacacagtcaattctgattttctttttcttttgcaagtcta1800


aatgttagaaaactttctttttttggagatagtctcattctgtcacccagactggagtgc1860


aggggggcaatcacggctcactgtagtctcgacctcccaggctcaagctgtcctcccacc1920


tcagcctcccaagtagctgagactacaggtgtgtgtccatgcacagctaactttttattt1980


tttttgtggagatggggtttcactatgttgcctaagctggtctcaaactcctgggctcaa2040


gcgatcctcccacctcagcttctcaaagttctgggactacaggcatgaaatactgtgcct2100


ggcctggggaccaggtgcattttaaggttccttggtgttcaaaaaccacgttcttagcct2160


agattgagcttagattgcctctctagacaactaccccttagttataattctgtgtcccct2220


ctgcatgcccttaaacattggacagtgaggtcacagtccacccaccctctctctgatctc2280


ccccttcctaagacttctcttttgcacatctagtgaggtgaaaatttggtctatgccagg2340


cccatttcctgcttttgtgtaaggaaggtgctcacataggaagtttttatttggttagag2400


acaggtttccctgtaggaagatgatggctcatttacactcagctgctctgcaagcagaaa2460


ctttacaacctgatgtcatattccattttggactgggtgcggtgactcatgcctgtaatc2520


ccagtactctgggaagccaaggcaggcagatcacttgaggtcaggagttcgagaccagcc2580


tggccaatacggcaaaacctcatcattactaaaaacacaaaaattagccaggtgtggcgg2640


cgagcacctgtaatcccagctactcgggaggctgagacaggagaatctcttgaatccagg2700


aggcagaggctgtggtgagccaagatgacacaactgcactccagcttgggcaacagggcg2760


agaccttgtttaaaaaaaaaattcaatattggggttggaacatttcagttgccattgaca2820


gaacacccaattcaaattgactgaagcaaagaagggaatttattgcctctttcacattga2880


aacccaggagtggataacactggcttcaggcaaagcttgaatcaggactcaatctacagg2940


ccagcacctttctcttggccggatgtcctcagggctggcagatgcagtagactgcagtgg3000


acagtccccaccttgttactgctactacactttgctcctctggcccaaggcatgaggaga3060


gaggctgtgtcagaaactgaagctgttctcaggatcactgggctcttcttggcagagggg3120


atgtctggcttgcctgaagggagtggctctgtaaggacgccttgatgctttcttcattaa3180


gattttgagcatttttacgtacttgagcttttttttttttttttttcaatttctagagga3240


actttttctctgttaattcctggaactgtattttgaatccttaaaggtgagccctcatag3300


ggagatccaaagtcctgtggttaacgccttcatttatagatgaggcagctgaggcctggg3360


gatgtgaacaacctgctcacagtcctcatttactggatttgacttcagccaggtgaactg3420


12/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gaatgccttg gggcgtggaa gggcattagg agtgtttcat ttgatatgtg aatgctcata 3480
aaaaaatgtc aaggaatgaa gaacaacaac tctcagtggt gcctgcattt ataattattt 3540
atgtgaaagt caaattcatg tacagtaaat ttgttataag aat 3583
<210> 9
<21l> 5516
<2l2> DNA
<213> Human
<400>
9


ccggccggaattccggctggatttcctcccggacatgacggtcgagggccgcctgctcgt60


tcctgacagaattaacggcacagccaacaagatgaacggagctttggatcactcagacca120


accagacccagatgccattaagatgtttgtcggacagatcccccggtcatggtcggaaaa180


ggagctgaaagaactttttgagccttacggagccgtctaccagatcaacgtcctccggga240


ccggagtcagaaccctccgcagagtaaaggttgttgtttcgtaacattttatacaagaaa300


agctgcacttgaggcccagaatgcactgcacaatattaaaactttacctgggatgcatca360


tcccattcagatgaaacctgcagatagtgaaaagtccaacgctgtggaagacagaaaatt420


gttcataggaatggtttcgaagaaatgtaatgagaacgacatcagggtgatgttctctcc480


atttggccagatagaagaatgccggatcctccggggacctgatgggctgagtcgaggctg540


tgcgtttgtcacattttctacaagggcaatggcacagaatgcaatcaaagccatgcatca600


gtctcagaccatggagggctgctcttcacctatcgtggtgaagtttgctgacactcagaa660


ggacaaagagcaaaggcgcctccagcagcagctcgctcagcagatgcagcagctcaacac720


tgccacctgggggaacctgacagggctgggcggactgaccccacagtatctggcgctcct780


gcagcaggccacctcctccagcaacctgggtgcgttcagcggcattcaacaaatggcagg840


catgaatgctttacagttgcagaacctggcgacgctggctgctgctgcagctgcggccca900


gacctcagccaccagcaccaatgcaaaccctctctctaccacgagcagcgccctgggagc960


cctcacgagtcccgtggctgcttcaacccccaactccactgctggtgcagccatgaactc1020


cttgacctctctcgggactctgcaaggactggctggagccactgttggactgaataatat1080


taatgcactagcagttgctcaaatgctctcaggtatggcggctctgaatggaggacttgg1140


cgccacaggcttgacgaatggcacggctggcaccatggacgccctcacccaggcctactc1200


aggaattcaacagtacgcagccgccgcgctgcccactctgtacagccagagcctgctgca1260


gcagcagagcgctgcaggcagccagaaggaaggtccagagggggcaaacctctttattta1320


ccaccttccacaggaatttggagaccagcacattctgcagatgttcatgccttttggaaa1380


13/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tgttatctct gctaaagtct tcattgacaa acagaccaat ctgagcaagt gctttggttt 1440
tgttagctac gacaatccag tctctgcaca agctgctatc caagctatga atggctttca 1500
gatcggcatgaaacgcttgaaggtgcagctgaagcgttccaaaaacgacagcaaacctta1560


ctgatcctaaccccagaggctccctgctctcattttagctttcttaggacatcttcatgc1620


ccgttagttcatcgtttgcctagcatgtccctgtggcgtctcaaaaaaaagtttcatcgt1680


cccgtcattgtttctgatgtctttctgacctcacatcatatttggttctcctactgacct1740


ttgatctagtttgacctttgaaatttgcatgtgacctcatctagctatgaattctgggaa1800


gtcaatgtgaaaaacattgctgcattcatgcaagactgaaatttattattagacaaattc1860


attatagaaaaaacctgtggcaaaaacgtttctttcttattttttttcttttcctaaaac1920


agacttgaaagtattatacagggattggcattcttcccggtcactggtaacaatagcaat1980


atgtgtccagggacacagaatgttggtttctaacagactacttccaaaaacagtttgaga2040


aaaaaactgtctgattttaagtctctagaggtctgtaatagtttttacatttttcaggca2100


gtgtaaagttttttgataaggccattttaggtggctcactttctcattaagatatatata2160


tagaaccactttttgtagattagtataagaaaaatatttaccctgttttggggcaaatgc2220


tacctatttgtgtcaccttttgctgaactcacagttagacaatccatggtttaatgcaca2280


tgaaattacctatattttatactgtttcaatgtacaggagaaaggttactgtaaactgtg2340


ttatgttggtgcttctgtgaattaagttgtggtttcatcatgagtcttaatgttctttgt2400


tgataagacaagtttagaattggtttacttaatacaaaaaaaaaaaaaagaatttcaaaa2460


aaaaaagttgtttgcttaaaaaaaatttcatgtgagggaaaaaaaaaaaaacctattcca2520


gaataagttttgtgttggcttgtgaagcattgatgtcattttttttaattgtggactatt2580


tagatgtgtttgtgttcagcaaaatgtgatctgtttttttcttttaaagaaaaaaagtga2640


aaatatatagtgccaaattccaaaggtacttccttcctagagcttcagtgtgtttcttgt2700


gagaagtaatttgataacatgggtattttattatgtgttttgtataaatccctaatattt2760


aaaaaaaaaaacaaaacaaaaaaaggttacaaagtttgttaacttgctatcctgtggtct2820


tgttgcctgaaattgttattgtttgttatttctctctgatgttttttgtaagacattgta2880


taagtgcccatgtcccacttttttaaccactccgcacatcagtgctgtgaaggcaacctc2940


accatgtattttcttcataatctatggaaacctctaaggtgagaaagttttgaactttta3000


accctttctacccagagctatctggaatgttgatgactttttatactgtcatgatttgag3060


tttgttttggggtgtttccaatttggatttttttccctgcatctatcctctaagttgttt3120


cggtttgactactttgttctttggttaagatccaaaagaaaacagaaaacaattccacga3180


14/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ggccaatcta aagggaaaaa atcctacact acttttacta cttttgatta tttctcattt 3240
ttgggaaaag aattcctaat gtgctactag aattccttct tcagttttaa cgagtaattg 3300
gataaaccct gagggaaaac ggaggtagat tcagcaccta acaatcctgt atgcttttga 3360
gatcacgttt agtgctatgt cctagtctag aatattttca tataccttgc agtaaaacca 3420
ctttgtggca ggacagtctc ttgaggggtt ttgtttctgt ttcctaaata ctcctaaata 3480
atatttctaa tcagccatta tgctggggca tctctgatcc cagtaggtac ctctgaatat 3540
accaggtgtc tggagttaga agcccatagc cctttcccag cctttttggt ttttttaatt 3600
gaacacattt catctaagta aagctcagtt ctttatcaca atttactgac caaataccta 3660
gcaccagttc ctgctgccac tttttaaagt gccatatgac tttctacgaa caggtacctt 3720
gctgtcttga caaatcctaa tgtcacgcct acagccccaa cacaagctcc agtcttcctc 3780
ttcggcatgc cctggaagct tcttggcctc agctcccctt ccccgctcag caccctgtta 3840
ggatcagtgt gtgtggatgg gatagccctg ggatggaaag gactagcctc tactgatgca 3900
aaaaaacaaa aagcaacaca aacgtttcct tcttatagca catgcacttc cttacaatga 3960
catgatttgt attatcctca catgtgttta ctactgctgg ggccttcctt catcctctga 4020
gggctatttt gtactttctg cagcaatcag cttaataaca acacttattg cacctgtctc' 4080
tctctgagaa cacggtgtgt ctcgacacgt accacgtaac gtggaaacac aagagcccac 4140
cacttgaatt tctaagacca tttcattctg aaacttctta tcaattacct aaatctcaac 4200
gaaaaacaat ttactgaagc cgactcccct ccccatctcc ctctcaacct caacccacct 4260
gcatgcatctcccccagaggaaaacactgagggtaggggacagggaggctcaggacgcgc4320


cctctgaatcggagtgtttcttcttcacaagtcaccaagagaggacatgagggggaaagt4380


ccttttttgcccttctccaaaaaataaccttccacagagacaaactgtccttctatccac4440


ttttatcttttaataaatatcaaaaggaaaaagctgcaagggtgcaaagggcctgtgcca4500


gaagaaaacacacacagggaaaccgctttttttaatcaattgtagagaatagtcattttt4560


aatctaaattagagaattgtgatacaatggcagtcctcaaaggcgtaacgagttcatctt4620


tctttcaccataggggttatagttggcttgtgctactctggaatcattttactgtttgtt4680


tttattatcttaagtgctaattaaaaaaaaaataaaattttaaaaaaacctgtagtttca4740


ttacctttttgaataatgtcatacaaaaaatgtatttgtttttttgtgctgtgagaattg4800


atgtttgtagattaataatcattttgtttagaattacaaaatagtttttaaatattgtct4860


gagaaaagccaaagttaatgcaacctagtggaaactgtaagaccatttgagtattgtttg4920


15/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ttttattgat gcatttggat tttgttgttt gatggaattt gagccaaaaa aaaaaatacg 4980
caggctttcc tatttctaca actgattgta cttatgcatt ttgtaccagt ggaacttttt 5040
atactggagattaaaaaaaaaatggaaatttttgtggcttgctctggtgggcccctgaca5100


atgactgatttcaagtttgatttcgggttgattgattgattgattgatagaaagaaagtt5160


gcttttcttttgagaattaaaaactttggcttgatttcttttttccctttgcttatatct5220


agcattagaattttgtcttaaaataacagcggtaagtttcactttttattctgtattgtg5280


cagttacacaataaggtaattagatttagaagtactcagtcactttaagtggataaatgt5340


attagttaaaactttagggtttgcttttttgctgtttagatcaaagttttttctgattct5400


tctgtcctcattgtgaacataaccgtgtagttgaaacagtcaaacttatttttgtaatgt5460


atgttattgtgtgatgcagtttttttgcttctgtctccaatattaaaccattttcc 5516


<210> 10
<211> 736
<212> DNA
<213> Human
<400>



ggctctcaccctcctctcctgcagctccagctttgtgctctgcctctgaggagaccatgg 60


cccggcctctgtgtaccctgctactcctgatggctaccctggctggggctctggcctcga 120


gctccaaggaggagaataggataatcccaggtggcatctatgatgcagacctcaatgatg 180


agtgggtacagcgtgcccttcacttcgccatcagcgagtacaacaaggccaccgaagatg 240


agtactacagacgcccgctgcaggtgctgcgagccagggagcagacctttgggggggtga 300


attacttcttcgacgtagaggtgggccgcaccatatgtaccaagtcccagcccaacttgg 360


acacctgtgccttccatgaacagccagaactgcagaagaaacagttgtgctctttcgaga 420
r


tctacgaagttccctgggaggacagaatgtccctggtgaattccaggtgtcaagaagcct 480


aggggtctgtgccaggccagtcacaccgaccaccacccactcccacccactgtagtgctc 540


ccacccctggactggtggcccccaccctgcgggaggcctccccatgtgcctgtgccaaga 600


gacagacagagaaggctgcaggagtcctttgttgctcagcagggcgctctgccctccctc 660


cttccttcttgcttctaatagacctggtacatggtacacacacccccacctcctgcaatt 720


aaacagtagc atcgcc 736
<210> 11
<211> 6129
<212> DNA
<213> Human
16/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
<400>
11


aattggaagcaaatgacatcacagcaggtcagagaaaaagggttgagcggcaggcaccca 60


gagtagtaggtctttggcattaggagcttgagcccagacggccctagcagggaccccagc 120


gcccgagaga~ccatgcagaggtcgcctctggaaaaggccagcgttgtctccaaacttttt 180


ttcagctggaccagaccaattttgaggaaaggatacagacagcgcctggaattgtcagac 240


atataccaaatcccttctgttgattctgctgacaatctatctgaaaaattggaaagagaa 300


tgggatagagagctggcttcaaagaaaaatcctaaactcattaatgcccttcggcgatgt 360


tttttctggagatttatgttctatggaatctttttatatttaggggaagtcaccaaagca 420


gtacagcctctcttactgggaagaatcatagcttcctatgacccggataacaaggaggaa 480


cgctctatcgcgatttatctaggcataggcttatgccttctctttattgtgaggacactg 540


ctcctacacccagccatttttggccttcatcacattggaatgcagatgagaatagctatg 600


tttagtttgatttataagaagactttaaagctgtcaagccgtgttctagataaaataagt 660


attggacaacttgttagtctcctttccaacaacctgaacaaatttgatgaaggacttgca 720


ttggcacatttcgtgtggatcgctcctttgcaagtggcactcctcatggggctaatctgg 780


gagttgttacaggcgtctgccttctgtggacttggtttcctgatagtccttgcccttttt 840


caggctgggctagggagaatgatgatgaagtacagagatcagagagctgggaagatcagt 900


gaaagacttgtgattacctcagaaatgattgaaaatatccaatctgttaaggcatactgc 960


tgggaagaagcaatggaaaaaatgattgaaaacttaagacaaacagaactgaaactgact 1020


cggaaggcagcctatgtgagatacttcaatagctcagccttcttcttctcagggttcttt 1080


gtggtgtttttatctgtgcttccctatgcactaatcaaaggaatcatcctccggaaaata 1140


ttcaccaccatctcattctgcattgttctgcgcatggcggtcactcggcaatttccctgg 1200


gctgtacaaacatggtatgactctcttggagcaataaacaaaatacaggatttcttacaa 1260


aagcaagaatataagacattggaatataacttaacgactacagaagtagtgatggagaat 1320


gtaacagccttctgggaggagggatttggggaattatttgagaaagcaaaacaaaacaat 1380


aacaatagaaaaacttctaatggtgatgacagcctcttcttcagtaatttctcacttctt 1440


ggtactcctgtcctgaaagatattaatttcaagatagaaagaggacagttgttggcggtt 1500


gctggatccactggagcaggcaagacttcacttctaatgatgattatgggagaactggag 1560


ccttcagagggtaaaattaagcacagtggaagaatttcattctgttctcagttttcctgg 1620


attatgcctggcaccattaaagaaaatatcatctttggtgtttcctatgatgaatataga 1680


tacagaagcgtcatcaaagcatgccaactagaagaggacatctccaagtttgcagagaaa 1740


17/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gacaatatagttcttggagaaggtggaatcacactgagtggaggtcaacgagcaagaatt1800


tctttagcaagagcagtatacaaagatgctgatttgtatttattagactctccttttgga1860


tacctagatgttttaacagaaaaagaaatatttgaaagctgtgtctgtaaactgatggct1920


aacaaaactaggattttggtcacttctaaaatggaacatttaaagaaagctgacaaaata1980


ttaattttgaatgaaggtagcagctatttttatgggacattttcagaactccaaaatcta2040


cagccagactttagctcaaaactcatgggatgtgattctttcgaccaatttagtgcagaa2100


agaagaaattcaatcctaactgagaccttacaccgtttctcattagaaggagatgctcct2160


gtctcctggacagaaacaaaaaaacaatcttttaaacagactggagagtttggggaaaaa2220


aggaagaattctattctcaatccaatcaactctatacgaaaattttccattgtgcaaaag2280


actcccttacaaatgaatggcatcgaagaggattctgatgagcctttagagagaaggctg2340


tccttagtaccagattctgagcagggagaggcgatactgcctcgcatcagcgtgatcagc2400


actggcccca cgcttcaggc acgaaggagg cagtctgtcc tgaacctgat gacacactca 2460
gttaaccaag gtcagaacat tcaccgaaag acaacagcat ccacacgaaa agtgtcactg 2520
gcccctcagg caaacttgac tgaactggat atatattcaa gaaggttatc tcaagaaact 2580
ggcttggaaataagtgaagaaattaacgaagaagacttaaaggagtgcctttttgatgat2640


atggagagcataccagcagtgactacatggaacacataccttcgatatattactgtccac2700


aagagcttaatttttgtgctaatttggtgcttagtaatttttctggcagaggtggctgct2760


tctttggttgtgctgtggctccttggaaacactcctcttcaagacaaagggaatagtact2820


catagtagaaataacagctatgcagtgattatcaccagcaccagttcgtattatgtgttt2880


tacatttacgtgggagtagccgacactttgcttgctatgggattcttcagaggtctacca2940


ctggtgcatactctaatcacagtgtcgaaaattttacaccacaaaatgttacattctgtt3000


cttcaagcacctatgtcaaccctcaacacgttgaaagcaggtgggattcttaatagattc3060


tccaaagatatagcaattttggatgaccttctgcctcttaccatatttgacttcatccag3120


ttgttattaattgtgattggagctatagcagttgtcgcagttttacaaccctacatcttt3180


gttgcaacagtgccagtgatagtggcttttattatgttgagagcatatttcctccaaacc3240


tcacagcaactcaaacaactggaatctgaaggcaggagtccaattttcactcatcttgtt3300


acaagcttaaaaggactatggacacttcgtgccttcggacggcagccttactttgaaact3360


ctgttccacaaagctctgaatttacatactgccaactggttcttgtacctgtcaacactg3420


cgctggttccaaatgagaatagaaatgatttttgtcatcttcttcattgctgttaccttc3480


atttccattttaacaacaggagaaggagaaggaagagttggtattatcctgactttagcc3540


18/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
atgaatatca tgagtacatt gcagtgggct gtaaactcca gcatagatgt ggatagcttg 3600
atgcgatctg tgagccgagt ctttaagttc attgacatgc caacagaagg taaacctacc 3660
aagtcaaccaaaccatacaagaatggccaactctcgaaagttatgattattgagaattca3720


cacgtgaagaaagatgacatctggccctcagggggccaaatgactgtcaaagatctcaca3780


gcaaaatacacagaaggtggaaatgccatattagagaacatttccttctcaataagtcct3840


ggccagagggtgggcctcttgggaagaactggatcagggaagagtactttgttatcagct3900


tttttgagactactgaacactgaaggagaaatccagatcgatggtgtgtcttgggattca3960


ataactttgcaacagtggaggaaagcctttggagtgataccacagaaagtatttattttt4020


tctggaacatttagaaaaaacttggatccctatgaacagtggagtgatcaagaaatatgg4080


aaagttgcagatgaggttgggctcagatctgtgatagaacagtttcctgggaagcttgac4140


tttgtccttgtggatgggggctgtgtcctaagccatggccacaagcagttgatgtgcttg4200


gctagatctgttctcagtaaggcgaagatcttgctgcttgatgaacccagtgctcatttg4260


gatccagtaacataccaaataattagaagaactctaaaacaagcatttgctgattgcaca4320


gtaattctctgtgaacacaggatagaagcaatgctggaatgccaacaatttttggtcata4380


gaagagaacaaagtgcggcagtacgattccatccagaaactgctgaacgagaggagcctc4440


ttccggcaagccatcagcccctccgacagggtgaagctctttccccaccggaactcaagc4500


aagtgcaagtctaagccccagattgctgctctgaaagaggagacagaagaagaggtgcaa4560


gatacaaggctttagagagcagcataaatgttgacatgggacatttgctcatggaattgg4620


agctcgtgggacagtcacctcatggaattggagctcgtggaacagttacctctgcctcag4680


aaaacaaggatgaattaagtttttttttaaaaaagaaacatttggtaaggggaattgagg4740


acactgatatgggtcttgataaatggcttcctggcaatagtcaaattgtgtgaaaggtac4800


ttcaaatccttgaagatttaccacttgtgttttgcaagccagattttcctgaaaaccctt4860


gccatgtgctagtaattggaaaggcagctctaaatgtcaatcagcctagttgatcagctt4920


attgtctagtgaaactcgttaatttgtagtgttggagaagaactgaaatcatacttctta4980


gggttatgattaagtaatgataactggaaacttcagcggtttatataagcttgtattcct5040


ttttctctcctctccccatgatgtttagaaacacaactatattgtttgctaagcattcca5100


actatctcat ttccaagcaa gtattagaat accacaggaa ccacaagact gcacatcaaa 5160
atatgcccca ttcaacatct agtgagcagt caggaaagag aacttccaga tcctggaaat 5220
cagggttagt attgtccagg tctaccaaaa atctcaatat ttcagataat cacaatacat 5280
19/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
cccttacctg ggaaagggct gttataatct ttcacagggg acaggatggt tcccttgatg 5340
aagaagttga tatgcctttt cccaactcca gaaagtgaca agctcacaga cctttgaact 5400
agagtttagc tggaaaagta tgttagtgca aattgtcaca ggacagccct tctttccaca 5460
gaagctccag gtagagggtg tgtaagtaga taggccatgg gcactgtggg tagacacaca 5520
tgaagtccaa gcatttagat gtataggttg atggtggtat gttttcaggc tagatgtatg 5580
tacttcatgc tgtctacact aagagagaat gagagacaca ctgaagaagc accaatcatg 5640
aattagtttt atatgcttct gttttataat tttgtgaagc aaaatttttt ctctaggaaa 5700
tatttattttaataatgtttcaaacatatattacaatgctgtattttaaaagaatgatta 5760


tgaattacatttgtataaaataatttttatatttgaaatattgactttttatggcactag 5820


tatttttatgaaatattatgttaaaactgggacaggggagaacctagggtgatattaacc 5880


aggggccatgaatcaccttttggtctggagggaagccttggggctgatcgagttgttgcc 5940


cacagctgtatgattcccagccagacacagcctcttagatgcagttctgaagaagatggt 6000


accaccagtctgactgtttccatcaagggtacactgccttctcaactccaaactgactct 6060


taagaagactgcattatatttattactgtaagaaaatatcacttgtcaataaaatccata 6120


catttgtgt 6129


<210> 12
<211> 1876
<212> DNA
<213> Human
<400>
12


gagccatgctcgcggcgatgggctctctggcggctgccctctgggcagtggtccatcctc 60


ggactctcctactgggcactgtcgcctttctgctcgctgctgactttctcaaaagacggc 120


gcccaaagaactacccgccggggccctggcgcctgcccttccttggcaacttcttccttg 180


tggacttcgagcagtcgcacctggaggttcagctgtttgtgaagaaatatgggaaccttt 240


ttagcttggagcttggtgacatatctgcagttcttattactggcttgcccttaatcaaag 300


aagcccttatccacatggaccaaaactttgggaaccgccccgtgacccctatgcgagaac 360


atatctttaagaaaaatggattgattatgtcaagtggccaggcatggaaggagcaaagaa 420


ggttcactctgacagcactaaggaactttggtttaggaaagaagagcttagaggaacgca 480


ttcaggaggaggcccaacacctcactgaagcaataaaagaggagaacggacagccttttg 540


accctcatttcaagatcaacaatgcagtttccaatatcatttgctccatcaccttcggag 600


aacgctttgagtaccaggatagttggtttcagcagctgctgaagttactagatgaagtca 660


20/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
catacttggaggcttcaaagacatgccagctctacaatgtctttccatggataatgaaat720


tcctgcctggaccccaccaaactctcttcagcaactggaaaaaactgaaattgtttgttt780


ctcatatgattgacaaacacagaaaggattggaatcctgcagaaacaagagactttattg840


atgcttaccttaaagaaatgtcaaagcacacaggcaatcctacttcaagtttccatgaag900


aaaacctcatctgcagcaccctggacctcttctttgccggaaccgagacaacttccacaa960


ctctgcgatgggctctgctttatatggccctctacccagaaatccaagaaaaagtacaag1020


ctgagattgacagagtgattggccaggggcagcagccgagcacagccgcccgggagtcca1080


tgccctacaccaatgctgtcatccatgaggtgcagagaatgggcaacatcatccccctga1140


acgttcccagggaagtgacagttgataccactttggctgggtaccacctgcccaagggta1200


ccatgatcctgaccaatttgacggcgctgcacagggaccccacagagtgggccacccctg1260


acacattcaatccggaccattttctggagaatggacagtttaagaaaagggaagccttta1320


tgcctttctcaataggaaagcgggcatgcctcggagaacagttggccaggactgagctgt1380


ttattttcttcacttcccttatgcaaaaatttaccttcaggcccccaaacaatgagaagc1440


tgagcctgaagtttagaatgggtatcaccatttccccagtcagtcaccgcctctgcgctg1500


ttcctcaggtgtaatattgttaagaaagaaaggggcaaggaaagtaagaagacatggcac1560


gtgttctgaaaccactggtgtctgctcagatgtgttgggacaaaatgaaagtgactttca1620


agaaagatcagaggaatttgactcagagaaaactagatccaaatcccagctctactgtct1680


cgtccgaattagccttgggaaaatcatttatatgctaaataatttacctttttatctagg1740


agatgaaaagaggataatgtttccttccataaagaaagttcttgtaagaatcaaaagaaa1800


tggtgagctttaagtggtttgtaaaccataaaacacatcataaaagttctatctataaaa1860


aaaaaaaaaaaaaaaa 1876


<210> 13
<211> 2375
<212> DNA
<2l3> Human
<400>
13


atgaagacaccgtggagggttctcctgggactgctgggtgctgctgcgcttgtcaccatc60


atcaccgtgcccgtggttctgctgaacaaaggcacagatgatgctacagctgacagtcgc120


aaaacttacactctaactgattacttaaaaaatacttatagactgaagttatactcctta180


agatggatttcagatcatgaatatctctacaaacaagaaaataatatcttggtattcaat240


gctgaatatggaaacagctcagttttcttggagaacagtacatttgatgagtttggacat300


21/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tctatcaatgattattcaatatctcctgatgggcagtttattctcttagaatacaactac 360


gtgaagcaatggaggcattcctacacagcttcatatgacatttatgatttaaataaaagg 420


cagctgattacagaagagaggattccaaacaacacacagtgggtcacatggtcaccagtg 480


ggtcataaattggcatatgtttggaacaatgacatttatgttaaaattgaaccaaattta 540


ccaagttacagaatcacatggacggggaaagaagatataatatataatggaataactgac 600


tgggtttatgaagaggaagtcttcagtgcctactctgctctgtggtggtctccaaacggc 660


acttttttagcatatgcccaatttaacgacacagaagtcccacttattgaatactccttc 720


tactctgatgagtcactgcagtacccaaagactgtacgggttccatatccaaaggcagga780


gctgtgaatccaactgtaaagttctttgttgtaaatacagactctctcagctcagtcacc840


aatgcaacttccatacaaatcactgctcctgcttctatgttgataggggatcactacttg900


tgtgatgtgacatgggcaacacaagaaagaatttctttgcagtggctcaggaggattcag960


aactattcggtcatggatatttgtgactatgatgaatccagtggaagatggaactgctta1020


gtggcacggcaacacattgaaatgagtactactggctgggttggaagatttaggccttca1080


gaacctcattttacccttgatggtaatagcttctacaagatcatcagcaatgaagaaggt1140


tacagacacatttgctatttccaaatagataaaaaagactgcacatttattacaaaaggc1200


acctgggaagtcatcgggatagaagctctaaccagtgattatctatactacattagtaat1260


gaatataaaggaatgccaggaggaaggaatctttataaaatccaacttagtgactataca1320


aaagtgacatgcctcagttgtgagctgaatccggaaaggtgtcagtactattctgtgtca1380


ttcagtaaagaggcgaagtattatcagctgagatgttccggtcctggtctgcccctctat1440


actctacacagcagcgtgaatgataaagggctgagagtcctggaagacaattcagctttg1500


gataaaatgctgcagaatgtccagatgccctccaaaaaattggacttcattattttgaat1560


gaaacaaaattttggtatcagatgatcttgcctcctcattttgataaatccaagaaatat1620


cctctactattagatgtgtatgcaggcccatgtagtcaaaaagcagacattgtcttcaga1680


ctgaactgggccacttaccttgcaagcacagaaaacattatagtagctagctttgatggc1740


agaggaagtggttaccaaggagataagatcatgcatgcaatcaacagaagactgggaaca1800


tttgaagttgaagatcaaattgaagcagccagacaattttcaaaaatgggatttgtggac1860


aacaaacgaattgcaatttggggctggtcatatggagggtacgtaacctcaatggtcctg1920


ggatcgggaagtggcgtgttcaagtgtggaatagccgtggcgcctgtatcccggtgggag1980


tactatgagtcagtgtacacagaacgttacatgggtctcccaactccagaagacaacctt2040


gaccattacagaaattcaacagtcatgagcagagctgaaaattttaaacaagttgagtac2100


22/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ctccttattc atggaacagc agatgataac gttcactttc agcagtcagc tcagatctcc 2160
aaagccctgg tcgatgttgg agtggatttc caggcaatgt ggtatactga tgaagaccat 2220
ggaatagcta gcagcacagc acaccaacat atatataccc acatgagcca cttcataaaa 2280
caatgtttct ctttacctta gcacctcaaa atactatgcc atttaaagct tattaaaact 2340
catttttgtt ttcattatct caaaaaaaaa aaaaa 2375
<210>
14


<211>
2248


<212>
DNA


<213> n
Huma


<400>
14


cccagcgccccggaagtgatctgtggcggctgctgcagagccgccaggaggagggtggat60


CtCCCCagagcaaagcgtcggagtcctcctCCtCCttCtCCtCCt tCCt CCtCCt120
CCtCC


ccagccgcccaggctcccccgccacccgtcagactcctccttcgaccgctcccggcgcgg180


ggccttccaggcgacaaggaccgagtaccctccggccggagccacgcagccgcggcttcc240


ggagccctcggggcggcggactggctcgcggtgcaggtaaagctccagatggctctggaa300


cttatgaggaaagagttggaggacgccttgactcaggaggccaacgtggggaaaaagact360


gtcatttggaaggagaaagtggaaatgcagaggcagcgcttcagattggagtttgagaag420


catcgtggctttctggcccaggaggagcaacggcagctgaggcggctggaggcggaggag480


cgagcgacgctgcagagactgcgggagagcaagagccggctggtccagcagagcaaggcc540


ctgaaggagctggcggatgagctgcaggagaggtgccagcgcccagccctgggtctgctg600


gagggtgtgagaggagtcctgagcagaagtaaggctgtcacaaggctggaagcagagaac660


atccccatggaactgaagacagcatgctgcatccctgggaggagggagctcttaaggaag720


ttccaagtggatgtaaagctggatcccgccacggcgcacccgagtctgctcttgaccgcc780


gacctgcgcagtgtgcaggatggagaaccatggagggatgtccccaacaaccctgagcga840


tttgacacatggccctgcatcctgggtttgcagagcttctcatcagggaggcattactgg900


gaggttctggtgggagaaggagcagagtggggtttaggggtctgtcaagacacactgcca960


agaaagggggaaaccatgccatctcctgagaatggggtctgggccctgtggctgctgaaa1020


gggaatgagtacatggtccttgcctccccatcagtgcctcttctccaactggaaagtcct1080


cgctgcattgggattttcttggactatgaagccggtgaaatttcattctacaatgtcaca1140


gatggatcttatatctacacattcaaccaactcttctctggtcttcttcggccttacttt1200


ttcatctgtgatgcaactcctcttatcttgccacccacgacaatagcagggtcaggaaat1260


23/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tgggcatccagggatcatttagatcctgcttctgatgtaagagatgatcatctctaaaat1320


tctgttcccaagatgcagtcctagcgtagcgaacgttcctggagtggggtgaaggatatc1380


aatatactaagttttaacagataccccatttaggtcagcacttgattcgttgttgctgtg1440


aaatatgtccatgggacaaaagagggaatatgaaatatttgcatatgggaagattataga1500


gcataataattttgtaaatggagcaatctcaacctctatttctagatcacattttcttga1560


tgtcttccttcaaattaatgaccttggattacataaggatttctatgcattcattataat1620


ttgttattcctttcaatatccttgtatttcaaatcttccatataagaattagacatggca1680


attcttaaattgattcagaatggtctgatactattccagtatcacctccttaattctgtt1740


tCtCCt ttCCtgattttCCttCtCattCt CtCCttCCCCgCtCtgtCtCtCtCtCC1800
Cgtt


ctgtcactctctctctctcgttccttattttttgtttcttacctcttactgtttaacctg1860


ttgcttccttctggattaatacatttagagccattcctttatatggtcacatttcctatg1920


actttactcaattacttttaaaatcctttctattctgagactaatttttaagaattacaa1980


agctcattcttctgaatctaatatcactaactcctagactttttccgttttctttggata2040


cactttaagtaggaatttatcagaattttcattcaactcgttctttaatgcagatattta2100


ctggttataagaccttaaggctgggtgcagtggctcacgcctgtggtcccagcgctttgg2160


ggggctgaggcgggtggatcacaggctcgggagttcggggccagcctggccagcatggtg2220


aaaccctgtctctactagaaaaaaaaaa 2248


<210> 15
<211> 330
<212> DNA
<213> Human
<400>
15


gcggccgcaggtacccgggctccacgtcagggtagacctggcgtccctcaatgccttcca60


tgtagttggccacgtaatccaccatctccttccctctccttcggaattcacttgcgttca120


tggtgtctgggctctgtcagaggtgaaaaatgctggaaattcgaattccttacagggcta180


ctctccttgatgggattctccaactttggggactgaagagcatgtggagaagctgctgag240


gcactcggcactgagacagtcactcttcttgaaactccaagccacacgtttccctcttct300


tgcatttccagccacatgtgcccctcgtgc 330


<210> 16
<211> 3370
<212> DNA
<213> Human
24/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
<400> 16
gcccccgccc ggcccgcccc gctctcctag tcccttgcaa cctggcgctg catccgggcc 60
actgtcccaggtcccaggtcccggcccggagctatggagcggcgctggcccctggggcta120


gggctggtgctgctgctctgcgccccgctgcccccgggggcgcgcgccaaggaagttact180


ctgatggacacaagcaaggcacagggagagctgggctggctgctggatcccccaaaagat240


gggtggagtgaacagcaacagatactgaatgggacacccctctacatgtaccaggactgc300


ccaatgcaaggacgcagagacactgaccactggcttcgctccaattggatctaccgcggg360


gaggaggcttcccgcgtccacgtggagctgcagttcaccgtgcgggactgcaagagtttc420


cctgggggagccgggcctctgggctgcaaggagaccttcaaccttctgtacatggagagt480


gaccaggatgtgggcattcagctccgacggcccttgttccagaaggtaaccacggtggct540


gcagaccagagcttcaccattcgagaccttgcgtctggctccgtgaagctgaatgtggag600


cgctgctctctgggccgcctgacccgccgtggcctctacctcgctttccacaacccgggt660


gcctgtgtggccctggtgtctgtccgggtcttctaccagcgctgtcctgagaccctgaat720


ggcttggcccaattcccagacactctgcctggccccgctgggttggtggaagtggcgggc780


acctgcttgccccacgcgcgggccagccccaggccctcaggtgcaccccgcatgcactgc840


agccctgatggcgagtggctggtgcctgtaggacggtgccactgtgagcctggctatgag900


gaaggtggcagtggcgaagcatgtgttgcctgccctagcggctcctaccggatggacatg960


gacacaccccattgtctcacgtgcccccagcagagcactgctgagtctgagggggccacc1020


atctgtacctgtgagagcggccattacagagctcccggggagggcccccaggtggcatgc1080


acaggtcccccctcggccccccgaaacctgagcttctctgcctcagggactcagctctcc1140


ctgcgttgggaacccccagcagatacggggggacgccaggatgtcagatacagtgtgagg1200


tgttcccagtgtcagggcacagcacaggacggggggccctgccagccctgtggggtgggc1260


gtgcacttctcgccgggggcccgggcgctcaccacacctgcagtgcatgtcaatggcctt1320


gaaccttatgccaactacacctttaatgtggaagcccaaaatggagtgtcagggctgggc1380


agctctggccatgccagcacctcagtcagcatcagcatggggcatgcagagtcactgtca1440


ggcctgtctctgagactggtgaagaaagaaccgaggcaactagagctgacctgggcgggg1500


tcccggccccgaagccctggggcgaacctgacctatgagctgcacgtgctgaaccaggat1560


gaagaacggtaccagatggttctagaacccagggtcttgctgacagagctgcagcctgac1620


accacataca tcgtcagagt ccgaatgctg accccactgg gtcctggccc tttctcccct 1680
gatcatgagt ttcggaccag cccaccagtg tccaggggcc tgactggagg agagattgta 1740
25/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gccgtcatctttgggctgctgcttggtgcagccttgctgcttgggattctcgttttccgg1800


tccaggagagcccagcggcagaggcagcagaggcacgtgaccgcgccaccgatgtggatc1860


gagaggacaagctgtgctgaagccttatgtggtacctccaggcatacgaggaccctgcac1920


agggagccttggactttacccggaggctggtctaattttccttcccgggagcttgatcca1980


gcgtggctgatggtggacactgtcataggagaaggagagtttggggaagtgtatcgaggg2040


accctcaggctccccagccaggactgcaagactgtggccattaagaccttaaaagacaca2100


tccccaggtggccagtggtggaacttccttcgagaggcaactatcatgggccagtttagc2160


cacccgcatattctgcatctggaaggcgtcgtcacaaagcgaaagccgatcatgatcatc2220


acagaatttatggagaatgcagccctggatgccttcctgagggagcgggaggaccagctg2280


gtccctgggcagctagtggccatgctgcagggcatagcatctggcatgaactacctcagt2340


aatcacaattatgtccaccgggacctggctgccagaaacatcttggtgaatcaaaacctg2400


tgctgcaaggtgtctgactttggcctgactcgcctcctggatgactttgatggcacatac2460


gaaacccagggaggaaagatccctatccgttggacagcccctgaagccattgcccatcgg2520


atcttcaccacagccagcgatgtgtggagctttgggattgtgatgtgggaggtgctgagc2580


tttggggacaagccttatggggagatgagcaatcaggaggttatgaagagcattgaggat2640


gggtaccggttgccccctcctgtggactgccctgcccctctgtatgagctcatgaagaac2700


tgctgggcatatgaccgtgcccgccggccacacttccagaagcttcaggcacatctggag2760


caactgcttgccaacccccactccctgcggaccattgccaactttgaccccagggtgact2820


cttcgcctgcccagcctgagtggctcagatgggatcccgtatcgaaccgtctctgagtgg2880


ctcgagtccatacgcatgaaacgctacatcctgcacttccactcggctgggctggacacc2940
,


atggagtgtgtgctggagctgaccgctgaggacctgacgcagatgggaatcacactgccc3000


gggcaccagaagcgcattctttgcagtattcagggattcaaggactgatccctcctctca3060


ccccatgcccaatcagggtgcaaggagcaaggacggggccaaggtcgctcatggtcactc3120


cctgcgccccttcccacaacctgccagactaggctatcggtgctgcttctgcccgcttta3180


aggagaaccctgctctgcaccccagaaaacctctttgttttaaaagggaggtgggggtag3240


aagtaaaaggatgatcatgggagggagctcaggggttaatatatatacatacatacacat3300


atatatattgttgtaaataaacaggaaatgattttctgcctccatcccacccatcagggc3360


tgcaggcact 3370


<210> 17
26/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
<211> 386
<212> DNA
<213> Human
<220>
<221> misc_feature
<222> (155)..(155)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (266)..(266)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (280)..(280)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (295)..(295)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (304)..(304)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (330)..(330)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (354)..(354)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (375)..(375)
<223> n is a, c, g, or t
<400> 17
gggaataagc ttgcgaccgc ttaattaaag atcttttttt tttttttttt ttttttttaa 60
gattcaagtc aaaattgttt tattgtcact cacatattta acataaaaag aaatgcagca 120
aatggctcag tatcgtattg aaaaaaaatc caggntgtgc agcttgttct attaacatct 180
gggagaagag ctgttcccac atcaggtcac agcagctgca gttctccaac gtccctttgc 240
agtacacagc cgtgggcaca cttggncaca gcccacgggn cagacaggta gcagncagct 300
cttnctttgc agggagggtg catttgcctn ctttgcactt gcagggagcc ggtncaggtt 360
ttagggagac acccnttggg tccagg 386
27/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
<210> 18
<211> 448
<212> DNA
<213> Human
<400>
18


tttgaattggatattttttaatgcaaattgttgtttttcttcatttgtctactttattaa60


gctgtcctcaggccccaagaaacatactgtcccctcatttagaaacagactaactccgtt120


ttcctccactatcccctcccctgtccttgatctgtagatcctgttaagacaggaaaaaca180


gtgttggtcaaagggtacacgctttcagttacaagatgaacaagttctgaatacgtaaga240


tagaacatgggaggtgatgtggccgggtgcagtgactcacgcctgtaatcccagcacttt300


gggaggccgaggtgggcggatcatgaggtcaagggatcgagatcatcctggccaacatgg360


tgaaaccccgtctctactaaaaatacaaaaattagctgggcatggtggcacacgcctata420


gtcccagctacttaggaggctgaggcaa 448


<210> 19
<211> 4574
<212> DNA
<213> Human
<400> 19
gagcgggcga gggagcgcgc gcggccgcca caaagctcgg gcgccgcggg gctgcatgcg 60
gcgtacctggcccggcgcggcgactgctctccgggctggcgggggccggccgcgagcccc120


gggggccccgaggccgcagcttgcctgcgcgctctgagccttcgcaactcgcgagcaaag180


tttggtggaggcaacgccaagcctgagtcctttcttcctctcgttccccaaatccgaggc240


agcccgcgggcgtcatgcccgcgctcctccgcagcctggggtacgcgctgaagcccggga300


ggcttggcgccggcgaagacccaaggaccactcttctgcgtttggagttgctccccacaa360


ccccgggctcgtcgctttctccatcccgacccagccggggcgcggggacaacacaggtcg420


cggaggagcgttgccattcaagtgactgcagcagcagcggcagcgcctcggttcctgagc480


ccaccgcaggctgaaggcattgcgcgtagtccatgcccgtagaggaagtgtgcagatggg540


attaacgtccacatggagatatggaagaggaccggggattggtaccgtaaccatggtcag600


ctggggtcgtttcatctgcctggtcgtggtcaccatggcaaccttgtccctggcccggcc660


ctccttcagtttagttgaggataccacattagagccagaagagccaccaaccaaatacca720


aatctctcaaccagaagtgtacgtggctgcgccaggggagtcgctagaggtgcgctgcct780


gttgaaagatgccgccgtgatcagttggactaaggatggggtgcacttggggcccaacaa840


28/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
taggacagtg cttattgggg agtacttgca gataaagggc gccacgccta gagactccgg 900
cctctatgct tgtactgcca gtaggactgt agacagtgaa acttggtact tcatggtgaa 960
tgtcacagat gccatctcat ccggagatga tgaggatgac accgatggtg cggaagattt 1020
tgtcagtgag aacagtaaca acaagagagc accatactgg accaacacag aaaagatgga 1080
aaagcggctccatgctgtgcctgcggccaacactgtcaagtttcgctgcccagccggggg1140


gaacccaatgccaaccatgcggtggctgaaaaacgggaaggagtttaagcaggagcatcg1200


cattggaggctacaaggtacgaaaccagcactggagcctcattatggaaagtgtggtccc1260


atctgacaagggaaattatacctgtgtggtggagaatgaatacgggtccatcaatcacac1320


gtaccacctggatgttgtggagcgatcgcctcaccggcccatcctccaagccggactgcc1380


ggcaaatgcctccacagtggtcggaggagacgtagagtttgtctgcaaggtttacagtga1440


tgcccagccccacatccagtggatcaagcacgtggaaaagaacggcagtaaatacgggcc1500


cgacgggctgccctacctcaaggttctcaagcactcggggataaatagttccaatgcaga1560


agtgctggctctgttcaatgtgaccgaggcggatgctggggaatatatatgtaaggtctc1620


caattatatagggcaggccaaccagtctgcctggctcactgtcctgccaaaacagcaagc1680


gcctggaagagaaaaggagattacagcttccccagactacctggagatagccatttactg1740


cataggggtcttcttaatcgcctgtatggtggtaacagtcatcctgtgccgaatgaagaa1800


cacgaccaagaagccagacttcagcagccagccggctgtgcacaagctgaccaaacgtat1860


ccccctgcggagacaggtaacagtttcggctgagtccagctcctccatgaactccaacac1920


cccgctggtgaggataacaacacgcctctcttcaacggcagacacccccatgctggcagg1980


ggtctccgagtatgaacttccagaggacccaaaatgggagtttccaagagataagctgac2040


actgggcaagcccctgggagaaggttgctttgggcaagtggtcatggcggaagcagtggg2100


aattgacaaagacaagcccaaggaggcggtcaccgtggccgtgaagatgttgaaagatga2160


tgccacagagaaagacctttctgatctggtgtcagagatggagatgatgaagatgattgg2220


gaaacacaagaatatcataaatcttcttggagcctgcacacaggatgggcctctctatgt2280


catagttgagtatgcctctaaaggcaacctccgagaatacctccgagcccggaggccacc2340


cgggatggagtactcctatgacattaaccgtgttcctgaggagcagatgaccttcaagga2400


cttggtgtcatgcacctaccagctggccagaggcatggagtacttggcttcccaaaaatg2460


tattcatcgagatttagcagccagaaatgttttggtaacagaaaacaatgtgatgaaaat2520


agcagactttggactcgccagagatatcaacaatatagactattacaaaaagaccaccaa2580


tgggcggctt ccagtcaagt ggatggctcc agaagccctg tttgatagag tatacactca 2640
29/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tcagagtgat gtctggtcct tcggggtgtt aatgtgggag atcttcactt tagggggctc 2700
gccctaccca gggattcccg tggaggaact ttttaagctg ctgaaggaag gacacagaat 2760
ggataagcca gccaactgca ccaacgaact gtacatgatg atgagggact gttggcatgc 2820
agtgccctcc cagagaccaa cgttcaagca gttggtagaa gacttggatc gaattctcac 2880
tctcacaaccaatgaggaatacttggacctcagccaacctctcgaacagtattcacctag2940


ttaccctgacacaagaagttcttgttcttcaggagatgattctgttttttctccagaccc3000


catgccttacgaaccatgccttcctcagtatccacacataaacggcagtgttaaaacatg3060


aatgactgtgtctgcctgtccccaaacaggacagcactgggaacctagctacactgagca3120


gggagaccatgcctcccagagcttgttgtctccacttgtatatatggatcagaggagtaa3180


ataattggaaaagtaatcagcatatgtgtaaagatttatacagttgaaaacttgtaatct3240


tccccaggaggagaagaaggtttctggagcagtggactgccacaagccaccatgtaaccc3300


ctctcacctgccgtgcgtactggctgtggaccagtaggactcaaggtggacgtgcgttct3360


gccttccttgttaattttgtaataattggagaagatttatgtcagcacacacttacagag3420


cacaaatgcagtatataggtgctggatgtatgtaaatatattcaaattatgtataaatat3480


atattatatatttacaaggagttattttttgtattgattttaaatggatgtcccaatgca3540


cctagaaaattggtctctctttttttaatagctatttgctaaatgctgttcttacacata3600


atttcttaattttcaccgagcagaggtggaaaaatacttttgctttcagggaaaatggta3660


taacgttaatttattaataaattggtaatatacaaaacaattaatcatttatagtttttt3720


ttgtaatttaagtggcatttctatgcaggcagcacagcagactagttaatctattgcttg3780


gacttaactagttatcagatcctttgaaaagagaatatttacaatatatgactaatttgg3840


ggaaaatgaagttttgatttatttgtgtttaaatgctgctgtcagacgattgttcttaga3900


cctcctaaatgccccatattaaaagaactcattcataggaaggtgtttcattttggtgtg3960


caaccctgtcattacgtcaacgcaacgtctaactggacttcccaagataaatggtaccag4020


cgtcctcttaaaagatgccttaatccattccttgaggacagaccttagttgaaatgatag4080


cagaatgtgcttctctctggcagctggccttctgcttctgagttgcacattaatcagatt4140


agcctgattctcttcagtgaattttgataatggcttccagactctttgcgttggagacgc4200


ctgttaggatcttcaagtcccatcatagaaaattgaaacacagagttgttctgctgatag4260


ttttggggatacgtccatctttttaagggattgctttcatctaattctggcaggacctca4320


ccaaaagatccagcctcatacctacatcagacaaaatatcgccgttgttccttctgtact4380


30/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aaagtattgt gttttgcttt ggaaacaccc actcactttg caatagccgt gcaagatgaa 4440
tgcagattac actgatctta tgtgttacaa:aattggagaa agtatttaat aaaacctgtt 4500
aatttttata ctgacaataa aaatgtttct acagatatta atgttaacaa gacaaaataa 4560
atgtcacgca actt 4574
<210>
20


<211>
546


<212>
DNA


<213>
Human


<400>
20


gatttctcccggaacctctgctcagcctggtgaaccacacaggccagcgctctgacatgc 60


agaaggtgaccctgggcctgcttgtgttcctggcaggctttcctgtcctggacgccaatg 120


acctagaagataaaaacagtcctttctactatgactggcacagcctccaggttggcgggc 180


tcatctgcgctggggttctgtgcgccatgggcatcatcatcgtcatgagtgcaaaatgca 240


aatgcaagtttggccagaagtccggtcaccatccaggggagactccacctctcatcaccc 300


caggctcagcccaaagctgatgaggacagaccagctgaaattgggtggaggaccgttctc 360


tgtccccaggtcctgtctctgcacagaaacttgaactccaggatggaattcttcctcctc 420


tgctgggactcctttgcatggcagggcctcatctcacctctcgcaagagggtctctttgt 480


tcaattttttttaatctaaaatgattgtgcctctccaaaaaaaaaaaaaaaaaaaaaaaa 540


aaaaaa 546


<210> 21
<211> 2880
<212> DNA
<213> Human
<400>
21


tgctgctctccgcccgcgtccggctcgtggccccctacttcgggcaccatggacacctcc 60


cggctcggtgtgctcctgtccttgcctgtgctgctgcagctggcgaccgggggcagctct 120


cccaggtctggtgtgttgctgaggggctgccccacacactgtcattgcgagcccgacggc 180


aggatgttgctcagggtggactgctccgacctggggctctcggagctgccttccaacctc 240


agcgtcttcacctcctacctagacctcagtatgaacaacatcagtcagctgctcccgaat 300


cccctgcccagtctccgcttcctggaggagttacgtcttgcgggaaacgctctgacatac 360


attcccaagggagcattcactggcctttacagtcttaaagttcttatgctgcagaataat 420


cagctaagac acgtacccac agaagctctg cagaatttgc gaagccttca atccctgcgt 480
ctggatgcta accacatcag ctatgtgccc ccaagctgtt tcagtggcct gcattccctg 540
31/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aggcacctgtggctggatgacaatgcgttaacagaaatccccgtccaggcttttagaagt600


ttatcggcattgcaagccatgaccttggccctgaacaaaatacaccacataccagactat660


gcctttggaaacctctccagcttggtagttctacatctccataacaatagaatccactcc720


ctgggaaagaaatgctttgatgggctccacagcctagagactttagatttaaattacaat780


aaccttgatgaattccccactgcaattaggacactctccaaccttaaagaactaggattt840


catagcaacaatatcaggtcgatacctgagaaagcatttgtaggcaacccttctcttatt900


acaatacatttctatgacaatcccatccaatttgttgggagatctgcttttcaacattta960


cctgaactaagaacactgactctgaatggtgcctcacaaataactgaatttcctgattta1020


actggaactgcaaacctggagagtctgactttaactggagcacagatctcatctcttcct1080


caaaccgtctgcaatcagttacctaatctccaagtgctagatctgtcttacaacctatta1140


gaagatttacccagtttttcagtctgccaaaagcttcagaaaattgacctaagacataat1200


gaaatctacgaaattaaagttgacactttccagcagttgcttagcctccgatcgctgaat1260


ttggcttggaacaaaattgctattattcaccccaatgcattttccactttgccatcccta1320


ataaagctggacctatcgtccaacctcctgtcgtcttttcctataactgggttacatggt1380


ttaactcacttaaaattaacaggaaatcatgccttacagagcttgatatcatctgaaaac1440


tttccagaactcaaggttatagaaatgccttatgcttaccagtgctgtgcatttggagtg1500


tgtgagaatgcctataagatttctaatcaatggaataaaggtgacaacagcagtatggac1560


gaccttcataagaaagatgctggaatgtttcaggctcaagatgaacgtgaccttgaagat1620


ttcctgcttgactttgaggaagacctgaaagcccttcattcagtgcagtgttcaccttcc1680


ccaggccccttcaaaccctgtgaacacctgcttgatggctggctgatcagaattggagtg1740


tggaccatagcagttctggcacttacttgtaatgctttggtgacttcaacagttttcaga1800


tcccctctgtacatttcccccattaaactgttaattggggtcatcgcagcagtgaacatg1860


ctcacgggagtctccagtgccgtgctggctggtgtggatgcgttcacttttggcagcttt1920


gcacgacatggtgcctggtgggagaatggggttggttgccatgtcattggttttttgtcc1980


atttttgcttcagaatcatctgttttcctgcttactctggcagccctggagcgtgggttc2040


tctgtgaaatattctgcaaaatttgaaacgaaagctccattttctagcctgaaagtaatc2100


attttgctctgtgccctgctggccttgaccatggccgcagttcccctgctgggtggcagc2160


aagtatggcgcctcccctctctgcctgcctttgccttttggggagcccagcaccatgggc2220


tacatggtcgctctcatcttgctcaattccctttgcttcctcatgatgaccattgcctac2280


32/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
accaagctctactgcaatttggacaagggagacctggagaatatttgggactgctctatg2340


gtaaaacacattgccctgttgctcttcaccaactgcatcctaaactgccctgtggctttc2400


ttgtccttctcctctttaataaaccttacatttatcagtcctgaagtaattaagtttatc2460


cttctggtggtagtcccacttcctgcatgtctcaatccccttctctacatcttgttcaat2520


cctcactttaaggaggatctggtgagcctgagaaagcaaacctacgtctggacaagatca2580


aaacacccaagcttgatgtcaattaactctgatgatgtcgaaaaacagtcctgtgactca2640


actcaagccttggtaacctttaccagctccagcatcacttatgacctgcctcccagttcc2700


gtgccatcaccagcttatccagtgactgagagctgccatctttcctctgtggcatttgtc2760


ccatgtctctaattaatatgtgaaggaaaatgttttcaaaggttgagaacctgaaaatgt2820


gagattgagtatatcagagcagtaattaataagaagagctgaggtgaaactcggtttaaa2880


<210> 22
<211> 5534
<212> DNA
<213> Human
<400>
22


tctcccgggagccactcccatgggcgcctctccagcccctggcctggaagcaccaggaac60


cctggggatggggcagaccctcacagcccggggtctggagccggtgtcggagctcatctg120


ggcccatgacctctccagacatttggcaaaatcaaggcccttagaccagggacagaccca180


agcccaggccctcccagaggtcctaggacgcaaccctttgtgcccttgggctctggaaga240


ggtttgggaagggtttggggtggaagatggcaaagagcagcttggccaggtgaggatgag300


gcagggcagacacaggccagtggggcgtgccatgtgccacagatggagaggaccaggagc360


cagtggcccggcaggcacagcccggttggcgtgggccagagcgcccatcactgacccgtg420


agaactcgactgcccctgccagctctggcactgccccctcccagccgccccgccctagca480


ccctggggggcaccccgcccaaccgtggcctggtccggcccctcccgccctttgctccag540


ttcccgggcttggcacctatagtgggggtgccgcccgcctgccaggctccggggccgggc600


ccacgggagggtggggcggctgggaagctggcacgctgccccgggggagcctctctcggc660


aggcgcccgggtgccgcgggggggagggggaacaaagggctcattctccccgtgcgcagc720


cggtggcatcgccggggcgttggcggaagcccccggggcccgggagggggcaggcccagg780


cgcggccgccgaatcacgggctcctgtttcccgcagggtgctggaggaggaaaccggcgg840


agcagcttccccactctcagttgcgcttctggcgatggcgatcagaggtcctgctgcgct900


ctccgccgcgctctacctccattagccgcgctgcgcggtgctgcgccctcgccggtgcct960


33/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ctctcctggg tcccaggatc ggcccccacc atccaggcac gacccccttc cccggcccct 1020
cggcctttcc cccaactcgg ccatctccga cccggggcgc gtgttccccc cggcccggcg 1080
ccttctctcc ctccgggggc acccgctccc tagccccggc ccggccctcc ccgcggcgca 1140
gcacggagtc tcggcgtccc atggcgcaac ctacggcctc ggcccagaag ctggtgcggc 1200
cgatccgcgc cgtgtgccgc atcctgcaga tcccggagtc cgacccctcc aacctgcggc 1260
cctagagcgc ccccgccgcc ccgggggaag gagagcgcga gcgcgctgag cagacagagc 1320
gggagaacgc gtcctcgccc gccggccggg aggccccgga gctggcccat ggggagcagg 1380
cgcccggtgc cggccacgac gaccgccacc gcccgcgccg cgaccggccg gtgaagccca 1440
gggacccccc tctgggagag ccccatgagg gcaggagagt gatggagagt acgcccagct 1500
tcctgaaggg caccccaacc tgggagaaga cggccccaga gaacggcatc gtgagacagg 1560
agcccggcag cccgcctcga gatggactgc accatgggcc gctgtgcctg ggagagcctg 1620
ctcccttttg gaggggcgtc ctgagcaccc cagactcctg gcttccccct ggcttccccc 1680
agggccccaa ggacatgctc ccacttgtgg agggcgaggg cccccagaat ggggagagga 1740
aggtcaactg gctgggcagc aaagagggac tgcgctggaa ggaggccatg cttacccatc 1800
cgctggcatt ctgcgggcca gcgtgcccac ctcgctgtgg ccccctgatg cctgagcata 1860
gtggtggcca tctcaagagt gaccctgtgg ccttccggcc ctggcactgc cctttccttc 1920
tggagaccaa gatcctggag cgagctccct tctgggtgcc cacctgcttg ccaccctacc 1980
tagtgtctgg cctgccccca gagcatccat gtgactggcc cctgaccccg cacccctggg 2040
tatactccgg gggccagccc aaagtgccct ctgccttcag cttaggcagc aagggctttt 2100
actacaagga tccgagcatt cccaggttgg caaaggagcc cttggcagct gcggaacctg 2160
ggttgtttgg cttaaactct ggtgggcacc tgcagagagc cggggaggcc gaacgccctt 2220
cactgcacca gagggatgga gagatgggag ctggccggca gcagaatcct tgcccgctct 2280
tcctggggca gccagacact gtgccctgga cctcctggcc cgcttgtccc ccaggccttg 2340
ttcatactct tggcaacgtc tgggctgggc caggcgatgg gaaccttggg taccagctgg 2400
ggccaccagc aacaccaagg tgcccctctc ctgagccgcc tgtcacccag cggggctgct 2460
gttcatccta cccacccact aaaggtgggg gtcttggccc ttgtgggaag tgccaggagg 2520
gcctggaggg gggtgccagt ggagccagcg aacccagcga ggaagtgaac aaggcctctg 2580
gccccagggc ctgtcccccc agccaccaca ccaagctgaa gaagacatgg ctcacacggc 2640
actcggagca gtttgaatgt ccacgcggct gccctgaggt cgaggagagg ccggttgctc 2700
ggctccgggc cctcaaaagg gcaggcagcc ccgaggtcca gggagcaatg ggcagtccag 2760
34/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
cccccaagcg gccaccggac ccttttccag gcactgcaga acagggggct gggggttggc 2820
aggaggtgcgggacacatcgatagggaacaaggatgtggactcgggacagcatgatgagc2880


agaaaggaccccaagatggccaggccagtctccaggacccgggacttcaggacataccat2940


gcctggctctccctgcaaaactggctcaatgccaaagttgtgcccaggcagctggagagg3000


gaggagggcacgcctgccactctcagcaagtgcggagatcgcctctgggaggggagctgc3060


agcaggaggaagacacagccaccaactccagctctgaggaaggcccagggtccggccctg3120


acagccggctcagcacaggcctcgccaagcacctgctcagtggtttgggggaccgactgt3180


gccgcctgctgcggagggagcgggaggccctggcttgggcccagcgggaaggccaagggc3240


cagccgtgacagaggacagcccaggcattccacgctgctgcagccgttgccaccatggac3300


tcttcaacacccactggcgatgtccccgctgcagccaccggctgtgtgtggcctgtggtc3360


gtgtggcaggcactgggcgggccagggagaaagcaggctttcaggagcagtccgcggagg3420


agtgcacgcaggaggccgggcacgctgcctgttccctgatgctgacccagtttgtctcca3480


gccaggctttggcagagctgagcactgcaatgcaccaggtctgggtcaagtttgatatcc3540


gggggcactgcccctgccaagctgatgcccgggtatgggcccccggggatgcaggccagc3600


agaaggaatcaacacagaaaacgcccccaactccacaaccttcctgcaatggcgacaccc3660


acaggaccaa gagcatcaaa gaggagaccc ccgattccgc tgagacccca gcagaggacc 3720
gtgctggccg agggcccctg ccttgtcctt ctctctgcga actgctggct tctaccgcgg 3780
tcaaactctg cttgggccat gagcgaatac acatggcctt cgcccccgtc actccggccc 3840
tgcccagtgatgaccgcatcaccaacatcctggacagcattatcgcacaggtggtggaac3900


ggaagatccaggagaaagccctggggccggggcttcgagctggcccgggtctgcgcaagg3960


gcctgggcctgcccctctctccagtgcggccccggctgcctcccccaggggctttgctgt4020


ggctgcaggagccccagccttgccctcggcgtggcttccacctcttccaggagcactgga4080


ggcagggccagcctgtgttggtgtcagggatccaaaggacattgcagggcaacctgtggg4140


ggacagaagctcttggggcacttggaggccaggtgcaggcgctgagccccctcggacctc4200


cccagcccagcagcctgggcagcacaacattctgggagggcttctcctggcctgagcttc4260


gcccaaagtcagacgagggctctgtcctcctgctgcaccgagctttgggggatgaggaca4320


ccagcagggtggagaacctagctgccagtctgccacttccggagtactgcgccctccatg4380


gaaaactcaacctggcttcctacctcccaccgggccttgccctgcgtccactggagcccc4440


agctctgggcagcctatggtgtgagcccgcaccggggacacctggggaccaagaacctct4500


35/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gtgtggaggtggccgacctggtcagcatcctggtgcatgccgacacaccactgcctgcct4560


ggcaccgggcacagaaagacttcctttcaggcctggacggggaggggctctggtctccgg4620


gcagccaggtcagcactgtgtggcacgtgttccgggcacaggacgcccagcgcatccgcc4680


gctttctccagatggtgcagggcctggtgagcacagtcagcgtcactcagcacttcctct4740


cccctgagacctctgccctctctgctcagctctgccaccagggacccagccttccccctg4800


actgccacctgctttatgcccagatggactgggctgtgttccaagcagtgaaggtggccg4860


tggggacattacaggaggccaaatagagggatgctaggtgtctgggatcggggtggggac4920


aggtagaccaggtgctcagcccaggcacaacttcagcaggggatggcgctaggggacttg4980


gggatttctggtcaaccccacaagcaccactctgggcacaagcagggcactctgttcccc5040


tcccccttaagccaacaaccacagtgccaccaagctcacacctgtccttctcaggctggc5100


atctcccccaccctgtgccccttttcatggtaccaggcccgcactgggggcaattgactt5160


cctccaatccccactcctccgagacccaggagacaaacagcccttccttggggaaacttg5220


ggaatcattctggcttaaacaacacctcctcctgctgctcactcccgctgagcccactct5280


actgccccagctccgtttctaccaccgcatcctcactgggctcactgcaggcatgctgaa5340


caaggggcctccaaccttctgccctcctgccaaaagatctggggagtgtgaggagagggt5400


ggcatcaggagctgctcaggcttggcggagggagcggcatgggcgatgtcactcagccce5460


ttcccggtccgcccgcttccctccttcatgatttccattaaagtctgttgttttgtgaaa5520


aaaaaaaaaa aaaa 5534
<210> 23
<211> 633
<212> DNA
<213> Human
<400> 23
actcttctgg tccccacaga ctcagagaga acccaccatg gtgctgtctc ctgccgacaa 60
gaccaacgtc aaggccgcct ggggtaaggt cggcgcgcac gctggcgagt atggtgcgga 120
ggccctggag aggatgttcc tgtccttccc caccaccaag acctacttcc cgcacttcga 180
cctgagccac ggctctgccc aggttaaggg ccacggcaag aaggtggccg acgcgctgac 240
caacgccgtg gcgcacgtgg acgacatgcc caacgcgctg tccgccctga gcgacctgca 300
cgcgcacaag cttcgggtgg acccggtcaa cttcaagctc ctaagccact gcctgctggt 360
gaccctggcc gcccacctcc ccgccgagtt cacccctgcg gtgcacgcct ccctggacaa 420
gttcctggct tctgtgagca ccgtgctgac ctccaaatac cgttaagctg gagcctcggt 480
36/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ggccatgcttcttgccccttgggcctccccccagcccctc ctccccttcc tgcacccgta540


cccccgtggtctttgaataaagtctgagtgggcggcaaaa aaaaaaaaaa aaaaaaaaaa600


aacaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa 633


<210> 24
<211> 393
<212> DNA
<213> Human
<220>


<22l>feature
misc


<222>_
(75) .(75)


<223>n is a, c, or
g, t


<220>


<221>feature
misc


<222>_
(81)..(81)


<223>n is a, c, or
g, t


<220>


<221>feature
misc


<222>_
(89) .(90)


<223>n is a, c, or
g, t


<220>


<221>feature
misc


<222>_
(95) . (95)


<223>n is a, c, or
g, t


<220>


<221>misc_feature


<222>(167)..(167)


<223>n is a, c, or
g, t


<220>


<221>misc_feature


<222>(179)..(179)


<223>n is a, c, or
g, t


<220>


<221>misc_feature


<222>(194)..(194)


<223>n is a, c, or
g, t


<220>


<221>feature
misc


<222>_
(237)..(237)


<223>n is a, c, or
g, t


<220>


<221>misc_feature


<222>(249)..(249)


<223>n is a, c, or
g, t


<220>
37/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
<221> misc_feature


<222> (276)..(276)


<223> n is a,
c, g, or t


<220>


<221> misc_feature


<222> (285)..(285)


<223> n is a,
c, g, or t


<220>


<221> misc_feature


<222> (295)..(295)


<223> n is a,
c, g, or t


<220>


<22l> misc_feature


<222> (312)..(312)


<223> n is a,
c, g, or t


<220>


<221> misc_feature


<222> (358)..(358)


<223> n is a,
c, g, or t


<220>


<221> misc_feature


<222> (370)..(370)


<223> n is a, or t
c, g,


<220>


<221> misc_feature


<222> (377)..(377)


<223> n is a, or t
c, g,


<400> 24


tttttttttt tgccgcccactcagactttattcaaagacc aggaagggcc ggtgcaagga60


ggggaggagg gcccnttgganggccagcnnggaanggaac ggctaccgag gctccagctt120


aacggtattt ggaggtcagcacggtgctcacagaagccag gaacttntcc agggaggcnt180


gcaccgcagg ggtngaactcggcggggaggtgggcggcca gggtcaccag caggcantgg240


cttaggagnt tgaagttgaccgggtccacccgaagntttt gcgcntgcag gtcgntcagg300


gcggacagcg cntttgggcatttcgtccacgttgcgccac ggcttttggg tcagcgcntc360


ggccaccttn tttgccntggccctttaacctgg 393


<210> 25


<211> 3726


<212> DNA


<213> Human


<400> 25
cagcgctgct ccccgggcgc tcctccccgg gcgctcctcc ccaggcctcc cgggcgcttg 60
gatcccggcc atctccgcac ccttcaagtg ggtgtgggtg atttcctggc ggggggagca 120
38/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gccaggtgagcccaagatgctgctgcgctcgaagcctgcgctgccgccgccgctgatgct180


gctgctcctggggccgctgggtcccctctcccctggcgccctgccccgacctgcgcaagc240


acaggacgtcgtggacctggacttcttcacccaggagccgctgcacctggtgagcccctc300


gttcctgtccgtcaccattgacgccaacctggccacggacccgcggttcctcatcctcct360


gggttctccaaagcttcgtaccttggccagaggcttgtctcctgcgtacctgaggtttgg420


tggcaccaagacagacttcctaattttcgatcccaagaaggaatcaacctttgaagagag480


aagttactggcaatctcaagtcaaccaggatatttgcaaatatggatccatccctcctga540


tgtggaggagaagttacggttggaatggccctaccaggagcaattgctactccgagaaca600


ctaccagaaaaagttcaagaacagcacctactcaagaagctctgtagatgtgctatacac660


ttttgcaaactgctcaggactggacttgatctttggcctaaatgcgttattaagaacagc720


agatttgcagtggaacagttctaatgctcagttgctcctggactactgctcttccaaggg780


gtataacatttcttgggaactaggcaatgaacctaacagtttccttaagaaggctgatat840


tttcatcaatgggtcgcagttaggagaagattttattcaattgcataaacttctaagaaa900


gtccaccttcaaaaatgcaaaactctatggtcctgatgttggtcagcctcgaagaaagac960


ggctaagatgctgaagagcttcctgaaggctggtggagaagtgattgattcagttacatg1020


gcatcactactatttgaatggacggactgctaccagggaagattttctaaaccctgatgt1080


attggacatttttatttcatctgtgcaaaaagttttccaggtggttgagagcaccaggcc1140


tggcaagaaggtctggttaggagaaacaagctctgcatatggaggcggagcgcccttgct1200


atccgacacctttgcagctggctttatgtggctggataaattgggcctgtcagcccgaat1260


gggaatagaagtggtgatgaggcaagtattctttggagcaggaaactaccatttagtgga1320


tgaaaacttcgatcctttacctgattattggctatctcttctgttcaagaaattggtggg1380


caccaaggtgttaatggcaagcgtgcaaggttcaaagagaaggaagcttcgagtatacct1440


tcattgcacaaacactgacaatccaaggtataaagaaggagatttaactctgtatgccat1500


aaacctccataatgtcaccaagtacttgcggttaccctatcctttttctaacaagcaagt1560


ggataaataccttctaagacctttgggacctcatggattactttccaaatctgtccaact1620


caatggtcta actctaaaga tggtggatga tcaaaccttg ccacctttaa tggaaaaacc 1680
tctccggcca ggaagttcac tgggcttgcc agctttctca tatagttttt ttgtgataag 1740
aaatgccaaa gttgctgctt gcatctgaaa ataaaatata ctagtcctga cactgaattt 1800
ttcaagtata ctaagagtaa agcaactcaa gttataggaa aggaagcaga taccttgcaa 1860
39/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
agcaactagt gggtgcttga gagacactgg gacactgtca gtgctagatt tagcacagta 1920
ttttgatctc gctaggtaga acactgctaa taataatagc taataatacc ttgttccaaa 1980
tactgcttagcattttgcatgttttacttttatctaaagttttgttttgttttattattt2040


atttatttatttattttgtgacggagagagattccatctcaaaaaaacaagttattaaaa2100


atgtatatgaatgctcctaatatggtcaggaagcaaggaagcgaaggatatattatgagt2160


tttaagaaggtgcttagctgtatatttatctttcaaaatgtattagaagattttagaatt2220


ctttccttcatgtgccatctctacaggcacccatcagaaaaagcatactgccgttaccgt2280


gaaactggttgtaaaagagaaactatctatttgcaccttaaaagacagctagattttgct2340


gattttcttctttcggttttctttgtcagcaataatatgtgagaggacagattgttagat2400


atgatagtataaaaaatggttaatgacaattcagaggcgaggagattctgtaaacttaaa2460


attactataaatgaaattgatttgtcaagaggataaattttagaaaacacccaatacctt2520


ataactgtctgttaatgcttgctttttctctacctttcttccttgtttcagttgggaagc2580


ttttggctgc aagtaacaga aactcctaat tcaaatggct taagcaataa ggaaatgtat 2640
attcccacat aactagacgt tcaaacaggc caggctccag cacttcagta cgtcaccagg 2700
ggatctgggttcttcccagctctctgctctgccatctttagcgctggcttcattctcaga2760


ctctggtagcatgatggctgtagctgtttcatgggccccttcaaacctcatagcaaccag2820


aggaagaaaatgagccattttttgagtctccttcatagacttgaataactctttttcaga2880


gcttctcacagcaaacctctcctcatgtctcctcatgtcttattgttcagaaatgggtaa2940


tgtggccatttcaccagtcactgccaacaacaacgaggttcctataattgtctctgagta3000


accctttggaatggagagggtgttggtcagtctacaaactgaacactgcagttctgcgct3060


ttttaccagtgaaaaaatgtaattattttcccctcttaaggattaatattcttcaaatgt3120


atgcctgttatggatatagtatctttaaaattttttattttaatagctttaggggtacac3180


actttttgcttacaggggtgaattgtgtagtggtgaagactcggcttttaatgtacttgt3240


cacctgagtgatgtacattgtacccaataggtaatttttcatccattaccctccttccgc3300


cctcttcccttctgagtctccaacatcccttataccactgtgtatgttcttgtgtaccta3360


cagctaagcttccacttataagtgagaacatgcagtatttggttttccattcctgagtta3420


cttcccttaggataacagcccccagttccgtccaagttgctgcaaaatacattattcttc3480


tttatggctgagtaatagtccatggtacatatataccacattttctttatccacttatca3540


gttgatggacacttaggttaattccattcaatttcattcaatttaagtatatttgtaagg3600


agctaaagctgaaaattaaattttagatctttcaatactcttaaattttatatgtaagtg3660


40/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gtttttatat tttcacattt gaaataaagt aatttttata accttgaaaa aaaaaaaaaa 3720
aaaaaa 3726
<210> 26
<211> 127145
<212> DNA
<213> Human
<400>
26


gatcacaggtgtgagacaccacacccagccagaaattgaaccttggtgagagacactgag60


tggggaagggcagagactgggagttaggagttacagcatctgaaggccacatcctggaga120


gatggccacagactcagccagtgaagaggaagtgctggggctggggccagaaccctgtct180


gtgtgacccctgagactgagctcagacacccctaaccctgaaggcacctctctttcagga240


ccaacagccaaaggcacagaagccactggcctgggagggactgtccctgggaatgaccct300


gctctctgagggctgggcatctggactccctctgctccagctcctctgtggttgtattcc360


tccatttctattctaattagtcagtttccatggctggataccataaaatctcagtagaag420


gaagaacaggccaaccatcagagctgttcaatttcagaaaatctctttttgttgctgggg480


acagagtctcactatgtcacccaggctggagtgcagtggcgcgatctcagctcactgaaa540


cctctgcctcccgggttcaagcgattctcctgcctcagcctcctgagtagctgggattgc600


aggtgcatgccaccttgcctggctaatttttgtatttttagtagagatggggtttcacca660


tgttggccaggctggtctcaaactcctaacctcaggtgatccacccacctcagtctccca720


aagtgtttggattacaggcgtcggccaccgcgcctggcccagaaaatctctttagtcggg780


acttgagaaagggactgggttccatctggtgggaatgggagggaggttcagtgtctgctg840


ccagtgagacctgggtttgttccctcccccctggctgtgtgatggaggcaagacccttca900


ttctttgagcctcagtgtcctgtctgtgaaacaggcaatgagcacatttatctcacaggg960


tcccggtgaggcacattgggataacataggtgaagcccttaacacagttctgggcaaagc1020


aatgtgacttctctcctccccagcggcacttgcaccacgtggggagaaactaggttaata1080


catccctgccacacataactaccaagtgcctgctgtgtgctggccacaacactaagagcc1140


ttacatgtggtccttcatttaattttcaaagtgatgacgatgattctcagtgcacagatg1200


gagactctga gcccagagag gctaaataaa ctgctctcaa ggacaccagc actttctgca 1260
aagagcccca gatcctaact aggacttacg ttgcctgcgc tgggaagaga cccaaatgcc 1320
tcccggctgt aggagtccct gattgcagac gtagggtctc agtccccgcc ccaagaagct 1380
gtaggtccag ttgaagaaga gacacacaca aggaaaagga aattgaactg agaaggcaaa 1440
41/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gcgtgactgt ggggcctctg ctatatccag ggtctccaga gaaaggacta gaagccacta 1500
ttccaattct gaggcctcag ggaagcagca agttcctgtg aggaaacagg atcccacagg 1560
tttcatcctc ctcctgtcac tcttctaggt ggggagggag ggctccccca cgtcccacat 1620
aagcacacagaaaggagaggccagggcagcacaggctcagaacctgaaggacttggggac1680


atcgccagccccatatccttgttttatacaccaggtagggcaggaactatggcaggtcca1740


cagaaaggggccggcagaagcacagccacgacgcaggccccctgggctgtccagtttctc1800


ccggacagaacatttcccttccctagcagcccccaacgtggagcactggatttggagtca1860


ggagacctgtgtcttctgcaatcactctgagaccaactcctgtgtaatcgtgagtgagcg1920


ccttcccatctctgggcctcagcttccacctctctaaaatgagggggttggattccatcc1980


aatgttataagagccaaaggttatgagttggtagcgcccccaccattccgggtttctcca2040


atctctccaggggcctcagagaccccagacagaagaggaacttggacagaggcttgggtg2100


ggggtggaggtggggattctgagccgtggatccaccctctgctgagtgccaggcctacag2160


gcaggcaggcagagcaggcaagagccgtcccctacacaaagggaattggcccctcatggt2220


gggacagaggccagaacccagctgggccctcaaccacccttctttcctccacaaccccct2280


cccagggatggtggcatccgaagccagcctggcaagggaactggttgccacgtggggact2340


tcccggagctgggggtgatgggaaacagggtgacgggaaacgtcctgaggttgcttcctc2400


cccttttgtttggatctcagactgacctgggaaccaactgggcagccatggggtattctg2460


atggtggggagttggagggggagaagggacctgccccatcccctcaggctgctttgcaag2520


ttaaaatagctgtgaagatctatctcccagaattctaaaagctaaaataccttttgaacc2580


accaccagaccattatgcctggagtggaaggatgcttagaggaatcccttcttttttttg2640


agatgaagtctcgctccatcacccaggctggagtgcagtggcgctatctcggctcactgc2700


aacctccacttcccagggttcaagcaattctcctgctttagcctctcgattagctgggat2760


tacaggcgtgcaccaccacgcccggctaatttttctattttttagaagagacgagggttc2820


accatgttggccaggctggtctcgaactcatgaactcaaatgatccacccgcctcggcct2880


cccaacacgctgggattacaggcgtgagccactgtgcccatctcgaatccctttttaaaa2940


cttcaggtatggctgggtgcggcggctcatgtctgtaatcccagcactatgggaggctga3000


gtcgtgaagatcatttgagcccaggagttcaagaccagcctgggcaacataggagaactc3060


gtctctattcaaaaaaataccaaaaaccaaaaaccaaaaaattgtaagtcatgacccact3120


ggtggatcttgaaattaattaagtcggtactctgagtaaatcagaatttttttttgagat3180


42/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ggagtctcac tctgtcaccc aggctggagt gcagtggtgt gatcttggct cactgcaacc 3240
tccacctcct gggatcaagc aattctcctg cctcagcctc ccaagtaact gtgactacag 3300
gtgtactccg ccatgcctgg ctaatatttt gtattttagt acagacgggg tttcaccatg 3360
ttgcccaggc tggtcttgaa ctcctgagct ctggcaatct gcccacttcg gcctcccaaa 3420
ctgctgggat tataggcgtg agccaccgtg cctggccgca aataaggatt taataatgac 3480
gatgataaaa tagaagggaa aatctcagag cacatcctgg gtagtaatag caaactgtct 3540
tggctgtgtg gtggctcatg cctctaatcc cagcatttta ggaggccaag gcaggaggac 3600
tgcttgaggc taggagttaa aatcagccta ggcaacacag tgaggcccca ttcctacaaa 3660
aaaaaaaaaa aaaagaaaga aagaaaaaat tagccgggta tggtggtgtg tgcctatagt 3720
cctagctact ccagaggctg aggcgggagg attgcttgcg cccaggagtt caaggctgca 3780
gtgagccatg atcgtgccat ggtacggcag cctgggtgac agagcaaggc cccaactctg 3840
aaaaacaaaa taaatacaat aaaataaaat ggtcaaaatg gcctggtgca gtggctggtg 3900
cctgcaacca gagctacttg agaggctgag gcaggagaat cactggagcc caggaggttg 3960
aggcaccact gaactccagc ctgggtgaga gtgagatcct gtctctttaa aaaagaaaaa 4020
acaaaaaaag caaactgtct catgaaactc ttgtttccat gttgcacgct ctgccaggtt 4080
gtgatgtaat gtatttctta ctctgggtca cagtcacaaa accttgaaat gtcactcact 4140
gtcttggctc atgcgtcgta agcctttgtt ccccaacagg gggaagtgaa ccagcacaca 4200
aggcccttcc gtcctgcgga gctcactgcc ttcctcagct cctggcccgc acttccgacc 4260
acacactggg gacacaccct cgggggggcc ccaccccagc agctgcccat gttcacacct 4320
cttcagttat ttcaaactcc gcctctctcg gcctgatgcc caacacttcc ttcacccaag 4380
gaggtcctgt tcaaatatca cttctggcca ggcgcggtgg ctcaggtcta taatcccagc 4440
acttcgggag gccccgaggc aggcagatca cctgaggtca ggagtttgag accagcctgg 4500
ccaacaggtg aaaccccgtc tctactaaaa atacaaaaat tagccaggtg tggtggcacg 4560
tgcctgtagt cccagctact caggaggctg aagcaggaga attgcttgaa cctgggaagc 4620
ggaggttgca gtgagccaag attgagccat tgcactgcgg cgtgggaggc agaggtagac 4680
tctgtctcaa aaaaaaaaaa agtcactttc tctgccagtc atatcttctg caaccctgag 4740
gagccaggca ggacgacccc tttaccctct gaatcaattg gtctgtatca gggtctggca 4800
gagggagggg aagttggccc ctctgattta atggatgaat caagaaaatg tgtgactgag 4860
ccatggattc atggggatgg ggtcctggag cagaggcttg ctgtgcacct actaggtgct 4920
gtgtacctca caagccactg gggacatcag accaccagaa taagtccact ttccccaagg 4980
43/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aaagtggtcaaatgtgggagccaggtgtgcaaatccccaccccagggtgataacagcccc5040


aataaaggcacatgcaagggggaccttcggagctgatgacactgtacaggcatctaagag5100


gctggtgacagggtcaccaagcagaggtctagagcagggctgagtggggtagggggggtt5160


cttccaggcaaaaggcaaaaactctgttggtaccgtgtaggtcttccacagcacatgcca5220


catgagaagaaacattcgcctggcgagtggctgaagtctataatcccagcactttgggag5280


gctgaggcaggtggatcgcttgagccaaagagtttgagatcagcctgggcaacatggcaa5340


aaccccgtctctacaaaaaatacaaaaattagccaggtgtggtaacccatgcctgtggtc5400


ccagctactcgggaggctgaggtgggaggattgcttaagcctaggaggtcaaggctgcag5460


tgagccatgattgtgccaccacactccagcctcagtgacagagtgagaccctgtctcgaa5520


aaaaaaaaaaaaaaaagagagggaaaggaaaaattttattttacatttatgtattgaggg5580


cagggaccatgcctgctgggctgctcaccactgctgagcaggattcctggtgtggcatcc5640


taacacaataaatatttactgaatgtgtactcaggaaactgcaaagggttcaggctggcc5700


tgagagtaaagtgaaagaaggaagtggtagaagagcccagaggtctgtgaccccagaacc5760


tggagggcacctgtggcctgggtctttctcctgcaggcactggggaaaagtcggagggtt5820


tattttatttaattaacttatttattaatcaattaattttttgagatggagtctcactct5880


gtcacccaagctggagtgcagtggtgcgatctcagctcactgcaacctctgcccaccggg5940


ttcaagcgattttcctgcctcccgagtagctgggattacaggcattcgccaccatgcccg6000


gctaatttttgtatttttagtagagatggggtttcaccaggctggccaagctggtctcga6060


actcctgacctcaagtgatcctcctgcctcggcctcccaaagtcctgggattacaggtgt6120


gagccaccgcgccaggccggtaggagggtttaaacaggaaagagataagcagtcagattc6180


atagtttagaaaatcctcaggttctggtgttcgggtggatgcctggagtggggatctgga6240


aatcaggggcaggggttagtaataacccaggtgaggagacttgagtctagaggcagccaa6300


gtggggacctatggaggagttcacgtgctgcaggtgtgcgccgccgaggcggagccaggc6360


tctggagctgccaggggctcagaagcctccctctcagatctctccccttttggccacaga6420


tgggaaggagagaggcactcacccgacccagcgtggcagtacagtagtgtccaacctgtc6480


actgttgggcgtggtggcgtgtacctgtagtcccagctactgaggaggctgagatggcag6540


cagcacttgagcccaggagttggaggctgcagtgagccgacagcgccactgaactctagc6600


ctgggtgacagagcgagaccctgtctctaaaaaacagaaaagaaaaattacaggtcgggc6660


gcagtggctcacgcctgtaatcccagcactttgggaggccgaggagggtggatcacgagg6720


44/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tcaggagttc aagaccagcc tggccaatat ggcgaaaccc cgtctctact aaaaatacaa 6780
aaattagcca ggcgtggtgg tgtgcgcctg tagtttcagc tacttgggag gctgaggcag 6840
gagaatagct tgaacccggg aggcggaggt tgcagtgagc cgagatcacg ccactgcact 6900
ccagcctggc aacagagcga gactctgtct caaaaaaaaa aaaaaaaaaa aaaaaaaaag 6960
aaaaagaagaaaaagaaaaaagagaaagaaggaaagaattacataacagtaagcaaccta7020


gctagatttgaaccaggccctgcagttctaaagcactggcttttgcggagcggcactcac7080


tccgcatcgtggcataggtagatttcttttctaaaggtgaggtcagtgctgggcacttag7140


caggcgcccggtgggctgcgccgtcctggaggaaggctgattcctcccaccccgactcct7200


ggctcgtgggtgggtaatccagcacattctccccaccccggcaaccaactttgtggccga7260


acaagccctccccggcttgttccgctggtcccaggcgcctgcgcatccggacacgatgag7320


gagcaggtgcgcggggccggggtgtgttcgagggggtcgtgcgcgcctgggctgcctccc7380


cgcggacggcggactgggccggggcggcgcttcctggcagagaggcgcggaggggcgtgg7440


ctttggagaggtgcccccggcgggctggcggcctggctgcggtgaaaggcgggcggacgc7500


aggtgacgacaaccgctccataaagggcgccgcggcgcgacgctcgccttatatgggcag7560


gctcggcgcgggaggggcggggcgttccacccagctggctccgcaccgaggcccggccga7620


acccccgaggggggaaacttctctgcgagggtggagcctcctcagcggcgtccccaggtc7680


ccgagaggggtccctacccaggctaagactcacgacgggctccaccctgcaggggctcaa7740


cttgcagaaaccctggggcctgccttccccaggggtctgccctcctcaggccctgctagg7800


gcactgactcggtttgtgctgtgtggcgttttttccttcaccccacctgggccgcaggtc7860


ctcgctagatagccgagggagggtcctttaagtgagctcacctcggagcccccagataac7920


caagcctgagcctcccggctacatggcgaggcttccccaatccggtcagccccaagcagg7980


tgcctttctctaactggcacaaaggaagtctcctagccaggctgagcccaagcctcggta8040


aacatgagccttggatccactggaagtgtttggctaactgggcccttcttggccagacaa8100


gactttaaccctaagaggaagctgccagcatgacgcagcccaccatattctccctccaag8160


ctctcttcatagcccgggtccttaaaaacccaaatctgtccaattgctacttgccgtcca8220


ctcgttgacagttactccgcttcacagcctcccgatcacctgagtgtcctccctcggctc8280


agtgcacagg gctctgtgag cttacagttc cctggttgcc gttccgtgcc tcccagccct 8340
gcacctgctg ctcctttctg gaaagccctt tccttgcaca ctcccagaca cgtgctcacc 8400
cttcagagag atacttctta gcgtcttctt cctgacattt gtagtgatta cttaaccttt 8460
ctgagcatca atttcttcat ctgcaagatg ggggtaaaat aatccccacc tcactgtgtt 8520
45/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
attgtgagga tcgaatgagt taatgtttgt aaaatgcctg gcatatagta gctgctcatg 8580
aaaaactcgt tgaccaaatt cctcttcctg tgctctaatt gctcatgtat gtgttgtgag 8640
tgccatgaag gctggcctct tccttttcca gctatgcata cctagttcct ggcacatata 8700
tagatcttga accagtgttt gttggcgaat gaatgaattt caggcagtag gggtcgggga 8760
gagaagagac ccctaactgt gatggtcatc aaccctcaca tctgccggga tgtagggcat 8820
tctaatgctt cccccctcag ttgcccagag cttcatggca accaggaggg acacagcatg 8880
gatatggacc ccgttttcca gataaaccta tgagtgatta gaggtgaagt aacttcccca 8940
cggttacaca atgagtggaa gagtcggcat cagggtgacc aacgtgtact tttttttttt 9000
ttttttgaga cggagatttg ctcttgtcgc ccaggctgga gtgcaatggc gcgatctcgg 9060
ctcactgcga cctctacctc ccaggttcaa gcaattctcc tgcctcagcc tcccaagtag 9120
ttgggattac agttgcccac acgcccagct aattttgtat ttttagtaga gatggggttt 9180
cttcatgttg gtcaggctgg actcaaactc ccaacctcgg gtgatctgcc cgcctcagcc 9240
tcccaaagtg ctgggattac aggcgtgagc cactgtgccc ggcccaatgt gtattattat 9300
tattattatt attttagcac tgagagttcc acgtcccagg aatctcttta gtctcaggca 9360
gccaggatgg ttggtcaccc aagatcaact tctaaacgtt agtctctgag gaccgccacc 9420
ttccaacctc ccctgcaccc gtcccattat tcccaagtat tttactgcgt tcctgaaggg 9480
gacacaggct ctccagccca gaaggtccaa cagattttaa aaagtcacac tctgattccc 9540
caaaaaagtt agactcacag cacagtaggg atgggggaca aggacattgg aagggcattg 9600
aggccaggtg tggtggctca cgcctgtaat cccagcactt tgggaggctg aggcgggtgg 9660
atcacttgag gtcaggagtt cgagaccagc ctggccaaca tggtgaaacc ccgtctctac 9720
taaaagtaca aaaacaagcc aggtgtggtg gtgcgcacct gtagtcccag ctactcggga 9780
ggctgaggca ggagaatcgc ttgaacccgg gaggcaaatg ttgcagtgag ctgagatcgt 9840
gccactgcac tccagcctgg gcgacagagt gagactctgt ctcaaaaaag aaaaaaaaga 9900
aggcccaggt aggagtttgc ttcactttga cagggactca tgggccactc ctgcaccagg 9960
ccctgggcct gggaccagga actgagagaa ggctggcccc cacctgtggg actctagcca 10020
ggtgggggag acagatgtat agacacaatg ccaacagttt ggttcctcga cggctggaga 10080
agggagtgat cgaccagggt ttctgaagaa ccccctcctg acgtggccac tcaccagctg 10140
acctcaggcc tgtcccttcc tttggctggc cctggacctt ctctgtcaac tcaggcagtt 10200
ggagctggtc cctgagggcc ttcctgccct gaagtcatga cttgtgggga gctgagttct 10260
46/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gggaaatgca tcctctggag aggcaccaga ggccgcgcat gcctgagtga gtgtgggggt 10320
gcgccctggc ctcactagcc aaacaccaac ttcatcttcc caggctaccc tggcccgagc 10380
agctccggct ccttccctgc ctgcctcatc ctcccaggcc actgtccagg aagctggcct 10440
ctctgcctgt tccccacagc ccctgggggt ggggccagag tagggcaaaa agggcctggg 10500
cctggcccag cagagcctct gcccctcctt cgggggctcc tgttcttgtg ggctgagagc 10560
tgcagccctg cagccggcct ggctgtggct cagtggtcag ggccaagtgc agagcaaaca 10620
ccctgcccac tgggcagcca tttcacggtc attcccaggc tgcatggggt ccccagtcgg 10680
gcaactaagt gcagatgtga aacaacgagc tttccaagat ccagggattt gacccttggg 10740
aaagagactc cctaagggaa ctgcttcctg tcactcccca accaccactt tgagaaataa 10800
ttttctctcc ctcaacctca ctgccagcct cagtcaagag caaaccgagg actggtagtg 10860
ggagctcagg gccaccttgg gattctctgc tctcgctgct ggctgagccc aggcaaggcc 10920
cctgccctct ctgggcttcc atttccctct cctgctccaa acttgctagc ttccttccct 10980
atctcaacat catagggacc cttcgagatg ggaactacta ataggggaaa tcatatggga 11040
aaccaggctg ggcgcagtgg ctcacaccta taatcccagt actttgggag gccgaggtgg 11100
gaggatcacc tgaggtcagg agttccagac cagcctgacc aacatggtga aaccctgtgt 11160
ctactaaaaa tacaaaaatt agccgggcgt ggtggcaggt gcctgtaatc ccagctactc 11220
aggaggctga gaggtagggg aatcacatga acctgggagg tggaggttgc agtgagctga 11280
gatcctgcca ctgcactcca gcctgggtaa cagagtgaga ctccatctca aaaataaaat 11340
aaaaaatgac catatcctta taggaaccat tattttgaac tcagaatctc agaaaaacca 11400
ggatttgggg cctggaactt tctttgtctt attttgtttt gttttggatt ttttggggag 11460
acagagtctt gctctgtcac ccaggctgga gtacagtggc gcgatctagg cttactgcaa 11520
gctccgcctc ccgggttcac gccattctcc tgcctcagcc tcccgccacc acgcctggct 11580
aattttttgt atttttagta gagatggggt ttcaccgtgt tagccaggat ggtctccatc 11640
tcctgacctc gtgatctgct cacctcggcc tcccaaagtg ctgggattac aggcgtgagc 11700
caccgtgcct ggctggggcc cggaactttc taaggcagag gcggcagaga caaagaggtg 11760
gctggaggtg gggcagtgcc gagccaagtc tcaggacatc cctactgccg agcctcccct 11820
cccacaaagt aaaccggcag gtgggcagtg caggcggggc ccagctcggg tttcactcct 11880
tCCCCgCt Ct cggggacaat aaaatgctcc ctttgccctg gaaatcccac ttgtataaaa 11940
tccaaaagaa gaaataagct cttatgttca aacaggtttg ttccaacctc atttataatg 12000
gaaaaatatt aactgaaaaa ttccttagta tccgacaatg ggggagaagt taacagtttg 12060
47/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
accggagctg agtgaeatgc aaaagggtgt ttgtggagtg cagggagctc ctgctgtgtg 12120
tgtgggaggg tggagagggc atggggagag gagcagggac cccagagtca gactgtctag 12180
gtttaaatcc tgtctgctcc ttcctagctg tgtgaccttg agtcataacc caaagccctc 12240
tgtacctcca tgtccccctc cataaactgg cactgggctg ggcatggtgg cttatgcctg 12300
taatcccagc attttgggag accaaggcag gtggatcacc tgaggtcagg agttagagac 12360
cagcctggcc aacatggtga aaccccgtct ctactaaaaa tacaaaaatt agccaggtgt 12420
agtggcaggt gcctgtagtc ccagctactc aggaggctga ggcaggagaa tcgcttgaac 12480
ccaggaggca gaggttgcag tgggccgaga ttgtgccact gtgctccagc ctgggtaata 12540
ggtgacagag cgagactccg tctcaaaaca aaacaaaaca aaaaaaagga gagagagact 12600
tgggggatgt gtgtgcccag aggaaaatcc atgtgaggac ccagcaagaa ggtggccacc 12660
cgcaagccaa gcagagaggc ttcaggagaa accaaccctg ccagcacctt gattttggac 12720
ttccagcccc agaactgtga aaaaataaac atctgttgtt taaaccaccc agtctgtgat, 12780
attttgtgat ggctggccta gcaaactaat acacattact aacacacaat aagagaagcg 12840
tttaataggg cgcttaccac gtaattgcat tgtgttctga cattacattt acgatctcat 12900
aaccatgagg agggtcctgt cctcccattt cagagatgaa ggaaactgag gcttggctag 12960
tgacggagag ggctgtgact ggagccagga ctgtgtgact ccaaggcccc accaaagcct 13020
cctcctggga tggaccatgg actttcctgc ctctgtgctg tgcatacgct ctcccttctg 13080
cctggaatac ccttcccacc acttgcctct caggacgagt cccagtcgat tcttcaaaac 13140
tcttcttggc ccggcaaggt ggctcacacc tgtaatccca gcactttgga aggccaaagt 13200
gggtggatca cttgaggtta ggagtttgag accggcctgg ccaacatggt gaaaccctgt 13260
ctctactaaa aatacaaaaa ttagctgggc cttgtggcag gtgcctgcaa tcccagctat 13320
tcaggaggct gaggcaggag aattgcttga acctgggagg tggaggttgc agtgagccaa 13380
gatcacacca ctgcactcca gcctgtgcaa cagagttaga ctgtctcaaa acaaaaacaa 13440
aaaacaactt ttctcaagca tcacctcctt cccatgcttt acccgacaat ctccttttgc 13500
agatgtgctg cttttcaggg cttgcggcca gtctgtactc tgtcaccatg gtggtaaatg 13560
tcatctctcc tgtagcattt agactttaga tgtgtccatg tgtttgctgt gaactcctgg 13620
aaggcagggg ctgtgtcttg ctctagttcc tatcacccag caggcccaga ggggctccgc 13680
acagacgctt gctggctgag gtagccagtt tggcctggag agagtattcc cgcctcagga 13740
gtggatcatg aggaaatgga atctcctgcc tccttgtggg gtgggggttg ggggaggtgg 13800
48/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ataaaagaga ggctccacct ggcacggtgg ctcgtgccca taatcccagc actttgggag 13860
gccgaggtgg gtagatcacc tgaggtcagg attttgagac cagcctggcc aacatggtga 13920
aaccccatct ctactaaaaa tacaaaaatt agctgggcac ctgtaatccc agctactcgg 13980
gaggctgagg ctggacaatc gcttgaatcc aggaggtgga gcttgcagtg agccaagatt 14040
gtgccactgc actccagcct gggggaaaag agcaaaattc catctaaaaa aaaaaaaaag 14100
cggatcaagg tccctactct gggcatgaga ggagggatcc tttgacactc ctgggagcag 14160
cagtgtggca gaggaggagg agcagggcat ggggtcagcc accctcagtc catttcccag 14220
ggtgtggcct taggcacggt cactacctct ctgggcttct gtctccacat gtatgaaatg 14280
gaatcagtcc ctccttccac aggtgttagg tcgaagaagg cacctctggt ggtatcggca 14340
cagaggctgg acactggatg acttctttgc tgggacactg aggtaggggg cagaccagag 14400
acagacagct acttgcctaa gctcacccag caagctggct gaaggtggag aactggcttg 14460
tcctccagtt ggtagttaac agctgtctag caggagtgtt cttgctccca ggagacgctc 14520
cgttggctgc cacagaggta agcgtgagag tgcgctcaga agtggctggg aggcatggag 14580
aacagaggag caggttcagg gtgaattcca gtgggcattc tccaagggtg aggtcactgc 14640
ctccaactcc ctagggctgc ctgagacaca ggcaccacca agccagctcc agagcaggag 14700
gaggtggtgg cagggaccag ggccaggtca cagggctgaa tgtaaggccc tcagcctggt 14760
acagcgacgg gcccctccca tggtgctggg gtccttacct tgggaagccc ggtgtttcct 14820
gtttaagatg tggctggggg taggggaaag gagaaagcca cacagataac acttctggaa 14880
cttccaatcg gtgccagcgt gcttccacct gctgagccgt gacctcattt gcagggactg 14940
tcatgagccc caacttggag atggtgcaac tggggctcaa aatggtgaaa accttgtccc 15000
aaaaggaaag cagtatagct aatgagcaag aacaaagaga atttgaaatt aaagacattg 15060
gggttcattc ttttcccctt ttttaaaatt tatttttggg ccgggcacgg tggctcacgc 15120
ctgtaatccc agcactttgg gacgctgagg tgggcggatc atttgaggtc aggagtttga 15180
gaccagcctg gccaacatgg tgaaaccctg tttctactaa aaatacaaaa attaaccagg 15240
catggtggca aatgcctgta atcccagcta ctcgggaggc tgaggcagga gagctgcttg 15300
aactcaggag gcgaaggagg ttgcagtggg cagagatcat gccattctac tccagcctgg 15360
gcaacagagc aagattccat ctcaaaaaca ataaaataaa taaataaaat ttatttttta 15420
tatttttatt ttttagaaca agatctcact ctgtcaccca ggctggagtg cagtggtgag 15480
atcacagctc actatagcct caaactcctg ggctcaagtg atcctcccac ctcaccctcc 15540
caagtagctg ggactacagg cgcacaccgc catgccaggc taattttttt ttaaattttg 15600
49/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tgtaaagaca gggtcttgct atgttgccca ggttggtccc gaactcctag gctcaaacga 15660
tcctcttgcc ttggcctccc aaagtgctgg gattacaggc gtgagccatc gtgtccggcc 15720
acatcggagt tcaaatctga gctctgaact ccattcatgc caagttactt aagccctcca 15780
agcctcagtt tccttgtctg taaaatggcg gtaacaatgg tccctgctgt tggggttgcg 15840
gtggagactc agtgagagga ttcatgtagc acacactcag taagtgccag ctgtcactgc 15900
cagcctattt caccaccgtg aacacagagc ctcagaatgg aaaagcagcc tgcccaaggt 15960
cgcacaactt gcaggtggca caggcaggat ctgaatccag atcagattct tcccgcccta 16020
cttctatcac cgtggaaggg cctggggggg cctgcagcca ggaggtggct ggaaagggag 16080
gttccttgga acaaccagtg gcccaggctt cctgcagagc cggggacccc agccctggcc 16140
agggtaaggg tcacgcctgc agctggtgtt ccaggcatcg gagaggaact gcggctgcag 16200
gcctggcagc cttaccgtcg ccagcatcct gccctccatg gacacggccc caacattgtt 16260
ttctgggccg ttccctgccc agagcccaca cattcgggat ttccgcagct tggccagcac 16320
taccttcgct tcctggagca gctttcccca ggcggccggg gtgggggttg agctggccct 16380
ggcccctggt aggggcaggc actgctcgga aggcagtggc agcagcgccg tcaacatcct 16440
cttgacctga caggtcctta cccgagttct acctcctcag aaacacagcg gccctcctca 16500
ctcccctctc ctgaggccag cgtagaaaag gccctacctc atttccactt tagggtaggc 16560
tggagtgaga gcccgggtta aaatcctagc cctactacaa aggtgctgtg acctgggcaa 16620
gcctcccctt ccctctgcct cacaagggat gctgggtagc ctgaggtgcc ttaggctgcc 16680
ctgacatcag ctcagggatg accggcgccc cgtgctctga ggtctctggg cataataagc 16740
tccttgatga cagggtcagt ttctctcccg tgttctgcaa gtttattttt attattatta 16800
ttatttttga gatggagtct tgctctgttg cccagactag agtgcaatgg tgtgttctca 16860
tctcaccgca acctctgcct cccaggttca agcgattctc ctgcctcagc ctcccaagta 16920
gctgcgatta caggcgtgca ctgccacgcc cggcaaattt ttgtattttt agtagaaaag 16980
gggtttcgcc atgttggcca ggctggtctc gaactcctga cctcaggtga tccacccgcc 17040
tcggcttccc aaagtcctgg gattacaggc gtgagccacc gcgcccggct ccatgttctg 17100
tatatttaga aggaacctgt gtgagtggcc accaaacgtt cactctgaac catgctggcg 17160
ctgcctgcag gtgagcgtgc ctgcccagag tggtgtctca gttgtctcac tgcccaccct 17220
ggcgctccgt ctcctctgtg ggctggcacc tgctccctgg tagggcggag ctgaggggca 17280
caagggagcg tggaagtcaa gcagccagcc cagcaaactc gagcttccac ccctgccgcc 17340
50/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tctctgcagg caaccacgtg cactgggtgt caagaaaaaa tatacagggg ccatatcccg 17400
ggttgtcttc aggctcggga agcctgcgac tttgtcccct ttccccggct tcccaacctg 17460
gtggctaaag gcttccagca ggtgtctgcc aaccccatcc acagtcatgg ggcccaatgt 17520
ggcacccaga gaatgaccgt gggctgacag cccagagcca gcggcatccc cggtgaggtc 17580
agtgtcctgg aattggtcaa acaggatcac caggaggatt ccgtgagcac agccagcatg 17640
actcacggcc atgatcagcc tcacgggcag aggctgccaa cctgggatgg ccacagccac 17700
cggctcacct tgcagggcaa cgcacctttt aaggagggag ctggagcagc gcccgggtcc 17760
tgcctctggc caaggcctct gccacacttc tccacgccca cccgggcaga gaggccagac 17820
ccccactggg ttcaaatttg gcaccacttt tcagacatga ccttgggcaa gtcgatttct 17880
ctgaactgtt tttttcactt atgatatgga aataatactt gcctcacaag agtggaattc 17940
gatgaggtaa tgtgtttaga aagtgcgtgg caaacggtgc cttttaagga gcggcagtgg 18000
ggtccggtgg aaagggccag ggctcgggag tcgaggcgcc ccagcattgt gctctggccc 18060
caccctgggc tcactgggtg tctttgaaag agttactcaa cctccgatct gctctgctcc 18120
cactgtgtca aatgagctga caccacttgc cttgttgcct gttgtgagat gaagatcaca 18180
cacacgccac cttctatcag atgacaggag gcagcgaggg tggttcctgg gggtgggtgt 18240
ggaaggctgc ctggccttga atcccagctc agccactcag gggctttgtg acctggggaa 18300
ggctcctcaa cctctcgggg caggtctcag gtggaatctg aagggcaacg ccttcccgcg 18360
gggctgtgct gagctgagac cctcaaaaca gtgccaggta cctgggaggt gcctcctgag 18420
tctgggcagg tcctgctcat cttaaccagg gcttttggcc tttgcaggat gttcactcca 18480
ccagcttccg tctccactga cgccagttgc tggttttgtc ccctccatgt gcttgtgaca 18540
gaccccaggg tctggggtcc ttcagaggcc acgggcccct ctcctccctc ggtctcggca 18600
gccttcccaa ggcagtcctt gggtgggccc ctggagaatg cagacagttc taatagaaca 18660
gggtgagcct ctgagaacag agcaatacca gccccatggc atccctgggg ccacggagta 18720
gggtgtcagg atccccctgc cgccaagcac ctgattcaca ggaagctggg gcctcatcca 18780
ggcaaccgag ccctaatgac agcttggccc taggagcaag gcagacggaa ggaaggcttt 18840
cttgactggc aagcctggct cccttggcac actcctctat ggccaagggg agctgggggc 18900
caagaggggt tgtctggtcc caaggcccag aagttcctgc aggcacccat gggaaggata 18960
gcctgatccc cacagggcca ggcacctgct ggggcagcca ggagccctgt cagttgggga 19020
ggcctcagaa gggtcaaggg gatcagctgt gggagcccag gtttcagagg caaccacgtc 19080
tggatagaaa ccccagctct gcatcccatg agccacagtg tctacatcgg ggtaatgggg 19140
51/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
acaacagcct cttgccttag gagggcacga ggactggcac atggcatcct tagaatagca 19200
gccactgctg acaagcatgt tagtgaacag gaagggctgg ttggagagag tgttgtggag 19260
ttaggggagg atgtggggac agtggacaag ccccctggga aagggtgaca agtgctctga 19320
gcccacacag atgtgacatt gcagatggtg cagacccttg ctttatttgt ctgacttgtt 19380
cacagttcag ccccctgctc agaaaaccaa cgggccagct aaggagagga ggaggcacct 19440
tgagacttcc ggagtcgagg ctctccaggg ttccccagcc catcaatcat tttctgcacc 19500
ccctgcctgg gaggcagctc cctggggggt gggaatgggt gactagaggg gatttcagtg 19560
tgggacccag ggtctgttct tcacagtagg aggtggaagg gatgactaag ttctttatca 19620
cagacctaca aaaaatgaga taattagata ttactctcac tagtttgggc ttcttttttc 19680
tttttctttt tacaaaacag cagctggaaa gagaaatgta ggtggcagac gagccaggca 19740
cgaggtttca gattggaagg gaccaagatg aggaccaagg tgtggctgcc tgactaggaa 19800
cgctgtgggc tggcccaggc tctcgccaca catcctggga gaactgccat aggccctaga 19860
aggagggatg aaaggcgtat gggagggaag acagcggtcc ccggatcagc agcagcacca 19920
ccatcctctg atggcccctg ggcagtccgc cagctcggaa gcactcaggg ctggagcctg 19980
ggctctaagc atgggcccca ggagccagac aggagggagg cagcaggaag ggctggcatg 20040
gaagggctga gttctattgg ggtcccacgc gggcaaggga accaggactc atccctgctt 20100
gtcagccaat cagcttcttc aggaaggcct ccaactgatc ctcatccttg atgcccacaa 20160
acttgtccac cacgtcccca ttcttcatgg ccagcacagt gggcaccgct gacacctggg 20220
tggagaggac aagggggtcc aagtgaattg ggagtgaata cttctcaact gccactcctg 20280
agcctttgtg gggaaggctg gtggcttatc cagggcactg acttcccaaa gccatgggca 20340
ggcctagagg aacatggctc ttctctcggt gcaggggtac tgcagggccc gggggccacc 20400
cgctgaagaa acgtcttcca ttgcgggctc ccaacagtac ccttcctccc ttaaccacaa 20460
gactgactca ctggcccagt ggttttgctg gaatgacagg agagatgaaa ataacccttg 20520
cagctgcagg ccagggctgg gggcagggag gagctcaggg gaagcctggc ccaggaggag 20580
acagaagctg ggggacagtt cgagtcctgg ctttgcactc actagcaagg gggccttggc 20640
cgggtcacag cacctttctg agcctcagtg tccttttcca taaaatgggg gtaatgtcta 20700
cctttagggt ttgggatgaa cattaaagat tcaagtatag gctgggcaca gtggcttata 20760
tctataatcc cagccttctg ggagactgag gctggaggat tgcttgagtt caagagttcc 20820
agaccagctt gggcaatata gtgagaccct ttgtttacta aaccccccca aaatattagc 20880
52/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
caggcatggt ggtacatgcc tgtactccca tactcgggag gctgaggcag gaggatcgct 20940
tgagcctggg agactgaggc ttcagtgagc tgtgattgtg ccactgcact ccagcctggg 21000
tgacagagac cctgcctcaa aaaaaaagag aaagatttga gtataaagca gagctcaggc 21060
tgggcgcggt ggctcacacc tgtaatccca gcattttggg aggctgaggt gggcagatca 21120
tttgaggtca ggagttcgag accagcctgg ccaacatggt gaaaccctgt ctctactgaa 21180
aatacaaaaa ttagtcgggc atggtggcag gcacctgtaa tcccacctac ttgggaggct 21240
gaggtgagag aattgcttga acctgggagg tggaggctgg agtcagtgga gattgcacca 21300
ctgcactcca gcctgggtga cagagtgaga ctccatctca taaataaata aataaataaa 21360
taaataaata cataaataaa gcagagctca ggttctggcg gacgcaatcc ggctcctacc 21420
agccaggtga gctggggcac gcccctcagt cactaagcct cagtgttctc agatgcagga 21480
tggagatact aagggcactg ccattagagg gcatgaaagc tgaatgaaat aacgcaagta 21540
aaggctcagc acagcgcccg gcaaataagc ttaggaacct ggcattgtgc ctggcatact 21600
gtgggcattc aaaaaacagt ggctacagag ggcacaagga aaagtccaac acaggcccca 21660
cgagagcaca ttagcttgct gctgtgatga gtgacagggt ccagaaactc agggacttct 21720
actggacagc atgagaggag aggcttggcc atacacaacc tgacgcttat tagcaggttg 21780
caggcagatg gcaaggacaa cattcttggt ctgtgaagca tttactcagt tccctcaggg 21840
acctgcatag gttatgtgga acgtggatga ggctgtggcc caccagactg gcattgtgag 21900
gtctctgctg cctgggatcc ctgcctggca ttcgtgggca tttgagaaaa ccatttaaac 21960
agaacaagat aggccggtcg ctgtggctca cgcctgtaat cctagcattt tgggaagcca 22020
aagcgggcag atcacttgag gtcaggagtt cgagaccagc ctgaccaaca tggtgaaacc 22080
ccgtctctac taaaaataca aaaattagcc gggcgtggtg gggcatgcct atagtcccag 22140
ctactcggga ggctgaggca ggagaatcgc ttgaacccgg gaggcagagg ttgcactgag 22200
ctgagattgt gccattgcat tccagcctgg gcgacagagc aagactctgt tccccccctc 22260
aaaataaata aataaaaata aacagaacaa gataaacaca gacttttctt acatacaaat 22320
taaactacaa agtaagagca gagattcaca caaacatacc aggtcttcac atatcccagt 22380
gctgccctgc cacggcccat cttggaagcc agtaagattc agaatgttca aaaaccatgc 22440
acatggtagt taggaaaggc acgcaggcca gaccatcccg ccctcaccca ctaactttac 22500
gtggcaggcc ctgcacccca ctcctcacgg acactttggg gacaaacaca gcaggtcaca 22560
ggacacagtc cttgtccttg ttagtgcctc aggccccttc aaaggctgtc cctgggctga 22620
tgtgggtggc aaaccctgtc tccaggcaga gcagggcccg aaagagtttg ctccaggaag 22680
53/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
cgcctgaagc caccagggcc ttcccaggca ttctttggtg ccctctagtg gtctgcaaag 22740
gcagctggag tgcctcaaag ccggagcctc ttggcagaag cagagagctc agccaccggc 22800
tcccacctgc acactgtcct attcctttaa ttaaaatata tgctttatgc cactgtataa 22860
gaagtggcct aacttttttc acggcaagac tctaagttca ctgaagaggc tcagagagtg 22920
gacttagcgt tccttaagaa ctccagatag gcacaagcac agtggctcac acctgtaatc 22980
ccaagtactt tgggaggcca aggcaggagg actgcttgag gtcaggaatt catgaccagc 23040
ctgggcaaca tagcaagacg tcgtctccat aaaaatatta aaaaaaaaaa aaaagaactc 23100
cagatgaagg ccataatgat ctcactcatg taaacctcca cacatgcttg aacacgcaca 23160
gaccctgctg gtgtcaggta gacagcagat gtgctgtcaa tggaggtctg gtcactactg 23220
atcaagggga tattttgaag ttgagcttaa acacacacac gcatacacac atatatacac 23280
acacacacat acacactacc cgcactaggg gctcacagga aacctgagct ggaatgggac 23340
ttccctcgac cctgaggagg cggctgaagc tctgctgctc ctgtgtctgg ctcacacatc 23400
aggaggtgcc ggtgcctgta aacactgcct tacatggaag tgcacagggc cttggcacat 23460
tcttctggaa tgttttgagt gtgaaagagg cagtgactga gccaactgag gggctgagga 23520
aaagatacgc tacgacgtgt tgcctgtcct gttccgtgaa gccacttgga acctcctatc 23580
cttggataaa gaccctctga actcggcagg agtgggggag tgtgtacgtg tgcgcagtct 23640
ctttctgcta acccgtagct cgcctgcacc gccactgagc tccgtgtcct ggtatgtctt 23700
ctcctgtccc accccgatgg catccatctg ttaactcagc taagggccta ccaagggaaa 23760
ggcacagtgc tgggtgctgc gggatgttgc aacctcctcc tcggctcatt gcagagttaa 23820
aaggaaaaga tcgctgtcac atgctgggtg ctttttcgtg tcaggaatga tataaacacc 23880
tctatacact atctcacact ctcctggctg tgggcaggat cattttaacg atgagaatac 23940
tgaggctcaa agggtgagca actgttccaa aatgatgtgg tgtaggacag gcgcggcagc 24000
tcctgcctgt aatcccagca ctttgggagg ctgaggaagg tgaatcatct gaggtcagga 24060
attcgagaca aggccggcca atgtggtgaa accttgtctc taccaaaaat acaaaaatta 24120
ggccgggcgt ggtggctcac gcctgtaatt ccagcacttt gggaggctga ggcaggagaa 24180
gtgcttgaat gcgggagatg gaggtcgcag tgagccgaga ttgcgccact tcactccacc 24240
tgggtgaaaa gagtgagacc ccctctaaaa aaaaaaaaaa aaaaaagctg ggatctgaaa 24300
caagatctgt ttgactttgc agtccagggg atcaaactct gttgtgcttc tgcccagcag 24360
caaagagaga gagacatcta ctgagtccca gcagggggaa gaacgtgggg acgcattaaa 24420
54/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ggatttcatg cttcaaatgc aaaatgccaa gtgctttgta aaagctttta gatatgagag 24480
ggttcttgga aaaacgatta ttgaaaaaat gaactacata acattctggc agaattaggt 24540
agacagtgaa aagatcaaga gtcgccaggc ctggagggag gaggaaggag agatgaacag 24600
gcagaggaga gaggacatgg aggcagtgaa atgactctgg atgatgctag aatgtggaca 24660
ccggctatga cacatttgtc caaacccaca gcaggcacaa caccaagagt gatcccctat 24720
gtaaactttt ggctttgggg gataatgatg tccgtgtagg ttcataagtt gtgacaaatg 24780
gaccaccctg gtatgggctg ttgatagtgt gggaggctgg gcatgcggga ggacagggga 24840
cttatgggaa gtctctgtac cttccccttc ctctcaattt tgccacgaac ctaaaactgc 24900
cctaaaaaca taaaatcctc aaaaagaaca acaacaaaaa atgagatcag tgactgctgg 24960
ggggttaagg gggtgagggg caggaaggag aggtgaactg ctggaaaaca ggggaaccga 25020
gggcggtgga acggttctgt atggcgctgg aatggtggac acatgccatt atacatttgt 25080
ccatgaactt tctcactggc aagcagtctg tgctgagagc ggcagctgag acacggcctt 25140
ccaaagagca gttcctcccc acagaaagtc agtccggggc cttcagaacc agaaagtcaa 25200
tctggggcct tcagaatgaa aaagtcagta tggggccttc agaacattgg,cttctctcca 25260
tgtcggctca ggacacccag ccctggcatt acctgggagc ttgttagaaa tgcagtcttg 25320
gtggccgggc gcggtggctc atgcctgtaa tgccagcact ctgggaggcc gaggtgggcg 25380
aatcacttga ggtgaggagt ttgagaccaa tctggtcaac atggtgaaac cccatctcta 25440
ctaaaaatac aaaaattagg ccaggtgtag tggctcacgc ccgcaatcct agcactttgg 25500
gaggccgagg cgggctgatc acctgatgtc aggagtttga gaccagcctg gcaaacatgg 25560
taaaaccttg tctctattaa aactacaaaa attagctggg cgtggtcgtg ggcacctgta 25620
atcccagcta ctcgggaggc tgaggcagga gaatcgcttg aacctgagaa gcggaggttg 25680
cagtgaaccg agatcgtgcc attgcactcc agcctgggcg acagagcgag actccatctc 25740
aaaaaagaaa aaggatttta ggccttaaag aaagccatca tggggggcac tgtagttctc 25800
tcagaggaaa cttcttcctc aggctctctt cagaaagaaa agaggaagga aggaaagaag 25860
gaagggaggg agagagggag ggggtcagga agaaccctgg ctggagcttc ctaaaccctg 25920
caatgatgtc agaccagggt ttggctaaac aacacggctg agaccaagtg atgtgggcct 25980
agcagccttg aggcctttct gtgtgacagc acagtcccca ggcagtggac agggcgggag 26040
cggtgggtgt ggggggagat tgagaggatt ccacaggagg catctccttc tcacttccca 26100
ggcttcaccg caggccttca gtgcccactc ccacaacagc ctcccgggga cggtcctcgg 26160
cattcccgcc accccacgag acactggagc agggcctgtg ggcttctttg catctgcagt 26220
55/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
agttaccata gtccctgcac atggctggcc ctcagggggt gtctgctgaa gagttatgaa 26280
tacattggct gaagctgaag ctgtagtgtc tggcagagcc aggaggcctg agacatctga 26340
agcccacgcg tgacctgtgg gaggccctag gagccccagc ccgggetctc acccgaggca 26400
tagccaggca ggggaaagcc aggggcatcc aaatgggcag atagatgcct ccctcactga 26460
gcaatcagtg gccaaacttt ttgaaaaagt gactcacccc tcccccagcc cctgtaaaca 26520
gccctcagtt cctaactccc aaagcaggcc tgctccagtg gtcacctgta gtggccaccg 26580
tgtttgtctg cctggtctcc atctcccctg cttctggtca ttgcagactg atgttccttt 26640
gggtaatcac tccccactcc ctgcgtagct caaggggcgg ccagcctgtt ctcaccccgc 26700
tcccaaccac ccatttcttg ctgcaggaga ctggttcagg gatgggtgcc tctatttgag 26760
ctggtctagt aagagtgaaa cctggacttg tatactctga ggaataaagc ggcctctttc 26820
attcacttgt tacctggagg aggaaggagg gaggggtgaa ggctcactcc ggccaggtta 26880
agatatttca agaaaatcag atatcgagat tttcacatga aatctgagtt tcaaatatca 26940
gcatctgctt cctattactt taaaatactt cgagtgccag actaaaagtg tctgtgagcc 27000
aggttgggcc cagaggctgc caggagcgcc ctcggctctg taacagcgct accttcagca 27060
tggctattca gagaccctcc caatccggct gcattatgct ttccccagct ccgtactcgg 27120
cccttcactc tggccaccca gacaaagtgg gcctctcccc tttctccagg tagtggtctc 27180
caaggcccag aggaagcccc caacccagac acctceaggc acctggcccc tgctggtctg 27240
taagcaaccc aggctcatca gacctcaggg cttttgcttt gcctgaattg ttcttccaaa 27300
gacccacatg cttcagtcac tcccttcctg tttttgccca aaggtcagct tatcagggag 27360
atctacccta tcccaccctt taaaaaagaa acccgctggg cgcggtggct tacgcctgta 27420
atcccagcac tttgggaggc caaggcaggt gggtcacccg aggtcaggag atcaagacca 27480
gcctggctaa catggtgaaa cctcatttct actaaaaata caaaaaatta gccggcgtgg 27540
tggcgcgtgc ctgtaatctc agctactccg gaggctggga caggagaact gcttgaaccc 27600
gggaggcaga ggttgcagtg agccgagatt gtgccactgc actccagctt gggcaacaag 27660
agcaaaactc tgtctcgaaa aaacaaaaac cctgcctcat acgcagtact cccatcctct 27720
cttcctgatg tatttttctc cattgaactt attatctaaa acaggggtca gcaaactata 27780
gttcacaggc ccaatacagc ctactgcttg tttttgtaaa taaagtttta ttgtaacaca 27840
gccatgccca tttgtttgta tagtgtctat ggctgctttc ggctacgagc ccagctgaat 27900
ggttgtagca gcgaccactg ccctgcaatg cttccaatac caaccagtcc tttagagaaa 27960
56/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aagtttgctg acccttgatt taaaatacta gaatgtagac tccacggagg cagagatttt 28020
gtcagttttg ttcactgcct tatcctcaac accaagtaac actacctggc acttgaggga 28080
ctctcaaata tctgctgaat aaacagacaa accaaccaac caagtgagac gactccatgt 28140
ctttgtgcac gctgtttcct cagcccttcc tcctcctctg cgcatccctc atggctcagc 28200
tcagaggttc tctctaacgt gaagcattcc ctgtcccctc cagctccccc acaagcaaac 28260
agtcccttct tcctttatgc gcctcttctt ttagcacttc tatattgaga tgatctttct 28320
acctgctgtt ctctcctgct agactaggag agatcttgct tggaaacaag atctcatctt 28380
gtgtcagaat cacaaatgct tggcacatcg agctcccaaa tgactgctca ctgaacatgt 28440
gggtagatgg ataaaggaat gtaccaatgt ctgagactaa gtgaatgacc tggtgttttt 28500
gggtcatacg atctacttcc taaaggtggt gaagagagac.aggtggctca gaggatcaag 28560
agccacctct gcaaagtgct ctgagctctt aaaagctctc gaaaaaccgg ctgggcgcag 28620
tggctcatgc ctgtaatccc agcactttgg gaggccaagg tgggtggatc ataaggtcag 28680
gagttccaga ccagtctggc caacatggtg ataccctgtc tctactaaaa atacaaaaaa 28740
ttagctgggc gtggtggtgt gcgcctgtag tcccagctac ttgggaggct gaggcaggag 28800
aatcgcgtga acccgggagg cagaggttgc aatgagccga gatcatgcca ttgcactcta 28860
gcccaggtga cagtgagaga ttccgtctca aaaaaaaaaa gctctggaaa aaccaagaca 28920
ccttgcttac tggctacctg tgctccccaa gatacctcct acaccagcta tccctgggcc 28980
tgacacctcc tatactggct tccctgtggc aactccctgt caatccatac ctcatactca 29040
atggcgaggt ctgtgtggtc atcaatatcc accttggcca tcaccacctt cccgtgctgc 29100
ttggccacca tcttctctaa cctcggcccc aggatcttgc agggtccaca ccacctcaaa 29160
aggcgagaaa ggaagcatcc agtcagtcaa aagagcgctc agcatcccct actggcttcc 29220
cagacctgca tctttccaag gaatcttttg cccttattat ctctgtttac catgtttaaa 29280
aattaacaca ccaaatggta atgccaggag attctgcaca tgggaaatct tcacagatcc 29340
cagactttta aaacacaggc ctcatcagaa gactcataat aaaagtgact catttcagta 29400
tatctcagat aaatatactg tcatataaaa ggatatggga ttggaagtta aaaggttcaa 29460
acagaggctt ctcaccaacc agctgattat tctggggccc tagtttcctt tttttctttt 29520
tttgagacgg agtctcgctc tatcccccag gctggagtgc agtggcgcga tctcggctca 29580
ctgcaagctc cgcctccctg gtttacgcca ttctcctgcc tcagcttcct cagtagctgg 29640
gactacaggt gcctgccaac acgcccagct aattttttgt attttttagt agagacgggg 29700
tttcaccgtg ttagccagga tggtctcgat ctcctgacct cgtgatccgc ctgtctcggc 29760
57/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ctcccaaagt gctgggatta caggcatgag ccaccgcgcc cggcctgggc cctagtttct 29820
tcatctgaaa aagagagatt atggctctca aagctattag gagagatcaa ctaaggcaat 29880
gtgggtaaac atgcattgga agctgtgggg atatttcaaa caccatgtgg actcagaact 29940
aaaaggaggg gaaccaatgg cctggagcgt ctacaacgca ccagtccctg gctcactttc 30000
tctgctttta ccaaacacac ccctcaactc tgcaaagaga acacaccttc caaagaaact 30060
gaagcccata cgagttaaga aacctgtgca agattagaga agcacagctg ggatcgatca 30120
caacccaaag ctgtgttgaa agtgttttct ttggccgggt gcggtgaccc acgcctataa 30180
ttccagcact ttgggaggcc gaggcaggcg gatcacctga ggtcaggagt tcaagatcag 30240
cctggccaac atggtaaaac ctcgtctcta ctaaaaatac aaagattagc caggagtggt 30300
ggtgtgcgcc tgtaatccca gcttctagga aggctgaggc aggagaatca ctttaacctg 30360
ggaggcagag gttgaagtga gctgagattg tgccactgca ctccagcctg ggcgacagag 30420
actctgtctc aaaaaaaaaa aaaaaaaaaa aagagaaagt gttttatttc acccacaggc 30480
tactctgatc ccacagcccc tgagttgacc attatcactg ccctgatcat aggtattccc 30540
ctctcgctgg ggaagctcat ccaggacagg cctggtgctg tcatctctat gtatgtggca 30600
ccaaggaaag tgcctggcac tgaatgaaca actcacacca ccccacttcc ttactgaaca 30660
aaatgaggca ttatcccatt tattgttcat ttcggaaggc ctctctggaa tgctcactac 30720
accaggaggc caagacagtt ccacctttca caaacccctg gctgacaact cctattttat 30780
tctcagcact tacttattta tttttgagat ggagtctcac tctgttgccc aggctggagt 30840
gcaatggcgc gatctcggct cactgcaact tccgcctccc gggttcaagc aattctcctg 30900
cctcagcctc ctgagtagca ggtgtggtgg tgcacaccgc acccagccag gcctgacggt 30960
tttaaatgct gaaaaatagg ccgggcataa tggctcacac ctgtaatcct agcactctgg 31020
gaggccaagg cgggagagaa tcacctgtgg tcaggagttt gagagactag cctggccaat 31080
atggtgaaac cccgtctcta ctaaaaatac aaaaaaatta tctgggtggt agtcccaact 31140
acttgggagg ctgaggcagg aaaattgttt taactcggga ggtggaggtt gcagtgagct 31200
gactgaacca ctgcagtcca gcctgggtga cagaatgaga ctctgtctca aaaacaaaaa 31260
aggaaaaaaa accctcaggc ctggcgcagt ggttcatgcc tgtaatccta gcactttggg 31320
aggccaaggt gggaggattg cttgagatca ggaggtagag actgcagtga gccgtgatcg 31380
caccactgca ctctacattc tagcctgggt gacagagtga gaccttgtct ctaaaagaag 31440
aaaaacaaaa acaactcata acactgaaaa acccagtgtg caagacctta tctcctatta 31500
58/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
caagtgaaga aagggagcac aaagatatca agtggcctgc ccaaggccac agggtgagtc 31560
agagaaacaa ctggaaagcc agcgaaacaa tctgtcagag acctgaccag aaggcccttc 31620
aatttctttt tctttttttt tttttttgag atggagtttc cctctgtcac ccaggctgga 31680
gtgcaatggc gcgatctcag ctcactgcaa cctccacctc ccaggttcaa gcgattctcc 31740
tgcctcagcc tcttgggtag ctgggattac aggtgcccgc caccacgccc gattaatttt 31800
tgtatttttg gtagagatgg ggtttcacta tgttggctgg gcaggtctca aactcctgac 31860
ctcaggtaat ccacctgcct cggcctctga aagtgctggg attacaggtg tgagccactg 31920
cgtccgacct gaaggcccct gaatttttaa cttatgctac actggtttct cccaggatgc 31980
ctcattcaga gggctttgtc cagcttttgt gtagttgggt gtctagccag gccccaaaga 32040
tctagaaatg aaaaagccca ggctaaaatt cagaaggcca gagggactta aatatctcta 32100
aagcaaactc agatagcact gaaaggaaac tccttcctat gccctgtatg cttgggcacc 32160
acggtagtga caccgataac tttttttttt tttttttgag atggaatttc actctttttg 32220
cccaggctgg agtgtaatgg cgcgatcttc agctcactac aaacactacc tcttaggttc 32280
aagtgattct cctgcctcag cctcccgagt agctgggatt acaggcacac accaccacgc 32340
ctagctaatt ttgtattttt aatagagaca gggtatcacc atgttggcca ggctggtctt 32400
gaactcctga cctcaggtga tctgcccgcc ttggcctccc aaagtgctgg gattacaggc 32460
atgagccacc gcacccggcc gacactgata actttttgcc agcccttctt gcggttttca 32520
tggcaggatg ttaacatcag cttatctgca gggccaggaa ctggtataca ccaaaagcaa 32580
ggtgacagtc atatttttcc aactctggtc catgctaaag atgacgctga gctttctggg 32640
gattgagaaa cagaacatgt gtttcccagc actaacagtc agctttgcag actgttcact 32700
tgtctgtctt ccaccagact gcattcccct tgagggcagg gactgggcct gaccagtctg 32760
tatattgagt ctacatatga gcagcataga acatggccgt gggacacagc aggcattcaa 32820
taaatacttg aacaagtagg accctagtct tctgtggacc cccaatactc actgtgcgtg 32880
gaaatccaca accactggtg tctcactgtt gaccactcgg tcttgaaagt caggtccatc 32940
ctggatatta aaggttgtca aggagatcct cgtggtgtat attgtccggg ctgggttggg 33000
tgttacagtc aggccaccag gactgcattg tggggtctgc agggctctgg aagtgagggg 33060
tggccactga ccctgagagg gcttcctgga gatgacagag gccaggaacc tcctcagaag 33120
aagtcgctga gccatctgtg agggaaagag gcagaagaac tggggcacac aaaaggaagt 33180
cgacacacta gaaaaagatt tggggagtac tcagggctca ggaagaggca gagttggaag 33240
caaaatgcaa ggaaatcata tgtaagattt gtagcgtgga agtgaggaag caatgagaat 33300
59/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
caaagggaag gaacagctag gcaaaccaga aggacaggaa aactggcttc acaaccaaaa 33360
agaaatcggg atttagatta taacggaaga atgggaggaa gaaaccaaca gatttaataa 33420
tgtatgtaag gaccaagtac cttacacaca ttattggtct tcctacagca acttccagga 33480
agttgctatt gtactgccca cactgcgagt aagggaagga atacgaggct caagtaagtt 33540
aagtgacatg cccaaagtaa ccccgctatt aaatgacagc caacactgga acccagggtc 33600
gtctgaaaag atgaaacgca acaattcaag gaggaactaa gagtgtgaga ggaaccaaaa 33660
acgaagagac atgtactgga gggaaccaat aaagaaggga catgtgtgga gggaactggg 33720
aaaaatcgga catcaccagg gaccctggct ctccggcgag ctagatcccc ccgcccgccc 33780
ggccgccagc ctgcgcagga acgcgctcgc ggcatgcctc agccgcgaca ccacctcgag 33840
ccacccccac agggctccta cctccctgca atgcgagcgg agggatgcac agcctagccc 33900
tccctgcctg tcaagggcac gcctgtcgtc acttcctcgg ggggggacgt acataacgtc 33960
acttccgggt acaggcaggc ggaagagcgt ccctctccaa tttttttttt tttttttttt 34020
ttttttgagc cagagtctcg ctctgttgcc aggctggggt gcagtggcgc gatctcggct 34080
cactgcaacc tccgccttcc gggttcaagc gattctcctg cctcagcctc ccgactagag 34140
gcgcgcgcca ccacgcccag ctaatttttt tatttttagt agagacgggg tttcaccacg 34200
ttggccagga cggtctcgat cttttgacct cgtgatccgc ccgcctcggc ttctcagagg .34260
gttgtgatta cgggcgtgag ccacagcgcc catctgtccc tctccaattt gaggggcgtc 34320
tgggattttc cgccaatggg aatggcgggc tgaggcacag ttgaaggggc ggggcctcag 34380
ctacggaccg gaagcaatgg gcaggccgtc ggggaacgga ttggaagagg cgggcgggcc 34440
ctggtctggg cgaaggcggg ggcggggcgg ggcggaaacg gaaggggtgg gcgggcccta 34500
gaggagggac cggaagagga ggtgatggag caggggtagc aatggagggt acttaaggga 34560
gaaaaggcag ttgagaagtc cccgtggttt tggattttgc aaactcttgt tgctttattt 34620
tatttacata tatttattta ttaatgacag agtctcgctc tgtctcccag gctacagtgc 34680
agtggcgtga tctccgctca ctgcaacatc caaatcccgg gttcaagtga ttttcctgcc 34740
tcagcctccc aggtagctgg gattacaggc gcgcgccacc acgccgggct gatttttgta 34800
tttttagtag agacggagtt tcgccatgtt ggccaggctg gtctggaact cctgagctca 34860
agtgatccgc ccgcttcagc ctcccaaagt gctgggatta caggcgtgag ccaccttgcc 34920
tggcctcctg tttataactg gcgctgtcca cttcctacag atgttgacag gttctgtttc 34980
tccatttaat atgtaaagct aagctcctca aaggcatgat gccctttata tgtaaaagaa 35040
60/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ctcaaccggg agtttagggg ccatccttta agtggccctc gtctgtgtcc gcctaaagga 35100
aaacaaatga aaactgaggc gagcctaatt taagcaggga gtttttttgg gtcaagttcg 35160
aagactgcaa ctcggagcag agattcaagt tgtcctgaat atacactcgg attagcagca 35220
gctgaaagag cgtttttaaa agaacaggca gtttccaaat tgttgatcaa agtttttttt 35280
tttttttttt ttttttttga gacagagtct cgctcttgtt gcccaggctg gagtgcagtg 35340
gcgcgatctc ggctcactgc aacctctgcc tcctgggttc aagggattct tctccctctg 35400
cctccccagt agctgggact acaggcgtgc ctcaccacgc ctagctaatt tttatatttt 35460
tagtagagac ggagtttcac catgttggct aggatggtct cgatctattg acctcatgat 35520
ctgcccacct gggcctccca aagtgctgga attacaggcg tgagccactg cacccagcct 35580
tttttttttt ttttttgaga cggagtcttg ctctgtagct aggctggagt gcagtggcat 35640
gatcttggct caccgcaacc tccacctcca gggttcaagg gattctcctg cctcagcccc 35700
ccaagtactt gggattacag gcgagcacca ccacacctgg ctaatttttt atatttttgg 35760
tacagaaatt ttatatttca ccatgttggc caggctggtc tcgaactcct gaccttaagt 35820
tatcgctcgc ctcggcttcc caaagtgctg ggataacagg cgtgagccac cgcgcctggc 35880
cgccctgccc atttttgtat cggttttctg tgtctctagc actttctttt ccacagccac 35940
ctatcaatcc tattcagcac ttccacagta ttttctagag agccaatttt cctgcctaat 36000
tcacattctg aatttcacag gcggaccagt cctgtttgtc cttatgccat agtcacttca 36060
ccctgatcgg cctcaggctt ctcatctgag caatgggaag aatgcctttc tcatagctgg 36120
gctgagggtt gcagtagaga cagaatccac atcattgctg cctgatgact cctgcaggga 36180
aagcctgaga gacacagaga aggctgagct ctcggcgcgc tacaaaaggg ctctcagcta 36240
catggtggct cctctgtcca gctagagctg agctggcctg ggtctggctt agtcacaagc 36300
aggctcaggg cacagctgag aggcaaaggg aaggaagcca ggactggcag cctgggctaa 36360
gggtaaaact tctacctcct accaatattt attgcagtgt ttttcaaact gcaggatatg 36420
gacgtcagtg ggtttgcaaa attaatttag tgggtggtga tctgcttttt aaaaaaacaa 36480
acatggtgcc aggcgtggtg gctcacacct gtaatcccag cactttggga ggccaaggcg 36540
ggcagttcac ttgaggtcag gagttcgaga ccagcctggc caacatggtg aaaccccatc 36600
tctactaaaa atacaaaaat tagccaagcg tggtggtaca cgcctgtagc cccagctact 36660
cgggaggctg ggcaggagaa tggcgtgaac ccgggaggcg gagcttgcag tgagccgaga 36720
tagtgccact gcactctggc ctgggcgaaa gagcaagact ctgtctcaaa aaaaaaaaaa 36780
aaaaaaatag ctctaaggtc ttgcactaac cggtatgacc tgtctggcgt ctttacaggc 36840
61/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
agtattggaa tgttataggg agacatacag ggtttaagaa atccatcacg gagaagacct 36900
tcaattatca attataggtt ttaaatttac ctcggctttg aaaggaatag gatacattgc 36960
tttctcttta ctacttcccc aggggtttgt aatttaacat gaaactgagt aatctgtaac 37020
tttcctcgat tctcgtcttt tgaccatacc ttgggatgaa tgagttcttt gtctgtggtg 37080
gggagcaagt ttagggaggg gaggaatctt ccctgattaa tatagaggcc taagccaaat 37140
tttagcatta aatctctcta ataggtttgt tcctgcctct ggaataaaca gaaatttaat 37200
attagctgat ttgcttttat atatgacttt tgttcttttt cccatttggg acattttctt 37260
ttgaagtgac ctatttttaa tctgaaacat ttattttgtc ctctttctct ccctttgcct 37320
ctccctctct gcctcttttt ctctctcact ctttctcttt gcctctctct ctgcctctct 37380
cttcctcttt gactctctcc ctttgccttt ctctctgcct ctctctttcc ctttttgcct 37440
gtctctctct ctttgactct gtctgttctg tcagtctttc tctctcctct aagttttttt 37500
tttctttact tttgagtctc ctggctttac tctttcatac tctatatatt gcctggagag 37560
tgggggtcta ggttcttttt tttttttttt tttttttttt gagacggagt ctcgctctgt 37620
cgcccaggct ggagtgtagt ggcgcgatct tggctcactg caacctccgc ctcctgggtt 37680
cacgccattc tcctgcctca gcctcccgag tagctgggac tacaggcgcc caccaccatg 37740
cccggctgct tttttttagt agagacgggg tttcaccgtg ttagccagga tggtcttggt 37800
ctcctgacct cgtgatccgc tcgccttggc ctcccaaagt gctgggatta caggcgtgag 37860
ccgccgcgcc cagccctcag tctaggttct ttataggttc tggccccctg ggtactttgt 37920
tgtatggtag acagcagaat ttttgccttc tgcttttgtt tttcatcatc ttttcttata 37980
tatacctttt gggcttctct tagaagctct tctataggtt tatctttcca gttctctatc 38040
ttttgtaatt tcttgttaat atctggccaa ctgttagtga caaaatgaag ttttaacatt 38100
ccctgcccaa gaggatcctt gagacctaga ccagtgtatt ttctcatttg ttcctttaat 38160
ctatctaaaa attctatagg cccttcatct ttcccttgct gtatatcaaa tattcgggta 38220
agatactgag ttcggggtac caattttttt tttttttttg agatggagcc ttgctctgtt 38280
gctcaggcta gagtgctgga gtgcagtggc gtgatctcgg ctcactgcaa gctccgcctt 38340
ctgggttcac gccattctcc tgcctcagcc tcctgagtag ctgggactaa aggcgcctgc 38400
cactatgccc agctaatttt tttgtatttt ttagtagaga cggggtttca ctgtgttggc 38460
caggatggtc tcgatctcct gaccttgtga tctgcctgcc tcggcctccc aaagtgctgg 38520
gattacaggc gtgagccact gcgcccagcc tcggggtact gatgctttaa tcccctttat 38580
62/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tatcaattcc ttaaggtcct gcatattttc tcggtgggct gcgttgttat tgtcccactg 38640
ggggtcttgg gtgggagttt tttgatctgc tgtaggaacg ttttggccag gagggtgttc 38700
gtgttcctag gctcccatag cagctctatg gatcatgtct ctttcttccc ccgagaagag 38760
gggaaaggga aattctgaat atctttttta cattgctcta tctcacgttg aagtccttta 38820
agggaaaggt acttaggtcg gtagtgagtg ggctcttggg acgattctca agaggcaggg 38880
ttgtaagaaa ggggacatca gagataggag aagggtctgg gacagcagct gcttttgttt 38940
ttggtccttt cattatcctt ctaacatttt aacattaggc ctgggggaat attactgttg 39000
ctagctttct cctttttatc tcttacctta cttggggcat ttcccatctt gggtcctggt 39060
taagctcaat ctcccctgtt ggagatgtct cgcctatcct ttagccccac ctgctggagg 39120
ctccttgcat tcatgcacac tttcaacccc cagaatatcc tgaccaccaa ggaaatactt 39180
tgtcacccct gcgatgtttc ttagcttggt ctctgcacac ttacttggtc gctgtggtac 39240
atgaggatcc tttcccccag gtcgccagcc cgtttctttc tgccttgctg agagtatagg 39300
tttattcgtc acactggttg gtctcgattc cttacccctg tggccaccgc aacaaggcag 39360
tgggacgtgc ctcctcatgg gagaggtcta gaccctcctc agaggaggat gggaatccca 39420
aatgagaccc caaatttgtt agaaataaat tttcagtgcc acaaaagaaa tagcactcaa 39480
acatacattt tctcagcaag gcaattttac ttctatacaa gagtgcgtct catggatggt 39540
gcaatggcga gagcacaccg gaacaaggga ggggaatggg ttcttatccc tgatgcaggt 39600
accccctact gctgtgttgt tcccctatgg gctagggttg gaccgcacaa tctaagctaa 39660
ttctgactgg ctattttaaa gagagcaggg gtataagcca gagtggtggg gtgagaagtt 39720
tagacaggaa agatggttac ggaccaggtg actaaaggtg actcaggtca gagcaggtga 39780
cagaggctag gaggggattg tttactgaaa ctaggggcaa ggagacataa agaatgagga 39840
aattaaaagt taaaatgaag aacaaagaac aggtgagctg aacatactga tacattggtt 39900
ctttggagag gatctcagaa ctcaatgtac ttaacaaatt acaggctaaa acctttgaag 39960
aagaatttat gatatcctac attatcatgg ggtaaacaat tcgtccctga cagaataagg 40020
ctactggagt tctcttcttg taactctggg aaggactaga gggaactgtg tctgcagtgg 40080
ggccaggtag ttaaaaagtc tggactgggc cgagcgtggt ggctcatgcc tgtaatccca 40140
acactttagg aggccaagac aggtggatca cctgaggtca ggagttcgag accagcctgg 40200
ccaatgtggt gaaaccctgt ctctactaaa aatacaaaaa ttagctgggc gtggtggcag 40260
gcgcttgtaa tcccagctac ttgggaggtt gagggaagag aattgtttag acccgggagg 40320
cagaagttgc agtgagccga catcgtgcca ttgcactcca gcctgggtga caagagcgaa 40380
63/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
atccattgca aaaaaaaaaa aaaagaaaaa gaaaaagtct ggaccaagcc aagaggggaa 40440
gaggacgtcc ccatgaaaga gctttggatc cagaaagccc gggttcttgg aattcttttt 40500
ctcttttcac ttttgttgta gcatactttg ttctttttta ttttttattt ttttgagatg 40560
gggtgtgggg gctttactgt gggtcttgct ttgtcaccta ggctggagta cagtggctcg 40620
gtctctgctc actgcaacct ccacctccca ggttcaagca attctcctgc ctcagcttcc 40680
caagtagctg ggatgacagg catgctccac catgcccagc taattttttt taccgttagt 40740
agagacaagg ttttgctatg ttggccaggc tggtctcgaa ttcctgagct caggtgatcg 40800
gcccactttg gcctcccaaa gtgctgggat tacaggtgta agcaactgta cccagcgcat 40860
gttttatttt aatttaattt aattaactta ttttttgaga tggagtttcc ctcttgttac 40920
ctaggctgga gtgcaatggc gcaatctcgg ctcactgcaa cctctgcctc ccgggtttaa 40980
gtgattctcc tgcctcagcc tctccagtag ctgggattat agacatgtgc taccacgcct 41040
ggctagtttt gtatttttag tagagatagg gtttctccat gttggtcagg ctggtctcaa 41100
actcctgacc tcaggtgatc cacctgcctg ggcctcccag agtgctggga ttgtccttgg 41160
aattctgagt ggatacatga agagttagta agaaccagtg aaaaagcaat cacttatgat 41220
cctgggcttt gaaaaatcac tgtgattatc ttatgcactt acaaatgaga ctaagacgcc 41280
tgatgggaaa gtgcagattg ctggtgagga agggcaatga agaagagact aggaaccaaa 41340
ttcatcatca ttatcacaca aaggcatttg gaaatgtcac cttacacatg gtgagcacat 41400
atgggtgcca gcccgagaca gcaggataag tttcacaaaa cttgaccagg caggttagaa 41460
gcaaggcatg gttcaggatg gcagagggca gggagacaga agggagtagg atgggagaga 41520
agagccagct ggaagatgag tcagggggtg caactgggga gagcagctct gaatcctgct 41580
tctcagtgag aaagttgcta agatggcttt gcagggagct gtcctatcgc tgctcgagat 41640
cagcctgctg ggcctatgat gataagcagg gctgaccctc ttgggctctg tagctaagcc 41700
caaaccctgc tgaaaatggg gcggggaggt tgaggcagtg tgtggcaagt gacacagacg 41760
gggactccca gctgggggtc cctggaatta cttgacatcc cacagctggt gtcttcagca 41820
gtcatctggg gcaacaatcc cacctgccca ttgtggttgt tgaggatatc agagcttttg 41880
ttttaaagcg cttgccacaa actcttaaga tgcggatggg tttcccctgt gaagcactcc 41940
acaggcggga tgcaggccca tctgaggagg ggcttggaag gaagaggagc acttgagacg 42000
gggcagaact gggctggcct ggggctcagc gacagctcca ttgcagacaa actgggctgg 42060
ggaaggcagc tcccacctgg cagaggatgc ccttctgccc cctgacagga gggaggagac 42120
64/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
caccgcatcc ccgactttca gccctcacgt gccatctggt ggctttgctg cagacactgc 42180
catgatctga gtggtctttg gcaatcacgc attggcggga gtgtgaggtt gcggggaaag 42240
agggactgac catgggccta ggtggggagg cctggccact gtgcccacag cttaggaagg 42300
gacagtcaga gctcctcttt gttgctatcg acggactgag ccagaggccc tggagccagg 42360
ggggaaccta gtggctcttg gtcgccaagc tgctggctgc tgtcctccag gcgcctgcct 42420
gtgggggcat agtcccgcag gagcctgctc tccactctgt gctgccaaag gctctcggta 42480
ctcacgagtc cctgcatcct caggtacccc tgctggcaaa agggtggcaa cttctggcgc 42540
gtgagggcga acaggaagca ggactctaca caaaagcaaa atgaggagaa tgagccaggc 42600
tgggacatgt ggggaggggt gcagaaaggg gagctgccaa tgccaggtgt gggggcttca 42660
ctgcaggcct tgcctggtat cttccatccc ttgaaactgg gagctgacct ttctgggcat 42720
ctcacgtcca acctgagtag gtcatgaatc atgaccctcc acgaggctcc agggcagggg 42780
gctgccttga cactctggaa gaacaaggct ccaaaataaa agcaaaccac agcaatgcct 42840
cagctcccag acatcagggc tgagcaccgg gctctgcagg caaccacact gggggcgggg 42900
ctccgacctt catgagcaga ccctcggcct ggtgcggctg ggaactcagt ggtcagttcc 42960
actgtgagct cagatctgcc tgcaaagacg cagtccctca acaacatttg agttgcaaat 43020
accatgtgca aagttctgat ctaaacagtg tgggggataa agaaaaacgg gtatatcctc 43080
atctgtccca caacagaaag ctggtgcatg aatcaaattt ggtcaatcat aagatagctg 43140
tggatactta tcatgtagaa atatgaagaa acggccgggc gtggtggctc acgccttaat 43200
ccgacaactc tgggaggccg aggccggtgg atcgcctgag gttaggactt cgagaccagc 43260
ctggccaaca taatgagaaa gaaaccccgt ctctagtaaa aatacaaaaa ttagccaggc 43320
gtagtgacaa acacctgtaa tcccagctac tcgggaggct gaggcaggag aatcactcga 43380
atccaggagg cggacgttgc agtgagccaa gatcgtgcca ctgcactcca gcctgggtga 43440
cagagactct gtctcgaaaa aaaaaagaaa gaaaaagaaa tatgaagaaa caaccaaaag 43500
aagccatgca aagagagaag ctactgaaag gaacaaccgc taggtctggg agttcctcgt 43560
gggaatgaga atgaaggtag ggaaagcggg tgacatagtt tgggtctgtg tccccgccca 43620
aatctcatgt tgaaatgcaa tctctaatgc tggaggtggg gctgctggga ggtgactgca 43680
tcacaggagt ggtttctttt tctttttttt tcttgaggca gagtctccct ctgttgccca 43740
ggcaggctgg agtacagtgg cacgatccca gctcactaca acctctgcct tctgggttca 43800
agtgattctc ctgcctcagc ctccccagta gctgagacta caggtgcccg ccaccacgct 43860
cagctaattt ttgtgttttt taagtaggga gagggtttca ccatgttggc ctggcttgtc 43920
65/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ttgaactcct gacctcaagc tatctgcctt tctcggcctc ccaaagtgct gggattacag 43980
gcgtgatcca gcatccagaa atagatgctg ccatgcgtcc atacagcctg cagaactgtg 44040
agccaattaa acctgtttct ttataaatta cagtctcagg tatttcttta tagcaatgtg 44100
agaacagact aatacagtga gaaaaagtca tttagccaag tacttataag actttaaaca 44160
aacagaagag ctgacacaga tatgggctca gccttctgag ggagttagag acaagggcag 44220
acagagtgtc aggaatgggc tggagtcctt ctgtaactct gagcgagcct tcttgcctcc 44280
ctgagcccct ctatctcaag tgaaaaatgg gcacagcaca aaggatgtcg tgaggcttcc 44340
atgggtgacc aggctgaaag gtgctccaga aatatgactt cctgtttatt tctgactctt 44400
agcatggagg cccctgggag gccaggccat ggcaagcctc tccaagcggg taagagagca 44460
gatgaggaag aggacagcgg gaagactggg agggcagcaa ggtggctgtt tggcaggcac 44520
caccttctga caacatcatc ccttctgcag ggggctcaga tgctcagcag aatctggggc 44580
cagcactaac agctgcacat cagctacagt aacagaggga cggctgccac tatgccagct 44640
ggccgcctgc tgggcggatt ctctccagtc caaggcagca gcacacagtg gcctgtacag 44700
tcaaacagtg tctagaaagt gggagacagg aggctaaagg gcctgggaca atgcattggt 44760
gggacccaca actcagggtg ggaattcact ccctcacaca ccctggcatt tttgttgttg 44820
ttggttttga gatggagtct cgctctgttg cccaggctgg agtgcagtgg catgatctcg 44880
ggtcactgca acatccgcct tccgggttca agcgattctc ctgcctcagc ctcccgagta 44940
ggtagctggg attacaggca cccaccactg cccccagcta atttttctac ttttagtaga 45000
aatggggttt caccatgttg gccagggctg gtctcgaact cctgacctca ggtgatccac 45060
ccacctcggc ctcccaaagt gttgagatta caggcgtgag ccactgcacc tggcctaaaa 45120
gtgtatttct tgagaaggtg tgcatttgct tctgtgattt ctatagctca atgatctcat 45180
gaagtttggc cccaaattta cataagcagg gcctactggt tgaatatttt cagagatttt 45240
tctctcccac tctatctagg gccaaaacca tgcatgtcat ctatctcctc ctttggaggg 45300
ttttggctcc cagcttccct actgagatcc aagctttatt ggagtgtctc taaacaggcc 45360
tcccatcctg ctccagctct gtcttcccac ccatacctgg ccctggcgcc ttcccatggc 45420
gcctggccct gctaatcctt ttgaaaagac atattatcag ctgggtgcgg tggctcacac 45480
ttgtaatccc aacacttcag caggctgagg caggcggatc acgaggtcag ttcgagacca 45540
gcctggccaa tatggtgaaa ccccatctct actaaaaaat aaaaaaatta gttgggcatg 45600
gtggcatgtg cctgtagtcc cagcttcttg ggaggctgag gcaggagaat cgcttgaacc 45660
66/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
cgggaggcgg aggttgtagt gagctgagat tgcgccacta cactccagcc tgggcaacag 45720
agcgagactc catctcaaaa aaaaaaaaaa gaagacatat tatccattat ttttaggtga 45780
gttgtaattt aacccacggc attgtcggga acagtagtct ggggtttgga tttccagata 45840
tgggtcctga aactccacgg gtcttgggtc tctgtgacct ttcttcaacc tggagctcag 45900
accctttgtc tttctgggag cttaagttac ctgcatagaa gcttcgcaaa tcggtgtcca 45960
aacagttctc caggaagcgc ctcagaggta ggatgtgccc gatcggggca gtccagtctg 46020
ttaagaagtc ttccacgatg tgatggatgg ccgtgggccg aggcaggggc cagtgtgcag 46080
ggcggaacct cacctcctgt tctgtgggga ggagagaggg ggccatgtca gagctgtgag 46140
gctgggcttc ccctcctcgg gccgacacag cacggatccc acacagccca aacacttccc 46200
tcgttcactc gtgctcggct ttcccgacag cctcctatgc tgggctgtgg tcagactgtt 46260
caagagccac ctgcagatat ttgaaaggct gccatgagga agaggaacta ggcttttccc 46320
ttgtggtttc ggaaggcagt gctgaagcta acaacgtgag gctggcgttt ccctaagact 46380
cacatggact gagatctact gtggctgctt tttattttgt attattattt gttggagaca 46440
gtctcgctct attgcccagg ctgtcatgca gtggcacaat ttaggctcac cgcaacctct 46500
acctcctggg ttcaagcgat tcttgtgcct ctgcctccag agtagctggg attacaggtg 46560
cccgccacca caccgagctc atattttaca tttttcgtag agatggggtt tctagtctct 46620
accatgttgg ccaggctggt ctcaaactcc tgacctcagg tgacccaccc gcctcagcct 46680
cccaaagtgc tgggattaca ggcatgagcc actgcgcctg gctgtggctg ctttcaaact 46740
ggcctttctc tgagaagact cagatagagg cgaggggtct cagcactcat ctagttcagc 46800
ttctccctgg tgtgggctcc cttctgtggt gttccagtca gatggccatc gagtcaagac 46860
ttggccgtcg ctattctggg aaacctgaat ttggaggtga ccaattcccc cactgaacag 46920
ctttaactct tagtgcctcc tttttctttt tttttgagac agagtctcgc tctgtctccc 46980
aggctagagt gcagtggcac aatcttggct cactgcagcc tctgcctcct gggttcaagc 47040
gattctcctg cctcagcctc cctagtagct gggactacag gcgcacgcca ccacgctggc 47100
taatttttgt atttttatta gagacggggt ttcactatgt cggccaggat ggtctcgacc 47160
tcctgacctc gtgatccgcc cgcctcggcc tcccaaaatg ctgggattac aggcgtgagc 47220
gaccgcgccc ggcctttttg tttgtttgtt tgtttttttt gagacagagt cttgctctgt 47280
agcccaggct ggagtgcagt ggtacaatct cggctcactg caacctctgc ctcccggatc 47340
ccggttcaag caattctcct gcctcagcct cctgaatagc tgggattaca ggcatgtgcc 47400
accatgccca gctaattttt gcattttttt catgtttttt tagagatggg gtttcaccat 47460
67/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tttggccagg ctggtcttga actcctgacc ttataatccg cttgccttgg tctctcaaag 47520
tgctgggatt acagtcatga gccaccatgc ccagcctctt agtgcctcct tatactgacc 47580
acagacctgc acccgtcact gctacctgct gacacgactt ctgcctttgg gaacaacccc 47640
tgtttaaacc accctcttct acctgactgc ccttcaagct ctgaagcagg gggtgcgttc 47700
ccgaggttgt tcacttattg gtagctactc tgtgcctgca gtgggctggc attctgtgta 47760
cactgtcagg tttaacctca tggaacccta caagaaaggt actgttgtaa tccccatttt 47820
acagagggga ggttgaggct cagagaggtt aagtaatggt ccaaggtcac acagtgacaa 47880
aatgacaggc ctagggattt tgcccagttt ctctgtactg tgttaaccag ctccagttcc 47940
ctctactctt cagacccctc ccgccccacc acagtcagcc gcctctggag acctgcagca 48000
gggccgtgtc cctcttacta cacagtgcct ggcggagagc acgacacccc ccgcatggcc 48060
tgtgccagtc acggtatgtg tcagaatctg gaagcatcgt tcatcattct cggaccttct 48120
gcccaagtgg tctctaggca gagtcccgca gccatcccac ctgtcagctg agcatgtgtg 48180
tgaaggtttc agggtgggtg acaaccttgc agacggtgag gtctgaggag cccacaggtt 48240
ggggaagggc agagacctgc tcaccggtgg ggaggtatct atagtagtag atgacaggat 48300
gaagaaagtt agactgccag gcatcttctg tgtgccccac agaccggtca tcaaagaaga 48360
cgtccttgtc ggggccagag aaatttctgc catattccat gttgatgacg aagagcccgt 48420
gctttgcctt cctccctgtg agtgtctcca gctgggccag catctgtatg gggaactcct 48480
ccaggtactc aaaggccgtg gaattcctgg gagaacagca acgcggggga ggccctcagt 48540
gctgtggcag aggtgagggg tgcagcccgg gggtgagcat gtgtgtgtgc gtgtgtatct 48600
ccccctctaa ggagcgtcaa tcaagcagca cacccctcac ttaacattac tttttcagct 48660
cagctctcac gcacatgtgg ggtagagacc agaaaattcc atgtaacctg aatgggatat 48720
ctggggaaag agtgtcccag gcagagagaa cagtcaggaa aaagccctga ggagtatgtg 48780
agcactttgt gttcaaggaa cagaagaggc cgacgtggct gaggggagtg aacagcaggc 48840
agagggcagg agagggggcc ggaggccttg agaggtcaag gagggctgcg cctcccatga 48900
cgagacgtga ggagtcgtct ggcccgagag gtgacactgc tggttgcttg ggaggactga 48960
gcagagctgg gatcagcatg cctcaggttt ctaaggacca ctctggttac tgtgctgaga 49020
acagacgcca ggccaagtgg ggcggctgtt gtatgggtgc aggtgataca gcctggtgat 49080
cgggaccgag gtggtggtgg tagagcaggt gagagctggt tgggctccag acatcatctg 49140
aaggcagagg tgacaagact tgcccatggt ttgcatgtgg ggtgttgaga caggggtgcc 49200
68/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aggcgtgctg actcacgcct gtaatctcag cactttggga gaccaaggcg ggtggatcac 49260
ctgaggtcag gagtttgaga ccagcctagc caacatggtg aaacctagtc tctactaaaa 49320
atacaaaatt agccaggtgt ggtggcatgg gcctgtaatc ccagctactc gggaggctga 49380
gacacgagaa tcgcttgaac ctgggaggtg ggctgcagtg agccaagatc gcaccactgc 49440
actccagcct gggcaagaca tagtgagact ctgagtcaaa aaaaaaaatt agccaggcat 49500
ggtggtgggt gcctgtaatc ccagctactt aggaggctga ggcaggagaa gtgcttgaac 49560
ccaggaggca gatgttgcag cgagcagaga tcgcaccact gcactccagc ctggatgaca 49620
gagcgagact gtctcaagaa aaaaaaaaga ggggcagggg catggagggt gatgcgaggg 49680
ttttgtgcag aaagcggctg cactacctgc atgtccctga acttggtgtg ctatagcacg 49740
ccctgccttt ggatcgggct gttccctctg actgaaggtt gctcccttgc ttctccctgc 49800
cacctgtctc cccccgcccc tcacccctct gtgctctgca ccgtttcctt ctcaggaact 49860
gtccatcctc tgggatctgc tgcttatcac taaattgact ctgacgatgg tggccggcaa 49920
ggccctggcc tgagggagct ctgagatcca cgtggctgcc tctgactact gctcatccac 49980
gtgatgccaa acactttcca caagtgacct ttactccttc ctttactgct gcaaggtagg 50040
cacaattatc cccattttgc agatgaggaa gaagggctca gagaggctca ctaatgtgcc 50100
cgtggccact cacaggactg tctgtagagt taatgtcatt gtttttcccc agaacaggca 50160
tgttccccac agcagccttc atcttaggaa agaactgggc acctcacacc tggaatagga 50220
agagaagcgc tatgcagcac gtcgggaaag ctgggccgag gggagtaggg tggggacggg 50280
ctactcactc cttcaacagg atgacatcgg ccagcacacc gaacatctgg tagagcccag 50340
aagcctcatt cacgcgccgc acgatggagc tggtcagctg tgtgatgggg agctcagtgg 50400
cgggccaggt gacgctgtgg tggcggtgct ccaggagccg gtgaacagca cgcactggaa 50460
cagccagagg gaggaacggc acgctgcact taccatttta tctctggtca ctgggaggga 50520
tgcccaggcc tcattgaccc ctgagaacgc catacacact ggtctccatg gcccagcgca 50580
aacgcctagg tggtgaacac atgaggggag gagatggcag ctgcctttag agcagggcca 50640
gcaggtattt tctggaaagg gccagacaat ccatattctc tgctttgtgg gtcatacacg 50700
actcagtgat gctgctcaat tctgccccta gtgtaaaagc ggccaagaca acaggcaaag 50760
gagtgagcac agctggagtt ggtctccagg ccagagtcca tctgcccctg cttcaggcca 50820
tctgcacgtg ggagtcccac cggccccacc tcacacaagg aacgtcaagt ccaacacgga 50880
gccttcccca gaaacctccc ccccttcaca gctctgtttc catcagagac gcgcctacag 50940
aaatctttga tttcgccctc tctttcacag cctaaatcca tctgtctcta agttcttttt 51000
69/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ttaaatattt tttattttat ttttttgaga cagggtctcg ctctgttgcc caggctggag 51060
tgcagtggtg cgatctcggc tcaccgcgac ctccgcctcc tgggttccag gaggaaccga 51120
ctcccagaat tgagtccaat cctttgcccg tactgtaaga cccctctgca gtggtcccta 51180
cacttattat tgtagtcctc taacctggaa taaagtccac cttaccgtct tcatttgtat 51240
tatgattttt gagacagagt ctcactctga tgcccaggct ggagcgcagt ggcacgatct 51300
tggctcactg caacctctgc ttcctggatt gaagtgattc tcctgcctca gcctcccaag 51360
tagtagggat tacaagcctg gctaattttt gtatttttag tagagatggg gtttcaccat 51420
gttggtcagg ctggtctcga acttctgacc taagctgatc tgccagcctc agcctcccaa 51480
aatgctggga ttataggcat gagccactac gcccagcctg ccttactgtc tttaaaaaga 51540
aaaaagaaat ataaatattg aatgtctttg agtggcagaa tataaagatt actccccgta 51600
attccctaca ttttcacatt tttgatgctc aggctaggca tggtggctca tgcctgtaat 51660
cccaacactt tgggaggctg aggtgggtgg atcgcttgag cttgggagtt tgagaccagc 51720
ctgggcaaca tggcgaaaac ttgtctctac cacacaaaaa taaaaacaac aaaattagct 51780
gggtgtggtg gtgcacgcct gaagtcccag ccactcagaa ggctgaggtg ggaggatggc 51840
ttgagtctgg gaagtcgagg ctgcagtgag ccgagatggc gccattgtac tccagcatgg 51900
gaaacaggaa gagacgctgt ctcaaaaaaa ataataatac taatttttta aagctcagct 51960
gtaagattat gactccattc tttcaaatag actcacctaa ccacctaact gaatactgta 52020
tgcctcactg agtgaatttc aaccaacaec ctgtccttct cagaaggtta accacaggag 52080
caggaacatc taatttttat ttatttattt atttttgaga cagagtttca ctctttttgc 52140
ccaggctgga gtgcaatggt gtgggcttgg ctcactgcaa cctccacctc caaggttcaa 52200
gtgattctct tgcctcagca tcccgagtag ttgggattac aggcgcccgc caccatgccc 52260
ggctaatttt gtattttaag tagaggtggg atttcaccat actggccagg ctggtctcga 52320
actcctgccc tcaggtgatc cacccacctc agtctaccaa agtgctggga tgacaggtgt 52380
gacccaccgt gcctggccac atctaacatt ttagactcct ctccacagaa agggcaccag 52440
tttgctttct atgaaagaag agaagacctt tgtagaaagt gtctttcagg aaagctcctg 52500
ggccttggag tttaattccc ataatggtga gaaaatcacc aaaactctga gcctcagagt 52560
tttacactct tgaggaaaat ggagatttca cacccacctt tcggggtgct ggcggccctg 52620
ccagggtcgt gtgttcagtg ctcagcccac tgaagtcacc caacatgcgt gaattcatct 52680
ctctcacttc ctttttattt cccatttact cctaaaatca caagtatcaa tttttggttg 52740
70/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gggattattt tagtgcaata aatagaatta tgtttttaaa agatatttta gtattttctt 52800
tgtaaacatt ctcaagttgg cagaaaattt atacccttgg tactgagagt tttgaaaaag 52860
aactgatata atccaattac attttttttt ttttttttga gatggagttt tgctcttgtt 52920
gcccaggctg gagtgcaatg gtgcgatctc agctcaccgc aacctccacc tcctgggttc 52980
aagtgattct cctgcctcag cctcccgagt agctgggact gcaggcgcac gccaccacac 53040
ctggctaatt tttgtatttt tagtagagac agggtttcgc cgtgttgccc aggctggtct 53100
tgaactcctg gcctgaagca atccacctgc cttggcctcc caaagtgcta ggattacagg 53160
cgtgagccat tgcacctggc ctacacttaa ttttatttta tttttgagac caagtctcgc 53220
tctgtcaccc aggctggagt gcagtggtat catcatggct cactgcaacc ttgacttcct 53280
ggactcaagg gatcctcctg cctcagcctc ccaagtagct aggactacag gcgtggactt 53340
ttacacttta tctgatactt tcctaaacat gtcgtcagac cacaaaaacc tgttgtcact 53400
tccccaagac aatttatgac aatgagctac tgacaagcaa tcccctaatg cttctggaca 53460
taggagtaga tttataaacc ctgggatgct gagagtggtt ccgtctgggg acagttctgc 53520
cttctcagct gggctcacct gtgtatcgga atccgtggat gaagccccca gcagatttcc 53580
ggtagtccac cgagtggctg gcagtaccca ggataaacag accccggctt cctttggatt 53640
cgtagctagc tcgaatcagc gggtacttct tgccgaatgc atttcccgag ttaagtctga 53700
gggacctgtc agtggaaagg gctgttcatg aaaatagctg ctatgtaaga ggcacttatt 53760
tatttagtta gttttgagat ggagtttcgc tcttgtcgcc caggttagag tacaatggcg 53820
tgatctcggc tcactgcaac ctctgcctcc tgggttcaaa ctattatcct gcctgagcct 53880
cccgagtagc tgggattata ggctcctgcc accatgccca gctaattttt gtatttttag 53940
tagagaccag gtttcaccac gttagccagc ctggtctcga tgtcctgacc ttaggtgatc 54000
tgtctgcctt ggcctcccaa agtgctggga ttacaagcgc gagccactgc acccagccag 54060
gaggcactta ttacagtggc acttattact ggcactgagt gccttagatt tctcgtctca 54120
tttaaacctc accatgaccc caggaggtgg gtattatcat ctccatttaa gagatgaagt 54180
cggccaggcg aggtggctca cgcctgtaat cccagcactt tggtaggccg aggcgggcga 54240
gtcacaaggt caggagttcg agaccagcct ggccaacaca gtgaaaccct gtcgctatga 54300
aaaaatacaa aaagagttag ctgggggtgg tggtgcaatg gctgtaatct cagctactca 54360
ggagactgag gcaggagaat cgcttgaacc taggaggcag aggttgcagt gagccgagat 54420
tatgccattg cactccagcc tgggcaacag agtaagactc tgtctcaaac aaacaaacaa 54480
acaaacaaac aatgaagtca ggccaggcac agtggctcac gcctgtaatc ctagcacttt 54540
71/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gggaggccga tggaaaggag ggtctggaca ggcacaccag cttctccttt gtctttctgc 54600
accctggtca gaagacaagt gaaagactgg atgctgcttt gataccaaac ctcccgaggt 54660
agtcggcagc aatgtttaaa atctaggctt cataaaatag cccttcaaaa tacaatgata 54720
aataacttaa gcaactaaca ttttattgag cacataatac atgccaagta ctttctttat 54780
tttaagagat agggtctcat tatgttgccc aggttggagt gcagcagcta ttcacaggca 54840
tgatcatagc acactgtagc cttgacctcc tgggctccag tgatcctcct gcctcagcct 54900
cctgagtagc taggtactca tcactgcacc tagctcccag cactttcttt cctttctttc 54960
tcccctctct ctccttcctt ctctcctctc tctttttttg tttttgagat ggagatcttg 55020
cactgtcgcc tgggctggag tccacaatgg cgcgatctcg gctcactgca acctccacct 55080
cccaggttca ggcgattctc ttgcctcagc ctcccgagta gctgggatta ccggcacgtg 55140
ccaccatgcc tggctaattt tttgtatttt tggtagagac ggggtttcgc tacattggtc 55200
aggctggtct tgaactccta accttgtgat ccgcccacct cagcctccca aagtgctggg 55260
attacagcat gagctactgt gaccagccat ctcttttttt ttttgagaca gggtctcact 55320
ctgttgccca ggctggaatg cagaggcatg atcttagttc accacagcct cgacctcctg 55380
ggctcaagta gtcctcccac cttggcctcc tgagtagctg ggaccacagg catgtgccaa 55440
cacacctggc taatttttgt attttttgta gaggtggggt ttcaccatgt tgtccaggct 55500
agtcttgaac tcctgagctg aagtagtatg cctgccttgg cctcccaaag tgctgggatt 55560
ataggtgtga gaccatgagc cactgcacct ggcctctgca cacattcttc tttctttttt 55620
tttttttttg agataagagt ctcgtcaccc aggctggagt gcagtggtgt gatctcggct 55680
cactgcaact tctgcttccc aggttccagc aattctccca cctcagcctc ctgagtagct 55740
gggattacag gcacccacca ccacgcttgg ttaaattttt gtatttttag tagagatggg 55800
gtttcaccat gttggccagg ctggtctcga actcctaacc tcaagtgatc cacctgtctc 55860
ggcctcccta agtgctggga ttacaggtgt gagccaccgc acccagcctc caagcatatt 55920
cttatgttaa tcctcgcaat aaccatatga gaaacaaact ttgaatccca ttttagacat 55980
gagaatactg ggccacagcg tggttaaata acttccgccg aggtcacaga tttggcaagc 56040
agagaatctc aggacaattc cggcacctgt gctctcagcc actacgctat attgccttcg 56100
agcaaattcc cctctgtatt ctctctgagc cggcctttcc aactcacagg tggaggctcc 56160
caatgctgat gaagatctgc tggtgttgct ccaggaccaa gggcctcagg gccacctggg 56220
accctcaatg gtcagagctc atgtcctgga gggaaatcag gcagcactca catccattct 56280
72/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ttgggtgctg tcctgagagc tctgtcgcca gcctactgaa cagccaccct gttcccctag 56340
ggaggggtca ggagggtttg ctaggagagc ccacctcctt ccgcatggaa ctcacttatt 56400
gaaaatggag aagtcaaagt tccagcccag gcagcggatt acccggtcat agggcacgcg 56460
catggcaaag ttgtcattgt cgtcctgggg gagggtgatg gagtcggcac tctggttggt 56520
gttggcttct tccaggaaga atttcggggt gacatggaac ttgcctttgc tgtccttcag 56580
gatggccaga tccgtcaggt cagactcgag cagcccgtcc agggacttga gctggtaggt 56640
atccagcagg ccattgttga tggctctgag cccacagaga atgcagggga gagagactca 56700
gaggaaagct gggcagtgca gctggggtca ggaagggcag gggagggttg gggaggctct 56760
ttccacactc tgggctccca gcacagaaca cacatgcggg gatgtggcct acctgaggtc 56820
tccaacgtag tgggtggccc aggacagacg gacccgggag cggctgagca tatggataaa 56880
gtttgtgaca cccaagatgt tctctgctgt ctcaaaggcc gagttcccac gacccaggat 56940
cagcacattc tggcctacaa agtcctcagg gtccacggac acggactcgt aaccctctgc 57000
atattcggag ccagggaagt caacctggtt ggggactgat aaaccagtgg ctacaaagag 57060
gacgctgcag gcggggacag aggaaagatg gcttagtctc ttagctataa gaccactaag 57120
tgaaaaccac tccctggacc cacccaccca cctgcctggc tccaaccgcc ggcccctaaa 57180
agaaaatagg acattcattc attcattttt cattcattca tctgtttacg ccctcatccc 57240
agtgcacttg agaggctctg cccttgcctc tccctgagct cacagtattt tccctagcac 57300
tgtactgggg gttaaatttg ccctgtgaga gaggagaaga tgacagtatg agaaatggag 57360
aattcaccta actttgcaca tagcagtcag accaggtatg actgctggtg atgaaatgaa 57420
acctgacatt ctactttccc ctttctgagt cctctgacag atacatctat ccactgagca 57480
gtaattctgt accaggccct gtactaagtg tatctgtgca ccatctttct gactcctcca 57540
agcaacctgg aggtggtatg tggcctgctt tacaggtgag gaggcacagg ccctgcaggc 57600
ccatggcttg agagctccta aaagcagcag agccagagtc taaacacaga taggcttgat 57660
tccaaagtcc tgctccttcc attggtgagg atcgccatcc aggggagggc agctggggac 57720
ttggatcctg ccggcttgca gaagaatgct ttgatcacag agtggtttca aaaatagaat 57780
tgaaggccgg gtgcggtggc tcatacctgt aatcccagca tttggggagg ctgaggtggg 57840
tggatctcct gaggtcagga gttcgagacc agcctggcca acgtcgtgaa atctcatctc 57900
caccaaaaat ataaaaaaat tagccgggtg tggtggtgct tgcctgtaat cccagctact 57960
ggggaggctg aggcaggaga atcgcttgaa ctagagaggc ggaggttgca gtgagctgac 58020
ctcgtgccat tgcactccag cctgggcgac agagtgagac tccgtcttaa aaaaaaaaaa 58080
73/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aagcgaaata ccctttttcg tccattcctc ccatacctac tggccaatca aggtgtgtgg 58140
ttcgtgtggg gaaggtccca gcttccgcag gtgagctctg gcaccggcct tacctgcact 58200
gatgcacctg gcccttctgg tcagttagga tgaagtagtg gccattccag gcctgtcggt 58260
ccttgtccag agtgacgtgg gcgatggtgg tgttgtactg gacacggagc cccagcgtgt 58320
ccgcgaagtc acccaggtag cgcaccatgt cgcgggcgtc ggggaagtag gcacgcgagt 58380
agtgtctgaa gagcagccgg gggtcgtggc tgagcagaga gttccagtcg tggcggaggt 58440
tgaactcggc gttagccttg cccgtgtacc gcttgttgat gctgatgagc ttgcggtgcc 58500
gcgggtagcg tgtgaagaag ctgccgggcc gcggggcccg ctcgaacact gcgtagtcgc 58560
gtccagcgcg ctgcaggaag taggccatct gcaggcccgc gggcccagcg cccagcacgc 58620
agtagtcccg gcgcgggggc accgacagcg ctgggtgcag ggcgatggcc aggagcagcc 58680
ccgggggacc ccacaacggg gccgcagcgg agaggcccat cctgcagcag atcagagggg 58740
taaggcctcg cacccggccc ggcggctggg agacacgagg cccagaaaga ggcggggcct 58800
gcgggaactc tcactgcaat ctgggtcacg gccaggccca gaagccgtcc tcagagctca 58860
tttgcccgga ctccaccgtt tcaagctggg acttggggct ccccggaatc ccgagcccct 58920
ccatcttatc tccctcaggg tctccttcct caggggcacc ggctccccgc ttatgattgt 58980
agtaacctcc accctgggga aggagagcgt actccccaat tttcccctaa tttgagggtg 59040
cccaacaccc ctttgaacca ccctccaggt tggaccttcc agaggccttg gcccctctcc 59100
agcgaccggg tgggagcctg aagtgggtgt ggcctgcgtg cgccccgccc cctgccaggg 59160
tccgcgcgcc ccaggctctt cggccacgtg acagggatgc cgcgcacacc tgccgcccgc 59220
ccgcgtgcgc ttcaggagcc gccaggtccc tacgcccgca gctccggcct ccccgcctcc 59280
gaccgaaccc tgagaaacgc gcgaacctcc cagccgctcc ggctgcaacc cgtggtctaa 59340
tgaggccgcg cttggctcgc ttgctccgcg gcggctccgc ccctcgcgcc cggaccaatg 59400
gcagggggcg gggtcacgtg cgcggcgcgc ggcacgccgg gaccagctgg caggctgcct 59460
gctccggccc agcgcgggag aggcgcgcgc gtgctgcgtt cgctgctccg ggggctggta 59520
gaggggcctg gggctagcgc gcacccgcga gggtggaagg tctggagatc cgggatgggg 59580
aactgggtcc ttcgttttaa aaggtgcctc tctacacgga gggaggggag cacgtgattt 59640
ttggagctaa tcctagctct catattccat gaatgtagcc aaacgctaaa actagttggc 59700
ctacccagtt ttgtgggact ggaaaccagc gtggtggagc caggaccgat aagccaatta 59760
acaagcgttt gctacagtga ctcagtgtac tgcttaccaa gtaacataca cgactgtcct 59820
74/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aatcttccac caaataggag aggtgggcaa ggcattgttt ccgacatttg gtagctgact 59880
ggtcaaatgg agacataggg atgaagggat atgtttacaa tcacaggaag tggagcctgg 59940
aattaaaact cagtggaggc aagataaatg gcaggaggaa gataacgtga actggatgat 60000
gaaggttggc ttcccagggg tggcaagtgg cccctgcatg agatttacat ggggagaaat 60060
acgaagtcag tgtaggaacc ttcaaagtcc agtgaaatgg ggctgagtgt tcttggggga 60120
agggcaggtg gaaagaactg cgagcctgca gatttgcatg gctggagatt ctttgaatta 60180
aaaatcgtag ctggggactc cttagaaaaa ttttcctgac ctctcaggcc tacaagtacc 60240
taccaaagaa tgtcatttac tttttctttt tttttttttt ttgagatgga gtctcactct 60300
gtcgcccagg ctggagtgca gtggcgtgat ctcggctcac tgcaagctcc acctcccagg 60360
ttcacgccat ttttctgccc cagcctccct agtagctggg actacaggtg cccgccacca 60420
cacccggcta attttttgta tttttagtag agacagggtt tcactgtgtt agccaggatg 60480
gtctcgatct cctgacctcg tgatccgccc gcctcggcct cccaaagtgc tgggattaca 60540
ggcgtgagcc accgcgcctg gccgaatgtc atttactttc ttcagtctgt gtcaacatca 60600
gagaaaagct ccctcagagc agaaattgtc cagtatctga catacggaag tttaagcatt 60660
tgttgaataa gcattgcaac cagagaggtc aggcagaata ctttgccaaa aataaagtag 60720
ggatgtctta tttcttcttt ttgagacaga gtctcactgt cacccaggct ggagtgcagt 60780
gacacaatca tggctcactg cagccctgac cttccaggct caagcgatcc tgcttcagcc 60840
tcccaaagtg ctagggatta caagtgtgtg ccatggcccc tggccaattt ttcaaaaaaa 60900
tttttggggg catatgtgta tatatttatg gggcatatga gatgttttga tagtcatgca 60960
atttggggat gtctgtttct tagtggttgt gaagattatg agaatgggtg ctggcaaaca 61020
agttcctaaa ataattgctg gtcttatgtg gtgaatacag tagtgggaaa ttaaacagaa 61080
ttcgtcaagt atggtagggc cctacgagta ggctgaacct agattgtaag caacaggatg 61140
ctactgggag tttctgaatg taggattact gcagcagtca acttggtagc cccatgcagg 61200
acagataaaa gcagtggaca gctactcggg aggctgaggc aggagaatgg cgtgaaccca 61260
ggaggcggag cttacagtgc ctgagattgc gccactgcac tccagcctgg gcaacagagc 61320
aagactccgt ctcaaaaaaa aaaaaaaaaa aaaaaaaggc agtggaaact gatgcaaagt 61380
attttcaggg aatgagcttg agtcacttcc acttgcttct gttaatcctg ttggacaggg 61440
ccatggtttg caagaggcaa tttggtgaat actggtccaa cctggaaacc cccggcacta 61500
gtcacaccac tttaatctgt tttttaacac tctgtattca cattgaaaac tccccaagta 61560
cactttttct ctccactgct tctaacacag ttcaagaaac cttttgcttg ctgaggttcg 61620
75/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
attcattaaa attaattttg tgttttttca agctacttta aaaaaaaaac ctgtaacttt 61680
agaaatgctg agcttttttt gagagtctct gtaatccaaa ttggagtgca gtggtgtgat 61740
CtCagttC3C tgCaaCCtCC gCCtCCtggg ttCgagtgaa tCtCCagCCt CagCCt .CCCa 6180
agtagctgga attacaggcg tgtgccacca tgcctggctg ttttgtattt ttagtagaga 61860
cggggttttg ctatgttgct caggctggtt ttgaactcct gacctcaagt gatccaccca 61920
cctcggcctc ccaaagtgct gggattacag gcatgagcca ctgcacctgg cctttttttt 61980
tttgataaag ggtctccttc tgtcacttag gctggagtgc agtggtgtga tcatagctca 62040
ctgcagcctt gaactcctgg gctcaagcaa tcctcccacc tcagcctcct gagtagctgg 62100
gaccacaggt ggaagcatca tgactggcta ataatttatt tttttgcaga gacaggccct 62160
ggtctccctg tgttgcccag gctggtctca aacttctagg ctaaagtgat ccttctgcct 62220
cagcctctca aagtgttggg attagaggtt tgagccacca tgcctgtttc ctcacctcta 62280
caatggtact actcctgcca gcatcacagt tctgtatgag gcttagatac tacagaaagc 62340
tcagcattaa tacctggcag ggtaattact ccatcaagtg tccagaacag aacagtgtcc 62400
acttacatag tttacatagc ctcggctggg tgcggtggct cacgcctgta atctcagcac 62460
tttgggaggc caaggcgggt agatcacctg aggtcaggag ttcgagacca tcctgaccca 62520
tatggcgaaa ccccgtctct actaaaaata caaaaattag ccaggcatgg tggtgcatgc 62580
ctgtaatccc agctactggg gggctgaggc aggaggatcg cttgaacctg ggaggtggag 62640
gttgcagtga gccgagatca tgctactgca ctccagcctg ggcaacaaag tgagattccg 62700
tctcaaaaaa aaaaaaaaaa aaaaaaaaag tttacatatc ctcaacatgc agagctctta 62760
tgacacaatg ctttgtaggg acaggcctga gtgtcaccag cccaagccaa gcttaaaaac 62820
aattcataaa ccattacaca atcacccagt gggacatcca tcaagctctc tgtggcagcc 62880
tccctcaggc gcagcagccc cacctcaccc acaccctgct tcacgctgta ctagtgctct 62940
gcactccagc tcctcacagt gaactctcca aaagcaacag gtggcccttc acacagccag 63000
caggcactca tgcttgtgga aatggacttc ttataacaaa tgaggacacc cagattctga 63060
attccacata gaaattgctg aatetcatcc ccactctgtc aggaatcttt gaagaaacga 63120
ctgtaaatcg ttaatgcagg cagacgatga gggaaagact aaacagatat atattttatt 63180
tcatctgcta aatgtcagag agcaagttag acacacattc cactaagcat caaaggccct 63240
cgtagtctcg gtggaaggac aaactccagc tccacatcac tggtttaagt ttcttcctct 63300
gaaagacaca aaaaatgtaa gagaaatgag ccaggttgtg tgatatgatg ttcactttcc 63360
76/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tttctgaacc tctgctggac tgtgcgtgag ttttcaacac ttccattccg aagttaagcc 63420
tttcagatgc tcacagggct gggcaggtat ttccttcagt caccagctgg tggagcagga 63480
gagacaactt tcaggctatt taacccggag cggagctttt ccctctagac caccggcttc 63540
aatctgggac ttccctcatc ttcctctacc tctgccacag tccagccgct tctctaaaac 63600
accgctatcc tccccaacca cttgatgtga tctaaaggct ctagaagaag ctcttggagc 63660
caaagtgaat gcttcttcat acttaagtct cagggaattc tcgaagtttt atcaaggtta 63720
aagatcacaa tggctacaga gcttgctccc gtgctagccc acagatcact ctagacctca 63780
gaaagtgggc tgctacacac cttcttcttc ctcttcttcc tcctcctctt cctcctcatc 63840
ttcatcagag ctgaaggtgc catcagggag gctgtagaca cggatgacct gcttgttggg 63900
gtccttgagg atgaggtatt tgccctcctc cagcttcatg cagatgtcaa tgacgcagcg 63960
taaaatgccc caggcattct ccacgctcag gttgatctgg ctggcaaact cattaggctt 64020
gaactgctgg gtgcctagga tgacgtggcg tgaggagtct ttcacgtggt accgagacac 64080
ataactaaca ggggaaggga tatcagtggt cagagcaggg cagcacagag acagcaacac 64140
ttgggatcaa atgtcaatta aatggtgata cctggtccac tgctattttt tctttttttt 64200
ttttttgaga cggagtctgg ctctgttgcc caggctggag tgcagtggcg ccatcttggc 64260
tcactgcaag ctccgcctcc cgggttcaca ccattctcct gcctcagccc cctgagtagc 64320
tggggctaca ggcgcccgcc actacgcccg gctaattttt tgtattttta gttgagacag 64380
ggtttcatcg tgttagccag gatggtcttg atctcctgac ctcgtgatct gccagcctgg 64440
gcctcccaaa gtgctaggat tacaggcatg agccaccgcg cccggcagtc cactgctatt 64500
ttcaagggaa agggaaaaca tcgtcttctg agttctcagt tctggatttc attgacacca 64560
ttgccctagt tcaggactcc attcagcatg cctgctgttt ggcatttgtc tcctaactga 64620
cccctccatc tctaccccac ccctggattt atctctgcca gtcaattgtc cagtacacgg 64680
ggaggggagg gtcaacctcc ctacccagac ccttcctttc acaagatcag ctgccagctc 64740
ctgcacagga atctcaccca agcttgaggt actcagatcc agccagcaaa gcacagcagg 64800
tccaccgggc caacttgtag ctgttgttct tcagctccgt ggcaatgaca gcccctcgct 64860
gagagtccag cttctgacgc cagtcaacgc cattacagtg ctgcaggaga gccccgttag 64920
agaaacagaa gcaagctcca aatgcccaag gtgctgggac ctcctctggc agagaaggaa 64980
ctccctagtc tgcttgctta gaaagtgggt aggtacgcac taaatcttac catttaagag 65040
acaaagacat agtcccttcc cttgcacagc ctgccgcaca gcagtcactc aacgacttac 65100
aattcctctc ttctaaaagc tcgcctagac agggaatgat ggatggacac acacggacac 65160
77/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
acacacacac acacacactt tagaagtgtc atataaacag cagagccaag tgtttactat 65220
gtgttgcgtg gtaaggaagg gcttcacaga ggacgtgtaa cagtgagcca agtggagaat 65280
attggctcaa gtgcaggtgt agccaggagg tcttgatctg agaggcatgg tgggatagga 65340
aagacaggca gagttggcct tagatggggg tggaagcctg cagtgggtgc aaagctgagt 65400
ctgacatttt acataaatgc acacacagta gaaaaggacc ccagagagat cctcttttct 65460
acccatatca tttgtagacg tgggaagttg gacccagagt gaaatgactg gtcaaaggtc 65520
acatgacaga ggttcccaaa ctttcttggt tcatggcaaa cacagggcaa aagaaatact 65580
caagaatttc ttttaaattt tttttctttt tttttttgag acggagtttt gctcttgttg 65640
cccagggtgg agtgcagtgg cacgatcttg gctcactgca acctccgcct cccgggttca 65700
agtgattctc ctacctcagc ctccctagta gttgggatta caggtgcccg ccaccatgtc 65760
cagccaattt ttgtattttt ggtagatacg gggtttcatc atgttggcca ggctggtctc 65820
gaactcctga cctcaggtga tccactcgcc ccggcctccc aaagtgctgg gattacaggc 65880
gtgagccacc gtgcccggcc aagaattcct tttatttagt tagggtcaaa ccatgtatta 65940
gtattctgac aagatgtctc tgtgtttccc taaaaaattt aaaatatcct gcagcactcc 66000
tgtgagtttg ctgtggcaca ttttttggag atggggtctc actatgttgc ccaagctggt 66060
gagttcagga tttgaactca tgaacccaag cgattctccc acctcaggct cctgagtagc 66120
taggactata ggtgcatact actgcataca gcttgctggg gcatgttaga attcttctcc 66180
caatctgcac tgctgatgaa gcgtgtattg gacaattgac tggcggagat aaatcaaata 66240
tagaagttgg gtggaggtag agaaatcagt taggagacaa atgtcaaaca ggcatgatga 66300
aatggggccc tgaactaggg caattatcag tgaaatccag gacagattca gaagacagca 66360
aagccttcta ttttgctaac agcaaaacag aataatgtaa aaaagaagtt ggagatgttg 66420
gaggctcaga gcttaggtgg aagaaagaca atgctgatgg acagctggcc cagaggcaat 66480
gacgggactg gggacacatg gaaggggaag gtgttttagc agaaaaacaa tgggaagtat 66540
aataaatcag agtagatttg agaaatcatt ttcaaagagt tcatggttga ggcctgggat 66600
gggcagaatt ctaagatgac ccccagtgac ccttgccctt gcagagtctc ctccccttga 66660
ctacgggcag aacctatggc taggatcaag tatcaccccc atgatcatcc taccttgtat 66720
gtcaaaaggg attttgcaga tgtaaggccg caaatcagtt taccttaata tacactacct 66780
ggctgggctc acccaaccgt atgagtctct taaatctagg tgtagaggtc ggagacggag 66840
gaagtcagag atctgaagca caagaaggat ctgatgtgct gttgctatct tggagatgga 66900
78/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gggggccatg tgacaaggaa tgcaggtggc ctctaggagc caagagaggc tcccagctga 66960
caactggcag ggggatgggg gcctcagtca tctaactgca gggaaatgaa ctttacccac 67020
aataagaatg ggcttggaag tggcttttct ttcagaacct ccagatgaga actcagttct 67080
atttctattg acaccatgat ttctgccttg tttggatttg tggccccacc caaactgcat 67140
gtcaaattgt aaactccaat gttggaggag gagcatggtg ggaggtgact ggatcatggg 67200
ggcagacttc cccctttggc actattcttg tggtaagagt attcaagaga tctggttgtt 67260
taaaagtgta taccaacctc ccccctctct ttctcctgct ctggccatga tgtgcctgct 67320
tctcctttgc tttctgccac cattgcaagt ttcctgaggt ctcctcagcc acgcttcctc 67380
tagagcctgc agaactgtga gccaattaaa cctcttttct ttataaatca cccactctca 67440
ggcatttctt tacagcagtg tgacaatgga ctaatacaag gaccaagcac acagcactgg 67500
acttctaacc tacaaaaccg tgagctaata aattggtatt gttaggccgg gtgctgtggc 67560
tcacgcctgt aatcccagca ctttgggagg ccgaggcagg cagatcacct gaggccggga 67620
cttcaagacc agtctgacca acatggagaa accccatctc tactaaaaat acaaaattag 67680
ctgggtgtgg tggtgcatgc ctataatcct agctactcgg gaggctgagg caggagaatc 67740
gcttgagccc gggaggtaga ggttgcagtg agccgagatc gcaccgttgc actccagcct 67800
gggcaacaag agcgaaactc cgtttcagaa aaataaaata aaaaataaaa gtaaaataca 67860
taaatcggta ttaagtcatt aagtttctgt taatttgtta tggtgcgaaa gaaaactaat 67920
acaaagttat ataatacaga agtatgtatg gcgaagagag ctgtccaggt gactccactg 67980
ggatcaaaaa ggaggggagc cagcaaagac gacatgcaaa cggaacaggg aaacgggtga 68040
gaccagagta acgcggtaac acagacggca aaacgacaca ggcacgacgg ccctgaatgc 68100
tttggggagc tcaccaggaa aaatccaaga aaaggccgct ggccccagag cggcaaacct 68160
tccagtgtgc tctttcaaca ggtgatgtgg gcgggggggc ggattgggag gggtggggtg 68220
gaaatagagg aggaaaagtg aaggaagcat gtttctttca aggtgcctct gaagagtcaa 68280
ttctgagcca gatcttagaa tccatgagtt aaagaaatga ggaattgcaa aaaatgtgtg 68340
aaaagattga aggcagtggc tcagtcaatg aaagaagagg tcaaaaagaa gagcggccag 68400
acttacagga aaactgccaa cccagataat aaggagagga aaaaatcaga tgctcaggga 68460
gcagaagtca acaggaggcc acaatggaac agagatgaag aaagtactgg aagaagggag 68520
ttaactggtt cctgcgtaaa aaataagcag aaaagttctt aacacttaac atagttctac 68580
acacacagtc atgctctttc tcagcaagga actaagcaga ggaaaaaact cacaagacaa 68640
aaaaaaacat ccaggtagct ctataagtaa cgaaagggga taagaaacag tttatacaac 68700
79/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ctagcctgcg taaacaggca ctgtagggaa tagagacatg gtgtcaccag gagggtgatg 68760
gagatggcgg ctcaccctgg aatcccactc attgagtgtc ttgatgttga tgaaggacac 68820
ttccccgttg gctccagtca tgacgccatc gtgctcacaa cggacaataa ggtcaatatc 68880
atctccaagc ttccacctgc ggtaactgca gcaaaaaaga aactcatgtg gtcactgggg 68940
attctataga gtggggcccg tgctccagtc tggccacaat acccaccaga gaggtgacct 69000
accggtacgc aacagaggcg atttcattct tatccatgtc gtcctccaca aacgggtttg 69060
ggttggggaa gttgtatctt tccttcccct gcaaaaacaa aggtgtcaca agacagagct 69120
aactttgttg acaaggccaa ggccaatcag tcagacccag cacctctgct tagttgcagc 69180
cctggccagg ttcctggggc ccttgatggg gctctgagct cgctgcctgt tttgtgccta 69240
cttgacccct cccaactgtt agcacctgat gaattagaac aatgacttag taaccatgct 69300
catctctact tcattttttt gccatggcat atattcacca tttgatgtaa atcaatttat 69360
tatttattgt tcactgtgtt tcctcctcca ctatcattaa attctgtaag ggcaggaact 69420
ttgttcaaag tcagagagcc taacatccaa gcccaggcat gtaactcccc tgctaaaggt 69480
ggggactgcg tctgacctgc tcagtcccac aaccaagagc ctagcacaaa gcagatgctc 69540
cacaaacagc agctgattaa ataagaatga atcaatgccc agagactcgt ttcctcacca 69600
ttctcaagca ctgctgggag aaattgtggt tgatgtaggt tgcctccatg gccaggttgc 69660
ggggtgaatt gaaggaatta ccttcatctt gagggggctc attggcagtc tcactcactg 69720
tcaggaggtc tgcaaaagcg tggcatggtc actcaccatg caacaaagag tcactgacaa 69780
tgtgcgcagc gctgtgggga gatgtggaga ggcaaacaac acaagtcctt ccttcaaaga 69840
actgccctct cctaaagtgg gtctccctgg tgtggaacac ataagcgggg gagtggggca 69900
gctgctccag gataactcaa gatactgtcc aacattcaat tcaatcacac agtaacgaag 69960
ctgtcccttt tcagtcgttt tggattcctc aagagaatga ttttgcaagc tttttaataa 70020
agacctcagg cttcaggctc agaatataaa cacttttttt tttgagatgg agtcttgctc 70080
tgtcacccag gttggagtgc agtggtgtgt ccacggctca ctgcaacctc tgcctcctgg 70140
gttcaagcga ttctcctgcc tcagcctcct aagtagctgg gattacatgt gtccaccacc 70200
acacctggct aatttttgta tttttagtag agactgggtt tcaccatgtt ggccaggctt 70260
ggtctcgatc tcctgatgtc aagtgattct ccgcctcggc ctcccaaagt ggcaggatta 70320
caggttgtga gccaccgtgt ccagcctgtt ttgttaattt ttgagtgaca tggttttcct 70380
ttatggtgta taaatacata tatgtatggt ataaaaaata tatatgtata tacagtaagc 70440
80/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aaacactgaa caaggtatgc aagatggcaa aagtcgaaaa aggggtattt aaatgaataa 70500
catttgggcc aggtgtgttg gctcacacct ctaatcgcag cactttggga ggccaaggct 70560
gatggatcac ttgaggccag gagttcgaga ccagcctcgc caacatggtg aaaccgtctc 70620
tactaaaaat atagaaagta gccaggcgta atggcacatg cctgtaatcc cagctattcg 70680
ggaggctgag gcagaagaat cacttgaatg tgggaggcag acgctgcagt gagccaagac 70740
tgcgccactg cactccagcc tgggtgacag agtgagactc tctgtctcaa ttaaaaaaaa 70800
aaaaaaacaa caaaaaagca acatttggaa gcttgctatt agggtgctgt gaggactcca 70860
aaagctgagg cctcaagcag gtactgcagt gacagtctct tctcctaacc tctaaagagt 70920
gtgggagatt cagacactgc tgctgtcaat tcccttggga agacagacca ctttctatcc 70980
attctctagt accagagact tgttctgtac caacaaaaat actcaatgcc tttgagttgc 71040
tccccaggca cgcttcttac caaagtcaga gttgtctctc ttgtcaaaga agagtttgga 71100
cccaactctc tggacgacaa tatcccagga atacactgag cgggtacagc tcatcagcgt 71160
ggccaggatg gcatcagtgg caaacacatt cccctgagtt tttgccagct gcaaagagga 71220
tcaaagagag aagatggaaa gacactccca ggtctcactg cccactcaca tggatgggaa 71280
agaactcctt tgctgaccac ataaatcctt aataaggagg ccccacctca ttgaccaaaa 71340
acactgcagc cagtgagcca gcaagtttcg ggtggcagtg gcactgcagc accctaagca 71400
cctgctagat tccagccaag tgcttcagat gctttcacct ttgccccagt ggtagtgcta 71460
tgtacatcta ccccttgttg cagatgagag aactaaggct ccagagacta agccaggaag 71520
cgcggcagaa ctgggcttca agtccagctg tgcttaacat ccacatttcc ggtctacctg 71580
gcaaagtgct tttacctata atacatacgt tattcccatlg tcttctgttc tttctgcagc 71640
ttcagctgta gaagccgaca gcattcctaa caagggggag aggggcagaa ggaggcgcac 71700
accttgcgga tgacagggtc gtctgtggtg gtgacagtgt ggaagatgcg cttgatgctc 71760
cgcagtggct tctcactcct cgtggtgatg cggtcaaagg ctttgtcgta gtattctagg 71820
gccccacaac actcactgtg ggaagagcag gcaaagacat gcaaagtaag agagataacc 71880
cccagttttt tcttttaagc catacatcca gaagtcttat ccaaaagtct aaaagaggtg 71940
gaaagcaatc tctggccaga gcaggagaga cgaatcctca gtgcttgctc agttcctgtc 72000
cacttaacac ctggcataga acacagcaag cacaactcat ctagcccaac gcccccattt 72060
taaaggtagg gtgaccgagg ctaagacagg agatgactag ttatagaagc acctgggtag 72120
gctgacttct cgtctggtgc tctggtttcc cactacctaa attccaccta cttgtccttt 72180
gaggtaagaa gctatttgaa atgtcaggag aagcaaagat tcctcctgaa gaattgctgt 72240
81/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gtttcttttc ctgacaagag ttttataact taatcttatt gctcttttgc tcaggatgcc 72300
aggaaacaga aatatacagt ttaataatca gcaaattcca ttctgctttc tctttctgcc 72360
aaaagagttg tataactcat ttcttctttc ctcaggatac caggaagtta aaaagaagtt 72420
tgcagtcagt gaacttctgc ttttcccctt ggtcttgatt tttttttttt tgagatggag 72480
tttcgctctt gttgcccagg ctggagtgca atggcaagat ctcagctcac tgcaacctcc 72540
acctccaggg tttaagtgat tctcgtgcct cagcctcctg agtagctggg attacaggtg 72600
tgtgccacca cacccggcta agtttttgta tttttagtag agactgggtt tcaccatgtt 72660
ggccaggctg gtcttgaact cctgacctca ggtgacccac tgcacctggc cggtcttgat 72720
ttttttcaaa tacctctgtt aaccttatga aatgtgtttt gagtaagtgg cttcaaagcc 72780
tttttggaaa tactagggct taagaaaata cccatcacca gctggtccac acacataaga 72840
gcagtgtaga aagtagtaaa agatgctgct tacatgtcct gtggctctga tacttccaag 72900
tagcgcatct tcatcaactg aggaaaatcc atttcctctt tcacttccca atcactacga 72960
acttcaactg aagagtctcg gggtttctgc agttgaaaac cattagagga aaaaaaagtt 73020
atagtccata caaaacataa ataaaagaca ggctaaaaat atgaagagct ggcctggtgc 73080
agtggctcat gcctgtagtc ccagcacttt gggaagctgg ggcaggatga ttgcttgagc 73140
ccaggagttt gaggctgcag tgagctatga ttgcactact gcactccagc ctgagtgaca 73200
cgagatcctg tctcaaacaa caaccacata aaacggaggg gctcagtggc cctttgggag 73260
gccaaggcgg gcagatcacc tgaggtcagg agttcgagac cagcctgtcc aacatggtga 73320
aaccccatct ctactaaaaa tacaaaaatt agccaggcat ggtgatgcat gcctgtaatc 73380
ccagctactc gggaggctga ggcaggagaa cagcttgaat ctgggaggcg gaggttgcag 73440
tgagctgaga tagcaccact gcactccagc ctgggtgaca gagcaagact gcgtctcaat 73500
aaaagagaga aaagaaaaag agcttttatt caataaatgg agtgctgact gttttataag 73560
acagaatccc tgactcccag gaatttatgg tgtggaagag gaccaaaggg atcaaaagtt 73620
caaaagcaaa tggggttcca ctcccaggta atgatgtcac ctgatgaaca tgtagaaggt 73680
cctttatatt tctctcgggt tattaactat tcttgataca gcatcatatc caacaaaatg 73740
tagcttcact tttgcttaca tgtgttctgt tctcagaatg cccacacaag cacacgcagg 73800
tgaacgttca cagcagcatc aataatagtc aaaaagtgaa aaacaactca aatgttcatc 73860
agcatgtgaa tggctcaaaa caacatgatg tataattcaa aggactctta tttggcaata 73920
aacaagaaaa gaagctcatc tgggctgggt gtggtgcctc acgcctgtaa tcccagcact 73980
82/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ttgggaggct gaggtgggtg gatcatctga ggtcaggagt ttgaaaccag ccgggccaac 74040
atggtaaaac cctgtctcta caaaacatat gaaaaaaaaa aaaaaaaagc cagacatgtt 74100
ggcacgtgcc tgtaatccta gctacctggg aggctgaggt gtgagaatca ctttaacccg 74160
ggaggcggag gttgcagtga gccaagatcg cgccactggc actgcagctt gggtgacaga 74220
gtgagattcc atcttaaaaa aacaaaaaac aaaaaccaaa aaaaccaaca acagatgaag 74280
cacagctgaa cttgaacaac atgggtttga agtacatggg tctacttaat atgcagattt 74340
tcttcaaaca aacatggatt gaaaatacaa gccaggcgca gtggctcatg gctgtaaccc 74400
cagcactttg ggaggctgag gtgggtggac tgcttgagct caggagtttg agaccagcct 74460
ggggaacatg gcagaacccc ctatctacag aaaatacaaa aattagccag gcgtggtggt 74520
gcatgcctat agtctcagct actcagaagg ctgaggtagg aggatcactt gaacccagca 74580
ggcagaggtt gcagttggct aagattcatg ccactgcact ccagcctggg tgacagagca 74640
agactctgtc tcaaaaaaga aaagaaaaag aaaacagtat tcttgggatg caaaccccga 74700
gtatatggag ggccgacttt tcatatatgt ggctaccaca ggccgaatgt gggacttgag 74760
aatgtgtaga ctttcatata ctgaaggaaa actgtaccga cacatgctac cacatggatg 74820
actcttgaaa acacgctaaa taaaagctgc cagttactaa agaccacata ttgtatgatt 74880
ccatttatgt aaaatgtcta gaacaaaaaa tcccgagaca gaaaacagat tcatagctgc 74940
ctactgctgg gctactgggg gtgctggtgt ttgggtgtgc ctcctggaat tcatttggca 75000
atctggttgc tactgcggca gtgtcgggag gtagggcctt taagagatta ggtcgttaaa 75060
aggaataaat gcctcatgcc cttctctcag gaatgggcta actacccaaa gtttagccct 75120
tttctctgtt gcaccctgct cccgcttctg ctttttctgc catgctatca agcagcatga 75180
ggccctcacc agatgtggct cctgatctgg gacttcccag tccccagaac catgagctaa 75240
agaaaccgct ttataactta cccactctca ggtattctgt tctagcaacg gaaaacagat 75300
caagacaggg tgactgctaa agggtaaggg attcttttga gggtgatgaa aatggtctga 75360
aattgaccag ttacagaact cttcaaatat attaaaaacc actaaattgt acggtatgtg 75420
aagtatatct catctaagct attaataaag acaaccaaat aaacagaacc aaattccaag 75480
gcagaattct ggtataaata cattacctgt gatttctgat cccatttctg cctaacccca 75540
aattgtttct ggaacttttt ctgcagtcga atgcgttctc tggaaagaca gacatatgat 75600
ctcagtgcag acctttaaac cagtggcttc ttcaaaaggc acacgctgcc attctcttca 75660
gctaaacctt accatcacca ctaactcctt taaactacga aaaatgggct tagagaaagg 75720
aagagaccca gacggtgcat actggaggtg ttagaaaagg tacactgcct ccaaatactg 75780
83/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
accagatgat tttacttcat ctatagtgac tgttcactga tagttccaat ctggggtgta 75840
gtggccgctg gaccacacaa caccaggagg ctcaaaggac cagcatacag ggggcttcct 75900
agagttgacc cacagcagaa ctgagcccag gtaagctcca gagcctcttc ttgcctgcct 75960
gtgtttccct ttagtgcgca tgaccagcac aaggagttag tttcctgccc atgctatctg 76020
ccatgaacca gcctgagaac gacaagctaa aagggggctt aactggttgt agaaagtatt 76080
ttcctttttt gcagtggtgg ggaatacaac catcctcctg ctttggtcct gtggtttcca 76140
aatacggcca gtctgggaag ggtgtcttgt tccagcagga tgaaaatctc acctctcttt 76200
ctgtttggca ctcttaggca ggatctgcag gttgaactgc aacatgttcc gacgatcttt 76260
gtctctgcgg aggttcctct gggcatcagc aagaaacatc catgttaaaa tcttggagat 76320
ttggctcaca ataggcagaa caagtgggag gtctttggag taaatttagg atgccaaatc 76380
ccaagtttca catcttactc tgtgctttca ctctacggca tcaacagctt gggggtgtt,a 76440
gggggtaagt g~cttggactt tgcttagacc tatactccca tgatatattt ttcattgaag 76500
tatgtttact gggtctcatt agattttctg agtttgcctc tttaaataat aataggcaat 76560
ctgactggac catctactta ataaagtctg cacacagcaa ttaagtgtgg taacaggcac 76620
aggtgcacct tcttatccag cacaaatgtt tttagcatac aagtctgatg tcctagctac 76680
tggcaaacag aaatataaac tatttaaatg catccctgat cctagtgcaa gttcaccttg 76740
gtaccacttg ttatggaacg gtgacccgag attcacgaaa agacctataa tatgcttccc 76800
tctctcatta ggagtcacaa ggtagcattt tttagcaggt gatggceaac agtaacagcc 76860
ccaagatggt gtggttgctg gctcttggcc tacctgggca aatctcattc gattccgctg 76920
gtaggccgtc ttctgtgtgc gcgctgtatc caccagctgg aagctacttt catcctcctc 76980
atggaaataa gcatattgac ttccaccacc aaactgagag gagtacttat ctggaggcaa 77040
aggtgatggc atgtagtaac tgcacccaca gactttacca gatatgcacc agtctaaagc 77100
cttgctattt caagtgtggt cttgagacct gtagcattgg ctgaaagctt gttagacaca 77160
cagactcaca gtcccacccc atacccactg aatcagaacc agcattttaa caagatcccc 77220
ggatgattca tatgcacatt caattttgaa caactctggc ctaaagaact ttctaagcca 77280
agaatctgaa ggactcaaac taacccattt cactctctgc gttattgtgt gagaatctga' 77340
ggtatttatt gctaaccacc atctccatta tcaggggccc atggcaggta tgtctaatag 77400
atcacgatat actttcttgc caatctcagc ctcagctatc ctaacttagt tctccaggca 77460
gccacctcca actatctgaa gtggcagaga gaaaaagcct ttttatggta ccaggatctt 77520
84/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aaaaccaggg gttttacttt tttttttttt tttttttttg gagacaggat ctggctctgt 77580
caccaggctg gagtacaata gcatgatctc tgctcactgc aacctctaac ttctgggttc 77640
aagtgattgt cctgcctcag ccacccgagt agctgggatt acaggtgcac gccaccacgc 77700
ccagctaatg ttttcaacag gtttttaaaa gggcccaaaa ccccatttta ataggctaga 77760
cctctttaat gaatggtcta agttttgagg gctatttcca aaaatgtggt tattgttaaa 77820
gcccagaata catccctaaa agttatgaat tattgttggc agtttcttcc cattctaaaa 77880
agctttcaga agaaggtcat tagaataaag aacaactttc ccaaggccct gattggggca 77940
ttcagttgca gaaacactta cttgtgtacc tcttatcttg gtatgtggct cctgtccagt 78000
ctgcaaccta cgaagaacaa gaaaagacag agaatgcaca ggtcaaccag gcaagtttct 78060
gcagaaccag aaatccctga gcgcgagagg acagcgtgga agagtctcag aatttgttca 78120
caacacctct gtaagtgccc agctcttcta tgactacacc cagagataac ctttctcagc 78180
tggcatccct ataagaaatt caggagttaa gattttgaga caataaaatc taaacaggga 78240
ctcgagagta gcagccacag ctgcaaagat tcagactcct gctgacaggc atgtaccttt 78300
cctagccgat ctcctttgct gaacggctgg tagggcatat cccgaaactg ctcgggaacc 78360
gcacagggac cccagcctga ggggttgtcc tggatcacgg gtgtcatgaa ctttgccatc 78420
ttccaaaatc tgaaaaatat aaatcatgtg agtagcggca tgaacgaagg cctcagagta 78480
caaaacaccc tccatatgaa gtaagcaaag acataaatga tagaactcaa aaagcaacac 78540
gcaaaatgga accctcaact gttgagcgac tactactgtt tttgttaatt atactgtgaa 78600
tatgtactta aaactgagaa gaatgcaaac aaaactgatt tttcatattt cattaattcc 78660
acgacactct ctttttactg taacatcttt aaaatgaggc tgcaccttgt gtttgacagg 78720
gtgttgtatt gattggtagt ttttcttttt ctgtgttaca taagtgttta aaaaaattta 78780
atggtgtcag atttgataaa atgtcctaat gttttttcaa atatagtaac cttgttttgg 78840
ttctgagata taccttcacc aattcataca aactcaactt ccctaagact tagtagtctt 78900
ttctttcttt cttttttttt tttgagacag agtctcactt tgtcacccat gctggggtgc 78960
agtggcgtgc aacttccgcc ttccgagttc aagcgattct cctgcctcag cctcctgagt 79020
agctgggatt acaggcaagc gccgcctggc tattttctgt gtttttagtg gagacagggt 79080
ttcaccatgt tgtccaggct agtcttgaac tcctgacctc aaatgatcct cccgcctcga 79140
cctcccaaag tgctgggatt acaggcgtga gccaccacgt ccagccacct tagtcttttc 79200
catctgcaaa ataaacaaga tccttgttct aagcactttg tataatgcca cacaagtatt 79260
cagacttgca aaagtgcatt tatgtatata gagtgctgag aaaaaaagat ctttaagtat 79320
85/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
atcctgaaat tcaattttcc tttctcattg tttcaatttt ctgccatcaa cgcaaatcct 79380
gtgtgcagtg caagcggaca taaagccagg cagaagaact gccagagggc caaggaggtc 79440
cccacagacc tcaggcccaa agttgccatg ttaaatgttc atgaatactg ccaggcactg 79500
ttcttactgt ttaccactca ttcattcata cagtcctgcc aacaatcctg tgaggtagga 79560
gccaatgtta tccgcactct ccagataaga aaaccaaagc acagagaaat gaagaaattg 79620
cccaaagttg aaatgctagt ggatgaaaaa cgtgaaccaa agcagtctga ccccagagtc 79680
tgcactctgc ataatgctat agccctcttg ggaattaaaa aaccggcgct gtatagcaga 79740
tggctgcccg acacttctat aaaaaaacct atgcatttat cttccgttgt aaccttctga 79800
aaatgcttag aaggcgagtt cctagaggaa aattcactac acaagtattt cttggaggcc 79860
gggcgcggtg gctcacgcct gtaatcccag cactttgaga ggccgaggtg ggcggatcac 79920
gaggtcagca gttcgagacc agcctggtca acatggtgaa acccagtctc tactaaaaat 79980
acaaaaatta gctgggcgtg gtggcgggca cctgtaatac cagctactca ggaggcggag 80040
gttgcagtga gccaagatcc tgccattaca ctccagcctg ggcaacagag caagactccg 80100
tctcaaaaaa acaaaaatca aatgtttctt ggaggctgga gagcaatcaa aagaacaggt 80160
atgctgaact tagtaaactc tcctcaaagc cccatgctgg ggagattgag gcttccttca 80220
gagatgacat ttgggtgaca gcaacacagg atgaacctag aagtttcatc tttctaatag 80280
aaactatagg aagaggacag aagaaaaagg gtggtggtct cagaacaatt tgtattaaat 80340
aaatattgct gagctcctac gtgttaggcc ctataccaga taatttaaca ccattgacca 80400
cccccccacc cctactttag aggcaaaaat ttgaagctca gcctactcaa gcagctgacc 80460
tcatcatttc aaaacagatt tgatttccag ggttgcctgc tgtcagtcca gccttctttc 80520
cattatatta cagctgggca gcagcccgca aagatcaggg gtttgagacc gtacatcata 80580
ataccaagac aacgagtctc aaaacacact ttaaaaaatc gggttctgtc agaagctcaa 80640
gaagggaaga ggcccgaggc tcgacctgca tcacctccct ggaaagccag ggatgagata 80700
ccctggcttt aataaatgtt ttttttttta agagcagagc ggaaccagga ggagaaactg 80760
agccgctcag caaaaacgaa gtaacagctg tactagtcac aggggcagga tagggaggtt 80820
ccaagagggc actcagaagg ggctctgtgg ttggcaggcc actacagatc ataagccgtc 80880
catcgctgaa cagggggtgg ggtagattta agatcagaga tcaaatctac ttctctatcc 80940
tagcctccag tttcacaaaa aaggaaagat aacctatgca ctgtgaattc ctaagaacag 81000
gggccaaaca ccgctcagcc tggtacccct aagacctcac tcaaaaagtc agggagtttt 81060
86/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
cggccacttc agaaagactt tgttgttacc cctccgtctt aacccaggtg agttaagtga 81120
caatcaaatt cacccagctc atgggcactg agcagggccg agggccaagg acctcaccca 81180
caaggtcgtg tcccgcgttc agtagcgtgc gggacgcggg gcccccgaaa gtggattcct 81240
gccccgccca gcggagggac ggcaacagca ggaagggact aagagaggtc tcttccggga 81300
ggccccccga aggctggacc tagtccgaac cggctccgga gggccgcagg aacctatgaa 81360
acacgccgct cacctgcaat ggcctcggcc ggccgggatg gcaacagatg gtgcgtgccg 81420
gggaccgcgt tagcagcagc actcttgaga aaccaggaaa agaggaaaca tgcgcgcgca 81480
gcgggcgccg ccgtaaacac gaccggcgct gtcgtaaact gctctcccgc ttcctctggg 81540
ttgggcggaa gaactcacga gccgtaaagc gaaggtccac ccggaaatcc gttactgcgt 81600
ttcgccaggc gtcctcatta gcctccgagg cgccgagacg cgagaggtgt gattggcact 81660
acgtcaggcg gtatccgggg acgcccaaag agggcgttca tcactgaaac ttggcggccg 81720
cgcaatcgaa gctcgaggcg gggagcgact ggcgcccttc tgtgtcccac aatgcttcgc 81780
ggcgcgcctc agcccccatg tatcccaccg tcacccgcga ctccccgcct gttctacctg 81840
cctgcttaat gtgaaactca gcgcagggga ggtccgtcgg tgtcttaggc ggtccttatt 81900
gttactcctc cgcctttata gttgtggaaa ctgaggctca gaagtgccaa gtgacctgcc 81960
tagatcagac tgttagttta gggttctaac cgccagagtt caaaccatac ttccgcagtt 82020
ctcaaactta attgtaggac agggatttct ggaacagtgt ttttatttat ttttatttat 82080
tttttgagac agggtttcgc tctgtcgccc aggctgaaat gtagtggcag gatcacggct 82140
tattgcaccc tcgacttctc aggtacaagc gatcctccca gttcagcctc ccgagtcgtt 82200
ggtgtacaca ggcacgcaca accacgcctg cctaattttt gtatttttgg tagagatggg 82260
gttttgctat gttgctcagg ctggtctcaa actcctgagc tcaacagtcc acccactggg 82320
gctagggtta caggcatgag tcaccgtacc cggccagcta atgattttta aaaattttgt 82380
agagacagcg tctcactatg ttgcccgggc tggtctttaa ctcctggtct aaagtggtcc 82440
tctcgcctca gcgtgcggag cagctgaggc tacaggtgca tgccaccatg cctggctaat 82500
tttttttttt agacggagtc ttgctctgtc ttccaggctg gagtggagtg cagtggcgct 82560
atctcagttc actgcaacct ccgcatccca ggttcaggtg attctcctgc ttcagtctcc 82620
cgagtagctg ggattgcagg cgtgtaccaa catgcccggc taattttcct tttagtagag 82680
acggggtttc accttgctga ccaggctggt ctcgaactcc tgacctcagg tgatctaccc 82740
acctcggcct cccaaagtgc taggattaca ggcgtgagcc actgcgtccg gctgcctggc 82800
taattaaaaa aaaaaaaaaa aacttctgtg gagacgaagt ctcatcatgt tgccaaggct 82860
87/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
agtctcaaac tcctgggctc aagcagtcct cctgtctcgg tctcccaaag tgctgggatt 82920
acgggcgtga gccaccacac ctgaccagga tagtattttt aaaaattcag attctgggtc 82980
tcattttgat agattatacg gatatgttta tgctggagcc caagagctcc gcattagctg 83040
tgattctgaa gtgacgactc aggaactgct ttactacagt agataacagt gctgtcctct 83100
cagcaactcc caggctatgg agttcctcct ggtgtctttc tttcggaatt ttaaaacaat 83160
gaaagataat ctgagggcat gactttattc aaacctcaga tcctttctac ctgacatagg 83220
tttccttagc cgcctagtat gtctccttta ttagaaaata tacctgaagt ctaggctctg 83280
ccacattctt ttttttttct tttcttttct tttttttttt ttgagacgga gtgtcgctct 83340
gttgccaggc gggagtgcag tggcgcgatc tcagctcact gcaacgtcca cctcctgggt 83400
tcaagtgatt ctcctgtctc agcctcctga gtagctggga atacaggcat gcgccaccat 83460
gcccagctaa tttttatatt tttagtagag acagggtttc accatgttgg ctgggatggt 83520
ctcaatccct tgaccttgtg atccccccgc ctcggcctcc caaagtgttg ggattacagg 83580
cataagccac tgtgcccagc cagctctgcc acttgatagc tatgtgtggc cttcacattc 83640
cttgccttgt ttccttattt gtaaattgaa gatgataatt agagggcgct gtgggggtga 83700
aaataaatgt gtgtgaaagg acttagtaat tccacttatc atttgggtga acttggacag 83760
gttattcaac ctcttttttt tttttttttt ttttttgaga cagagtctcg ctctgttgcc 83820
caggctggag tgcagtggcg agatctcggc tcgctgcaac ctctgcctcc caggttcaag 83880
caattatctg ccccagcctc ccgagtagct gggattacag gtgcccacca ccatatcegg 83940
ctaatttttt gtactgttag tagagacggg gtttcaccat gttggtcagg ctggtctcga 84000
actcctgacc ttgtgatcca cccgcctcag cctctcaaag tgctgggatt acaggcgtga 84060
gccaccgcac ctggcctatt caacctctct aaacctgctt attcatctga aaaatgagaa 84120
tgctaatagc agcacctatt tccataagct ctctcccaac tgctcatttt ttttttttcc 84180
taatttttgt taatggtgtc tggtgaattg tgcccagtgg aaagccttgt agtcatcact 84240
ggtagttcgt ttttccttcc ctcccacatt tagttcttca ctatgttctc tttattctac 84300
ttgcacaatg catcttgaat gctatcactt tttttttttt tttttttttg agacagagtc 84360
ttgccctgtc acccaggctg gtgtgcagtg gcgcaatctc agctcactgc aacctccgcc 84420
tcccgggttc aagcaattct cctgcctcag cctcccaagt agctgggatt acaggcgtgt 84480
gccaccacgc ctgcctaatt ttttgtatct ttagtagaga tggggtttct ccatgttggt 84540
caggctggtc tcgaactctt gaccttgtga tccacccgcc tcggcctctc aaagtgctgg 84600
88/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gattacaggc gtgagccact gtgcccagcc gaatgctatc actttttatc cccatttcac 84660
atcacgcttg gatacactct tgctgctcta gggtttcttc tctatatggt ggtcaaagga 84720
atctgtccac aaccttctac tagcttccca ttatatgctt agagggaaat atgaatatct 84780
ttttgtggcc tgtgtggtca ctgtctacct ttgttatttt taaaatattt acttctttga 84840
gacagggtct tgctctgttg tccaggctgg agtgcagtgg tgtgatcatg gctcactgca 84900
gtcttgacct tttgggctca agcaatcctc ccacctcagc ctccgagtag gtgggactag 84960
aggctcatgc tgccactcct ggctaatttt taattttttg tagaaatggg gtctcactat 85020
gttgccccgg ctggtctgga actcctgggc ttaagccatc ctccagcctt ggcctcccaa 85080
tatgctggga ttacaggtgt aagccacctc acctggccac tggtctacct ctagccacca 85140
tattcttctt gtgccttaaa tacactgaac ttctttcttt ctttttcttt tttttttttt 85200
tgaaacggag tctagctctg ttgtccagcc tggagtgcag tggtgtgatc ttggctcact 85260
gcaacctctg cctctggggt tcaagtgatt ctcctgcctc agcctcccaa gtagctggaa 85320
ctacaggtgt gtgcctccac accaggctag tttttgtatt tttagtagag acggggattc 85380
atcatgttgg ccaggctggt ctcaaactcc tgacctccag tgatccatcc accttggcct 85440
cccaaagtgc tgggattaca ggcgtgagcc actgtgccca gcccaccagc cttctttcca 85500
tctcagcagg gcctctggac ttgacgttct ttctgcatgg cacactcttc ccccaggttt 85560
cctggtagtt gaattggtct catcatctat gcctctgctc gagagttaac tccttatgca 85620
ggtcttttct gaccatcatt tctaaaacag gtgattgtat tagtccattt tcatgctgct 85680
gataaagaca tactggagac tgggaaattt acagaagaaa gaggtttaat ggacttacag 85740
ttccacatgg ctggggaggc ctcacaatca tggcagaagg caaggaggag caagtcacat 85800
tttacatgga tggtagcagg caaagagaga gcgcttgtgt aggggaactc ccccttttaa 85860
aatcgtcaga tcttgtgaga cttattcact atcatgagaa cagcatggaa aagacctgcc 85920
cccatgattc gattacctcc ccctgggtcc ctctcacagc acatgggaat tcaagatgag 85980
attttggtga ggacacagcc aaagcgtatc actggcatag agtaggtgct taagtaggta 86040
ctcattgact gagttaatga aaaaaagaat ctggccagtg gtggtgtctc atgcctgtaa 86100
tcccagcact ttgagaggcc aaggcgggca gatcacctga ggtcaggagt ttgagaccag 86160
cctggccaaa atggtgaaat cctctactaa aaaaacaaaa attagccagg tgtggtggaa 86220
ggcaccctgt gatcccagct acctgggagg cggaggttgc agtgagctga gatagcacca 86280
ctggactcca gcctgggctg caagagcgaa actccatctc aaaaaaaaaa aaaaaaaaga 86340
aagaatcaaa attggaggac caggtgtggt gtctcatgcc tgtagtccca gcactttggg 86400
89/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aggccgaggc aggtggatca cctgaggtcg ggagtttgag atcagcctgg ccaacatggt 86460
ggaacctcat ctctactaaa aatacagaaa ttagccaggc gtggtggtgg gtgcctgtaa 86520
tcccagctac tggggaggct gaggcaggag aattgcttga atctcgtaag tggaggttgc 86580
agtgagccaa gatcacacca ctgcactcca gcctgggtga cagagtgaga gtctgtctaa 86640
aaaaaaaaaa aaaaaaattg gtatgagatt aactggcatt aatgaggacc actcctcggc 86700
agcagacctg ttgtatttat gatcaataat gtgagattct tgctttcaaa gggcttccat 86760
tccaaccaaa ggaatgatga cagaaatgtt tttttttctt ttttaaaatt ttttaatttt 86820
aattatatat ttcattttac tcaatatatc caaaatatta tcaccatacg atataaaagc 86880
cttattaatg ggaatgtttt acattctttt ttgtgctaag ttaccaaaat ctggtatata 86940
tttcacatgc atggcataac tcaatttgca ctagctatat ttcaaatgtt caaaagccac 87000
atgtagctaa tgactattat attggacaga tctaaatata gagttttcct gaaacttaaa 87060
gacgtttcat gagactagca cttagtaagt gtggacaaga gaggaatgag atgaagctgg 87120
agtgggacag gcagtgatag atcacacagg gcctggtagg cttgggaagg agtttggatt 87180
ttatactaat ggcattaggt cacctcctac aagaagtctt tcctaatgtc ccaaaaagag 87240
ttaaccactc catctcttgt gccaccatgg cttttgatga aaaacccaat atggcacccc 87300
ggattcttta ttatatcttt tagtatatac atggctgatt tctcctcaag ggcagtgaat 87360
gtgtctttat tcatctcttt attcccaagg cctggcacac ctcttagcat ataataggta 87420
ctatatattt attggaagag tgaatgagtg ggggtgcgag aatggattcc ttcagatcta 87480
ttttccagct cattaattct ccctctagct atgtctcatc tgctatttaa cacatccctt 87540
gagttttcat tttaacaact atgttttcat ttctaaaata tctgtatggg ttctttttca 87600
aattagcctg gtcaatttag agtttcttct acttatctcg ttttgtgatt ctacatttca 87660
tatctttaaa tatttcatag ttattttata ttccataccg aatagttcca atgtatcaag 87720
tgccttggga tctaaatctg ctggtgattg attttcctga ctctcactca tggtggctta 87780
ttttcttctg tatctgattt tcttcagttg tgagttcaca tttgttcgat cttaacctgt 87840
cctgctttag cagtggtttt caaagtgtgg ttcctggacg agcacaataa acagcacctg 87900
ggaatttttt agaaatgcaa gttctagggc tgggcacggt ggcacatgcc tgtaatccca 87960
gcactttggg aggctgaggt gggtggatca tgaggtcagg agttcgagac cagccggacc 88020
aacatagtga aaccccatct ctactaaaaa cacaaaaatt agccaggcgt agtggcatgt 88080
gcctgtaatc ccagctactc gagaggctga ggcaggagaa tcacttgaac ccggaaggtc 88140
90/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gcggtgagca gagatcgctc tactgcactc cagcctgggc gacacagcga gactccgtct 88200
caaaaaaaaa aaaaaaaaaa tgcaagttct agagccccca tcccagactt gctaaatgag 88260
aaatgctgaa agtgaggccc agtaacctgt atttgacaag ccctatagaa ggttctgaca 88320
cacactggcg tatgaaaacc actgcttgca agataatttg gtttacctct ttaggaagcc 88380
aaggagtgct accgaccagc agccacttta gtttttattt ttaatttttt agttttttat 88440
tgactatgcc ttataaaagg accagcagcc actttaactt tttggggctg ggcttaaact 88500
agagttgcag gctcagcttt actatgctgc tgctggccta aggctgttta ctgcctgtag 88560
tgctggtatc atttgcagtc agggcaatct tacctttagc gctgtgttct tctccactgc 88620
tttcccctcc tgttccacct caatataatt ttgtgggagg aggaggggag ggttgaagga 88680
actgtcttca aagatttctg taatttacag tgaacccaaa aattacatta aaagtctgta 88740
ttatccagga tcgagctgtt ttaccatggg aaagcccatc agagtaccca accctccata 88800
tggccagaaa gaacaactct gtctgaatac acgagtttca ggggctgctt gtgccttcac 88860
tcattagggt taaaacatgg tcttaaagct gaaggccgcc tctgacctga cagctccaag 88920
tcctgcggac tcctgcgccc agtaatcacc tccatggcga agcactgttc ctgctcccgc 88980
aggcggctat aggtccacag caggctctga aagtgctccc acagctggac acgctgcccc 89040
aggtctgggg gccgcagcct gagggcagag ccagagaggg cgggagagac cacgagaaag 89100
ctggtctctc ccacacccaa caaaaggacc agagtcccag ctcagtgtta gagccaggtg 89160
agcccatgtg acctgcccac acagctggga aagcgggtcg ggtttctggc ccagctctag 89220
ctgtggagtg gggtgggata ggcacggagc cagaaggcag gcagctgagc aaatcacctc 89280
actcttcaat ctctgtcaca caaacacatg tcatataaac ccagctagag agagccaggg 89340
tggtgcttaa gcttctcaca cagaggccac tgaacacaga aaggtctggt ctatcatcag 89400
ggccctacac agggttgcag ccatctcgga tgctggcaag gtctgcactg gccaatgtgg 89460
ttcatgtaac aggcatctac cacctgcagc atttgccact gaaaccatga cctatctggg 89520
ctaaaatggc tcatgaaaca atgtttgtgc atttga.gaaa tgcctcgagc atgtacagct 89580
tccgctgcag gtccccctcg ctcttggtgt ggtcgccatt gatggcaatg aacaggcatt 89640
ctccaaacag gtgaaggaca tacagggagt tgctgttttc catggagaag caggtgtagg 89700
tgtccgagag cttctccagc atcgtcatgg aggagatgat gaccggggct aggagggggc 89760
tgagctggtc ctgtagggca gggagctctt cttcctcatt ctctgactgc ccgaacttca 89820
gctggagact ctcttcaaac tcctcatccg tccagtagaa gagggcctct gtgccctcaa 89880
tggccaccaa gatgcacttc atcttggtaa ggagcacagt ggagcgtcca gacagccaga 89940
91/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ggttcagaaa gggctgcagc agacagactc tgtgactgcc tcatcggaga gcagcacaac 90000
atccctggtc ctgcaaatgc ggatcgcggc gtgcacagca ccccgcctgc gggacagaaa 90060
tgttttctga actgaaaaag ggggactaca ggtgcctgcc aggccctcca tatacataca 90120
tccccctatg tctgtgtcta gaagtgagat acaccgttat ttctgttttc tgattggcct 90180
ttttagtttt ttgagacaga gtctccctct cttacccagg ctggagtgca gtggctcgat 90240
cttggctcac tgcaacctct gcctccgggg ttcaggcaat tctcctgcct caggctccgg 90300
agtagctgga attacaggcc tgcaccacca cgcctggcta atttttgtat ttttggtaga 90360
gacggggttt ggccatgttg gctaggctgt tctcgaactc ctaaactcat gttatccacc 90420
ccccctcggc ctcccaaagt gctgggatta caggtgtgag ccaccgcaac tggcccattg 90480
gcctttcttg ttgtactgtt ctgtcccttc caggtaagac aggtacattt tctagtagta 90540
agctcctgtg tcttaaaaaa gaaaataaca ttcattgagt gcttacttta tgccaggcac 90600
tgtgctatgg gctttatata aataatttcc tctctgaaaa aaacaaagac aacaaaaaaa 90660
attacttctt tgattctttt ctaaaagttc cttgaaattg ccatggaccc tcccattcgt 90720
gcaggtgggg agaaagaagc tcagagtcgt tgagtacttg gcccagtgag taaatggtgg 90780
agccaggatt tgtgaacagt tttgtggact cagaagcttc catcccttac aggggtggtg 90840
aagaaggcct ttccgagagg cccgagaggc cccaaggcag aaccatccag ccaagcccac 90900
cccaaattcc tgtcccacag aaaccaagag agataataaa aagacggttg cagggttgtc 90960
tcgcccctcc tctgtctctt gcctgctctc tctaaggaat tcagagcctt cccatcttga 91020
ataccagcgg cagctccaga atttccccgt gggacaggct tactgagagc cgtcttgtga 91080
agggggtagc cctggacttg cctgggagct gtgtctgtgt agcaggtact ctgctttcag 91140
gaggatgcag gttttgttgg gggagagtgt tccagggact gtgaggggac tgagcctgct 91200
cctgaagcca tctccttttt atttaatttt atttttttga gacagagtct cgctgtgttg 91260
cctaggctgg agtgcagtgg caagatcttg gctcactgca acctccatct cccggttcaa 91320
atgattctcc tgcctcagcc tcccgagtag ctgggattac aggtgcccgc caccatgcct 91380
ggcaaattgt tgtattttta gtagagatga ggtttcacca tgttggtcag gctggtcttg 91440
aactcctgac ctcaggtgat ccacctgact tggccttcga aagtgctggg attacaggca 91500
tgagccactg cgcccgaagc catctcttgg taaaatactg ctgagcattc agacagaaca 91560
gaattaggag aaagagaagg aaccagcatt gatttcttca acacactgtg ctaggtacct 91620
caggcatttc gattattcta ggctgtgagt gaagagttgt tgccagaatc taaagtgtgt 91680
92/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tctgagaact tggccaaatg tagggtgacc atatgactta ccattcaaat ttgggacact 91740
ttgggggtga cgaagggatt actatcaata attatgccct gggattgtct cacttaaact 91800
gggaggtatg gtcaccctag gcagaaggga agtaaaatgg tcctctgtta ctgattatct 91860
gttgctgtgt aaccaatcac accaaaattt agtggtttaa aacaacaaca gtctttttat 91920
tatatctctt agtttctgtg ggtcaggaat tgggagaggg cttggctggg tggttctgac 91980
ctggggtctc tcatgcatta tagtttggtg tgggtggagc ttctgttttt ctctctctcc 92040
atttagcctc agggtcattc tgtagtgagt ccatgtgggg agttcagagc aagtattctg 92100
gcgaacaagc tggaagccat gctgccttct gtgatctagc ctccgaagtt atacagcatc 92160
tctcccatcc ccgtaacttg ttggttccaa gtgagtcaca agcctgccta gagtcaaggg 92220
cgagggagga cagagactga atttcttgct gggtaaggca caaagttatg gaacaagtat 92280
gtggagtggg aggtattgtc gtggccatct taggggtatg aactctgcca tggatgcaga 92340
ctggcctttt ctaagagtca tcagtttggt tatctgcaaa catgactgaa gagtgtgggg 92400
tacatcaatg ccaggcaaag tttctgaagg agtctggctc agagggggag gcctggaata 92460
cgatcctagt ttaccaaggg gaacctggtc agttaccttg caactttgga gaaagagtga 92520
atggaagtgt ccctcagtag gggacattta ggaaggggat ggtcacagag ccagggctgg 92580
cattgtccag ggcacaggtt cttggttgcg ctggctcaag catcatcccc attccccggg 92640
taagactgtc ctcccaaaac agaggtggct tcaagctgct ctgtgataaa cacttttttt 92700
tttttttttt tttgagatgg agtctggctg tgtcacccag gctggagtgc agtggtgcaa 92760
tcttggctca ctgcaacctc tgcctcccag gttcaagtga ttcttatgcc tcagcctccc 92820
tagtagctgg gattacaggt gcctgccacc atgcctggct aatttttgta tttttagtag 92880
agatggggtt tcaccacgtt ggtcaggctg gtctcgaatt cctgacctca tgatccgccc 92940
gcctcggcct cccaaagtgc tgggattaca ggcgtgagcc accgtgcctg gccgataaat 93000
gcttcttaat gctgttgttt attctgactc cctgccacca agcagtgctg tgacaccgtg 93060
gatcctcatg gaacttgtgc tgtagggaag cacgtgctgg ttaggctgat ggaagtgctc 93120
cattctgctg gtggggtatt tactgtgctc tccaataata aatggatctt ctgctatgcg 93180
tcagccttgt aagtttggtc aaagggagtc tgccaccgcc ttgtgtgcag aaagatcccg 93240
gatatcctgt ggtggattca cctcattggg accggtcagt gtggccaacc tctcttccag 93300
agtggcaact tgcgtttcct tgcttatctt ttaagaagca ccataggaat catcacccca 93360
ttttatagac gagaacactg aggctcagag aggaggaatg tcttgcccca ggtgagccag 93420
ctggtcaggg tgcatttgga atggaaaccc aggtgtggct gaaaccaaag ctggcactct 93480
93/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ccatgcacaa ttccaaaacc cacaaagctc tgaaaatcta aagctttttc atgagattgg 93540
ggcaagcatt tgatggcaaa cctgatatga attggatgtg aggttattta tagtctttat 93600
tttgtcccac ttagcgtgaa tatttataca ttttgctgca gaaaaattaa agggtttatg 93660
gaatattgct ccagagctca ctggcatgtc acctgatatg cggtagatcc actcgaaaac 93720
ctttcaggaa tccaaagaat tccaagttat aaagcacatt gaggccggat gtggtggctt 93780
cagacctgta atcccagcac tttgggagcc caaggcgggc agctcaccag aagtcagtag 93840
tttgagacca gcctgggtga aacctcatct ctactaaaat acaaaaatta gccaggcgtg 93900
gtggtgggtc cctgtaatcc cagctactgg gggaggctga ggcatgagaa tcgcttgaac 93960
ccaggaggtg gaggttacag tgagccaaaa tcgggccact gcactccagc ctggccgaca 94020
gagtgaaact gtgtctcaaa ataaataaaa tataaaataa aatacataaa ttgataaagc 94080
acattgagcc gcgaggattt cagataagaa attgtggagc tgtgctacct gtaccaaact 94140
tttctgtctc ggttaggcag agatcactac ccccattctg cagatgagga agactgaggg 94200
caaggaacat ggtgtcccag gtaggacggc agccatttta tcatcctgtt ggaggctgtg 94260
ccagcaggaa aggaagcttt ggagccacca gcccacccca gcctcccaag aaccttgttg 94320
tctcagcaaa atttcagaac tagaaaacct ggaaagatta aagccccaaa gaatgccaca 94380
agtcccccag gaagaaaggg aggctttgct gtgcgttcca gtggtcgaca ttctaaatca 94440
ttttttattt cagctgcatg tacactcacc catcacagga ccagttctca gaatagagag 94500
gtacctgttg aatcatccac cctacttcct gcctcgtgtg ggcatgtctc caagtgctga 94560
gccatccgct tcgctgccgt ggcctgagat atatcaggat ttgcaggcct ggcgacagga 94620
gacaaaatag attcccattt ccttcagaac catttagcta gtttagagag tgtttgactg 94680
tttcaatggg atgagcaata accaggcctc tccttggctc cttctctctg ccccatatgt 94740
tttcttctgt tggaagctgg gatttggggt cttagggcca aagataaata ctgattttgg 94800
ctcgatctgg ccgcacagct gtgggctagt aggtgcccct ctctgaacct caggccccca 94860
ctttctgcag cacagtgttg ttctcatctc tgtttttttt tttttttttt ttttttgaga 94920
tggagtctct ctctgttgcc taggctggag tgcagtggtg cgatttcagc tcaccgcaac 94980
ctccatctcc tgggttcaag caattctccc cacctcagcc tcccgagtag ctgggattgc 95040
aggtgcctgc caccaggccc agcggatttt tgtgtttttt agtagagaca gagtttcacc 95100
atgttggcca ggctggtctc gaactcctga cctcaggtga tccgccctcc tcagcctccc 95160
aaaatgctga gatgacaggc atgagccacc gcatccggtc tctcatctct tcataccaca 95220
94/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tgccttggtt cccactgccc cggcgggtgc ctggagagcc ttgtggctgg ggctgagtga 95280
ccgcaaggtg atatttaagg tggtctcatg gagcagtctg acatcactgt aatgcaagca 95340
gacatctggg gagtcagact gactgaattt gaattccagc gatttaaatt tttaccactg 95400
ttgtgtgacc ttgggcaagt tgtgtgacca tttgagccat agcttcttca tctgtaaaat 95460
agatggaatc atagcatgta ccacttcggg agggagggag aatagaatta ggtcagattt 95520
tatatgtgac atgcttaagg cagtgcctgg catgcaaata agcccttgat acatgccagt 95580
ggggttactc tggttaccag aaacttggaa gtaggggctt tggctggggc aagatctcgc 95640
aacatttaaa~aagcaatcac tgaccgggca ccgtggctca tgtctgtaat cccagcactt 95700
tgggaggccg aggcaggtgg atcacgaggt cagaagatcg agaccatcct ggctaacacg 95760
gtgaaacctc gtctctacta aaaatacaaa aaattagccg ggtgtggtgg tgggcgcctg 95820
tagtcccagc tactcgggag gctgaggcag gagaatggca tgaacccggg aggcgaagct 95880
tgcaatgagc caagatcatg ccactgcact ccagcctggg tgacagagag agactccgtc 95940
tcaaaaaaaa aaaaaataaa taaataaaaa gcaatcactg gtcactcgtg aggaaccagg 96000
ccccgagttg gtcactcagc gttcaggtgg agaccttgcc atgctatcaa gtaacctaga 96060
gtctattttt ttttttaaga tggagtttca ctctgtcgcc caggctggag tgcaatggca 96120
cgatcttggc tcactgcaac ctctgcctcc catgttcaaa cgattctcct gcctcagcct 96180
cccgaatagc tgggattaca ggcacccgcc accacacccg ggtaatttct gagtagagac 96240
tgggtttcac catgttggcc aggctggtct'tgaactcctg agctcaagtg atccacccgc 96300
cttggcctcc caaagtgctg ggattacagg tgtgagccac tgtgcccagt caagtaactc 96360
agagtctaat ggggaaagta gatgtggcta atccaggggc tgcaatacct ataaagtcct 96420
taatcaaata tattttgcgt ctatgtttaa aaagcagatt tcacctaaaa atctagtttt 96480
ttggcttctc ttaagatctg gcaacaccgg gctggccttc ctgcgatacg agaagaagct 96540
ggagctgaat aggagttgcc cccttggcca ggggctctct actttgcctc agtccccact 96600
actccctatt gcaccagatt caaacttctt catagtcatg catgtttgcc gctggggcct 96660
gtgggagttt gctgataagt tgcagtgcaa tgctgtgggt gctgtgagag cacgatgagc 96720
aataataact cagccttggg cagtcaggaa aagcttccca agggaggcga agtcacagct 96780
gcttctctat aaaacctgca gatgctgctg aacaccctca tctttatggc tcaaggacat 96840
gaataaagga cgcaaagtca gagctcacga ggaatctctg gcataaagcg actgaggccc 96900
agtgacttat ctcgggtcac acagcctgct gatggcagaa gtggggctag aactaggatt 96960
accaaccaga aacctttttg gactactttc cctagaacca gagctgtcaa ccagaaacag 97020
95/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ttctgggcca ctctacctcc cctgtctctg gattcctcgg gagttaggag gatttgtact 97080
ctggaatctt agacttgagt cctgtctctg ccatttactt gcagtatgac ctcagatgag 97140
tcacttcctt tccttgaacc tcagtttcct catctgtaag gtagagctaa ggattctgac 97200
ctcaaaggag tgttctgagg gccaaacgtt gggaaagtgg acaggaggca atctcagaca 97260
tctcattagc tcaagaggac tctagatacc tgagggtcat tatgactgtt gacaagtagc 97320
caccttctcc caagagattt tgttaccatc tgtttaacag tgaccttgaa ggggatccat 97380
cccccacttt gcccttgcca gtcccttaaa ggagcacgca tggcctttgg tcaggcttgg 97440
accctggaag ggaatgcttt gggattctct gactttgggt gtgaactggg ccctggatgc 97500
agagcccaag ggttcccctc tcctgggagg ctccaaggtc acagcgagta ctagggtaga 97560
gttgggaagg aagcagaatt tcctgggcaa aagaaatgtc aataattctt ttgttttctt 97620
caaggcatct acctgcctat ctggggctcc ccttaaatcc catgtctgtg gctggaacta 97680
ttgagactct cctactttga ggaggtccca ctgtcctgag ttcaaatcct gacttttctc 97740
cttattagtt gagtgtgact ttggttggac aagatttcaa attcctctaa actccaatgt 97800
cctcatctac aaaatgggcc tcttaagagt acacatttgg taaggtttag tgggaattaa 97860
gtgagattat gtgtgaaagg gtttagcaca gtgtagagct cagtcaatgc ccgttattac 97920
tgtgattgga aattagaatg attgccaccc atcgtgtttg tataacactt gaccatttct 97980
gaacttatgc ttctcttacg ccatttgatc ttcgcaatga ctctttgagg tggccggtgc 98040
agggatcatg acctcattgc acagatgaga caactggagc tcagagaagg caaccgtcta 98100
ctcaaggtca cacagcttga gtatggcaga gtggcagagc caagttcact tcttgttctt 98160
tttttttaag atggagtccg gctctgttgc ccaggctaga gtgtagtggc atggtcttgg 98220
ctcactgcaa cctccgcctc ccgggttcaa gcgatttcct gctaattttt gtatttttag 98280
tagagaaggg gtttcaccat gttggctagg ctggtcttga acccctcacc tcaagtgatc 98340
cacccgcctc ggcctctcaa agtgctagga ttacaggcgt gagccaccac acctgatctc 98400
aagtcttctg agatgaagat taaacagcac cttccacagg gtcagaccgg acgagacaag 98460
accaggcttt gaccacgtgg ttgggttgtt ccctgggtgc ttcatatctc ccaaaaactc 98520
cttgatagaa ataatccaca atgctgtttc aaaccctttt tgcctctgtt tatgctctga 98580
gcctgtacca cctctagggg cgaagaaact tctcctttct ccgtggcgtc aaacggactt 98640
ttccttgtat ttgtcctaaa gggacctcag cagcccctcc ccgttgggtc cgtcaaagca 98700
ctctgccaga aggtctgtgt gttcttcagt gtgggcacat gatggcgctg ctccacaacg 98760
96/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
catgaaaaat caggcccaac ccacccctca ccccccgccc cccggactgc atttcaacgc 98820
atcaaagatc aattaaacac ctactatgtg caagtgactg tgattgctcc ggggagggct 98880
tcagttattc aatactgtta tgtttagcta tattaataat agccgtaata acatcggtac 98940
agggcttcat agtttatcga gcaatttacg tggattatct ggttctatct gccaagcagt 99000
cctgatgcgt tagatcgggt gggtctttct gtcccacttg aggaggaaac tgaggcacgg 99060
agggtgacag aacttatgta aaggcacggg ggagagaggc acatggtagg catttgatga 99120
attataggtg gtggatggaa tgaggcagac ccaggcatct atctcctcca ggttgttatt 99180
catcagtgag ggccgggatt gtatcttatt tgtctttcca tccccactcc tagcacggct 99240
tctgattgag ggcttccaca gacctctgtg gcagggagag gagaggcagg gggattccct 99300
gtaggctgca atgccgaaca gctcctggaa ggctctctga gggtgtgcag gctgagagag 99360
gtggcttctg ggctggagac tgcaaagaga ggaggtcact gccttcaccg tgtagcattt 99420
gcaggacatg aatgactcac cgtaattcag ctcctgaagg caccaagtag ctgagtggtc 99480
aggatgattc attcattcat tcaacaaacg ttttctgagt gcctgttaca tgctaagcat 99540
taagaatgca ggtatgcaaa cacagcctct gtccccctgg agcttccaga gcagtggagg 99600
agatggaggg caaagagcta gcaatgcggt ttggtttgag ttgcccagaa gtctgtactg 99660
agtgccacgg ggtaaccaag tctagtggca cagtgtgaag gctacaagag ggggagatgt 99720
tttgcaggat ttgaaggatg aaatgaattt gcagataacc agacaaagaa aggtgcatga 99780
ggactggggg aaggaaagca tcaggggcag tggggtatgt acgggcagga gctgtcaaag 99840
ggcgtcagtc atgtgtttga ggatgggtaa cagatgcagt aggaaagaca gtggtaccag 99900
cagggagggc cttgaaagct attctgagga ctgtgaattg catcttgtat ttgtcaggga 99960
atcaccatgc tgggagctct gctaggagct cagagttcca tggagaaggt gggcaaagag 100020
aggcccatca ctcatgttta ctgagccttg actatttcgt ggtgctaagc acttcttggg 100080
ccttggttta ttgtctgtct tataaggcag gtactgtgat catccccatt ttatacacga 100140
gtaaactgag acttgggata ctgacataag tttttcccaa ggtcataaaa ctggtactag 100200
tggagtcagg acttgtcttt tttgtttttt aatggtcacc tttactaaag ctgaagtgta 100260
tgggtttttc acggatgggg tacaaaattc aaaaggctca aaaagtccca agtgaggttg 100320
ctcttctttt tttttttttt tgggatggat tctcgctctg ttgcccaggc tggagtgtag 100380
tgggatgatc ttggctcact gcaacctctg cctcctgggt tcaagcgatt ctcctgtctc 100440
agcctcctga gtagctggga ctacaggcac atgccaccac gtctggctaa tttttttgta 100500
ttttttagca gagacagggt ttcaccatgt tggtcaggct ggtcttgaac tcctgacctc 100560
97/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gtgatctgcc caccttggcc tccctccctc cccagaggtg actactctta cactttcttg 100620
tgttttttat tttctagaga ctttgcctgt ttgttttgtg agaggtgttt tatatagaca 100680
taagcacaaa aagcaagaca agacaagtgc ctgttaacta caaacatggg ctttgggaag 100740
agccagtgtg ggtttagatc ttgacttttt ctgagagcct gacaagtgtc accattaaat 100800
gctggtttgg acaaagggtg ggcgggcttg gagggtggga tgaggatggc agggggtagg 100860
gacgtggaca tcaagaggtc tgtgtgcaca agtgtgactg tgtgggcctg gactgggggt 100920
gaggtgatca gatggggaca ggaaatgggg actgcagagg cctggtgaga gacagagcag 100980
ggacgaggca ggggagagcg gctgctgcgg ggctgtcata gccggcaggc gtttggcagg,101040
gcagaaggca cagtaagagg aagagaggca gcctgcgggc ttggcttggg acagcctctc 101100
taaggctcgt gctgactctc gagcagttcc agctcagcag gccatgcaca cgaaccagga 101160
agctgggtgg actgggctgg gaaggaggcc atgggctcag gagcccggga gatctggtcc 101220
cagtgcccag tggggattct gggcaagcca attcctctcc aggcatctgt gcgggtcagc 101280
gccacacgga agcccctcgt ccctgttgat cttcactgta gagggagagg cagggaaagg 101340
cttgggagat gccgggctgg gatgggctag gggcttggaa tgcctgccca gaggttttca 101400
gggcggcatc tcagcaagtg tccacagtgt gcagagctct cccaggcagg atgggcacct 101460
atacatgcat gcatatgtgt actttacatg ttatatgtaa tacaatgtaa tacatgttat 101520
tttgctcggt tcccacttcc ccttttagaa gccagttgat atataatgag ttggtgtcct 101580
cccattcttt ttgatgcatt gaggatccta agtctgtgcc ccagtcccca tagtctgttc 101640
acttcctggc ttcctggaag aacaaaatgt ccccgcctcc tctcgttctt tccctgcccc 101700
actcctagaa tcagctgttt ttctaaggag cccaggtttt cttccctgag aaatgctatt 101760
tgggtggggg agagggaggg aagcaacaag ctgtggggga agagcctcga tctgggcaac 101820
ccctttgctc ttgtgacctc gagcaagtcc ctcggggcat taggggacca gttatgtcct 101880
ttctagactc acctgaggcc aagaagatgt gggaaacatc catcctgtgt gcctgcggtc 101940
tggaaaggca cagccccagc tctgcccctg tgtggctgtg tgattctggg tttcttaacc 102000
tctctgagcc tcagagtccc catctgtgag ataggaataa catgaggctt tttttttttt 102060
tttttttttt ttttaagaca gggtcttact ctcttgccca ggctgaagtg caatgacatg 102120
atcatagctc attgcaacct tgaactcctg ggttcaagtg atcctcccga ctcagcctct 102180
caaagtgcta ggattacagg catgagccac tgcatctggc acgtggacat ttctgactta 102240
tctcaactag ggaaggtact caataaatgc taattccctt cttcctcccc ttaattattt 102300
98/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gacttcagta ccccaggaaa tgaggactgg gatattggat ggtttgggag aggaggaaag 102360
aggtgtccag ggaaaaggaa gaaattggga aatagaagac cacggacaaa taaaagagga 102420
ggggttaatt cagaataggg aagacgggcc aggcgcaggg gctcacacct gtaatcccag 102480
cactttggga agccgagaca ggcggatcac gaggtcagga gttcgagacc agccttgcca 102540
atatggtgaa accccgtctc tactaaaaat acaaaaatta cctgggcgtg gtggcactca 102600
actgtagtcc cagctgctca ggaggctgag gcagaagaat cgcttgaacc tgggaggcgg 102660
aggttgcagt gagctgagat cgtgtcactg cactccagcc tgggcaacag agcaagactc 102720
catctcaaaa ataaaaaaaa agaaaagaaa agaatagaga agatgatttt aatcatcaga 102780
gctttccaat aaaggcaggc tctggctgct tgggggaggt tgagagcctc ctgtcattag 102840
aggtatgcaa gtagaggctg agggattgtg agccacacag atgtgtttgt gaggactcgc 102900
aatggccagg aggtagattc cttcactcag caaactttgg gagagggctg tccttgcctg 102960
gtcctgtaat ggggcaggga agccaaggtg aataggacac catccctggc cccagggagc 103020
gcccagccca ggaaataagc aaatcgctga gatcctttta ctctgcagtt ctgtgctttg 103080
aagcatccaa gccttggagg gagttggctg gggattttca gtgtgcgcct tttggtattg 103140
atccactgaa gttggagctg gctggggaat ggcaggagga cgccgcagtg ttattagtgc 103200
ggaggacacg ctgtaatctg tcagtgtcac cccggttgca gctggccagg aaccatcctg 103260
ctgttaacgc ctcccttccc agcagccatg gagcacacaa cttgtacagc acctgccagt 103320
gcctccacct ctccttgtag gagggagagt gtggatattt attctttttc tgcatctccc 103380
tagcatgagt cctcgtctcc aatcacacta atttattcag tgttttccaa cacaccttgg 103440
gcattcctac ctctgtacct tcagttacca gaattcccta ccagcggtgg tcactcctgt 103500
ccattcatcc atccacctgt ccatccatcc aatcatccat ccatccaccc acctatccat 103560
tcaatcatcc atccattcat ccgtcatcca tccatccccc cattcatcca ttcaatcatc 103620
catccatcca ttcatccatc cacccaccca ccttccatcc attcaacttt gcaatccgct 103680
tcagttcaat tcaattcaat tcacctttat tcaactcata aggttactgg gctttgccat 103740
gtaccacaca catgtgataa gtgaggcatg cctctgccct caaggagccc atgggaagaa 103800
tcctccccat tctccatggc cagctttgca tctcacctct gttaatcctt tgccatgccc 103860
ttcagcagaa gcaacggact ctgaagggct gtcctgtgag gagagttcag ttctggcttt 103920
catgaattgc agaggacaga gctcagacaa ggagagaggc aaagggtggg gaggaggtga 103980
gagtgagatg agctagtggg acggggattt tggctttgtg gagggagctg cttccagtta 104040
gctgtgagta ctcagcagtg tattggggga tgaagggaaa gagaaggggg caaggaaacc 104100
99/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
actattggag aagtgggtta gtgtggcggt gaggaggtga gctctgcagc caatggacta 104160
cctggcttat tgtctcagct ccaccatatt cctgctgtgt gaacctgggc acatatctta 104220
acatctctga gcctccatgt cctcatttgt aaaatgagga taataagacc tatctcacaa 104280
tgttgccttt agcattaaca catgcagtgc ttaaattaat gcgtggcaca aagggagagc 104340
ttaatagatt ccagctttgg ttgtgactac tcctattacg taccagctac tatgccagga 104400
gctttcattc cagtgtgtcc tctgagctaa ccctatgcgg ggattattga acccattttg 104460
cagatgagga aatgaagacc gacggaagct atctcttgag ctcgtcatgc agctggcgaa 104520
gggtggagca gggcttcaaa tgcagacctt tccaactcca ttgtccctgc tctcctgcgt 104580
gccctttcct gccttttctc aaggggtgag tgctctgaga tgcaaagatt ggaagacttc 104640
catcccagct tctgcctagg gcactctttt ggccttctct agttgtagcc ctgaattgtt 104700
aattactgtt tcatgtatgt tttctctgct ccccagagac catgagatca agaaaaaaga 104760
ttttcttctc cacggcaact gaagtgttga ctttgacagt gaaagctaca gagtgtatga 104820
tgtttccctt tttgccttgc ttgccaggaa gcttgtgctt tttgtcaaac tgcttacttc 104880
ccctttccat ggttttggtc ttctaccttt gacagacttt tattcataag tcttactgta 104940
agctgttcta ctcatagaat aagctgaata aatagaaatt gaattgaatg gaaaaggatg 105000
ggttacaaat tacaagtaaa taattcattt tatatttaat ttaatttatt tatttacttt 105060
tgagatggaa tactgctgtc acccaggctg gagtgcaatg tcgtgatctc actgcaacct 105120
gcgcctcctg agtttaagtg attctcccgc ctcagcctcc caagtagctg ggattacagg 105180
tgcccatgcc tggctaattt ttgtattttt agtagagatg gggtttcacc atgttggcca 105240
ggctggtctc gaactcctga cctcaggtga tccatccgcc ttggcctccc gagtgctggg 105300
attacagatg tgagccactg tgcccggcct gcaagtaaat aattcaaata aaatcacgag 105360
cttcaggaaa gaaaaatgcc tttcttatat cgggccattg ccacagtgtt tagccctgag 105420
ccctggttct ggctgggtga agtttgcatg gaaagcccag tggtgatttt ccctgttgtg 105480
tctggatcag tggctctcct tgcacctaga atataactca aaggccttcc ctttggatta 105540
gagcagcagt ccccgacctt tttggcacca gggatcagtt tcatggaaga caatttttcc 105600
acatactggg tgggaaactg tttctcctca catcatcagg cattagttag agtctcataa 105660
ggaacaggca acctagatct ctctcatgca cagttcacag taggactcat cctcctgtga 105720
gtatctaatg ctgccgctga tgtgacagga ggtggagctc aggtggtaat tctccatcac 105780
ccgctgctca cctcctgctg tgtggccctg gtccaaggcc cagggattgg ggaccccggg 105840
100/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
attagaggac tgacccctgc ccacctcttc caccttatcc tgtgtaactt gtccccttgc 105900
tcacccagga taactactgg agtcatcttt gagatgttct cacaagccag gttctttccc 105960
tgcttcagaa aagaggcttt gtggctgggc gtggtggctc acacctgtaa tcccagcact 106020
ttgggaggcc gaggcaggcg aaccacctga ggtcaggagt tcgagaccag cctgaccaac 106080
atagagaaac ccggtcttta ctaaaaatac aaaattagct gggagtagtg gcacaagcct 106140
gtaataccag ctactcgggg aggctgaggc aggagaatca cttgaacccg ggaggcagag 106200
gtggtggtga gctgagatca tgccattgct ctccagcctg ggcaacaaga gcaaaaacta 106260
cgtctcaaaa aaaaaaaaaa aaaagaaaaa gaggctttgc atgtgccgtt ccctctgcct 106320
ggagccctct gctctctccc atcccctgct tctgcctggc tcatcattcc tacgcttcaa 106380
atttctgctg aaagtcagca tcttagggag gcctcccctg actgctctgt ttaaaggggt 106440
tgtggtagct ggtctgcaaa gacaactccc agtgcttcct ggcctctcct gtgtatgctg 106500
ctgttcccat caagaaacag actctatttc tcctcctcct ggaagtgggc cgggcgttgg 106560
gcctggcttt ggccaatgga atgtggcaga ggtaatttac tgaggcttcc gaggtgaggc 106620
cttcagatga ctggcagctt ctccttcctg ccacctggaa cccagctggt atgctgtggg 106680
aagcccatat cacatagaga gacacagcgg gagaaatggg gtgttcagct caacagccca 106740
gttgaacccc cagccaacag tcagcatgga ttccagccat gtgcgtgagc cagcctgggt 106800
gctgcagccc aggtgagccc ctgaatgact gcaggcccag ctaacatcat acggaacaga 106860
agaaccaccc aactgagccc acagaactgt gggagataat aaaatggtat tgctgtttta 106920
agccactgaa tttccagtca tctaaagaga ggttaatccc tgataaattt ctctctttct 106980
ctctctctct cttttttttt ttttttagag agacaagttc tcactacgtt gcccagactg 107040
gagtgcagtg actgttcaca agtgcaatca tagtgcactg cagcctcgaa ctcctagtct 107100
caagcatccc tcctgcctca gcctcctggg tagctgatat tctaaaaatc attgccccaa 107160
tgcacttact tcatagcatt cacaataatc tataattata taattatttg attcttaact 107220
tgctaatttt cccttttttc tttttctttt tcttttcttt tctttttttt tttttttgag 107280
acagtctcgc tctgttgccc aggctggagt gcagtggcat ggtcttggct cactgcaatc 107340
tccacctctt gcattcaagc aattttcctg cctcagcctc ccgagtagct gggattacag 107400
gcatgcgcca tcatgcccgg ctaatttttt gtatttttag tagagatggg gtttcaccac 107460
gttggccagg ctggtttcaa actcctgact tcatgataca tctgcctcag cctcccaaag 107520
tactggaatt acaggcgtga gccaccgcac ctggccaatt ttccctttct tcctatagca 107580
catgagttac agaaggctgg gaccatgttt gtcttgattg cagctatccc cagcattaag 107640
101/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
cacagtgaat ggcatgtggt gggagctgaa agaatgaaag aatgaatgaa tgaatgaatg 107700
aatgaatgca aggcatcgga gtggtcttga agtgttccta agagccagtg taagtctctg 107760
tggctgcagc ccaggctgat atagcaccag aaaggagatg ggtatggcct aagtctcagt 107820
tctctggggc tttcacgact cagaactgta caacactccc tgacaccacc tctataaccc 107880
agatctccac acccctgcca ggaagaatca cccttttcct tctccttgcc cttctgtatc 107940
ctgcacagct ctccattagg ggacccgaca ggtctccgcg catgctcgtg tgtatagatg 108000
atggaagcag gacagaataa tgggtatgaa tgagggctct ggatccagag acccccacct 108060
ttgaacccca gtccaccaca ttctaaggat atcttggtgc catggctaca gatattgagt 108120
gttcactcac ataggaagtg ctgtgtaagt gtgagcttac attacaattg ccatgtgcca 108180
ggcactactc tcacgtcttg aattcattta cttcatacaa ccttataagg tggttgctat 108240
tatcattccc ctcttacaga tgaggcaact gacgtgtgga taatttgccc aaagttgcgg 108300
atctgaaccc tgccaatgtg gctacagagc ccaccttctt cttttttttt tttgagacgg 108360
ggtctctctc tgttgcccag gttggagcgc agtgatgcaa tcatggctca ctgcagcctt 108420
gaactcctgg gctcaagtga ctcttccatc tcatcctccc aagtagctag gactgaaggc 108480
gtgcaccacc atgcccagct aatttttgta ttttttgtag agacagggtt tcaccatgtt 108540 .
gcccagcctg gtctcaaact cctgagctgg cgtgatccac ccagcttggc ctcctaaagt 108600
tctgggacta cagccgtgag ccaccgtgcc tggtccagag cccaccttct taaccctcat 108660
actgcctctc tcgttctcaa ggtagaaccc tcgttctgcc tccctgagcc tcagttttca 108720
tacctataaa tgggataata atgcctgttt aatagggcta tgataccatg atctggcagt 108780
gcctgacaca ttgtagaatc tcaataaatc ccaatttgct gtggcaagat agatgaacag 108840
acttccaaac caaggagggc tttgaagctt tactgtgagg gtgctagaga accactgaaa 108900
gttttcgagt aagacaatga catagtgaag ctgtggctta gctccagtcc taccttttcc 108960
cgcctctgtc cccccaacaa ttagctctat gctgcctgag gttggtatct gagtttcaca 109020
tccctgtctt acctccccgt gaggtgctga gatttgaact gtttcaggat cgtgatagtt 109080
catcccgggc ctggaatgaa tggggtggga gggatgttct tgatcttgtg ggactcatct 109140
caaagggctg cctcagagat cccatctggg gccccatttc tgtctccacc tccagcccta 109200
ctgactgaca gaggtgcctg ggtttcatat gactgacttc gtattcccct tggaatccct 109260
tctgcagcat agtggatgag gtgagacaga ggctggtaac tcggtggaag agagaggagg 109320
gagaaaaaac aagggagcca gaacaggaga gagtgggaga cagggggaca gagagagaga 109380
102/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gtggtggaga gagggcgagc cagagtgagg gaaagatggg ctcactgctt cagggcgggg 109440
tgcacctggt gacagaaatg ggccacctga ccttgtgctg tgttcccttg ttctgacaga 109500
tatggtgagg ccatctgacc ttgtgctgtg ttcccttgtt ctgatggatg ttgtgagtct 109560
gtgtgggtgc acaagcatgc acatgtggtc tgtgtgtcca catagatgcg agcgtctgtg 109620
acatagcatg caccctgtct gctggcctgt gcatggaagt gcacagatgg gtctccaagg 109680
acctagggac taagcatgtg gagaaccatg tgcagtgcct atgtacgtcc tcagccccag 109740
cgtcacctcc tccatgtgcc tcacccccta ttcgttcacc ctcctccccc tgtggtggca 109800
ttatcacctt tcttggtcag tctctgctta cctgtccctg tctctgcctc tattgagagc 109860
ttcctgcagg aaagtccaca tccttgtcat ccctgtactc ttggcagcaa gatcaaggct 109920
tgctggggca ggtgatcaat aaaggctgat gactgattga gtatatttgt gtgaatggat 109980
ctacttccag aagcgtgtgt gggtgtgtat gtgtgtgtgt gcacgcacat gtgcacacat 110040
ggaaacatgt atgtggccat acacaaatgc acatgcactg tggggtgtgg atgtgtctct 110100
gagatgtcca tgaatgagcc tctgggcaca caccatgccc acagattgat gcagtgatat 110160
gctggcaaat gtttaacaac cggctcttca ttgaaaaaaa gaatgctgtt gggccgggcg 110220
aagtggctca ccctgtaatc ccagcacttt gggagtctaa ggtgggcgga tcatgaggtc 110280
aagagatcga gaccatcctg gccaacatgg tgaaacccca tctctactaa aaatacaaaa 110340
attagctggg tgtggtggcg cacacctgtg gtcccagcta cttgggaggc tgaggcggga 110400
gaatcacttg aacctgggag gcggaggtag cagtgagcca agatctcatc actgcactcc 110460
agcttggtga cagagtgaga ctctgtctca aaaaaaaaaa aaaaagaaaa gaaaagaaaa 110520
ggaaaaataa gccctgatta gcagcatttg cccattgctg tagtgtaaat gttcccacca 110580
tggccgactt caagttgctg ctgtggcgtc atggaatatg gagttagctg ggaagagatg 110640
cacataactg gctcacatga gcccacagga gttggcttca gtacacggaa gtattcatgt 110700
ctgtgactgc ccagcccatg atgggcaggg gaggcagtgc aaagttcccc tggtgatggt 110760
aatgcttctt tccagagctg tgccctgggg gagcaggcag ttgctggctg ccagccagct 110820
ttcaccaagc ggccttagaa gtcagtctaa accaatactc cttgttaggc aggtctaggc 110880
gctcaccaac acagcagcac cttccctcac tccctgcaga ggctttgaag tttttggatt 110940
tggtgaagtc agcatgactg caaggaggaa ttgctaagcc tgaagcatga atggaagagg 111000
gggaaggagg aacgcttcaa acctccatct gaggcaggtg gccagggatg ctggaaggtc 111060
tggaggccct gggccttgtg cctgcttgaa gccgattcac tgtgtaagcc tggacacatc 111120
gcttgccctt gctggcctcc acctgtgact tccgtgaagg gagaggtctt ctgagctccg 111180
103/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tggcctctac ctgaccctct gggagttggt ccttaaactg cgctctgagt gttaaaatct 111240
acattcaaaa ggcagagaga ggctgtgttg gccttaaaca agagcaagag gggaccctgc 111300
cctggccctc ctcagaccag gccctttccc acatggtgag gaattcacag gccaaggcga 111360
tgtgctcacc ccaagcccta ccctttgcta gacactcgtc tgatgcctgc tgctgtagaa 111420
tttctgctcc aagagtcctg ccgtgctggc ttccagggct ggctgccatc tgtcctcctg 111480
aggacccatg tcctcctgcc ttaagcagtg gttttgggaa agctgggtgt gcaggctggg 111540
atgtgtgccc actttgtggg agatgccctg aacgtgctga gtggagctgg aagtgggaaa 111600
ggaggagggg tgggtcatgg gcagggagct gtggtcttgg gttccagggt gggcttgccc 111660
catgctgcta ctttgaggag cagaatgcag aggaggttga gaattctaaa ttcaaaccta 111720
acattttagt ttgtcacaag gacatatttg ccaggacaga ggatagacca tatttttaaa 111780
ttttatttta tattttattt taattttttt tgagatagag tctcgctctg tcacccaggc 111840
tggagtgcag tggcgcgatc tcggctcact gtaacctctg cctcccgggt tcaagcaatt 111900
ctctgcctca gtctaccgag tagctgggat tgcaggcgcc caccaccacg ctcggctaat 111960
ttttgtgttt ttagtagaga cgggatttca tcatctcggc caggccggtc ttgaactcct 112020
gacctcatga tccaccttcc tcggcctccc aaagtgctgg gattacaggg gtgagccacc 112080
tcgcctggct gatagaccat tttttaaggt cgttagttcg atgtgcagct gttaaatctt 112140
cagacttaag ttatggagag tgagcctccc tttctactct tgccctggac cccacaagtg 112200
ttaggggtga gcctggagag agagataatt gagattggtg ggggcttggt ggtgtggccc 112260
cagcagactg aggctgagtt gaacagggag ttttgaacat tggacccttc tagagtagac 112320
ttttccgggc cacgtcatac agggcttacc ttctcttagg tctgtgcggt gtgtaggtgt 112380
catctgcttg ccatctcctt tctctggagc cccaggagag ctgtacagtg agtatgcttc 112440
cccaacacat cttagatagc actgttatct tagacagctg ttttggggca tgacaggtca 112500
tccttccaat ggggcctttc tctgatgtca aaggtcaaat cctcctgtta gcattccatc 112560
ttgtctttct catctcttca agttaagaga gtcccaggga ccctccccat tcttctgcca 112620
ctccatggct ctcctcttcc tgagaagcac ccctctgcag ggagccccct gagtaaactg 112680
gtagggtcat gtccattcca aactgcacaa tttcacgggg gaaaatggaa accctggagt 112740
gtaactggga tgttgagtgg ggctgcttta ttctaaaaga taaaactcaa ggacgtcatg 112800
ctctctgtct tcaaatatct gaggggctgt catgctgaaa agggaaggga tttattcagt 112860
gttgttggag tgtgaaggaa gaggtggatt aaaattcagt gtgcagagaa gacttttgcc 112920
104/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aaagagtgct gcttagcact ggctggtgct atctttggag ggggtgagcc cgctgtcact 112980
ggaggcgtgc aagtatccct aaaggatatt taatagggaa ctcatgatct agagagtggg 113040
gggacaccct actgtacagc atctaaacct ctcatcccca ataatctgta gctttaggat 113100
tgttttaaat aggatgccag gagttgggaa aggaattaaa gaaattcact gaagtgagga 113160
ccaagctata aaaaaaaaaa atctttattt catgtaccag gatttttttt ttcagttttc 113220
tgctttttaa aatttttttt ctgttaacag tctgaaaaaa aaaaaaagga ctcaccaaga 113280
aaataaatgg aggttagttt cttgaactgg tctgagctgg acatgagcaa tcatccacac 113340
ccctgggcag caacgccctt gcagttccgg tcctggctcc ttccctccgg accccctagc 113400
cccttctcag ccatggcgat gtcaccccac accccagtgg ctttcttcaa gcacacccag 113460
aacccaggcc ttgcgccatg gaaagaagca ctgatcgcct tcccagacgc tctgccagaa 113520
ttcggagaac tggagctagt ttttctcttc agacagtgct cgcttgggtg cggttttctt 113580
ggggaccctc ccttctccct tcgctctcat ccttgatccc tttaggtctg gaatctggtg 113640
ggatggcggg caagattggg gtgggagagg ggtagagttc agtttctgcc cagactgagg 113700
gcaacttggt tgttgttacc acaccttgaa ttgtctccca ttgttctgcc ccagggccca 113760
tgacctcccc ctgtacttct gggctgggct ggccgatgtt ctgccccttg ctgacctggg 113820
aaaataactt tcctttccca ggcaaaagac aggaaaggca ggtgagatgt gcaagctcaa 113880
aaagccttac tagccattct ctagaactcc ccagagagct caacctcagg aaatgccggt 113940
gtcaagaaaa atgcaaaccg ggggagactc gcaggcagag gcaggggggc ctcaccttga 114000
ccttcagtca cctgggagta acttgcagac tgttctgaaa tttccagctc aggaaagctg 114060
ttggatttct gtcagtctga actggccctt gtcactctgg ggaagaaagg ggagaaacac 114120
aggatgccct tgacctttag tctgtggtgc aagtttaact tttggggttg gtccttacac 114180
tgggatggaa ctgctaaaat tttcctctcc attccctcag ccttgagccc tcccagtaaa 114240
cctcagagga tcctcttttt cacagacccc caaagacact ggggaagccc tggtggcaga 114300
gctcttctcc caaggaagcc tctttaactc tccatgatcg cagcaagggg acacaaagtg 114360
aagaagggct ttggggaccc ctgcgtcttt cccctctttg cctgaacagc tttatgtttg 114420
ctcacatgtg tgtatttttg ctttgacatt ggatgtgggg gcaggtgttc ggggagcaca 114480
gtgaggaggt atatggtgtg tgtgtgtgtg tgtgtctgag aggctgactg atgatgagcc 114540
tgggggcttg gtggcagctg tcctggtcat ccctggcata tcctcggggc aggtggcaga 114600
tcttaagtca cagatacata gagcaagaat gggcctttag tgcttctctg ggtcaatcca 114660
catgcttaca tggggggaaa attaaggccc agagaggcca tgcagcaagg aattccggaa 114720
105/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tccagtcctg gattctagac gggtgccctt cccatgcatg cgagtggtgt gtgtgtgtgt 114780
gtgggtatgt gtgcgtgtgt gggtatgtgt gcatgtgtgt gttcatgtgt atgctctgtt 114840
gggaggttgt gaatgaacac aaaggccagt gtggagttgt tgtcgtccat ggctttggag 114900
ggcatgagtc aatttccttt gagccacgcc cctggccgtg tatgggatgg aagggttgag 114960
actgagtgtg tccctgtgag tgactgcagt gctgggctaa gtggactgtg tatgtgtgtg 115020
tgaacgtgcc tgtgtgcgtg tggggtgtgt ggtctctttc tttgttggat tctgtcttcc 115080
cccattcgca gcaccttcct tgtctgagga agccaccttt ccatcacaga gaccccctgc 115140
agctcactgg gaccttccgc tactccctcc aaccttcaag cccagctctc acctctcaca 115200
acggttttgc tttgtttttg taaatggatt tgtatattcg ttttctgttt tttttttctt 115260
tacaagttcc ctgctaaagt ttaagtcccc caccccgccc cattttttgt tttcacagtt 115320
taaagctgga aaagaattaa aagaaaaata ctatctgatt ttcttgcaag taaatccact 115380
tattttgtat ttacatttat ttatagtctg tggttttttt attaaaaaaa aatcaccact 115440
tgtttttcct ttttcttttg taaaaagaag cctttttgca gtgtcattgt tgaacccgct 115500
gggccccaag ggggcatcag tgagtccaag gacccccaaa gggtcaatga acccccttcc 115560
caggggactg gggggcttat gagtcagggg gtccaccatc gccccagggt catcaggtgg 115620
ccctgaggtg aggggtgagg agggagagct gtttcatgtc ccccgggggg gggggtggca 115680
tctcctgacc ccaaggacag gagcttgggg acatgacccc aagaggctca ccctgaggat 115740
tccggggttt ccggcatett ggtaagccac cggcagcctc ccctctcctt ccctttcctc 115800
aaggcctagg aagtcatcac agtgggttaa ggagcattaa ggactgggaa cctggggcca 115860
ggcaagcccc aagtgtaccc ccctccaggc accctaacgg agaggaggga caagggctcg 115920
gtcacctgga ggcctacgat tgccccatca~atgctgggcg gagccggctc gagctctgag 115980
ccttcctgga gttcctgggg cacccaccca ggggctccag ggacctggca gtgactgcag 116040
gctcacctgg ccccagggcc cctgagtctc gccccccaat ctcccaggga ggcagggccc 116100
gctgggggtt aaagggaaca gaaaagtaac tctccccgag ttaaaaaaaa aaaaaaaaag 116160
taacataaac cctgaaaaat acaaaggaca tcccctttcc tttctgttct catttttttt 116220
ttttttgctt taatgttatc ttggttccct tttatttttt catttaaatt gatttttatt 116280
aaatgttaaa ataatggtac atgggaaatc atgcattttc ttttagattt attttctatt 116340
tttaattttt tatccctctc gctttttttt aaagtttgtt ttcttccctc gtttatattt 116400
tcccacattt cctgttgttt tgcttctttg ttcctcttat attttgttct tttttttaaa 116460
106/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
atttacttgt tatgtttttt ctcttttttt gtgtgtgtgt gtttttttgt tttttgtttt 116520
tttgtttttt ttgttttttg tttttgcttt tggaaggtct cccagcggag ggtctgggtc 116580
tccccgcccc gccccgcccc cggggaccgc gccctcctcc cgcggtcttc tggcgaggcc 116640
cgcggtcttt atacgggggt ggtccggcgg ttggctgtgt tggagtggag agagtccttg 116700
ttctccttct ggatacagtt gtgaacctgg aggaagctgt tatccctgtc ggagttgtag 116760
gtggcggtgg gcgtggtggc ggccttcagg gggtccctgc tgagcgtgta catggagatc 116820
tccgtggacg gcagggtgtt gaagcccttg atgcccacgg gggaggcgtc cctggagtgt 116880
gagggctccg tggagcgcga gctggagcgg ctgcggcgct ggtagcggta gcggtagctg 116940
gggatgcggg tgatggcaga ggcctggagg tagtccgtgg cgcgggccgt ggcccgcagc 117000
tgtttgtgcc ggtcgataaa catgtgcacc gccagcaccc cgaccatctc ggcgatgatg 117060
aaggacaggg ccccgaagta gaaggaccag ccgtatgagt aactattctt tttggagtcg 117120
ctcttggagg ggtctccggc attggcagat atgtacacta tgatgccaat gatgttactc 117180
agacctgcgg ggcgcagggt ggcggggtgg gggatcagag agaaggacgt tagtttctca 117240
ggaagtcggc cacagggcag ccgtaaagga cggggacagc tgtgtgggcc ttccccggtc 117300
ccgcgccttc atgaacaggt ggggcggtgt agatggacat ccgcaagctt ccccttaaca 117360
ttttatcttt ccattcagag agagccacaa gggaagcgct aatggaaaca gacatgggca 117420
gggcgggaga agggaggcat ttcacaaggc gctgagtaac taataataga tattgttcat 117480
tgagccttct ctacctgctt tcactgcttg gtgcttctca agcagggcac agatgaggaa 117540
acaagcacag agaggttaag gaacttgctt aaggctgcac agggcttcaa agctggtgta 117600
gcagcgggtg aaggcgggct gatggagcca ggctggcctg cgttcaaagc cttcgcaagt 117660
taaccttggt ttgagtttcc agatctgtag aatgggagta aggttaagcc ttactcttta 117720
gggccacgga gagggttaaa tgggtgaata catgtgagta ctcttagatg ttggtggttc 117780
cttttttttt ttttaagata cagtcttgct ctgtcaccca ggctggagtg cagtggtgtg 117840
atcacagctc actgcagtct caaactcctg ggatcaagcg atcctcccac cttagcctct 117900
ctagtagctg ggattatgta tgcgtcacca tgcccagctg attaaaataa aaaaatttct 117960
gtagagacgc ggtcttgagg cctcgctgtg ttgcccaggc tggtctcgga ctcctgagct 118020
caagtgatcc tcctgtctca gcctcccaaa gtgctgggat tgcaggcgtg agccactgca 118080
cccggcctga tgttggtcat tcttattaaa tggctcaggc tacacccagg ttctttttct 118140
ggcatctgaa gtgagtgtga ctcatctgtc atgtaactgg gctcagacat ctggatgtgg 118200
gtgcctgcct gctcccacct gagtagaaca gtgaggggag agtccaccct tggtttccaa 118260
107/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ggtgaagctg agtatcccat aggggttgga acagcgaggc acttgggtgc cctctctcca 118320
gcctcctcat gggtttactt gcaccgggaa gggaaagggt aagtggcaat tggccaagta 118380
ccctgagagg aagcgggcat ttgggccttt tctcaagtgg tgggaagaag atggggtgtg 118440
gggatgctcc tggaggattt ggtacaggct cgggagttgc tacaggacag gagccccccc 118500
accaccttcc tcccctgcaa cacgacctag tgcaagtctt ggagatttcc tctcctctct 118560
ccccatctct ctctgccagg ccctcgtggc ccctgagcac ccacacccca gccttcttcc 118620
cagtggcagg actggatcag tggctgttac ctgcagacac gaagaagatg ccggcactca 118680
ggatgatgtt gtgtcgagtt ttgtagaact cgctggctgc gatgcagagg ccacccatga 118790
aaagcagaat cacactcagg attgggaaaa tgctggaggc cctcacggcc cctgtggaac 118800
acagagggtc agggagaaag agaacggcat ggctgtgaga ctgaggcaca cagaggcagg 118860
tgggagagca gccccgaggc gctgggggtt tatggacaca gccttagagg agaggttgct 118920
ttgcaatcct agggagggag agacagcgag caggccactg cccagctcac agccctgcag 118980
gagctcccca ctgcctccag ggccaaactc cagcacaccg tcaggcacac agggccctgt 119040
gtgacttggc ctctgcccac ttccagctcc cacggctccc agtcctcatg ttctctctcg 119100
tcccaccaca tcaaacttcc cacgacatgt catttcatgc tgctgacttt tgaaatacag 119160
agcttcctac tggaatgtct ttcctattct tcactcagca aactcttctt catccttcaa 119220
aacccagctc gaagtcccct cttctgtaaa gccttccctg acttccttag gcaaagttat 119280
gagctccctc gtctgcactt tggggccctt gggcacgctg agaggcagtg tggtatagtg 119340
gttaggtgga accacgtggg ttggatttga gtctggctgc agcatttatt agctgtgcaa 119400
tagaaaaagt atctcacctc tgtgtgcctc agtttcctca tctgtaaagc agggatggta 119460
ataatgccaa gctcctaaga ttgttgtgag gattaaatga gttgattcag gcaatgcact 119520
tagataagtt tctggtgtct ataataaaca ttcaatgcat gatattataa taaatatttg 119580
tgtatacata tgcttccacc atgaaccatg ggtcgtgaga caaggactgt ggctttacaa 119640
agaaaaagtt tcttgtcttt atcctctctg ttcaacgaca cagtagtctg ccaatagaag 119700
ctcattaagt gaataaatgt ggggtcgtgg tccagaagga aggaacaggc acattgcaaa 119760
gaaaacaaag taagaagaga aaeccctcta gataaggact gacaaacagg accggagaag 119820
aaaagaatat ggtaatgaaa agggagaaac agaaggtgag ggccagggct cctacagttg 119880
ggggtggatg ggggaaaagg gggacaggtg gctaagggca gaggtcgggg ctacatgtgt 119940
ttgtgggggg agcagcacct gaatgaggac ccagaggtgt tggggagccc ttcacaaagt 120000
108/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gtctttgcga agtaaaacat ttttttttta atccaaattc aaataggcag tgagtgacct 120060
caggacccag ctccgtgtcc tgggagccat gggctaggca ggaggcagag ctggcttgag 120120
gcaggggtga gggaaaatat gtcttcttta ttattattat tttttgagac ggagtcttcc 120180
cctgtcaccc aggctggagt gcagtggtgc aatctcggct cactgcaact tctgcctcct 120240
gggttcaagt gattctcctg cctcagcctc ccaagtagct gggactacag gcgtgtacca 120300
ccatgcttgg ctaatttttg tacttttagt agagatgggg tttcactatg ttggccaggc 120360
tggtctcaaa ctcttgacct catgatctgc ccaccttggc ctcccaaagt gctgggatta 120420
caggcttgag ccaccgtgcc tggccaaaga tgtcttcttt aaatggtgct taagtggttt 120480
ctaaggaagt tgagtcctga taattacagg accctttggc caagcccagg gattggtcag 120540
ggaggttggt tttggagggg aatgtgccag gagcggagct tcctcttatc cccatccccg 120600
tccccaccct tttgggtggg agtgtgttca agaaggatct gtgagaagag aatttctcta 120660
tatagaactg tagggatttt tctttttctt ttttaaaatt tatttttatt tttatttttt 120720
gagatggagt cttgctctgt tgcccaggct ggagtgtagt ggtgtgatct cggctcactg 120780
cagcctccac ctcccaggtt caagcgattc tcctgcctca gcctcccaag taggtgggac 120840
tacaggtgtg cgccatcaca cctggctagt ttttgtattt ttagtagaga cggggtttcg 120900
ctatgttggc caggctggtc ttgaactcct gacctcaagt gatctgcccg cctcggcctc 120960
ccaaagtgct gggattacag gcgttaaaag gggattttag gcagtttgct gagatgtgtg 121020
tgatgtgaaa actcttcttc tgtcctcacc atggatctgc agcatagtct acactgctca 121080
caaatgggtg agtgggttat ttggggggga cctgaagaag ggcagggctc ttggggcaaa 121140
actgagctgc atatagggaa gcaggggtgg gaggatgggg gcttggggtg gctgggctac 121200
tctgcagcct cagcaccctc cttctcttgg gcgggatggg gctgctcctc cacagacccc 121260
agggaggtgt tctctccttg caaatcattg ctaagacaac acgctgtatc cctaacctga 121320
tcccccagcc caaacacacc cacatccaca cccacgcgtg acagacatgc atgactaaaa 121380
agccacctta actctcatct ttataagcac atgaggatgg tgagagctta ctgaaaaccc 121440
aggagaagag agagaatatt tgttaaacac ccattcggtg ttgggtcttg agcaggtacc 121500
taacatatat gatataattt catcctcata acagtccggc agggtgtgtt tttttgcccc 121560
aatttacaga caagaaaatt gaggttcaga gagagaaact cccctgccac ccagctagtg 121620
aaccaggatt catatccaga ccagctcaac ttttggagca ccctgtagtc tccctatgtg 121680
gcttccaagg agcccaggaa gggtgagtgc cacagggcct ggagaactgg gtttgggtcc 121740
cacctgtgcc actcacttgc tgtgtggcta aggcgggtgc tcacttcctc tgtttttccc 121800
109/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ctgtgtaaca tggggtatgg cctgttagat ggtttctttt tgtttgtttg ttttagatac 121860
agagtcttgc tctatacccc aggctggagt gcagtggcgt gatcttgact cactgcaacc 121920
tccgtcttcg gggttcaagc aattctcctg cctcagcctc ccaagtagct gggattatag 121980
gcgcccgcca ccatgtccgg ctaatttttg tatttttagt agagatgggt tttcgccatg 122040
ttggccaggc tggtctcaaa ctcatgacct caggtgatcc accggcctcg gccttccaaa 122100
gtgctgggat tacaggcctg agccaccgcg cccggccgtt agatagtttc taatagctct 122160
gccctttcca tgtggacatg gtcctggcca gccacaaagg ggaatgacag aagagagaag 122220
gaaagaaaga aagaggtcgg tgtggcttcc gaggcgcagc agcagcagct cagaggaaca 122280
ggcagaagaa aggctctggc cttccccctc caagaaagtg gggtcttact acccacagga 122340
tgcctgcagg tcgccgaccc aattgtgccc tcacagcaaa tggactcaca gcagcccagg 122400
gcttgatttt tccagttgag ccccatctgc tgtgggaacc cggatgcccc agctcagccc 122460
tcctgccagc agggggaggg agcgtcggct gcggagggag ctgggatgca tgcgtgtggg 122520
cagccagagg ccaggcatgt gtggacaaga tggagggcgg cgggagagca gggaggggtc 122580
tgctgtgttg cagccagcaa agagcaatgt ggaggaatca gaacggcttc agaagccacc 122640
aaggcagcgt atgacatgct ctaaataatg accaccagcg gggaatacaa acagaagcct 122700
cttcggcaca gaagagccag ccccaagctc tggcctttcg tggaagaggc ctctttgccc 122760
agaaagaagg caacaggccg ggcgcggtgg ctcacgcctg taatcccagc actttgggag 122820
gcagaggtgg gtggatcacc tgaggtcagg agttcgagac cagcctggct aacatggtga 122880
aaccccgtct ctactgaaaa aaacacaaaa attagccggg catggtggtg cgtgtcagta 122940
gtctcagcta ctgggggtgc tgaggcagga agatagcttc aacttggga.g gcggaggttg 123000
cagtgagctg agatcgcgcc actgcacccc agcctgggca acagagcaag actccatctc 123060
aaaaaaaaaa aaaaaaaaaa aggcaacagt gggcaaccag caaatagcac catgcttagg 123120
ccactagact tggcagggcc cagatccagg tgggaaggaa gctggtttag gagcaagcag 123180
ggacttctac attggagacg tttcttgaag gaggtatttc tggctgggta gtgtcacaaa 123240
cggaatgggg attttggagt tagtcacact tgactttgaa tcctcgcttt gtcagttatc 123300
aacagtgtga cccttgggca agggtcatta ctgctctgag cctcagtttc cccatcctgt 123360
gaaatgggaa tagtaaaaat aatatttagc ttataggaat gttgtaaggc cttgctgctg 123420
caagtgtggc ctgaggccca gcggcattgg catctgatta gaaaggcagc cctgccaggc 123480
atggtggctc atgcctgtaa tcccagcact ttgggatgct gaggtgagcg gatcacatga 123540
110/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
agtcaggagt tcgagaccaa cctggccagc atggcgaaac cttgcttcta ctaaaaatac 123600
aaaaattagc cgggcgtgac ggtaagtgcc tgtaatctca gctacttggg aggctgaggc 123660
aggagaaccg cttgaacccg ggaggcagag gttgcagtaa actgagattt cgccactgca 123720
ctctagcctg ggtgacggag cgaggttcca tctcagaaaa aaagaaaaaa gaaatgccgc 123780
ccctcagctc tttcccccaa ctgagtcata atctccattt taatgagatc cccagagcaa 123840
gatttgcatg catatgaaag tttgagaagt gctgttataa gaattaaatt ggggctgggc 123900
tcggtggctc acacetgtaa tcccagcact ttgggaggcc gaggctggtg gatcacttga 123960
ggtcaggagt tcaagaccag cctagccaat atgatgaaac ctcgtctcta ccaaaaataa 124020
aaaaattagc tgggcatggt ggtgcacacc catagcccca gctacttggg gggctgaggc 124080
aggagaatcg cttgaacgcg ggaggcagag gttgcagtga gccaggatct caccactgca 124140
ctccagcctg ggcgtcacag caagattctg tctcaaaaac aaaaaaaaaa aaaaaaagaa 124200
ttaaattggg tcctaccttt tactgtgtct cacactagaa gttgcacagt aaaaggtagc 124260
aatttttatt tctgaggtcc ctcttcccaa aacatcagtc caggcataac ttccctataa 124320
attgtcctca cttcctacaa agccaagcat ggtcttgttg ccaaaatcta tcacaagagt 124380
caggaaatat ctgatttatt taatgaacaa atatttactg gtctcctatg agtaagcata 124440
tggcacttca cattacctga caacatttat ggagcccctc ccctgtacca ggccttgttc 124500
taagagcggt gtaaacctca taccagcccc atgaagccat gggctttggc ttcaaggaga 124560
ttacacacgc ctaaagctga cactggcaaa cttgttctgt gaagggaaag acagcaaata 124620
ttttcatctt tgctggccat atggtctcag ttgcaatttc ttaactttgc agttgtagca 124680
cataaacagc cataaacaat atgtaaacaa atgaacgtgg ttgtcttcca ataaaacttt 124740
atttacaaaa tcactttggg aggccgaggg ggctggatca cttgaggtca ggagttcgag 124800
accagcatgg ccaatatggc gaaaccccat ctctactaaa aatacaaaaa ttagcccggc 124860
gtggtggcgc atgcctgtag tcccagctac tcgggagccc gaggcaggag aatcgtttga 124920
acccaggagg cagaagttgc agtgagctga gatcaagcca ctgcactcta gcctgggcag 124980
tgggtgacag agtgagtgag actccatctc aaaaaaaaaa aaaaaatcag gtggtgggct 125040
ggatgggctg gatttggcct gctagtcata cttggccagc tgtggccaag agtatactct 125100
atactgggga aaaggccacg tggtccagag cagggagatg ctttgctcta ggctagctgt 125160
gaatccagtg agcaaatatg gactgagtgc ccaccgctgt gctagacctg ggcttggcat 125220
gagagacatg aggggtccaa aacaggcctg gttcatgtct ttctagagct tatactctca 125280
tgaaggacat gtatgccatc agataatcac acagcctgga taacgtgcta tgaaagaaaa 125340
111/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gtacctatat ggcaccatga gggtatgtga caggctaatg tcacatgtag acaactaatg 125400
tccatagaga gcttagagta tgccgaggac tgttttgagc actgcacata cacaaactcg 125460
ttagttctca ttacaactct gtgaagtaag tacttcatat tatttttatt ttttaaattt 125520
attttagttc tacttattgc attatcttaa gcagcatata atagtatggc ctctgaaatg 125580
tgatagacct ggattcaaat ccaatgcttt tgttttttac tttttaatta ttattattat 125640
ttttttgaga cagagtcttg ctctgtcacc caggctggag agcagtggcg tgatctcggc 125700
tcactgtaac ctctgcctcc tgggtttgag tgattcttgt gtctcagcct cccaagtagc 125760
ttagattaca ggccatgtgc catcacacct ggctaatttt tgtattttta gtagagacgg 125820
ggtttcacca tgttggccag cctggtctcg aacttctggc ctcaaatgat atgcctgcct 125880
cagcctccca aagtgccggg agtgcaggcg tgagccacca cacatggcct atataggtat 125940
tttaattatc cccactctac agagaccaaa ctgaagcaag gagaggttaa gccatttgtt 126000
caagatttgt gaatccaggc agtctgactc tagggtctgt gtgtctaacc actgcattcc 126060
cttcttttca ggctctacac tttgctgccc ttcaaagcat cctctgagct tatgtgggga 126120
tcaggacagg tctccctgag gaagtggtgg tagagctgac ctctggcgaa taaggagcag 126180
ctgattaggc acaatgaagg cagggctgtg ggagagagag cagcaggagc cgaaggtgga 126240
ggaggcatgg ctccttcaga gacctggaag aaggctggat cacgaggagc cagtggaaga 126300
gtgtggggag cactgaaggg aggagccagt ggaggagtgt ggggagcacc taaggagagg 126360
aggcaggcgg gtctgggcca cgtggggcct catgagttga gctaaagagc ttagctttat 126420
cccaagagca atgggaaact ttaaagggct tagaacaggc agggctgtca tgatctgatt 126480
tgcatcttaa gaagcaaacg gattacgaag gggtcaaggg tggctccagg gaagcagtga 126540
gaaggctact gcagctgatc ggagaggagt gatgccggtg cttgggccag ggtaggtaca 126600
aagggcatgg acagaggcag atgtgtctga gagatgttta ggaggtgaat tgaagcttga 126660
tggatggata tgggtagtga agagggtggc gttgaggtta acttctaggt ttcagacttg 126720
ccagctgggt ggaaaaaacc acttaggggg actgggagag gacccagcct agcagtgagt 126780
agagagtagg ggaggagcct gggcgaggtg gctcacgcct gtaatcccag cactttggaa 126840
ggctgaggcc ggtggatcac ctgaggtcag gagttcgaaa ccagcctggc caacatggtg 126900
aaaccccatc tctactaaaa aaatacaaaa ttagccaggg gtggtggcgc atccctgtaa 126960
acccagctac ttgggaagct gaggcaggag aattgcttga acctgggagg tggaggttgc 127020
cgtgcaccaa aattgtgcca ttgcactcca gcctgggcaa caagagcgga actctgtctc 127080
112/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aacaaaacaa aacaaaacca aaacaaaaca aaacaaacaa aaaaagagac tagaggagga 127140
agatc 127145
<2l0> 27
<211> 2406
<212> DNA
<213> Human
<400> 27
agtttactct acatcatagc agagaaaatg gacaaaacac agctgttttg catgtaggag 60
aatactaaccctgcacagattgtgatggtgatgtggaatatactaaagcctagaacgcac120


ctcctctgcatgactaatatgttctgcacaagacatgaaggcacagacagcactgtcttt180


cttcctcattctcataacatctctgagtggatctcaaggcatattccctttggctttctt240


catttatgttcctatgaatgaacaaatcgtcattggaagacttgatgaagatataattct300


cccttcttcatttgagaggggatccgaagtcgtaatacactggaagtatcaagatagcta360


taaggttcacagttactacaaaggcagtgaccatttggaaagccaagatcccagatatgc420


aaacaggacatcccttttctataatgagattcaaaatgggaatgcgtcgctatttttcag480


aagagtaagccttctggacgaaggaatttacacctgctatgtaggaacagcaattcaagt540


gattacaaacaaagtggtgctaaaggtgggagtttttctcacacccgtgatgaagtatga600


aaagaggaacacaaacagcttcttaatatgcagcgtgttaagtgtttatcctcgtccaat660


tatcacgtggaaaatggacaacacacctatctctgaaaacaacatggaagaaacagggtc720


tttggattctttttctattaacagcccactgaatattacaggatcaaattcatcttatga780


atgtacaattgaaaattcactgctgaagcaaacatggacagggcgctggacgatgaaaga840


tggccttcataaaatgcaaagtgaacacgtttcactctcatgtcaacctgtaaatgatta900


tttttcaccaaaccaagacttcaaagttacttggtccagaatgaaaagtgggactttctc960


tgtcctggcttactatctgagctcctcacaaaatacaattatcaatgaatcccgattctc1020


atggaacaaagagctgataaaccagagtgacttctctatgaatttgatggatcttaatct1080


ttcagacagtggggaatatttatgcaatatttcttcggatgaatatactttacttaccat1140


ccacacagtgcatgtagaaccgagccaagaaacagcttcccataacaaaggcttatggat1200


tttggtgccc tctgcgattt tggcagcttt tctgctgatt tggagcgtaa aatgttgcag 1260
agcccagcta gaagccagga ggagcagaca ccctgctgat ggagcccaac aagaaagatg 1320
ttgtgtccct cctggtgagc gctgtcccag tgcacccgat aatggcgaag aaaatgtgcc 1380
tctttcagga aaagtatagg aaatgagaga agactgtgac aactcatgac ctgcatcctt 1440
113/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aatatccagtgacttcatctcccctttcttcaccacaattccaggcaatggcctgtcgga1500


ccagacaattctaccactgcaaagagttgtaaccattttctggtatcacatttatttttc1560


aagacatacttttcaagacatcattcactgacccactacctgcattgagtataaatgcct1620


ggatgttaaggattccaatttaactttgaaaagaactgtctcattcatttacatttctgt1680


tacagtcagcccaggaggttacagtgagctctccactaagaatctggaagaaatgcatca1740


ctaggggttgattcccaatctgatcaactgataatgggtgagagagcaggtaagagccaa1800


agtcaccttagtggaaaggttaaaaaccagagcctggaaaccaagatgattgatttgaca1860


aggtattttagtctagttttatatgaacggttgtatcagggtaaccaactcgatttggga1920


tgaatcttagggcaccaaagactaagacagtatctttaagattgctagggaaaagggccc1980


tatgtgtcaggcctctgagcccaagccaagcatcgcatcccctgtgatttgcacgtatac2040


atccagatggcctaaagtaactgaagatccacaaaagaagtaaaaatagccttaactgat2100


gacattccaccattgtgatttgttcctgccccaccctaactgatcaatgtactttgtaat2160


ctcccccacccttaagaaggtactttgtaatcttccccacccttaagaaggttctttgta2220


attctccccacccttgagaatgtactttgtgagatccaccctgcccacaaaacattgctc2280


ttaacttcaccgcctaacccaaaacctataagaactaatgataatccatcacccttcgct2340


gactctcttttcggactcagcccacctgcacccaggtgaaataaacagctttattgctca2400


~aaaaa 2406


<210>
28


<211>
530


<212>
DNA


<213>
Human


<400>
28


tgtttttcacacactggatgtttattattagaaaatagcttctatcagctgtcagtacca60


aacaagttgaaaggagcgagcttctcaccatatttttttttctccttaatgatatttaaa120


taaacagctcactgtgtgagctcacgccctttttccctttaaaaactgaataattaaatg180


aagtttagtacaaaacattcttcaaatatgacttgttctgcatctgttatgctgtctcct240


tgagtaatggacgcgaaagagatgaaaaagaccactcaggctaccaaagtaccccaaaga300


atccatacgagaaactgagaaacaaactaactcaaataagacccaaccaaaccaagaaac360


cagtttttacgttgactttttgattttgattatcatctaagtttaatatatatatatatg420


tgtgtgtgtttgaaatagtaataaaaaaggaagaattgaattgcatccgtagcaggacaa480


ccttcctcat acgttaaaga ggtgttcaga aaattccata cagtatctgc 530
114/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
<210> 29
<211> 1785
<212> DNA
<213> Human
<400>
29


gggggaattatgttgatgactattctctctattctctctctctctctttttttttttttg 60


gagatagagtcttgctctgtcacccaggctggatcttggctcgctgcagcctctgcctcc 120


tgggttcaagcgattctcctgccttggcctctcgagtggctgggattgcaggcacctgcc 180


accgcgcccggctagtttttgtatttttggcagagatggggtttcgccgtgttggccagg 240


atggtctcgatctcttgacctcatggtctgcctgccttggcctcccaaagtgccggaatt 300


acaggcatgagccaccacacctggccactgttctcaaattgtattatggagttttttttt 360


ttttacaaaatatggatatattttaatttactcaaatgggaactactgataagcagttct 420


tatttttccagcataagcaaggctacaataaatatctttgaatatatgtactgatgcttt 480


ttgttttttgttgaagctatatcccaataagtgataagtacggtctaagagagaacatgt 540


tttttacaattttgattgatatcatattgggccacgcatggtggctcaggcctggcatcc 600


cggcactttgggaggttgaggtgggaggatagcttgagctcaggagttcaagaccagctt 660


gagcaacctggtgagacctcatctctactaaaaaaacaaaacaaacaaacacaaaattag 720


ctaggtgtggtggcatgtgccagtagtcccagctagttgggaggctgaggtggaaagatt 780


gcttgatcctgggaggttgaggctacagtgagctgtgatggtatcactgcactctatcct 840


ggacaacacagcaagaacctgcctcaaacaaatgtatttggttgatattgtatcagattt 900


cttctgaaaaacgttttaatggtttagactttcaccaagtgcaagaaactggcattttct 960


ttgtaactggcctggaatgttaccactcttttaaacttttgtcaagatgatcgtgagaaa 1020


tagtatctaattacttcaatttgcatttccctgactcctaatgaagttcagcatctcttc 1080


aaatctttattgggcatttggattttctcttcagtgaattgcttcatcatattctccatt 1140


tattctaaagttgtgttcctatttgtcgctttcaaatctagtttggtggaatccttgcat 1200


gttagaaaccttaaccctcgtaatatgtgttgtagatatttttccctcgcctatgagttg 1260


tctttcatccttgagcatgagttttagagtcagaagaacaacagtaggatttgaatcatg 1320


ttacgttattttctagttgtcgtattttttatttcttcagcctcttagaatcttagtttc 1380


ctttaaaatt gagataatag tatctacttt attcaaaaaa attttttggc tggacgcggt 1440
ggctcacgct tgtgatccca ccattttggg aggccaaggc aggcggatca cctgaggtca 1500
ggagtttgag accagcttgg ccaacgtggt gaaaacccat ctctactaaa aatacaaaaa 1560
115/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ttagccaggt acagcggggc atgcctgtag tcccaggtac tcgggaggct gaggcaggag 1620
aatcacttga acccgggagg cagagatgag gtagtgagct gagatcgcac cactgcactc 1680
cggcctgagt ggtagggcga gactctgtct caaaaaaaaa attgtttttt catttatttg 1740
tttgttgaga ctccacttca aaaaataaaa aaaaaaaaaa aaaaa 1785
<210> 30
<211> 2653
<212> DNA
<213> Human
<400>
30


gaagttacaagagtagtagatgaacaactaaaggcgttgcttgagtccatggttgatgct 60


gctgagaatctttgtcccaatgtgatgaaaaaagcccacattcgacaagacttgattcat 120


gccagcaccgaaaagatttctattccacgtacctttgttaaaaatgtcctgttggagcag 180


tctggaattgatatccttaacaaaattagtgaagtaaaattgacagtggcctcgttcctg 240


tctgatagaattgtggatgaaatcctggatgcactctcacattgccatcataaactggct 300


gaccatttcagcagacgtggcaagacccttcctcaacaagaatccttagagatcgagctg 360


gctgaggagaggccagttaaacgttccatcatcacagtggaggagctaacagagatagag 420


cgtttggaagatctggatacctgtatgatgacccctaaatccaaaaggaagagtatccat 480


agccgaatgctgcggcctgtttctagggcttttgaaatggagtttgatctagataaagcg 540


ctggaagaggtaccaattcacatcgaagacccgcccttcccatccctcagacaggagaag 600


cggagctcgggatttatctctgagttgccctctgaagaggggaagaagctggaacacttt 660


accaagttaaggccaaaaaggaataagaagcagcaacccacccaagcagcggtctgtgct720


gccaacatagtctcacaagatggtgaacagaatggtctcatggggagagtggatgaaggt780


gtagatgaattttttaccaagaaggtgaccaaaatggattccaagaaatggtcaacaaga840


ggctcagagtcccatgagcttaatgaaggaggagatgaaaagaaaaagcgagattctcgg900


aaaagtagtggctttctcaatttaatcaaatcccggtccaaatccgagcgaccaccaacg960


atcttgatgacagaagaaccctcctcaccaaaaggggcagtcagaagtccacctgtggac1020


tgtcccaggaaggacacaaaggccgccgagcacaatggcaattctgaacggatagaggag1080


ataaaaacacctgactcctttgaagagagtcaaggggaagaaatagggaaggtggaacgg1140


agtgacagca agagcagccc acaggcaggg cggaggtatg gggtccaggt gatgggcagt 1200
ggtctgctgg cagagatgaa agccaagcaa gagaaccgct ttggtttggg aacaccagaa 1260
aagaatacca aagcagaacc caaagcggaa gcaggctcca ggtctcggag ctcatccagc 1320
116/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
acacctacgagcccgaagcccctcctgcagtcccccaaacccagtctggcagcacggccc1380


gtcatcccgcagaaaccaagaaccgcctcacggcctgatgacattccagactctccatct1440


agcccgaaagttgcccttcttccacctgtcctgaaaaaagttccttcagacaaagagaga1500


gatggccagagtagcccccagcccagccccaggacattttcacaggaagtttcaaggaga1560


agctggggccagcaggcccaggagtatcaagaacaaaagcaacggtcctccagtaaagat1620


ggccatcaaggcagcaaatctaatgactccggggaagaagcagaaaaagagtttattttt1680


gtgtaaaggtcacccacgcagaagtcttcctgtgcagggtgctttggtagccatcagaga1740


ggaaccaagggcaacatcttttcttcccaggcgttcttctctgggtgctttattctcttc1800


tttttctttatttcgcccccacccccatcccctgccttttttttttttttttttttgtat1860


agaaacagatccatttcttggtaatcaaag.cacatttgtttggtcttcctccaacccttt1920


gcatttgatttctaaacattccttcatatgcctttaatgaaagccagcaattatcccatg1980


ggccctacttgaatttatctgaggcagctacagattgccctgcaagatgagtttttggag2040


ataaatgaaataactggacacacactcacacaagtaacaccacagcagacctcggagtac2100


tgctaagtgtacctgtgtcaaatccgcacaggactcaatatagcaatttattcttgatgt2160


atgcaattgcacattgtaattatattaacagagcacactaataatttgtatagattatat2220


atattagatcttgggtatggtttttaccttctcccatggggaacttcttccttcctgatg2280


tggaattgtacatttaaagcttggtcggtgacctttgcataccatcaacgagcacagcta2340


agaacagagtgagagaggcccatggctgattttaccatgtgcccagattaatgtatatag2400


ttgattggaatgaggttttatgaatattcatgtttttgaaggcctttaatttctgtctgc2460


atattagcttttaatgtgtgattttaagagagaatactttgacacctgtaaaaatcaaaa2520


tactactctttataagacatttcacaaatattcacttacattacaggctggaagtatttt2580


attcatatgtatatttataccaataaaatgattttacaagtggaaaaaaaaaaaaaaaaa2640


aaaaaaaaaaaaa 2653


<210> 31
<211> 1379
<212> DNA
<2l3> Human
<400> 31
tgcaagatgc ccctgaagct gcgggggaag aagaaggcca agtccaagga gaccgccggg 60
ctggtggagg gcgagccgac gggcgcgggc ggcgggagcc tctcagcgtc ccgggctccc 120
gcacgcaggc tggtcttcca cgcgcagctg gcgcacggta gtgccacggg ccgagtggag 180
117/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ggcttctcca gcatccagga gctctacgcc cagatcgcgg gcgcgtttga aatctcgccg 240
tcggagatct tatattgcac tttaaacaca cctaaaattg acatggaaag actcttagga 300
ggacaactaggactagaagatttcatatttgcccatgtgaaaggaatcgaaaaagaagtg360


aatgtgtataaatctgaggattcacttggtctcaccattacagataatggtgttggctat420


gcttttataaagagaattaaagatggtggtgttattgactcagttaaaacaatctgtgtt480


ggggatcatattgaatccataaatggagaaaatattgttgggtggcgtcactatgatgtt540


gctaagaagttaaaggaattaaaaaaggaggaactctttactatgaagttaatagaacct600


aagaaggcatttgaaatagagctgaggtcaaaggctggaaagtcatcaggagaaaaaatt660


ggttgtggaagggcaacacttcgcctgagatcaaaaggtcctgccaccgtggaagaaatg720


ccttctgaaaccaaagcaaaggcaattgaaaagattgatgatgttcttgagttgtacatg780


ggaattcgagatattgatttagccaccacaatgtttgaagctggaaaggacaaagtaaat840


ccagatgaatttgctgtggcacttgacgaaactcttggagactttgcgttcccagacgaa900


tttgtctttgatgtttggggagtcattggtgatgccaaacgaagaggattatgatgtgta960


cactccatctctgaagaaacaacccatcgttcttttttttctcttttttaaaaagtccta1020


taagatctgtttttggacacctttactaactctggtttaatttcatgtgtatggaatata1080


ttctttgaaatataattttggtaattttgatttctgggcactttttaacattgctgatgt1140


agtatgcttaagagaaatgacctaaataaggatcaattgtaatattcattcaaaaggttt1200


ttaaaagtaagttttaaggagtatttctcgacagatgattttcttctccattaataccca1260


tgctttgtttttcacatataaatagatgatttcaatagctttgtagttttttttcaaaat1320


cttaatgtaaactaggattggagtatgatttacctcatagtatcttcactgtgttatcc 1379


<210> 32
<211> 585
<212> DNA
<213> Human
<400> 32
tttttttttt ttttaaaaaa gagcatttta ttttaataaa gaataaaaga gatcaatata 60
ctgttttaat ggatacaaaa ataaatattc attcagcata ttaaagatat gtgctttgac 120
attcatttga attggagatt caagcctatt gttatcttat gaacacttca gcaaacagga 180
ctgccattct taaaaatata atgctttgtt ggacaaaagg gacaagccac gtcccctggt 240
cctctcctct attcgcctgt gaactccatc cacacgtaaa ggacctctgg gtctgactgt 300
cccctccaca ggcatggtgc tgggaaaagg aaacaggcat atctggcttt tcagatttta 360
118/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aaccggaaac tctcacagtc acaaatccac catgagactt gggagattgg atgagctgtc 420
tcccaaaccc taacaccttc caccttctca aaatgaaggc tgccctttca ctgggaggtt 480
ctgaatgcgg gatggtgctg actcaggctg ggcacaaagg agaaaggagg acatggaaaa 540
tccgacaatt caaagtacaa atatttcaaa cacatgtgaa aacca 585
<210> 33
<211> 1964
<212> DNA
<213> Human
<400>
33


tgatgacaacaatggaagcagtggagtccccggagtccctggccgccgttgcttacctgc60


tgaaccttgtcctgaagcgtgttcccagccctgtgcttattaagaagttctctgatacct120


ccaaagccttcatggatatcatgtcagctcaggccagcagcggctccacctctgtcctcc180


gatgggtcctttcctgcctggccacccttctgcggaagcaagacctggaggcctggggct240


accccgtgacccttcaggtgtaccatgggctgctgagcttcacggtgcatcccaagccca300


agatccggaaggctgcccagcatggagtatgctcagtcctcaagggcagtgaattcatgt360


ttgaaaaggcccctgcccatcatcctgctgccatttccactgccaagttctgcatccagg420


agattgagaagtctggaggctccaaggaggccaccaccacgctgcacatgctgacgctgc480


tgaaggacctgctgccctgcttcccggaaggcctggtgaagagctgcagtgagactctcc540


tcagggtcatgaccttgagccatgtgctggtgacagcctgtgccatgcaggcctttcaca600


gcctcttccacgccaggcctggcctgagcaccctgtcagcagagctcaacgcccagatca660


tcacggccctgtacgactatgttcccagtgagaatgatttacaacccctgctagcctggc720


ttaaggtcatggagaaagcccacatcaacctggtgaggttgcagtgggacctggggctag780


gccacctccctcgcttttttggaactgcggtgacctgcctcctttccccacacttgcaag840


tgctgactgctgctacgcagagcctcaaggagatcctgaaggaatgcgtggctccccaca900


tggctgacattggctccgtgacctcctcggcctcaggccctgcccaatctgttgccaaga960


tgttcagggcagtggaggagggcctgacgtacaaattccatgcggcctggagctccgtgt1020


tgcagctgctgtgtgtcttcttcgaggcgtgtgggagacaggccgaccctgtgatgagga1080


agtgcctccagtccctgtgtgacctgcgcctctcccctcatttcccccacacggcggctc1140


ttgaccaggcagtgggggctgcggtgaccagtatgggacctgaggtggtgctgcaggctg1200


tgcctttggaaattgatggctctgaggagactctggatttcccacggagctggctgctgc1260


ctgtcatccgagaccatgttcaggaaacgcgacttggtttttttcaccacctacttcttg1320


119/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
cccctggctaacaccctgaagagcaaagccatggacctggctcaggcaggcagcacagtg1380


gaatctaagatctacgacacactccagtggcagatgtggacactcctgcctgggttctgc1440


acaaggcctacagatgtggccatctccttcaaagggctggcacggacgctgggcatggcc1500


atcagcgagcgtccagacctgagggtcaccgtgtgccaggccctgcgcaccctcatcacc1560


aagggctgccaggcagaggctgaccgtgctgaagtgagtcgctttgccaagaactttctg1620


ccgatcctcttcaacctgtatgggcagcccgtggcagccggggacactccagcccctcgc1680


cgggctgtgctggaaaccatcagaacttacctcaccatcactgacactcagttggtgaac1740


agtctcctggaaaaagccagtgagaaggtgctcgaccctgccagctctgactttaccaga1800


ttgtctgtcctggacctggtcgtggccttggctccgtgtgctgacgaagctgccatcagt1860


aagctatactccaccatccggccctacctagattgctaacaaatcagaaatatgacaatt1920


aatgattaaagactgtgattgccaccaaaaaaaaaaaaaaaaaa 1964


<210> 34
<211> 2599
<212> DNA
<213> Human
<400>
34


aaatccgagcctcgcgtgggctcctggcccccgacggacaccaccaggcccacggagccc 60


accatgccgcgcccggcccccgcgcgccgcctcccgggactcctcctgctgctctggccg 120


ctgctgctgctgccctccgccgcccccgaccccgtggcccgcccgggcttccggaggctg 180


gagacccgaggtcccgggggcagccctggacgccgcccctctcctgcggctcccgacggc 240


gcgcccgcttccgggaccagcgagcctggccgcgcccgcggtgcaggtgtttgcaagagc 300


agacccttggacctggtgtttatcattgatagttctcgtagcgtacggcccctggaattc 360


accaaagtgaaaacttttgtctcccggataatcgacactctggacattgggccagccgac 420


acgcgggtggcagtggtgaactatgctagcactgtgaagatcgagttccaactccaggcc 480


tacacagataagcagtccctgaagcaggctgtgggtcgaatcacacccttgtcaacaggc 540


accatgtcaggcctagccatccagacagcaatggacgaagccttcacagtggaggcaggg 600


gctcgagagccctcttctaacatccctaaggtggccatcattgttacagatgggaggccc 660


caggaccaggtgaatgaagtggcggctcgggcccaagcatctggtat,tgagctctatgct 720


gtgggcgtggaccgggcagacatggcgtccctcaagatgatggccagtgagcccctagag 780


gagcatgttttctacgtggagacctatggggtcattgagaaactttcctctagattccag 840


gaaaccttctgtgcgctggacccctgtgtgcttggaacacaccagtgccagcacgtctgc-900


120/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
atcagtgatggggaaggcaagcaccactgtgagtgtagccaaggatacaccttgaatgcc960


gacaagaaaacgtgttcagctcttgataggtgtgctcttaacacccacggatgtgagcac1020


atctgtgtgaatgacagaagtggctcttatcattgtgagtgctatgaaggttataccttg1080


aatgaagacaggaaaacttgttcagctcaagataaatgtgctttgggtacccatgggtgt1140


cagcacatttgtgtgaatgacagaacagggtcccatcattgtgaatgctatgagggctac1200


actctgaatgcagataaaaaaacatgttcagtccgtgacaagtgtgccctaggctctcat1260


ggttgccagcacatttgtgtgagtgatggggccgcatcctaccactgtgattgctatcct1320


ggctacaccttaaatgaggacaagaaaacatgttcagccactgaggaagcacgaagactt1380


gtttccactgaagatgcttgtggatgtgaagctacactggcattccaggacaaggtcagc1440


tcgtatcttcaaagactgaacactaaacttgatgacattttggagaagttgaaaataaat1500


gaatatggacaaatacatcgttaaattgctccaatttctcacctgaaaatgtggacagct1560


tggtgtacttaatactcatgcattcttttgcacacctgttattgccaatgttcctgctaa1620


taatttgccattatctgtattaatgcttgaatattactggataaattgtatgaagatctt1680


ctgcagaatcagcatgatttttccaaggaaatacatatgcagatacttattaagagcaaa1740


ctttagtgtctctaagttatgactgtgaaatgattggtaggaaatagaatgaaaagttta1800


gtgtttctttatctactaattgagccatttaatttttaaatgtttatattagataaccat1860


attcacaatggaaactttaggtctagtttcttttgatagtatttataatataaatcaatc1920


ttattactgagagtgcaaattgtacaaggtatttacacatacaacttcatataactgaga1980


tgaatgtaattttgaactgtttaacactttttgttttttgcttattttgttggagtatta2040


ttgaagatgtgatcaatagattgtaatacacatatctaaaaatagttaacacagatcaag2100


tgaacattacattgccatttttaattcattctggtctttgaaagaaatgtactactaaag2160


agcactagttgtgaatttagggtgttaaactttttaccaagtacaaaaatcccaaattca2220


ctttattattttgcttcaggatccaagtgacaaagttatatatttataaaattgctataa2280


atcgacaaaatctaatgttgtctttttaatgttagtgatccacctgcctcagcctcccaa2340


agtgctgggattacaggcttgaaagtctaacttttttttacttatatatttgatacatat2400


aattcttttggctttgaaacttgcaactttgagaacaaaacagtcctttaaattttgcac2460


tgctcaattctgtttttcgtttgcattgtctttaatataataaaagttattacctttaca2520


tattatcatgtctatttttgatgactcatcaattttgtctattaaagatatttctttaaa2580


ttaaaaaaaa aaaaaaaaa 2599
121/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
<210> 35
<211> 3060
<212> DNA
<213> Human
<400>
35


tccggaaggaggcgaaccctgaggcgggcccggcaagccttccctgcggccggcagagcc 60


caacgactagtgggactccgcgggggcgggggtagctggagcctggctctggcctggcag 120


gagccgagcttgttccggaagaagccgagcggacgggggccagcctcagcgtcccgggag 180


tgaggcgatagctgcggcggcgacagcgcgggccgggatgaaccgcgacggctgaggcag 240


cggaggtgccggctgcgcgggccccagtgagactccctcgaagcggcagcccaccgttcg 300


gggctttgcctcgagccgagccctgcccccgcgagcctcccggacccctttgtgcggccg 360


gaggcggcggcgggaacggccatggcggccaacatgtaccgggtgggagattacgtctat 420


tttgagaactcttccagcaatccttacctggttagacggattgaggagctcaacaagact 480;


gcaaatggaaatgtggaggcaaaggttgtctgtcttttccggcgcagggacatttctagt 540


agcctcaacagcctggctgatagtaatgccagggagtttgaagaggaatcaaagcagcca 600


ggggtgtctgagcagcagcgccatcaactgaagcaccgggaactttttctttctcggcaa 660


tttgaatcattaccagccacccacatacgggggaaatgcagtgtgaccctcttgaatgag 720


acagatatcttgagccagtacctggaaaaggaggactgctttttttactcactggtgttt 780


gaccccgtgcagaagacacttctcgctgatcagggcgagattagagttggttgcaaatac 840


caagctgagatcccagatcgcctagtagagggagaatctgataatcggaaccagcagaag 900


atggagatgaaggtctgggacccagacaaccctctcacagaccggcagatcgaccagttt 960


cttgtggtggcccgagctgtgggaacctttgcaagagccctagattgtagcagctccatt 1020


cggcagccaagcttgcacatgagtgcagctgctgcctcccgagatatcactctgtttcac 1080


gccatggataccttgcaaaggaacggctacgacctggctaaggccatgtcgaccctggta 1140


ccccagggaggcccggtgctgtgtcgggatgagatggaggaatggtcagcctcagaggcc,1200


atgctatttgaggaggccctagagaagtatgggaaggacttcaatgatattcgccaggat 1260


tttctaccctggaagtcacttgccagcatagtccagttttattacatgtggaaaaccaca 1320


gaccggtatattcagcagaaaaggttgaaagctgctgaagcagacagcaaactgaaacag 1380


gtctacattcccacctacactaagccaaaccctaaccagatcatttctgtgggttcaaaa 1440


cctggcatgaatggggctggatttcagaagggcctgacttgtgagagttgccacaccaca 1500


cagtctgctcagtggtatgcctggggcccacctaacatgcagtgccgcctctgtgcttcc 1560


tgttggatctactggaagaagtatgggggactgaagaccccaactcagcttgagggggcc 1620


122/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
actcggggca ccacggagcc acactcaagg ggtcatttat ccagacctga agctcaaagt 1680
ctctctcctt acacaaccag cgccaacagg gccaagctac tggctaagaa cagacaaact 1740
ttcctgcttc agaccacaaa gctgacccgt cttgccagac gcatgtgcag ggacctatta 1800
cagccaagga gggccgcccg acggccttat gctcctatca atgccaatgc catcaaagca 1860
gagtgctcca ttcgacttcc taaggccgcc aagactccat tgaagattca ccctctggtg 1920
cggctgcccc tggcaactat cgtcaaagat ctggtggccc aggcacccct gaaaccaaaa 1980
acacctcggg gtaccaagac accgatcaac agaaaccagc tgtcccagaa ccggggactg 2040
gggggcatta tggtgaaacg ggcctatgag actatggcag gggcaggggt tcctttctct 2100
gccaatggaa ggcctctggc ttcagggatt cgttcaagct cacagccagc agccaagcgt 2160
cagaaactaa acccagctga tgcccccaat cctgtggtgt ttgtggccac aaaggatacc 2220
agggccctac ggaaggctct gacccatctg gaaatgcggc gagctgctcg ccgacccaac 2280
ttgcccctga aggtgaagcc aacgctgatt gcagtgcggc cccctgtccc tctacctgca 2340
ccctcacatc ctgccagcac caatgagcct attgtcctgg aggactgagc acctgtgggg 2400
aagggaggtg ggctgagagg tagagggtgg atgcccaggg cacccaaacc tcccttccct 2460
ttcgtgtcga agggagtgag gagtgaatta aggaagagag caagtgagtg tgtgtccctg 2520
gaggggttgg gcgccctctg gtgttaccac ctcgagactt gtctcatgcc tccatgcttg 2580
ccgatggagg acagactgca ggaacttggc ccatgtggga acctagcctg ttttgggggg 2640
taggacccac agatgtcttg gacagttttg gggggagggt tttttaattt tttaaaagtt 2700
ttgcctccct ttgtgaaagg ggatggggag gggaagagta aacagataac aggtggtggt 2760
acctggttgg gggagggggg cgtgcactgc catgtctttt tttttttttt tttttttttt 2820
tttcctaatt gggggtttct ctttctgtcc ggtgtccgga ctttcctaat tggagtttga 2880
ggcccctaag ctggcatcaa ccccaggcca cgctcgctct ttccttccct cccctccccc 2940
tctgcctttt gtacgccagt tctcagaaat aaagatcttt tgtccgtttt tttaacctcg 3000
gattctgtaa ttggttctta tagtaacaaa taaaaagctg ttttcttcag cttctcctgg 3060
<210> 36
<211> 15720
<212> DNA
<213> Human
<400> 36
caacccacac cgcccctgcc agccaccatg gggctgccac tagcccgcct ggcggctgtg 60
tgcctggccc tgtctttggc agggggctcg gagctccaga cagagggcag aacccgatac 120
123/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
cacggccgcaacgtctgcagcacctggggcaacttccactacaagaccttcgacggggac 180


gtcttccgcttccccggcctctgcgactacaacttcgcctccgactgccgaggctcctac 240


aaggaatttgctgtgcacctgaagcggggtccgggccaggctgaggcccccgccggggtg 300


gagtccatcctgctgaccatcaaggatgacaccatctacctcacccgccacctggctgtg 360


cttaacggggccgtggtcagcaccccgcactacagccccgggctgctcattgagaagagc 420


gatgcctacaccaaagtctactcccgcgccggcctcaccctcatgtggaaccgggaggat 480


gcactcatgctggagctggacactaagttccggaaccacacctgtggcctctgcggggac 540


tacaacggcctgcagagctattcagaattcctctctgacggcgtgctcttcagtcccctg 600


gagtttgggaacatgcagaagatcaaccagcccgatgtggtgtgtgaggatcccgaggag 660


gaggtggcccccgcatcctgctccgagcaccgcgccgagtgtgagaggctgctgaccgcc 720


gaggccttcgcggactgtcaggacctggtgccgctggagccgtatctgcgcgcctgccag 780


caggaccgctgccggtgcccgggcggtgacacctgcgtctgcagcaccgtggccgagttc 840


tcccgccagtgctcccacgccggcggccggcccgggaactggaggaccgccacgctctgc900


cccaagacctgccccgggaacctggtgtacctggagagcggctcgccctgcatggacacc960


tgctcacacctggaggtgagcagcctgtgcgaggagcaccgcatggacggctgtttctgc1020


ccagaaggcaccgtatatgacgacatcggggacagtggctgcgttcctgtgagccagtgc1080


cactgcaggctgcacggacacctgtacacaccgggccaggagatcaccaatgactgcgag1140


cagtgtgtctgtaacgctggccgctgggtgtgcaaagacctgccctgccccggcacctgt1200


gccctggaaggcggctcccacatcaccaccttcgatgggaagacgtacaccttccacggg1260


gactgctactatgtcctggccaagggtgaccacaacgattcctacgctctcctgggcgag1320


ctggccccctgtggctccacagacaagcagacctgcctgaagacggtggtgctgctggct1380


gacaagaagaagaatgcggtggtcttcaagtccgatggcagtgtactgctcaaccagctg1440


caggtgaacctgccccacgtgaccgcgagcttctctgtcttccgcccgtcttcctaccac1500


atcatggtgagcatggccattggcgtccggctgcaggtgcagctggccccagtcatgcaa1560


ctctttgtgacactggaccaggcctcccaggggcaggtgcagggcctctgcgggaacttc1620


aacggcctggaaggtgacgacttcaagacggccagcgggctggtggaggccacgggggcc1680


ggctttgccaacacctggaaggcacagtcaacctgccatgacaagctggactggttggac1740


gatccctgctccctgaacatcgagagcgccaactacgccgagcactggtgctccctcctg1800


aagaagacagagaccccctttggcaggtgccactcggctgtggaccctgctgagtattac1860


124/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aagaggtgca aatatgacac gtgtaactgt cagaacaatg aggactgcct gtgcgccgcc 1920
ctgtcctcctacgcgcgcgcctgcaccgccaagggcgtcatgctgtggggctggcgggag1980


catgtctgcaacaaggatgtgggctcctgccccaactcgcaggtcttcctgtacaacctg2040


accacctgccagcagacctgccgctccctctccgaggccgacagccactgtctcgagggc2100


tttgcgcctgtggacggctgcggctgccctgaccacaccttcctggacgagaagggccgc2160


tgcgtacccctggccaagtgctcctgttaccaccgcggtctctacctggaggcgggggat2220


gtggtcgtcaggcaggaagaacgatgtgtgtgccgggatgggcggctgcactgtaggcag2280


atccggctgatcggccagagctgcacggccccaaagatccacatggactgcagcaacctg2340


actgcactggccacctcgaagccccgagccctcagctgccagacgctggccgccggctat2400


taccacacagagtgtgtcagtggctgtgtgtgccccgacgggctgatggatgacggccgg2460


ggtggctgcgtggtggagaaggaatgcccttgcgtccataacaacgacctgtattcttcc2520


ggcgccaagatcaaggtggactgcaatacctgcacctgcaagagaggacgctgggtgtgc2580


acccaggctgtgtgccatggcacctgctccatttacgggagtggccactacatcaccttt2640


gatgggaagtactacgactttgacggacactgctcctacgtggctgttcaggactactgc2700


ggccagaactcctcactgggctcattcagcatcatcaccgagaacgtcccctgtggcact2760


acgggcgtcacctgctccaaggccatcaagatcttcatggggaggacggagctgaagttg2820


gaagacaagcaccgtgtggtgatccagcgtgatgagggtcaccacgtggcctacaccacg2880


cgggaggtgggccagtacctggtggtggagtccagcacgggcatcatcgtcatctgggac2940


aagaggaccaccgtgttcatcaagctggctccctcctacaagggcaccgtgtgtggcctg3000


tgtgggaactttgaccaccgctccaacaacgacttcaccacgcgggaccacatggtggtg3060


agcagcgagctggacttcgggaacagctggaaggaggcccccacctgcccagatgtgagc3120


accaaccccgagccctgcagcctgaacccgcaccgccgctcctgggccgagaagcagtgc3180


agcatcctcaaaagcagcgtgttcagcatctgccacagcaaggtggaccccaagcccttc3240


tacgaggcctgtgtgcacgactcgtgctcctgtgacacgggtggggactgtgagtgcttc3300


tgctctgccgtggcctcctacgcccaggagtgtaccaaagagggggcctgcgtgttctgg3360


aggacgccggacctgtgccccatattctgcgactactacaaccctccgcatgagtgtgag3420


tggcactatgagccatgtgggaaccggagcttcgagacctgcaggaccatcaacggcatc3480


cactccaacatctccgtgtcctacctggagggctgctacccccggtgccccaaggacagg3540


cccatctatgaggaggatctgaagaagtgtgtcactgcagacaagtgtggctgctatgtc3600


gaggacacccactacccacctggagcatcggttcccaccgaggagacctgcaagtcctgc3660


125/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gtgtgtacca actcctccca agtcgtctgc aggccggagg aaggaaagat tcttaaccag 3720
acccaggatg gcgccttctg ctactgggag atctgtggcc ccaacgggac ggtggagaag 3780
cacttcaaca tctgttccat tacgacacgc ccgtccaccc tgaccacctt caccaccatc 3840
accctcccca ccacccccac ctccttcacc actaccacca ccaccaccac cccgacctcc 3900
agcacagttt tatcaacaac tccgaagctg tgctgcctct ggtctgactg gatcaatgag 3960
gaccacccca gcagtggcag cgacgacggt gaccgagaac catttgatgg ggtctgcggg 4020
gcccctgagg acatcgagtg caggtcggtc aaggatcccc acctcagctt ggagcagcat 4080
ggccagaagg tgcagtgtga tgtctctgtt gggttcattt gcaagaatga agaccagttt 4140
ggaaatggac catttggact gtgttacgac tacaagatac gtgtcaattg ttgctggccc 4200
atggataagt gtatcaccac tcccagccct ccaactacca ctcccagccc tccaccaacc 4260
acgacgacca cccttccacc aaccaccacc cccagccctc caaccaccac cacaaccacc 4320
cctccaccaa ccaccacccc cagccctcca ataaccacca cgaccacccc tctaccaacc 4380
acc~actccca gccctccaat aagcaccaca accacccctc caccaaccac cactcccagc 4440
cctccaacca ccactcccag ccctccaacc accactccca gccctccaac aaccaccaca 4500
accacccctc caccaaccac cactcccagc cctccaatga ctacgcccat cactccacca 4560
gccagcacta ccacccttcc accaaccacc actcccagcc ctccaacaac caccacaacc 4620
acccctccac caaccaccac tcccagtcct ccaacgacta cgcccatcac tccaccaacc 4680
agcactacta cccttccacc aaccaccact cccagccctc caccaaccac cacaaccacc 4740
cctccaccaa ccaccactcc cagccctcca acaaccacca ctcccagtcc tccaacaatc 4800
accacaacca cccctccacc aaccaccact cccagccctc caacaacgac cacaaccacc 4860
cctccaccaa ccaccactcc cagccctcca acgactacac ccatcactcc accaaccagc 4920
actaccaccc ttccaccaac caccactccc agccctccac caaccaccac aaccacccct 4980
ccaccaacca ccactcccag ccctccaaca accaccactc ccagccctcc aataaccacc 5040
acaaccaccc ctccaccaac caccactccc agctctccaa taaccaccac tcccagccct 5100
ccaacaacca ccatgaccac cccttcacca accaccaccc ccagctctcc aataaccacc 5160
acaaccaccc .cttcctcaac taccactccc agccctccac caaccaccat gaccacccct 5220
tcaccaacca ccactcccag ccctccaaca accaccatga ccacccttcc accaaccacc 5280
acttccagcc ctctaacaac tactcctcta cctccatcaa taactcctcc tacattttca 5340
ccattctcaa cgacaacccc tactacccca tgcgtgcctc tctgcaattg gactggctgg 5400
126/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ctggattctggaaaacccaactttcacaaaccaggtggagacacagaattgattggagac5460


gtctgtggaccaggctgggcagctaacatctcttgcagagccaccatgtatcctgatgtt5520


cccattggacagcttggacaaacagtggtgtgtgatgtctctgtggggctgatatgcaaa5580


aatgaagaccaaaagccaggtggggtcatccctatggccttctgcctcaactacgagatc5640


aacgttcagtgctgtgagtgtgtcacccaacccaccaccatgacaaccaccaccacagag5700


aacccaactccgccaaccacgacacccatcaccaccaccactacggtgaccccaacccca5760


acacccaccggcacacagaccccaaccacgacacccatcaccaccaccactacggtgacc5820


ccaaccccaacacccaccggcacacagaccccaaccacgacacccatcaccaccaccact5880


acggtgaccccaaccccaacacccaccggcacacagaccccaaccacgacacccatcacc5940


accaccactacggtgaccccaaccccaacacccaccggcacacagaccccaaccacgaca6000


cccatcaccaccaccactacggtgaccccaaccccaacacccaccggcacacagacccca6060


accacgacacccatcaccaccaccactacggtgaccccaaccccaacacccaccggcaca6120


cagaccccaaccacgacacccatcaccaccaccactacggtgaccccaaccccaacaccc6180


accggcacacagaccccaaccacgacacccatcaccaccaccactacggtgaccccaacc6240


ccaacacccaccggcacacagaccccaaccacgacacccatcaccaccaccactacggtg6300


accccaaccccaacacccaccggcacacagaccccaaccacgacacccatcaccaccacc6360


actacggtgaccccaaccccaacacccaccggcacacagaccccaaccacgacacccatc6420


accaccaccactacggtgaccccaaccccaacacccaccggcacacagaccccaaccacg6480


acacccatcaccaccaccactacggtgaccccaaccccaacacccaccggcacacagacc6540


ccaaccacgacacccatcaccaccaccactacggtgaccccaaccccaacacccaccggc6600


acacagaccccaaccacgacacccatcaccaccaccactacggtgaccccaaccccaaca6660


cccaccggcacacagaccccaaccacgacacccatcaccaccaccactacggtgacccca6720


accccaacacccaccggcacacagaccccaaccacgacacccatcaccaccaccactacg6780


gtgaccccaaccccaacacccaccggcacacagaccccaaccacgacacccatcaccacc6840


accactacggtgaccccaaccccaacacccaccggcacacagaccccaaccacgacaccc6900


atcaccaccaccactacggtgaccccaaccccaacacccaccggcacacagaccccaacc6960


acgacacccatcaccaccaccactacggtgaccccaaccccaacacccaccggcacacag7020


accccaaccacgacacccatcaccaccaccactacggtgaccccaaccccaacacccacc7080


ggcacacagaccccaaccacgacacccatcaccaccaccactacggtgaccccaacccca7140


acacccaccggcacacagaccccaaccacgacacccatcaccaccaccactacggtgacc7200


127/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ccaaccccaa cacccaccgg cacacagacc ccaaccacga cacccatcac caccaccact 7260
acggtgaccc caaccccaac acccaccggc acacagaccc caaccacgac acccatcacc 7320
accaccacta cggtgacccc aaccccaaca cccaccggca cacagacccc aaccacgaca 7380
cccatcacca ccaccactac ggtgacccca accccaacac ccaccggcac acagacccca 7440
accacgacac ccatcaccac caccactacg gtgaccccaa ccccaacacc caccggcaca 7500
cagaccccaa ccacgacacc catcaccacc accactacgg tgaccccaac cccaacaccc 7560
accggcacac agaccccaac cacgacaccc atcaccacca ccactacggt gaccccaacc 7620
ccaacaccca ccggcacaca gaccccaacc acgacaccca tcaccaccac cactacggtg 7680
accccaaccc caacacccac cggcacacag accccaacca cgacacccat caccaccacc 7740
actacggtga ccccaacccc aacacccacc ggcacacaga ccccaaccac gacacccatc 7800
accaccacca ctacggtgac cccaacccca acacccaccg gcacacagac cccaaccacg 7860
acacccatca ccaccaccac tacggtgacc ccaaccccaa cacccaccgg cacacagacc 7920
ccaaccacga cacccatcac caccaccact acggtgaccc caaccccaac acccaccggc 7980
acacagaccc caaccacgac acccatcacc accaccacta cggtgacccc aaccccaaca 8040
cccaccggca cacagacccc aaccacgaca cccatcacca ccaccactac ggtgacccca 8100
accccaacac ccaccggcac acagacccca accacgacac ccatcaccac caccactacg 8160
gtgaccccaa ccccaacacc caccggcaca cagaccccaa ccacgacacc catcaccacc 8220
accactacgg tgaccccaac cccaacaccc accggcacac agaccccaac cacgacaccc 8280
atcaccacca ccactacggt gaccccaacc ccaacaccca ccggcacaca gaccccaacc 8340
acgacaccca tcaccaccac cactacggtg accccaaccc caacacccac cggcacacag 8400
accccaacca cgacacccat caccaccacc actacggtga ccccaacccc aacacccacc 8460
ggcacacaga ccccaaccac gacacccatc accaccacca ctacggtgac cccaacccca 8520
acacccaccg gcacacagac cccaaccacg acacccatca ccaccaccac tacggtgacc 8580
ccaaccccaa cacccaccgg cacacagacc ccaaccacga cacccatcac caccaccact 8040
acggtgaccc caaccccaac acccaccggc acacagaccc caaccacgac acccatcacc 8700
accaccacta cggtgacccc aaccccaaca cccaccggca cacagacccc aaccacgaca 8760
cccatcacca ccaccactac ggtgacccca accccaacac ccaccggcac acagacccca 8820
accacgacac ccatcaccac caccactacg gtgaccccaa ccccaacacc caccggcaca 8880
cagaccccaa ccacgacacc catcaccacc accactacgg tgaccccaac cccaacaccc 8940
128/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
accggcacac agaccccaac cacgacaccc atcaccacca ccactacggt gaccccaacc 9000
ccaacaccca ccggcacaca gaccccaacc acgacaccca tcaccaccac cactacggtg 9060
accccaaccc caacacccac cggcacacag accccaacca cgacacccat caccaccacc 9120
actacggtga ccccaacccc aacacccacc ggcacacaga ccccaaccac gacacccatc 9180
accaccacca ctacggtgac cccaacccca acacccaccg gcacacagac cccaaccacg 9240
acacccatca ccaccaccac tacggtgacc ccaaccccaa cacccaccgg cacacagacc 9300
ccaaccacga cacccatcac caccaccact acggtgaccc caaccccaac acccaccggc 9360
acacagaccc caaccacgac acccatcacc accaccacta cggtgacccc aaccccaaca 9420
cccaccggca cacagacccc aaccacgaca cccatcacca ccaccactac ggtgacccca 9480
accccaacac ccaccggcac acagacccca accacgacac ccatcaccac caccactacg 9540
gtgaccccaa ccccaacacc caccggcaca cagaccccaa ccacgacacc catcaccacc 9600
accactacgg tgaccccaac cccaacaccc accggcacac agaccccaac cacgacaccc 9660
atcaccacca ccactacggt gaccccaacc ccaacaccca ccggcacaca gaccccaacc 9720
acgacaccca tcaccaccac cactacggtg accccaaccc caacacccac cggcacacag 9780
accccaacca cgacacccat caccaccacc actacggtga ccccaacccc aacacccacc 9840
ggcacacaga ccccaaccac gacacccatc accaccacca ctacggtgac cccaacccca 9900
acacccaccg gcacacagac cccaaccacg acacccatca ccaccaccac tacggtgacc 9960
ccaaccccaa cacccaccgg cacacagacc ccaaccacga cacccatcac caccaccact 10020
acggtgaccc caaccccaac acccaccggc acacagaccc caaccacgac acccatcacc 10080
accaccacta cggtgacccc aaccccaaca cccaccggca cacagacccc aaccacgaca 10140
cccatcacca ccaccactac ggtgacccca accccaacac ccaccggcac acagacccca 10200
accacgacac ccatcaccac caccactacg gtgaccccaa ccccaacacc caccggcaca 10260
cagaccccaa ccacgacacc catcaccacc accactacgg tgaccccaac cccaacaccc 10320
accggcacac agaccccaac cacgacaccc atcaccacca ccactacggt gaccccaacc 10380
ccaacaccca ccggcacaca gaccccaacc acgacaccca tcaccaccac cactacggtg 10440
accccaaccc caacacccac cggcacacag accccaacca cgacacccat caccaccacc 10500
actacggtga ccccaacccc aacacccacc ggcacacaga ccccaaccac gacacccatc 10560
accaccacca ctacggtgac cccaacccca acacccaccg gcacacagac cccaaccacg 10620
acacccatca ccaccaccac tacggtgacc ccaaccccaa cacccaccgg cacacagacc 10680
ccaaccacga cacccatcac caccaccact acggtgaccc caaccccaac acccaccggc 10740
129/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
acacagaccc caaccacgac acccatcacc accaccacta cggtgacccc aaccccaaca 10800
cccaccggca cacagacccc aaccacgaca cccatcacca ccaccactac ggtgacccca 10860
accccaacac ccaccggcac acagacccca accacgacac ccatcaccac caccactacg 10920
gtgaccccaa ccccaacacc caccggcaca cagaccccaa ccacgacacc catcaccacc 10980
accactacgg tgaccccaac cccaacaccc accggcacac agaccccaac cacgacaccc 11040
atcaccacca ccactacggt gaccccaacc ccaacaccca ccggcacaca gaccccaacc 11100
acgacaccca tcaccaccac cactacggtg accccaaccc caacacccac cggcacacag 11160
accccaacca cgacacccat caccaccacc actacggtga ccccaacccc aacacccacc 11220
ggcacacaga ccccaaccac gacacccatc accaccacca ctacggtgac cccaacccca 11280
acacccaccg gcacacagac cccaaccacg acacccatca ccaccaccac tacggtgacc 11340
ccaaccccaa cacccaccgg cacacagacc ccaaccacga cacccatcac caccaccact 11400
acggtgaccc caaccccaac acccaccggc acacagaccc caaccacgac acccatcacc 11460
accaccacta cggtgacccc aaccccaaca cccaccggca cacagacccc aaccacgaca 11520
cccatcacca ccaccactac ggtgacccca accccaacac ccaccggcac acagacccca 11580
accacgacac ccatcaccac caccactacg gtgaccccaa ccccaacacc caccggcaca 11640
cagaccccaa ccacgacacc catcaccacc accactacgg tgaccccaac cccaacaccc 11700
accggcacac agaccccaac cacgacaccc atcaccacca ccactacggt gaccccaacc 11760
ccaacaccca ccggcacaca gaccccaacc acgacaccca tcaccaccac cactacggtg 11820
accccaaccc caacacccac cggcacacag accccaacca cgacacccat caccaccacc 11880
actacggtga ccccaacccc aacacccacc ggcacacaga ccccaaccac gacacccatc 11940
accaccacca ctacggtgac cccaacccca acacccaccg gcacacagac cccaaccacg 12000
acacccatca ccaccaccac tacggtgacc ccaaccccaa cacccaccgg cacacagacc 12060
ccaaccacga cacccatcac caccaccact acggtgaccc caaccccaac acccaccggc 12120
acacagaccc caaccacgac acccatcacc accaccacta cggtgacccc aaccccaaca 12180
cccaccggca cacagacccc aaccacgaca cccatcacca ccaccactac ggtgacccca 12240
accccaacac ccaccggcac acagacccca accacgacac ccatcaccac caccactacg 12300
gtgaccccaa ccccaacacc.caccggcaca cagaccccaa ccacgacacc catcaccacc 12360
accactacgg tgaccccaac cccaacaccc accggcacac agaccccaac cacgacaccc 12420
atcaccacca ccactacggt gaccccaacc ccaacaccca ccggcacaca gaccccaacc 12480
130/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
acgacaccca tcaccaccac cactacggtg accccaaccc caacacccac cggcacacag 12540
accccaacca cgacacccat caccaccacc actacggtga ccccaacccc aacacccacc 12600
ggcacacaga ccgggccccc cacccacaca agcacagcac cgattgctga gttgaccaca 12660
tCCaatCCtC CgCCtgagtC CtCaaCCCCt CagaCCtCtC ggtccacctc ttCCCCtCtC 12720
acggagtcaa ccacccttct gagtacccta ccacctgcca ttgagatgac cagcacggcc 12780
ccaccctcca cacccacggc acccacgacc acgagcggag gccacacact gtctccaccg 12840
cccagcacca ccacgtcccc tccaggcacc cccactcgcg gtaccacgac cgggtcatct 12900
tcagccccca cccccagcac tgtgcagacg accaccacca gtgcctggac cccaacgccg 12960
accccactct ccacacccag catcatcagg accacaggcc tgaggcccta cccttcctct 13020
gtgcttatct gctgtgtcct gaacgacacc tactacgcac caggtgagga ggtgtacaac 13080
ggcacatacg gagacacctg ttatttcgtc aactgctcac tgagctgtac gttggagttc 13140
tataactggt cctgcccatc cacgccctcc ccaacaccca cgccctccaa gtcgacgccc 13200
acgccttcca agccatcgtc cacgccctcc aagccgacgc ccggcaccaa gccccccgag 13260
tgcccagact ttgatcctcc cagacaggag aacgagactt ggtggctgtg cgactgcttc 13320
atggccacgt gcaagtacaa caacacggtg gagatcgtga aggtggagtg tgagccgccg 13380
cccatgccca cctgctccaa cggcctccaa cccgtgcgcg tcgaggaccc cgacggctgc 13440
tgctggcact gggagtgcga ctgctactgc acgggctggg gcgacccgca ctatgtcacc 13500
ttcgacggac tctactacag ctaccagggc aactgcacct acgtgctggt ggaggagatc 13560
agcccctccg tggacaactt cggagtttac atcgacaact accactgcga tcccaacgac 13620
aaggtgtcct gtccccgcac cctcatcgtg cgccacgaga cccaggaggt gctgatcaag 13680
accgtgcata tgatgcccat gcaggtgcag gtgcaggtga acaggcaggc ggtggcactg 13740
ccctacaaga agtacgggct ggaggtgtac cagtctggca tcaactacgt ggtggacatc 13800
cccgagctgg gtgtcctcgt ctcctacaat ggcctgtcct tctccgtcag gctgccctac 13860
caccggtttg gcaacaacac caagggccag tgtggcacct gcaccaacac cacctccgac 13920
gactgcattc tgcccagcgg ggagatcgtc tccaactgtg aggctgcggc tgaccagtgg 13980
ctggtgaacg acccctccaa gccacactgc ccccacagca gctccacgac caagcgcccg 14040
gccgtcactg tgcccggggg cggtaaaacg accccacaca aggactgcac cccatctccc 14100
ctctgccagc tcatcaagga cagcctgttt gcccagtgcc acgcactggt gcccccgcag 14160
cactactacg atgcctgcgt gttcgacagc tgcttcatgc cgggctcgag cctggagtgc 14220
gccagtctgc aggcctacgc agccctctgt gcccagcaga acatctgcct cgactggcgg 14280
i
131/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aaccacacgc atggggcctg cttggtggag tgcccatctc acagggagta ccaggcctgt 14340
ggccctgcag aagagcccac gtgcaaatcc agctcctccc agcagaacaa cacagtcctg 14400
gtggaaggct gcttctgtcc tgagggcacc atgaactacg ctcctggctt tgatgtctgc 14460
gtgaagacct gcggctgtgt gggacctgac aatgtgccca gagagtttgg ggagcacttc 14520
gagttcgact gcaagaactg tgtctgcctg gagggtggaa gtggcatcat ctgccaaccc 14580
aagaggtgca gccagaagcc cgttacccac tgcgtggaag acggcaccta cctcgccacg 14640
gaggtcaacc ctgccgacac ctgctgcaac attaccgtct gcaagtgcaa caccagcctg 14700
tgcaaagaga agccctccgt gtgcccgctg ggattcgaag tgaagagcaa gatggtgcct 14760
ggaaggtgct gtcccttcta ctggtgtgag tccaaggggg tgtgtgttca cgggaatgct 14820
gagtaccagc ccggttctcc agtttattcc tccaagtgcc aggactgcgt gtgcacggac 14880
aaggtggaca acaacaccct gctcaacgtc atcgcctgca cccacgtgcc ctgcaacacc 14940
tcctgcagcc ctggcttcga actcatggag gcccccgggg agtgctgtaa gaagtgtgaa 15000
cagacgcact gtatcatcaa acggcccgac aaccagcacg tcatcctgaa gcccggggac 15060
ttcaagagcg acccgaagaa caactgcaca ttcttcagct gcgtgaagat ccacaaccag 15120
ctcatctcgt ccgtctccaa catcacctgc cccaactttg atgccagcat ttgcatcccg 15180
ggctccatca cattcatgcc caatggatgc tgcaagacct gcacccctcg caatgagacc 15240
agggtgccct gctccaccgt ccccgtcacc acggaggttt cgtacgccgg ctgcaccaag 15300
accgtcctca tgaatcattg ctccgggtcc tgcgggacat ttgtcatgta ctcggccaag 15360
gcccaggccc tggaccacag ctgctcctgc tgcaaagagg agaaaaccag ccagcgtgag 15420
gtggtcctga gctgccccaa tggcggctcg ctgacacaca cctacaccca catcgagagc 15480
tgccagtgcc aggacaccgt ctgcgggctc cccaccggca cctcccgccg ggcccggcgc 15540
tcccctaggc atctggggag cgggtgagcg gggtgggcac agcccccttc actgccctcg 15600
acagctttac ctcccccgga ccctctgagc ctcctaagct cggcttcctc tcttcagata 15660
tttattgtct gagtctttgt tcagtccttg ctttccaata ataaactcag ggggacatgc 15720
<210> 37
<211> 3941
<212> DNA
<213> Human
<400> 37
accatctact ccacagtcag ctcatccaca actgccatca cctcaccttt cactaccgca 60
gagactgggg tgacttccac accttcatcc ccatcttctc tgagtacaga catcccgacc 120
132/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
acatccctaagaactctcaccccattatctttgagcaccagcacttcattgactacaacc 180


acagaccttccctctatacccactgatatcagtagcttaccaaccccaatacacatcatt 240


tcatcttctccctccatccaaagtacagaaacctcatcccttgtgggcaccacctctccc 300


accatgtccactgtgagagcgaccctcagaagtactgagaacaccccaatcagttccttt 360


agcacaagtattgttgttacacctgaaaccccaacaacacaggcccctcctgtactgatg 420


tctgccactgggacccaaacatcccctgtacctactactgtcacctttggaagtatggat 480


tcctctacgtccactcttcatactcttactccatcaacagccttgagcaagatcatgtca 540


acatcacagtttcctattcctagcacacattcctccacccttcaaacaactccttcaatc 600


ccctctttgcaaacttcactcacatctacaagtgagttcactacagaatctttcactagg 660


ggaagtacgtctacaaatgcaatcttgacttcttttagtaccatcatctggtcctcaaca 720


cccactattatcatgtcctcttctccatcttctgccagcataactccagtgttcgctact 780


accattcattctgttccttcgtcaccatacattttcagtacagaaaatgtgggctccgct 840


tctatcacagcctttcctagtctctcttcctcttcaactaccagcacttctccaaccagc 900


tcctctctgaccacagctctcactgaaataacccccttttcttatatttcccttccctcc 960


accacaccctgtccaggaactataacaattaccatagtccctgcctcccccactgatcca 1020


tgtgttgaaatggatcccagcactgaagctacttctcctcccaccactccattaacagtc 1080


tttccctttactactgaaatggtcacctgtcctagctccatcagtatgcaaactactctt 1140


gctacacatatggacacttcttccatgacgccagaaagtgagtccagcatcatacctaat 1200


gcttccagttccactggcactgggactgtacccacaaacacagttttcacaagtactcga 1260


ctgcccaccagtgagacctggctgagcaacaactctgtgatccccacacctcttcctggc 1320


gtctctaccatcccgctcaccatgaaaccaagcagtagcctcccgaccatcctgaggact 1380


tcaagcaagtcaacacacccatccccacccaccgccaggacttcagagacatcagtggcc 1440


actacccagactcctaccacccttacaacgcgcaggacaactcccatcacttcttggatg 1500


accacacagtccacgttgaccaccactgcaggcacctgtgacaatggtggcacctgggaa 1560


cagggccagtgtgcttgccttccggggttttctggggaccgctgtcagctccagaccaga 1620


tgccagaacgggggccagtgggatggcctcaagtgccagtgccccagcaccttctatggt 1680


tccagttgtgagtttgctgtggaacaggtggatctagatgtagtggagaccgaggtgggc 1740


atggaagtgtctgtggatcagcagttctcgccggacctcaatgacaacacttcccaggcc 1800


tacagggatttcaacaagaccttctggaatcagatgcagaagatttttgcagacatgcag 1860


133/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ggcttcacct tcaagggtgt ggagatcctg tccctgagga atggcagcat cgtggtggac 1920
tacctggtcc tgctggagat gcccttcagc ccccagctgg agagcgagta tgagcaggtg 1980
aagaccacgc tgaaggaggg gctccagaac gccagccagg atgcgaacag ctgccaggac 2040
tcccagaccctgtgttttaagcctgactccatcaaggtgaacaacaacagcaagacagag2100


ctgaccccggaagccatctgccgccgcgccgctcccacgggctatgaagagttctacttc2160


cctctggtggaggccacccggctccgctgtgtcaccaaatgcacgtcgggcgtggacaac2220


gccatcgactgtcaccagggccagtgcgttctagagacgagcggtcccgcgtgtcgctgc2280


tactccaccgacacgcactggttctctggcccgcgctgcgaggtggccgtccactggagg2340


gcgctggtcgggggcctgacggccggcgccgcgctgctggtgctgctgctgctggcgctg2400


ggcgtccgggcggtgcgctccggatggtggggcggccagcgccgaggccggtcctgggac2460


caggacaggaaatggttcgagacctgggatgaggaagtcgtgggcactttttcaaactgg2520


ggtttcgaggacgacggaacagacaaggatacaaatttccatgtggccttggagaacgtg2580


gacaccactatgaaggtgcacatcaagagacccgagatgacctcgtcctcagtgtgagcc2640


ctgcggggccccttcaccaceccctccgccctgccccggacacaagggtctgcattgcgt2700


ccatttcaagaggtggccccaggacgcgggcagcccaggctcctgctgttcttgggcaag2760


atgagactgttcccccaaatcccatccttctccttccaacttggctgaaacccacctgga2820


gacgcagttcacgtccaggctcttccactgtggaatcttgggcaagtcagtaacgagcct2880


cagtttcctcacctgcaaaacgggtacagcattcctgtatgatagctcacgccgttgttg2940


tgaaaaccacatagacttggtcaattctcggtcctactctgccctcccgtctcagccctc3000


gtgttgccattgcctctctcggatcctccaatcctcacgtccttcacctggtctctggcc3060


ctggttcttattttctctcaattccctactgcctgtttcttactttgaacctggaggcag3120


cctgcagccccatcccatctcctgccctctcotgatctaactccctgctgcatctcttgc3180


tctcattccttagacgtcctccccttttgaccccgttccttcatccatcctgcaccccag3240


tcccccagccctaaatcctccctcctctcctcacatcctggtccctagcaaggtatagat3300


agcctctgtgtcttaggataccccgggtgctgttccctcggtcaccctgttgcccagttc3360


cccgtttctcttgctctcattccttgtatcttctccccttctgagcccgtccattcatcg3420


gttctgcccccgactcccccagccctaaataccccagctcctaattcccccctcaccccg3480


ttgctcaattccccgtttctcttgctctcattccttgtatcttctccccttctgagcctg3540


tccattcatc ggtggttctg cccctactcc eccagcccta aataccccag ctgctgttcc 3600
tccccatcac ccagccaccg gattctccat tcaccccttt ctctcacccc tggagccccg 3660
134/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tgggtggggg cagggcatga gttccccagt ccccaaggaa aggcagcccc ctcagtctcc 3720
ctcctcctca ttcccttcca tctccctccc ctctgccttt taaacccatc ccctccgatt 3780
cccctcctcc cccctctctc cctggtgtca actcgattcc tgcggtaact ctgagccctg 3840
aaatcctcag tctccttggc ggggaagatt ggctttgggg acaggaagtc ggcacatctc 3900
caggtctcca tgtgcacaat atagagttta ttgtaaaaag c 3941
<210> 38
<21l> 5992
<212> DNA
<213> Human
<400> 38
aaattgctgt gaccgcagca tctctaggaa gacgctttat tcctgaagga cactgactgt 60
cacttgggaa ccaagaagcc ctctgcagtc atgagctctg acgcagaaat ggccattttt 120
ggagaagcagctccctacctccggaaaccagagaaggagagaatcgaggctcaaaatcgt180


ccattcgattccaagaaagcctgctttgtagcggataataaggaaatgtatgtgaaaggc240


atgatccagactagggaaaatgacaaagtcatagtcaagaccctcgatgaccggatgctc300


actctgaacaatgaccaggtcttccccatgaaccctcccaaatttgacaagatcgaggac360


atggccatgatgactcacctgcatgaacctgctgttctgtacaacctcaaagagcgctat420


gcagcctggatgatctacacctactcaggcctcttctgtgtcaccgtcaacccctacaag480


tggctgccggtgtacaagcccgaggtggtggctgcctacagaggcaaaaagcgccaggag540


gccccgccccacatcttctccatctctgacaatgcctatcagttcatgctgactgatcga600


gacaaccagtctatcctcatcaccggagaatccggggctgggaagactgtgaacaccaag660


cgtgtcatccagtattttgcaacaattgcagttaccggggacaagaagaaggagacacag720


ccaggcaaaatgcagggaaccctagaggatcagatcatccaggccaacccactgetggag780


gcctttggaaatgccaagactgtgaggaatgacaactcctcaagatttgggaagttcatt840


cggattcattttggagccacaggaaagctggcatcggcagacatcgaaacttatctgtta900


gaaaaatccagagtgacgtttcaattatccagtgagagaagctatcatattttctaccaa960


attatgtcaaacaagaagccagaactaattgacctgcttctgatctccaccaaccccttc1020


gacttcccct tcgtgagcca aggagaggtc acggtagcca gtatcgatga cagtgaagaa 1080
ctgctggcga cagataatgc cattgacatc ctgggcttca gctcagagga gaaagtcggg 1140
atctacaaac tgacgggagc cgtgatgcat tatgggaaca tgaagttcaa gcagaagcag 1200
cgtgaggagc aggcggagcc agacggcacc gaagtggctg acaaagccgg atacctgatg 1260
135/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ggactgaattctgcagaaatgctgaagggcctgtgctgtccaagggtgaaggttggcaat1320
1


gaatatgtcactaaagggcaaaatgtccagcaggtgaccaattcggtgggtgctctggcc1380


aaagccgtctacgagaagatgttcctgtggatggtcacccgcatcaaccagcagttggac1440


accaagcagcccaggcagtacttcatcggggtcttggacattgctggctttgagatcttt1500


gatttcaacagcctggagcagctgtgcatcaacttcaccaatgagaaactgcaacagttt1560


ttcaaccaccacatgttcgtgctggagcaggaagagtacaagaaggaaggcatcgagtgg1620


gagttcattgacttcggaatggacctggctgcctgcatcgagctcatcgagaagcctatg1680


ggcatcttctccatcctggaagaggagtgcatgttccccaaggcaacagacacctccttc1740


aagaacaagctgtatgaccagcatcttggaaaatccaacaacttccagaagcccaagcct1800


gccaaaggcaaggctgaggctcacttctcgctggtgcactatgccggcaccgtggactac1860


aacatcgccggctggctggacaaaaacaaggaccccctgaatgagactgtggtggggctg1920


taccagaagtcttcgctgaagcttctctccttccttttttccaactatgctggtgcagag1980


acaggtgactccggaggaagcaagaagggcgggaagaagaagggctcctctttccagacc2040


gtgtcggccgtgttcagggaaaatttaaacaaattgatgactaacttaaggagcacccac2100


cctcactttgtacgatgtctgattcccaatgagaccaagactcctggtgtgatggaccac2160


tacttggtcatgcaccagctgcgctgtaacggggtcctcgagggcatccggatttgcagg2220


aagggattccccagccggatcctctatgctgacttcaagcagcggtaccggatcctcaat2280


gccagtgctatccctgaagggcagttcattgacagcaaaaatgcctcagagaagctcctc2340


aactccatcgatgtggaccgggagcagttcaggttcggcaacaccaaggtgtttttcaaa2400


gctgggctcctgggacttttggaggagatgagagatgagaagctggtgacgctgatgaca2460


agcacgcaggcggtgtgcagggggtacctgatgcgggtggagttcaagaagatgatggag2520


aggagggactccatcttctgcatccaatacaacatccgctcttttatgaacgtcaagcac2580


tggccctggatgaacctgttcttcaaaatcaagcccctgctgaagagtgcagaggccgag2640


aaggagatggccaccatgaaggaagactttgagaggaccaaggaagaactggcccgatct2700


gaggctcgccggaaggagctggaggagaaaatggtctccctcctgcaggagaagaatgac2760


ctccaattgcaggtccagtctgaaacagaaaatctgatggacgctgaggaacggtgtgaa2820


ggactcatcaaaagcaagatcctactggaagcaaaagtcaaggagctgacggagagattg2880


gaagaggaagaggagatgaattctgaattggttgccaagaagaggaatctggaagataaa2940


tgctcctctctcaagagagacattgatgatctggagctgaccttgacgaaagttgaaaag3000


136/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gagaagcatg ccacagagaa caaggtaaag aatctttccg aagaaatgac agcacttgaa 3060
gaaaacattt ccaaattgac caaagaaaag aaatctctac aggaggccca tcagcaaaca 3120
ctggatgatc ttcaggtgga agaagataaa gtcaatggtc taatcaaaat aaatgccaag 3180
cttgaacagc aaacagatga tcttgagggt tccttagagc aggagaagaa actgcgggcg 3240
gacttggaaa gggcgaagag gaagctggaa ggagatctga aaatgtccca ggaatccatt 3300
atggatctag aaaatgaaaa gcagcaaata gaagagaaat tgaaaaagaa ggagtttgaa 3360
ctcagtcagt tacaagccag aatagatgac gaacaagtcc acagtttgca gtttcaaaag 3420
aagattaaag agctgcaagc ccgcatagaa gagctggagg aggaaattga agcggaacac 3480
acgctcagag ccaagattga gaagcagcgc tcagatctgg ccagggaact ggaggagatc 3540
agcgagaggc tggaagaagc cagtggggcc acttcagccc agattgagat gaacaagaag 3600
agggaggctg agttccagaa aatgcgcagg gacctggagg aggccaccct gcagcacgaa 3660
gccacagcag ccaccctgag gaagaagcaa gcagatagtg tggccgagct tggggagcag 3720
attgacaacc tgcagcgggt gaagcagaag ctggagaagg agaagagcga gctgaagatg 3780
gagatcgacg acatggccag caacatcgag gctctctcca agtcaaagag taacatagaa 3840
agaacgtgcc ggacggtaga agatcaattt agtgaaatca aagccaagga cgagcaacag 3900
acacagttga tccatgatct gaacatgcag aaagcaagac tgcagaccca aaatggggag 3960
ctgagccacc gagtggaaga gaaggagtct ctgatttcac agctgaccaa aagcaagcag 4020
gccctcaccc agcagctgga ggagcttaag aggcaaatgg aagaagaaac caaggccaag 4080
aacgccatgg cgcacgccct gcagtcctcc cgccacgact gtgacctgct gcgggaacag 4140
tatgaggagg agcaggaagc caaggccgag ctgcagaggg cgctgtccaa ggccaacagt 4200
gaggttgccc agtggaagac caaatacgag acggacgcca ttcagcgcac agaagagctg 4260
gaggaggcca agaaaaaact ggcccagagg ctccaggaag cagaggagaa gacggagacg 4320
gcgaactcca agtgcgcatc gttggagaaa accaagcaga ggctgcaggg agaggtggag 4380
gatctgatgc gggatctgga gcgctcccac accgcctgtg ccacactgga caagaagcag 4440
aggaacttcg acaaggtcct tgcagagtgg aagcaaaagc tggacgaaag ccaggctgag 4500
ctggaagctg ctcagaagga gtccaggtca ctcagcactg aactcttcaa gatgaggaat 4560
gcctatgagg aggtggtgga ccagttagag acactgaggc gagagaacaa aaatctgcaa 4620
gaagagattt ccgacttaac tgagcagatt gcagaaactg gcaagaatct tcaggaagcg 4680
gaaaagacca agaagctagt ggagcaggaa aagtcagatc tgcaggtcgc cttagaagaa 4740
gtggagggtt ccttggaaca cgaggagagc aagatcttgc gcgtgcagct agagctgagc 4800
137/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
caggtgaaatccgagctagaccgcaaggtcattgagaaggatgaagaaatcgagcagcta4860


aaaagaaacagccagcgggcagcagaggccctgcagagcgtgctggatgctgaaatccgc4920


agccggaacgacgccctgaggctaaagaagaagatggagggagaccttaatgagatggag4980


attcagctgggccactccaaccgccagatggcagagacccagaggcatctgcgcacggtc5040


cagggccagctcaaggactcccagctgcatctcgatgacgccctgaggagcaatgaggac5100


ctcaaggagcagctggccatcgtggagcgcaggaatggcctcctgctggaggagctggag5160


gaaatgaaggtggccctggaacagacggagcggacccgcaggctgtcagagcaggagctg5220


ctggacgccagcgaccgcgtgcagctcctgcactcccagaacacaagcctgataaatacc5280


aagaaaaaactggaggctgacatagctcagtgccaggcagaggtggagaactcgatccag5340


gagtccaggaacgcagaggagaaggccaagaaggccatcacggatgctgccatgatggct5400


gaggagctaaagaaggaacaggacaccagcgcccacctggagcggatgaagaagaacctg5460


gagcagacggtgaaggacctgcagcaccgtctagatgaggctgaacaactggcgctgaag5520


ggcgggaagaagcagatccagaaactggagaaccgggtgcgggagctggaaaatgagctt5580


gatgtggaacagaagaggggagctgaagccctgaagggagcccacaagtacgaacgcaaa5640


gtcaaggagatgacttaccaggctgaggaggaccgcaagaatatccttaggctccaggac5700


ctggtggacaagctgcaggccaaagtgaagtcttacaagaggcaggctgaggaggcggag5760


gagcaggccaacacgcagctgtccagatgccggagagtccagcatgagctagaggaggcc5820


gcggagagggcggacatcgctgagtcccaggtcaacaagctgagggccaagagccgagac5880


gtgggcagccagaagatggaagaatgaggctcacctgatgctcgttgccatgggacacct5940


ccgagagagtggagggaaaatgtgtgagaaataaattctcctaaatactcgg 5992


<210> 39
<211> 661
<2l2> DNA
<213> Human
<400> 39
ggagtggcag ccggagtctg aactgtcctg ggggaccaag caggagctta agatgggcaa 60
gacctggggc cctgggcaga cgcatcaaag caggcagaag caggcatggc cagcaggaag 120
accaagaaga aggaaggggg tgccctccgg gcccagagag cctcatccaa tgtcttctcc 180
aactttgagc agactcagat ccaggagttc aaggaggcat tcacactcat ggatcagaac 240
cgagatggct tcattgacaa ggaggacctg aaggacacct atgcctccct gggcaagacc 300
aacgtcaagg acgacgagct ggacgccatg ctcaaagagg cctcggggcc catcaacttc 360
138/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
accatgtttc tgaacctgtt tggggagaag ctgagcggta ccgacgccga ggagaccatt 420
cttaacgcct tcaagatgct ggacccggac gggaaaggga aaatcaacaa ggagtacatc 480
aagcgtctgc tgatgtccca ggctgacaag atgacggcgg aagaggtgga ccagatgttc 540
cagttcgcct ccatcgatgt ggcgggcaac ctggactaca aggcgctcag ctacgtgatc 600
acccacgggg aggagaagga ggagtgagac cca.gccgggt caataaacct ggacgcttgg 660
a 661
<210> 40
<211> 5749
<212> DNA
<2l3> Human
<400>
40


cgcgggagccaacttcaggctgctcagaggaagcccgtgcagtcagtcacctgggtgcaa60


gagcgttgctgcctcgggctctcccgctgcagggagagcggcactcgctggcctggatgt120


ggttggatttaggggggctccgcagcaggggtttcgtggcggtggcaagcgctgcaacag180


gtagacggcgagagacggaccccggccgaggcagggatggagaccaaaggctaccacagt240


ctccctgaaggtctagatatggaaagacggtggggtcaagtttctcaggctgtggagcgt300


tcttccctgggacctacagagaggaccgatgagaataactacatggagattgtcaacgta360


agctgtgtttccggtgctattccaaacaacagtactcaaggaagcagcaaagaaaaacaa420


gaactactcccttgccttcagcaagacaataatcggcctgggattttaacatctgatatt480


aaaactgagctggaatctaaggaactttcagcaactgtagctgagtccatgggtttatat540


atggattctgtaagagatgctgactattcctatgagcagcagaaccaacaaggaagcatg600


agtccagctaagatttatcagaatgttgaacagctggtgaaattttacaaaggaaatggc660


catcgtccttccactctaagttgtgtgaacacgcccttgagatcatttatgtctgactct720


gggagctccgtgaatggtggcgtcatgcgcgccattgttaaaagccctatcatgtgtcat780
'


gagaaaagcccgtctgtttgcagccctctgaacatgacatcttcggtttgcagccctgct840


ggaatcaactctgtgtcctccaccacagccagctttggcagttttccagtgcacagccca900


atcacccagggaactcctctgacatgctcccctaatgctgaaaatcgaggctccaggtcg960


cacagccctgcacatgctagcaatgtgggctctcctctctcaagtccgttaagtagcatg1020


aaatcctcaa tttccagccc tccaagtcac tgcagtgtaa aatctccagt ctccagtccc 1080
aataatgtca ctctgagatc ctctgtgtct agccctgcaa atattaacaa ctcaaggtgc 1140
tctgtttcca gcccttcgaa cactaataac agatccacgc tttccagtcc ggcagccagt 1200
139/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
actgtgggat ctatctgtag ccctgtaaac aatgccttca gctacactgc ttctggcacc 1260
tctgctggat ccagtacatt gegggatgtg gttcccagtc cagacacgca ggagaaaggt 1320
gctcaagagg tcccttttcc taagactgag gaagtagaga gtgccatctc aaatggtgtg 1380
actggccagc ttaatattgt ccagtacata aaaccagaac cagatggagc ttttagcagc 1440
tcatgtctag gaggaaatag caaaataaat tcggattctt cattctcagt accaataaag 1500
caagaatcaa ccaagcattc atgttcaggc acctctttta aagggaatcc aacagtaaac 1560
ccgtttccat ttatggatgg ctcgtatttt tcctttatgg atgataaaga ctattattcc 1620
ctatcaggaa ttttaggacc acctgtgccc ggctttgatg gtaactgtga aggcagcgga 1680
ttcccagtgg gtattaaaca agaaccagat gacgggagct attacccaga ggccagcatc 1740
ccttcctctg ctattgttgg ggtgaattca ggtggacagt ccttccacta caggattggt 1800
gctcaaggta caatatcttt atcacgatcg gctagagacc aatctttcca acacctgagt 1860
tcctttcctc ctgtcaatac tttagtggag tcatggaaat cacacggcga cctgtcgtct 1920
agaagaagtg atgggtatcc ggtcttagaa;tacattccag aaaatgtatc aagctctact 1980
ttacgaagtg tttctactgg atcttcaaga ccttcaaaaa tatgtttggt gtgtggggat 2040
gaggcttcag gatgccatta tggggtagtc acctgtggca gctgcaaagt tttcttcaaa 2100
agagcagtgg aagggcaaca caactattta tgtgctggaa gaaatgattg catcattgat 2160
aagattcgac gaaagaattg tcctgcttgc agacttcaga aatgtcttca agctggaatg 2220
aatttaggag cacgaaagtc aaagaagttg ggaaagttaa aagggattca cgaggagcag 2280
ccacagcagc agcagccccc acccccaccc ccacccccgc aaagcccaga ggaagggaca 2340
acgtacatcg ctcctgcaaa agaaccctcg gtcaacacag cactggttcc tcagctctcc 2400
acaatctcac gagcgctcac accttccccc gttatggtcc ttgaaaacat tgaacctgaa 2460
attgtatatg caggctatga cagctcaaaa ccagatacag ccgaaaatct gctctccacg 2520
ctcaaccgct tagcaggcaa acagatgatc caagtcgtga agtgggcaaa ggtacttcca 2580
ggatttaaaa acttgcctct tgaggaccaa attaccctaa tccagtattc ttggatgtgt 2640
ctatcatcat ttgccttgag ctggagatcg tacaaacata cgaacagcca atttctctat 2700
tttgcaccag acctagtctt taatgaagag aagatgcatc agtctgccat gtatgaacta 2760
tgccagggga tgcaccaaat cagccttcag ttcgttcgac tgcagctcac ctttgaagaa 2820
tacaccatca tgaaagtttt gctgctacta agcacaattc caaaggatgg cctcaaaagc 2880
caggctgcat ttgaagaaat gaggacaaat tacatcaaag aactgaggaa gatggtaact 2940
140/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aagtgtcccaacaattctgggcagagctggcagaggttctaccaactgaccaagctgctg3000


gactccatgcatgacctggtgagcgacctgctggaattctgcttctacaccttccgagag3060


tcccatgcgctgaaggtagagttccccgcaatgctggtggagatcatcagcgaccagctg3120


cccaaggtggagtcggggaacgccaagccgctctacttccaccggaagtgactgcccgct3180


gcccagaagaactttgccttaagtttccctgtgttgttccacacccagaaggacccaaga3240


aaacctgtttttaacatgtgatggttgattcacacttgttcaacagtttctcaagtttaa3300


agtcatgtcagaggtttggagccgggaaagctgtttttccgtggatttggcgagaccaga3360


gcagtctgaaggattccccacctccaatcccccagcgcttagaaacatgttcctgttcct3420


cgggatgaaaagccatatctagtcaataactctgattttgatattttcacagatggaaga3480


agttttaactatgccgtgtagtttctggtatcgttcgcttgttttaaaagggttcaagga3540


ctaacgaacgttttaaagcttacccttggtttgcacataaaacgtatagtcaatatgggg3600


cattaatattcttttgttattaaaaaaacacaaaaaaataataaaaaaatatatacagat3660


tcctgttgtgtaataacagaactcgtggcgtggggcagcagctgcctctgagccctcgct3720


cgtccacggtcttctgcatcactggtatacacactcgttagcgtccatttcttatttaat3780


tagaatggataagatgatgttaaatgccttggtttgatttctagtatctattgtgttggc3840


tttacaaataattttttgcagtcttttgctgtgctgtacattactgtatgtataaattat3900


gaaggacctgaaataaggtataaggatcttttgtaaatgagacacatacaaaaaaaatct3960


ttaatggttaataggatgaatgggaaagtatttttgaaagaattctattttgctggagac4020


tatttaagtactatctttgtctaaacaa~ggtaatttttttttgtaaagtgcaatgtcctg4080


catgcataatgaaccgtttacagtgtatttaagaaagggaaagctgtgccttttttagct4140


tcatatctaatttaccattattttacagtctctgttgtaaataaccacactgaaacctct4200


tcggttgtcttgaaacctttctactttttctgtactttttgttttgttcttggtctcccg4260


cttggggcatttgtgggactccagcacgttttctggcttctgcttcatcctgctccatcg4320


gggaatgacacactgcggtgtctgcagctcctggaaggtgtcatttgacaacacatgtgg4380


gagaggaggtccttggagtgctgcagctttgggaaagcctgcctcgtttcccttttcctc4440


tagaagcagaaccagctctacgagagtgagactgggaacttgatggctcagagagcatct4500


tttcctcccattttagaaaatcagattttctcctgtgggaaaaaaaaattccatgcactc4560


tctctctgttaaagatcagctattcccttctgatcttggaaagaggttctgcactcctgg4620


aaccggtcacaggaacgcacagatcatggcaggatgcgctgggacggcccatcttggcaa4680


ggttcagtctgaatggcatggagaccgggagatagaggggttttagatttttaaaaggta4740


141/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ggttttaaaaataagttttatacataaacagttttggagaaaaattacagatcatataag4800
r


caagacagtggcactaaaatgtttaattcattaatctgtttgtttggcactgatgcaatg4860


tatggcttttctcttgccccaaatcacaaacatatgtatctttggggaaactaacaatat4920


gattgcactaaataaactactttgaatagaggccaaattaatcttttaaaaatgatgata4980


atcatcaggtttactcagtgaaatcatattaattattttccaaaatctaaaagctgtagc5040


tggagaagcc catggccacg aggaagcagc aattaattag atcaacactt ttctccaggg 5100
ttcaccatgc aggcaacatt accttgtctt tcaaaagaca cctgccttag tgcaagggga 5160
aacctgtgaaagctgcactcagagggaggagtctttcttacataatttgcaatttcagga5220


atttaatttataggcagatctttaaatacagtcaacttacggtgcacagtaatatgaaag5280


ccacactttgaaggtaataaatacacagcatgcagactgggagttgctagcaaacaaatg5340


gcttacttacaaaagcagcttttagttcagacttagtttttataaaatgagaattctgac5400


ttacttaaccaggtttgggatggagatggtctgcatcagctttttgtattaacaaagtta5460


ctggctctttgtgtgtctccaggtaactttgcttgattaaacagcaaagccatattctaa5520


attcactgttgaatgcctgtcccagtccaaattgtctgtctgctcttatttttgtaccat5580


attgctcttaaaaatcttggtttggtacagttcataattcaccaaaaagttcatataatt5640


taaagaaacactaaattagtttaaaatgaagcaatttatatctttatgcaaaaacatatg5700


tctgtctttgcaaaggactgtaagcagattacaataaatcctttacttt 5749


<210> 41
<211> 2306
<212> DNA
<213> Human
<400>
41


tcatcatccaagtttgtagttcatttaaaaatacaacattaaacacattttgctaggatg 60


tcaaatagtcacagttctaagtagttggaaacaaaattgacgcatgttaatctatgcaaa 120


gagaaaggaaaggatgaggtgatgtattgactcaaggttcattcttgctgcaattgaaca 180


tcctcaagagttgggatggaaatggtgatttttacatgtgtcctggaaagatattaaagt 240


aattcaaatcttccccaaaggggaaaggaagagagtgatactgacctttttaagtcatag 300


accaaagtctgctgtagaacaaatatgggaggacaaagaatcgcaaattcttcaaatgac 360


tattatcagtattattaacatgcgatgccacaggtatgaaagtcttgccttatttcacaa 420


ttttaaaaggtagctgtgcagatgtggatcaacatttgtttaaaataaagtattaatact 480


ttaaagtcaaataagatatagtgtttacattctttaggtcctgaggggcagggggatctg 540


142/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tgatataacaaaatagcaaaagcggtaatttccttaatgttatttttctgattggtaatt600


atttttaacagtacttaattattctatgtcgtgagacactaaaatcaaaaacgggaatct660


catttagactttaatttttttgagattatcggcggcacaatcactttgtagaaactgtaa720


aaaataaaagtatctcctagtcccttaattttttcataaatatttctggcttttgagtag780


tgtatttatattgtatatcatactttcaactgtagacaattatgatgctaatttattgtt840


tcttggtttcacctttgtataagatatagccaagactgaagaaaccaaatatatgtgttt900


actgtagcatgtcttcaaattagtggaacttagttcagggacatagaagagtcttaatga960


attaaaatcattcacttgattaaatgtctgtaaatcttcatcattcctactgtagtttat1020


ttaatatctattgtaaattatgtgacttgtagcttcctctggttttcaagtaaactcaac1080


aaggtggagtcttacctggttttcctttccaagcattgtaaattgtataccaaagatatt1140


agttattacttctgtgtgtacaaagaggattattttattatgtttattaatcacctctaa1200


tactcatccacatgaagggtacacattaggtaagctgggcgttgactcatgcgcagtctc1260


agtcacccgtgttatcttcgtggctcaaaggacaatgcaaaatcgccgatcagagctcat1320


acccaaagcattacagagaacagcagcatcattgccctccccagctgaaaaacaagttgg1380


ctagaagatacatggagaggaatggtgtggtcaacagttaatgaaacggttctatcatgc1440


atgtgtaatgtggatggagacaattataagatttgactataactatttggagggtcttta1500


acattgccaaaaaaacaaatatgttgatttttattttattttattttttattttaagagg1560


cgggatcttgatctcacatgttgcccaggctggccttgaactcctgggctcaagcattcc1620


tcctgcctcagcctcccccatagctgggactaggggtgcatgccagcatacctggctacg1680


ttgactcttaaaatctatgttctcttattttaaagatacagtgctccccactgaaaatta1740


aacctaaaaaatgtcacatattggtatgttgttaacctggtagattaaatcatgagaatg1800


attagaaagacgggcaacacagcgggttacatccacactgctgatcacaccaacgacagg1860


agctgataag caagaaagcg tcacagccag cgtctgttca cccaaggttg acaagtgaag 1920
tttctctaat gttgattgtt agccgatttg taacctggca tttacttagc aactgcctta 1980
tcaattacag gatttgccgg taaaagcaga ctcaaatata aaggtttttg gcttaacttg 2040
gtttattata gttgctctat gtttgtaaac agacaatctc taatgtctga ttatttgtat 2100
cacagatctg cagctgcctt ggacttgaat ccatgcaatg tttagagtgt gaagtcagtt 2160
acttgttgat gttttcttac tgtatcaatg aaatacatat tgtcatgtca gttcttgcca 2220
ggaacttctc aacaaaatgg aatttttttt ttcagtattt caataaatat tgatatgccc 2280
143/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
agcctgataa aaaaaaaaaa aaaaaa 2306
<210> 42
<211> 7609
<212> DNA
<213> Human
<400>
42


atctaccaccttaaaaccctgatctagaaaaaatatatattcatgataggaagttataac 60


taagaaaatttatttgcctcttaatgctcctgaatgaaagaaattatccctttgttcttt 120


gggaggacttgtgtatctgagattgttgtaataatcagtcattttattaaaaccttgaca 180


tgatcaccagggaggaaaaatagagcaatagtcaaaacctgtgtgttagtccaagatgac 240


ttctgaagaaatgacagcttctgttctcatacctgtgactcagagaaaagtggtttctgc 300


ccagtcggctgcagatgaaagtagtgaaaaggtctcagacatcaatatttcaaaagcaca 360


tactgtcagacgaagtggggagacttctcataccatctcacaactgaacaaacttaaaga 420


agaaccttctggaagcaacttgccaaagattctctcaatagcgagggagaaaatagtgag 480


tgatgagaacagtaatgaaaaatgttgggagaaaatcatgccagattctgcgaaaaacct 540


taacattaactgcaacaacatattgagaaaccatcagcatggccttcctcagagacaatt 600


ttatgaaatgtacaactctgttgctgaggaagacttgtgtttagaaactggaattccttc 660


tccactggaaagaaaggtgttccctggaattcaactggaactagacagaccttccatggg 720


cattagtcctttaggaaatcagtcagtgatcatagagacaggcagagcacaccctgacag 780


cagaagggcagtatttcattttcattatgaagttgacagaagaatgtcagacactttctg 840


taccctatcagaaaacttaattttagacgattgtggaaattgtgtaccactacctggggg 900


tgaggagaagcaaaagaaaaactatgtggcatatacctgtaaactgatggaattggccaa960


aaattgtgataataagaatgagcagctgcagtgtgatcattgtgacaccttgaatgataa1020


atacttttgctttgaaggctcttgtgagaaggttgacatggtatattcaggtgatagctt1080


ttgtaggaaagactttactgacagtcaagctgccaagacctttttgagccattttgagga1140


cttccctgataattgtgatgatgtagaagaagacgcttttaaaagcaaaaaggagcgatc1200


cactttgttagtcaggagattctgtaaaaatgacagagaagttaagaaatctgtgtatac1260


tggaacaagagcaattgtgagaactctgccttctggccacattgggctgactgcatggag1320


ttacatagatcagaagagaaatggtcccttactgccttgtgggagagtaatggaaccccc1380


gtcaacagtggagataaggcaagatgggagccaacgtctgtcagaagcccagtggtatcc1440


tatctacaatgcagtgagaagagaagaaacagaaaatacagttggatctctactccattt1500


144/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
cctcaccaag ctcccagcct ccgagacagc ccatggaagg ataagcgttg gtccatgctt 1560
aaagcaatgt gtccgagaca ctgtatgtga gtatcgcgcc accctccaaa ggacttcaat 1620
atcgcagtac atcaccggtt ctctcctaga agcaaccacg tctttgggag caagaagtgg 1680
ccttctcagt acttttggag gatccactgg acgaatgatg ctgaaagaac gccagccagg 1740
cccctctgtg gccaattcca atgccctccc ttcaagttca gctgggatca gcaaggagct 1800
gatcgatctg cagcctctca tccagttccc agaggaagtc gccagcatcc tgatggagca 1860
agagcagact atttaccgca gggtcttgcc agtcgactac ctttgcttct taacacggga 1920
cttgggcact cctgaatgcc agagctcctt gccctgcctc aaagcatcca tctcagcgtc 1980
gattcttacc actcagaatg gagagcacaa tgcccttgaa gatctggtga tgaggtttaa 2040
tgaggtgagc tcctgggtga catggctgat cctcacggca ggctccatgg aggagaagcg 2100
agaagtcttt tcatatttgg tgcatgtggc caaatgctgc tggaacatgg gcaactacaa 2160
cgctgtcatg gagttcttgg ctggcctcag gtcaagaaaa gttttaaaaa tgtggcagtt 2220
catggaccag tctgatattg agaccatgag gagcctgaag gatgctatgg cccagcatga 2280
gtcctcttgt gagtacagaa aggtggtgac acgtgccctg cacatccctg gctgtaaggt 2340
ggttccattc tgtggggtgt ttctgaagga gctctgtgaa gtgcttgacg gcgcctccgg 2400
tctcatgaag ctttgcccgc ggtacaattc ccaagaagaa actttagagt ttgtagcaga 2460
ttacagtgga caagataatt tcttacaacg agtgggacaa aatggcttaa agaattcgga 2520
gaaggagtcc actgtcaaca gcatctttca ggtcatccgg agctgcaatc gaagtctgga 2580
gacagacgag gaggacagcc ccagtgaagg gaacagctcc aggaaaagct ccttgaagga 2640
taaaagccga tggcagttta taattggaga tttgttggat tcagacaatg acatctttga 2700
gcaatccaaa gaatacgact ctcatggttc agaggactca cagaaggcct tcgaccatgg 2760
gacggagctc atcccttggt acgtgctgtc catccaagcc gatgtgcacc agttcctgct 2820
gcagggggcc acggtcatcc actacgacca ggacacacac ctctctgccc gctgcttcct 2880
ccagcttcag cccgacaata gcaccttgac ctgggtaaag cccacaactg cctccccagc 2940
cagcagtaaa gcaaaacttg gtgtacttaa taacacagct gagcctggaa aattcccact 3000
actgggtaat gctggattaa gtagcctgac ggaaggggtc ttggatcttt ttgcagtgaa 3060
ggctgtatac atgggccacc ctggcattga tatacacact gtgtgtgttc agaacaaact 3120
gggtagcatg ttcctgtcag agactggtgt gacattgctc tatgggcttc agaccacaga 3180
caacagatta ttgcacttcg tggcaccaaa gcacacagct aaaatgctct tcagcggatt 3240
attggaactc actagagctg tgagaaagat gaggaaattc cctgaccaaa gacagcagtg 3300
145/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gctgcggaaa cagtacgtca gcctttatca ggaggatgga cggtatgaag gcccaacttt 3360
ggctcacgct gtggagttgt ttggtggcag acggtggagt gctcgaaacc ccagccccgg 3420
aacatcagca aagaatgctg agaagcccaa tatgcagaga aacaataccc tgggcataag 3480
cactaccaag aaaaagaaga aaatcctcat gaggggtgag agtggagagg taactgacga 3540
tgagatggcaacccgaaaggccaagatgcacaaagagtgtcgaagccggagtggttctga3600


tcctcaagacattaatgaacaagaagaatcagaggtgaatgccatcgctaaccctccaaa3660


ccccctcccttccagaagagcccactctttgaccacagctgggtcccccaacttggctgc3720


cgggacgtcatctcccatcaggccagtgtcctcccctgtgctgtcttcttcaaacaagag3780


cccatccagtgcttggagcagtagtagctggcacgggcggatcaaaggcggcatgaaggg3840


atttcagagcttcatggtttcagatagcaacatgagttttgttgaatttgttgagctgtt3900


caaatcattcagtgtcaggagccgcaaggacctgaaggatctgtttgatgtctatgcagt3960


gccctgcaaccgatctggctccgagtcagccccactctacaccaacctgacaattgatga4020


aaacaccagcgatcttcagcctgacctagatctgttgaccagaaatgtctcggatttggg4080


gttgttcattaagagtaaacagcagctatcggacaaccagaggcagatatctgatgccat4140


tgctgctgcaagcattgtgacaaatggcactgggattgagagcacatctctgggcatttt4200


tggggtgggcatacttcagctcaacgatttcctcgtgaattgccaaggagaacactgcac4260


ttatgatgaaatcctcagcatcatccagaagttcgagcctagcatcagtatgtgtcatca4320


gggactaatgtcatttgaagggtttgccaggtttctgatggataaagaaaattttgcctc4380


aaaaaatgatgagtcacaggagaacattaaagaactgcagctacccctctcatactatta4440


catcgaatcttcgcacaatacctacctcacgggccatcagctcaaaggagaatcctcggt4500


agaactctacagccaggtccttttgcaaggctgtcgaagtgtagaattggactgctggga4560


cggagacgatgggatgcccatcatttatcatggacatacgccgacaaccaagatcccctt4620


caaggaagtggttgaagccattgatcgcagtgccttcatcaactctgacctgccaatcat4680


catatcgattgagaaccactgttcattgcctcagcaacgaaaaatggcagaaattttcaa4740


gactgtgtttggagaaaagctggtgactaaattcttatttgagactgatttctcagatga4800


tccaatgcttccttcacctgaccaactcagaaagaaagttcttcttaaaaacaagaagct4860


aaaagcccatcagacgccagtggatatcttaaagcaaaaggctcatcagttagcatctat4920


gcaagtgcaggcttataatggtgggaatgccaacccccgacctgccaataatgaggaaga4980


ggaagatgaggaggacgaatatgattatgactatgaatccctttctgatgacaacattct5040


146/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ggaagacaga cctgaaaata aatcatgtaa tgacaagctt cagtttgaat ataatgaaga 5100
aatcccaaag aggataaaga aagcagataa ctctgcttgc aacaaaggaa aggtttatga 5160
tatggaactg ggagaagaat tttatcttga tcagaataaa aaggaaagca gacagattgc 5220
accagagctt tctgaccttg taatctatcg tcaagcagta aaatttccag gactgtcaac 5280
tctaaatgca tctggctcta gcagaggaaa agaaaggaaa agcaggaagt ccatttttgg 5340
caacaatccg ggcagaatga gcccagggga gacagcatca tttaacaaaa catctggaaa 5400
aagttcctgt gaaggcattc gacagacctg ggaggaatct tcttcccccc tcaacccaac 5460
cacgtccctc agtgctatca ttagaactcc caaatgttat catatctcgt cgctgaatga 5520
aaatgccgcc aaacgtctgt gtcgcaggta ttctcagaaa ctgatccagc acaccgcctg 5580
tcagctgctg agaacttacc ctgctgccac ccgcatcgac tcttccaacc cgaaccccct 5640
catgttctgg ctccatggga tacagcttgt ggcactcaac taccagactg atgatctccc 5700
tttacattta aatgctgcaa tgtttgaggc aaatggtggt tgtggttatg tattgaaacc 5760
tccagttctg tgggacaaga actgccccat gtatcagaag ttttctccac tagaaagaga 5820
tctggacagc atggatcctg cagtctattc tttaactatt gtctctggtc agaatgtgtg 5880
ccccagtaat agcatgggaa gcccgtgcat tgaagtcgac gtcctgggca tgcctctgga 5940
cagctgccat ttccgcacaa agcccatcca tcgaaacacc ctgaacccca tgtggaacga 6000
gcagtttctg ttccgcgttc acttcgaaga tcttgtattt cttcgttttg cagttgtgga 6060
aaacaatagt tcagcggtaa ctgctcagag aatcattcca ctgaaagctt taaaacgagg. 6120
atatcgacat cttcagctgc gaaaccttca caatgaagtc ttggagattt ctagtttatt 6180
cattaacagc agaaggatgg aagaaaattc ctctggcaat accatgtcag cctcttcgat 6240
gtttaataca gaagaaagaa aatgtttgca gactcacaga gtcacggtgc atggggtccc 6300
agggccagag ccctttaccg ttttcactat taatggaggc accaaggcaa agcagcttct 6360
gcagcaaatt ctgacaaatg aacaagacat caaacctgtt accacagact attttttgat 6420
ggaagaaaaa tattttatat ctaaagaaaa gaatgaatgt aggaaacaac cattccagag 6480
agccattggt ccagaagagg agatcatgca aattttaagc agctggtttc cagaagaggg 6540
atacatgggc aggattgtct taaaaaccca gcaggaaaac ctagaagaga aaaacattgt 6600
tcaagatgac aaagaggtga tcttgagctc agaggaggag agtttctttg tccaagtgca 6660
tgatgtttct ccagagcaac ctcgaacagt catcaaagca ccccgcgtca gcactgcaca 6720
ggatgtcatt cagcagacct tatgcaaagc caaatattcc tacagcatcc tgagcaaccc 6780
caatccaagc gactatgtgc ttttggaaga ggtggtgaaa gacactacca acaagaagac 6840
147/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
taccacacca aagtcctctc agcgggtcct tctggatcag gagtgtgtgt ttcaagccca 6900
aagcaagtgg aaaggtgcag gaaaattcat ccttaagcta aaggagcagg tgcaggcatc 6960
tcgagaagat aaaaagaaag gcatttcttt cgcaagtgaa ctcaagaagc tcaccaagtc 7020
aactaaacag ccccgaggac ttacatcacc ttctcagctc ttgacctcag aaagtatcca 7080
aaccaaggaggagaaacctgtgggtggcttgtctccagtgacacaatggattaccgacag7140


tgactaagggcagcatgtttaacccaggtggagatctttaagcaagaagttaaagagtga7200


acatggtggaaaaaatataattattttcatcagacttaaactggaaattgatgatttctg7260


aactgaagccttcacacatgtgagatccatgctgaggagaagcaaaatggcacagggcta7320


gttgccaccaaccaatttactgatgaatgaagcccaggggactgccattttataaatgtc7380


agcagttggaaaaatcgtcacgaattgacttagagcaagggtcagcaagcttgtctgtaa7440


agggccaaacagtaaatattttagggctgggggccataaaatatgttgcaaccacccaat7500


tctgccattgtagtgcaaaagcagccatagacaacacatacatgaacgaacgtggctgta7560


ttccaataaaactttatttatggacactgaaaaaaaaaaaaaaaaaaaa 7609


<210> 43
<211> 1922
<212> DNA
<213> Human
<400>
43


gcacgagaatgtccctgagacccagaagggcctgcgctcagctgctctggcaccccgctg60


cagggatggcctcctgggctaagggcaggagctacctggcgcctggtttgctgcagggcc120


aagtggccatcgtcaccggcggggccacgggcatcggaaaagccatcgtgaaggagctcc180


tggagctggggagtaatgtggtcattgcatcccgtaagttggagagattgaagtctgcgg240


cagatgaactgcaggccaacctacctcccacaaagcaggcacgagtcattcccatacaat300


gcaacatccggaatgaggaggaggtgaataatttggtcaaatctaccttagatacttttg360


gtaagatcaatttcttggtgaacaatggaggaggccagtttctttcccctgctgaacaca420


tcagttctaagggatggcacgctgtgcttgagaccaacctgacgggtaccttctacatgt480


gcaaagcagtttacagctcctggatgaaagagcatggaggatctatcgtcaatatcattg540


tccctactaaagctggatttccattagctgtgcattctggagctgcaagagcaggtgttt600


acaacctcaccaaatctttagctttggaatgggcctgcagtggaatacggatcaattgtg660


ttgcccctggagttatttattcccagactgctgtggagaactatggttcctggggacaaa720


gcttctttgaagggtcttttcagaaaatccccgctaaacgaattggtgttcctgaggagg780


148/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tctcctctgtggtctgcttcctactgtctcctgcagcttccttcatcactggacagtcag840


tggatgtggatgggggccggagtctctatactcactcgtatgaggtaccagatcatgaca900


actggcccaagggagcaggggacctttctgttgtcaaaaagatgaaggagacctttaagg960


agaaagctaagctctgagctgaggaaacaaggtgtcctccatcccccagtgccttcacat1020


cttgaggatatgcttctgtactttttaaaagcttatagttggtatggaaaacatttttct1080


tatttttaagtgttattaattatatctatggaaaaactattcctgaaatatatacagtct1140


tatgtcccaatcagagtcttttaacctatgatttaaaaatgtataagtaacagaaattaa1200


catattttaatgactttactttttatttctaagaaaagtatttgaaaaatggaataattt1260


taaatcaatgataattctagggatcatgaactcccagaagattttattatttaattgtaa1320


aggtagaggccggacgcagtggctcacgcctgtaattccagcactttgggaggccgaggt1380


gggcgggtcagttgaggtcaggagttcaagaccaggctggccaacatggtaaaaccctgt1440


ctctactgaaaaacaacaaaaacaaaaacacaaattagtcgggtgtggtggcacacacct1500


gtagtcccaggtacttgggaggctgaggcaggaggatcgcttgaacccaggaagcagagg1560


ttgcagtgagctgagatcgtgctactgcagtccagcctgggctacagagtgagactgcat1620


ctcaaaaaaaacccmaaaaaacaaaaacaaacaacaacaacaaaattataaaggtagaaa1680


ataaatctaaattgtgtcgtaattaagattattaaaatgagaattatacaatgacttatt1740


tttggtggcaaatactttaggagcaataatgccttatggtaattattgatgtatagtttt1800


ttttgtttatgaagtcaaatttgtataaatttttttaattcaaaggaaaagttttatgtg1860


attttaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa1920


1922
as
<210> 44
<211> 1182 '
<212> DNA
<213> Human
<400> 44
aggacaccag gcacagagat ccaaactatt atatcaaatc caatccctaa aatggaagaa 60
gccaaaagcc aaagtttgga ggaagacttt gaaggacagg ccacacatac aggacccaaa 120
ggagtaataa atgattggag aaagtttaaa ttagagagtc aagacagtga ttcaattcca 180
cctagcaaga aggagattct caggcaaatg tcttctcctc agagtaggaa tggcaaagat 240
tcaaaggaac gagtcagcag aaagatgagc attcaagaat atgaactaat ccataaagag 300
aaagaggatg aaaactgcct tcgtaaatac cgtagacagt gtatgcagga tatgcaccag 360
149/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aagctgagttttgggcctagatatgggtttgtgtatgagctggaaactggaaagcaattc420


ctagaaacaattgaaaaggaactgaagatcaccacaattgttgttcacatttatgaagat480


ggtattaagggttgtgatgctctaaacagtagtttaacatgccttgcagcagaataccct540


atagttaagttttgtaaaataaaagcttcgaatacaggtgctggggaccgcttttcctta600


gatgtacttcctacactgctcatctataaaggtggggaactcataagcaattttattagt660


gttgctgaacagtttgctgaagaattttttgctggggatgtggagtctttcctaaatgaa720


tatgggttactacctgaaagagaggtacatgtcctagagcataccaaaatagaagaagaa780


gatgttgaatgaagattcactatgtcaatatctcatgtttatcctttaggtattggatga840


tggttttggtagtatctatattgcttttgtgaacacagagtatgggcacggctatgctaa900


cttgacaaaaatgactgatgcaacaatcgagttattagcatttcatagtattagttactc960


aaattgatacaatgcttgactacaaaacaaagctgtcttcagcaacattattagtagaca1020


aagaggatgtggataatattatgacatttttcaaaaatccctttcaagttatgttttgtc1080


ttttttactccattttccctcatcactgttattatttggacttttcaaattacattattc1140


attataattttctttgtgtaataaaaatgaaatctcatgaag 1182


<210> 45
<211> 3160
<212> DNA
<213> Human
<400> 45
cctcccctcg cccggcgcgg tcccgtccgc ctctcgctcg cctcccgcct cccctcggtc 60
ttccgaggcgcccgggctcccggcgcggcggcggagggggcgggcaggccggcgggcggt 120


gatgtggcaggactctttatgcgctgcggcaggatacgcgctcggcgctgggacgcgact 180


gcgctcagttctctcctctcggaagctgcagccatgatggaagtttgagagttgagccgc 240


tgtgaggcgaggccgggctcaggcgagggagatgagagacggcggcggccgcggcccgga 300


gcccctctcagcgcctgtgagcagccgcgggggcagcgccctcggggagccggccggcct 360


gcggcggcggcagcggcggcgtttctcgcctcctcttcgtcttttctaaccgtgcagcct 420


cttcctcggcttctcctgaaagggaaggtggaagccgtgggctcgggcgggagccggctg 480


aggcgcggcggcggcggcggcggcacctcccgctcctggagcgggggggagaagcggcgg 540


cggcggcggccgcggcggctgcagctccagggagggggtctgagtcgcctgtcaccattt 600


ccagggctgggaacgccggagagttggtctctccccttctactgcctccaacacggcggc 660


ggcggcggcg gcacatccag ggacccgggc cggttttaaa cctcccgtcc gccgccgccg 720
150/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
caccccccgtggcccgggctccggaggccgccggcggaggcagccgttcggaggattatt780


cgtcttctccccattccgctgccgccgctgccaggcctctggctgctgaggagaagcagg840


cccagtcgctgcaaccatccagcagccgccgcagcagccattacccggctgcggtccaga900


gccaagcggcggcagagcgaggggcatcagctaccgccaagtccagagccatttccatcc960


tgcagaagaagccccgccaccagcagcttctgccatctctctcctcctttttcttcagcc1020


acaggctcccagacatgacagccatcatcaaagagatcgttagcagaaacaaaaggagat1080


atcaagaggatggattcgacttagacttgacctatatttatccaaacattattgctatgg1140


gatttcctgcagaaagacttgaaggcgtatacaggaacaatattgatgatgtagtaaggt1200


ttttggattcaaagcataaaaaccattacaagatatacaatctttgtgctgaaagacatt1260


atgacaccgccaaatttaattgcagagttgcacaatatccttttgaagaccataacccac1320


cacagctagaacttatcaaacccttttgtgaagatcttgaccaatggctaagtgaagatg1380


acaatcatgttgcagcaattcactgtaaagctggaaagggacgaactggtgtaatgatat1440


gtgcatatttattacatcggggcaaatttttaaaggcacaagaggccctagatttctatg1500


gggaagtaaggaccagagacaaaaagggagtaactattcccagtcagaggcgctatgtgt1560


attattatagctacctgttaaagaatcatctggattatagaccagtggcactgttgtttc1620


acaagatgatgtttgaaactattccaatgttcagtggcggaacttgcaatcctcagtttg1680


tggtctgccagctaaaggtgaagatatattcctccaattcaggacccacacgacgggaag1740


acaagttcatgtactttgagttccctcagccgttacctgtgtgtggtgatatcaaagtag1800


agttcttccacaaacagaacaagatgctaaaaaaggacaaaatgtttcacttttgggtaa1860


atacattcttcataccaggaccagaggaaacctcagaaaaagtagaaaatggaagtctat1920


gtgatcaagaaatcgatagcatttgcagtatagagcgtgcagataatgacaaggaatatc1980


tagtacttactttaacaaaaaatgatcttgacaaagcaaataaagacaaagccaaccgat2040


acttttctccaaattttaaggtgaagctgtacttcacaaaaacagtagaggagccgtcaa2100


atccagaggctagcagttcaacttctgtaacaccagatgttagtgacaatgaacctgatc2160


attatagatattctgacaccactgactctgatccagagaatgaaccttttgatgaagatc2220


agcatacacaaattacaaaagtctgaatttttttttatcaagagggataaaacaccatga2280


aaataaacttgaataaactgaaaatggacctttttttttttaatggcaataggacattgt2340


gtcagattaccagttataggaacaattctcttttcctgaccaatcttgttttaccctata2400


catccacagggttttgacacttgttgtccagttgaaaaaaggttgtgtagctgtgtcatg2460


151/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tatatacctt tttgtgtcaa aaggacattt aaaattcaat taggattaat aaagatggca 2520
ctttcccgtt ttattccagt tttataaaaa gtggagacag actgatgtgt atacgtagga 2580
attttttccttttgtgttctgtcaccaactgaagtggctaaagagctttgtgatatactg2640


gttcacatcctacccctttgcacttgtggcaacagataagtttgcagttggctaagagag2700


gtttccgaaaggttttgctaccattctaatgcatgtattcgggttagggcaatggagggg2760


aatgctcagaaaggaaataattttatgctggactctggaccatataccatctccagctat2820


ttacacacacctttctttagcatgctacagttattaatctggacattcgaggaattggcc2880


gctgtcactgcttgttgtttgcgcatttttttttaaagcatattggtgctagaaaaggca2940


gctaaaggaagtgaatctgtattggggtacaggaatgaaccttctgcaacatcttaagat3000


ccacaaatgaagggatataaaaataatgtcataggtaagaaacacagcaacaatgactta3060


accatataaatgtggaggctatcaacaaagaatgggcttgaaacattataaaaattgaca3120


atgatttattaaatatgttttctcaattgtaaaaaaaaaa 3160


<210> 46
<211> 1224
<212> DNA
<213> Human
<400> 46
gggcaggaag acggcgctgc ccggaggagc ggggcgggcg ggcgcgcggg ggagcgggcg 60
gcgggcgggagccaggcccgggcgggggcgggggcggcggggccagaagaggcggcgggc 120


cgcgctccggccggtctgcggcgttggccttggctttggctttggcggcggcggtggaga 180


agatgctgcagtccctggccggcagctcgtgcgtgcgcctggtggagcggcaccgctcgg 240


cctggtgcttcggcttcctggtgctgggctacttgctctacctggtcttcggcgcagtgg 300


tcttctcctcggtggagctgccctatgaggacctgctgcgccaggagctgcgcaagctga 360


agcgacgcttcttggaggagcacgagtgcctgtctgagcagcagctggagcagttcctgg 420


gccgggtgctggaggccagcaactacggcgtgtcggtgctcagcaacgcctcgggcaact 480


ggaactgggacttcacctccgcgctcttcttcgccagcaccgtgctctccaccacaggtt 540


atggccacaccgtgcccttgtcagatggaggtaaggccttctgcatcatctactccgtca 600


ttggcattcccttcaccctcctgttcctgacggctgtggtccagcgcatcaccgtgcacg 660


tcacccgcag gccggtcctc tacttccaca tccgctgggg cttctccaag caggtggtgg 720
ccatcgtcca tgccgtgctc cttgggtttg tcactgtgtc ctgcttcttc ttcatcccgg 780
ccgctgtctt ctcagtcctg gaggatgact ggaacttcct ggaatccttt tatttttgtt 840
152/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ttatttccct gagcaccatt ggcctggggg attatgtgcc tggggaaggc tacaatcaaa 900
aattcagaga gctctataag attgggatca cgtgttacct gctacttggc cttattgcca 960
tgttggtagt tctggaaacc ttctgtgaac tccatgagct gaaaaaattc agaaaaatgt 1020
tctatgtgaa gaaggacaag gacgaggatc aggtgcacat catagagcat gaccaactgt 1080
ccttctcctc gatcacagac caggcagctg gcatgaaaga ggaccagaag caaaatgagc 1140
cttttgtggc cacccagtca tctgcctgcg tggatggccc tgcaaaccat tgagcgtagg 1200
atttgttgca ttatgctaga gcac 1224
<210> 47
<21l> 4465
<212> DNA
<213> Human
<400>
47


caattgtcatacgacttgcagtgagcgtcaggagcacgtccaggaactcctcagcagcgc60


ctccttcagctccacagccagacgccctcagacagcaaagcctacccccgcgccgcgccc120


tgcccgccgctcggatgctcgcccgcgccctgctgctgtgcgcggtcctggcgctcagcc180


atacagcaaatccttgctgttcccacccatgtcaaaaccgaggtgtatgtatgagtgtgg240


gatttgaccagtataagtgcgattgtacccggacaggattctatggagaaaactgctcaa300


caccggaatttttgacaagaataaaattatttctgaaacccactccaaacacagtgcact360


acatacttacccacttcaagggattttggaacgttgtgaataacattcccttccttcgaa420


atgcaattatgagttatgtcttgacatccagatcacatttgattgacagtccaccaactt480


acaatgctgactatggctacaaaagctgggaagccttctctaacctctcctattatacta540


gagcccttcctcctgtgcctgatgattgcccgactcccttgggtgtcaaaggtaaaaagc600


agcttcctgattcaaatgagattgtggaaaaattgcttctaagaagaaagttcatccctg660


atccccagggctcaaacatgatgtttgcattctttgcccagcacttcacgcatcagtttt720


tcaagacagatcataagcgagggccagctttcaccaacgggctgggccatggggtggact780


taaatcatatttacggtgaaactctggctagacagcgtaaactgcgccttttcaaggatg840


gaaaaatgaaatatcagataattgatggagagatgtatcctcccacagtcaaagatactc900


aggcagagatgatctaccctcctcaagtccctgagcatctacggtttgctgtggggcagg960


aggtctttggtctggtgcctggtctgatgatgtatgccacaatctggctgcgggaacaca1020


acagagtatgcgatgtgcttaaacaggagcatcctgaatggggtgatgagcagttgttcc1080


agacaagcaggctaatactgataggagagactattaagattgtgattgaagattatgtgc1140


153/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aacacttgag tggctatcac ttcaaactga aatttgaccc agaactactt ttcaacaaac 1200
aattccagta ccaaaatcgt attgctgctg aatttaacac cctctatcac tggcatcccc 1260
ttctgcctga cacctttcaa attcatgacc agaaatacaa ctatcaacag tttatctaca 1320
acaactctatattgctggaacatggaattacccagtttgttgaatcattcaccaggcaaa1380


ttgctggcagggttgctggtggtaggaatgttccacccgcagtacagaaagtatcacagg1440


cttccattgaccagagcaggcagatgaaataccagtcttttaatgagtaccgcaaacgct1500


ttatgctgaagccctatgaatcatttgaagaacttacaggagaaaaggaaatgtctgcag1560


agttggaagcactctatggtgacatcgatgctgtggagctgtatcctgcccttctggtag1620


aaaagcctcggccagatgccatctttggtgaaaccatggtagaagttggagcaccattct1680


ccttgaaaggacttatgggtaatgttatatgttctcctgcctactggaagccaagcactt1740


ttggtggagaagtgggttttcaaatcatcaacactgcctcaattcagtctctcatctgca1800


ataacgtgaagggctgtccctttacttcattcagtgttccagatccagagctcattaaaa1860


cagtcaccatcaatgcaagttcttcccgctccggactagatgatatcaatcccacagtac1920


tactaaaagaacgttcgactgaactgtagaagtctaatgatcatatttatttatttatat1980


gaaccatgtctattaatttaattatttaataatatttatattaaactccttatgttactt2040


aacatcttctgtaacagaagtcagtactcctgttgcggagaaaggagtcatacttgtgaa2100


gacttttatgtcactactctaaagattttgctgttgctgttaagtttggaaaacagtttt2160


tattctgttttataaaccagagagaaatgagttttgacgtctttttacttgaatttcaac2220


ttatattataagaacgaaagtaaagatgtttgaatacttaaacactatcacaagatggca2280


aaatgctgaaagtttttacactgtcgatgtttccaatgcatcttccatgatgcattagaa2340


gtaactaatgtttgaaattttaaagtacttttggttatttttctgtcatcaaacaaaaac2400


aggtatcagtgcattattaaatgaatatttaaattagacattaccagtaatttcatgtct2460


actttttaaaatcagcaatgaaacaataatttgaaatttctaaattcatagggtagaatc2520


acctgtaaaagcttgtttgatttcttaaagttattaaacttgtacatataccaaaaagaa2580


gctgtcttggatttaaatctgtaaaatcagatgaaattttactacaattgcttgttaaaa2640


tattttataagtgatgttcctttttcaccaagagtataaacctttttagtgtgactgtta2700


aaacttccttttaaatcaaaatgccaaatttattaaggtggtggagccactgcagtgtta2760


tctcaaaataagaatattttgttgagatattccagaatttgtttatatggctggtaacat2820


gtaaaatcta tatcagcaaa agggtctacc tttaaaataa gcaataacaa agaagaaaac 2880
caaattattg ttcaaattta ggtttaaact tttgaagcaa actttttttt atccttgtgc 2940
154/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
actgcaggcctggtactcagattttgctatgaggttaatgaagtaccaagctgtgcttga3000


ataacgatatgttttctcagattttctgttgtacagtttaatttagcagtccatatcaca3060


ttgcaaaagtagcaatgacctcataaaatacctcttcaaaatgcttaaattcatttcaca3120


cattaattttatctcagtcttgaagccaattcagtaggtgcattggaatcaagcctggct3180


acctgcatgctgttccttttcttttcttcttttagccattttgctaagagacacagtctt3240


ctcatcacttcgtttctcctattttgttttactagttttaagatcagagttcactttctt3300


tggactctgcctatattttcttacctgaacttttgcaagttttcaggtaaacctcagctc3360


aggactgctatttagctcctcttaagaagattaaaagagaaaaaaaaaggcccttttaaa3420


aatagtatacacttattttaagtgaaaagcagagaattttatttatagctaattttagct3480


atctgtaaccaagatggatgcaaagaggctagtgcctcagagagaactgtacggggtttg3540


tgactggaaaaagttacgttcccattctaattaatgccctttcttatttaaaaacaaaac3600


caaatgatat ctaagtagtt ctcagcaata ataataatga cgataatact tcttttccac 3660
atctcattgtcactgacatttaatggtactgtatattacttaatttattgaagattatta3720


'tttatgtcttattaggacactatggttataaactgtgtttaagcctacaatcattgattt3780


ttttttgttatgtcacaatcagtatattttctttggggttacctctctgaatattatgta3840


aacaatccaaagaaatgattgtattaagatttgtgaataaatttttagaaatctgattgg3900


catattgagatatttaaggttgaatgtttgtccttaggataggcctatgtgctagcccac3960


aaagaatattgtctcattagcctgaatgtgccataagactgaccttttaaaatgttttga4020


gggatctgtggatgcttcgttaatttgttcagccacaatttattgagaaaatattctgtg4080


tcaagcactgtgggttttaatatttttaaatcaaacgctgattacagataatagtattta4140


tataaataattgaaaaaaattttcttttgggaagagggagaaaatgaaataaatatcatt4200


aaagataactcaggagaatcttctttacaattttacgtttagaatgtttaaggttaagaa4260


agaaatagtcaatatgcttgtataaaacactgttcactgttttttttaaaaaaaaaactt4320


gatttgttattaacattgatctgctgacaa.aacctgggaatttgggttgtgtatgcgaat4380


gtttcagtgcctcagacaaatgtgtatttaacttatgtaaaagataagtctggaaataaa4440


tgtctgtttatttttgtactattta 4465


<210> 48
<211> 631
<212> DNA
<213> Human
155/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
<400>
48


caatacagctaaggaattatcccttgtaaataccacagacccgccctggagccaggccaa 60


gctggactgcataaagattggtatggccttagctcttagccaaacaccttcctgacacca 120


tgagggccagcagcttcttgatcgtggtggtgttcctcatcgctgggacgctggttctag 180


aggcagctgtcacgggagttcctgttaaaggtcaagacactgtcaaaggccgtgttccat 240


tcaatggacaagatcccgttaaaggacaagtttcagttaaaggtcaagataaagtcaaag 300


cgcaagagccagtcaaaggtccagtctccactaagcctggctcctgccccattatcttga 360


tccggtgcgccatgttgaatccccctaaccgctgcttgaaagatactgactgcccaggaa 420


tcaagaagtgctgtgaaggctcttgcgggatggcctgtttcgttccccagtgaagggagc 480


cggtccttgctgcacctgtgccgtccccagagctacaggccccatctggtcctaagtccc 540


tgctgcccttccccttcccacactgtccattcttcctcccattcaggatgcccacggctg 600


gagctgcctctctcatccactttccaataaa 631


<210> 49
<211> 701
<2l2> DNA
<2l3> Human
<220>
<221> misc_feature
<222> (464)..(464)
<223> n is a, c, g, 0r t
<400>
49


tttttttttcgcataaatattgcttttattacaagaaagaagagaccacctctgaagtaa 60


ggcacaacacaattccattgtcactgtggcagaagtccctgttgctcatccctttgatct 120


cagccaagactgtggtccacgggcctaaggcacttgagcttttccctcaactgaagtgta 180


gggggtgcctgagagctgagcctcgtgggagtgtccatggtctctggacctgcatcgaag 240


ttcatgtgtttccactggtgctgaagatgaacatcaagaattactagacatgtaaaagtg 300


tctttaagtgtctttcctcctgagtccacctttggcaatggtccccaaagcctggcccct 360


tagagatgcagctccagatcctggccaccctcagggttcaaagagactggcccaggggta 420


cacaattgctggaatattctctgcgagtcatgcacacgtgcggnggtgaggtgcagttat 480


atggtgacacacacagtgttactgtgagctctcagggtgcacagagggcaggtgacaagg 540


gcatcagctaatctgtcccacctggtccagcccatccagttcaggggcatcaagggggct 600


gaggccccggtagccactgtagaccctgtgactatcactgacacegtcactgggctccat 660


tgggcaaatgtagtccgcgattcatcgaacttcttttttct 701


156/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
<210> 50
<211> 602
<212> DNA
<2l3> Human
<400>
50


atttagaaatgtaaacatttatttaaaagtaggtagcaagttaaaaatgaatacttgcct 60


gaaatcataaaacataatcaagttctttttaaaacagttaatttttttcctataatttac 120


tttcatcgaaagtatattatctttgtttaacatgctagatagaagcaatttagcaacata 180


aaatatattagctatagtatgttcaaaagaatgagaaatataaattcagagatgagacca 240


tcattttttgcagttaaaaaaaaatgttgattctggtgcaacatacactgattatccagg 300


ttttacattttagggctgaaaccctgaggaacctgctggtgactgtttagcactgagcag 360


agttcagtgtgcatgcgcttccagagttaaaagctaaagcagactgagaaacaaaaaacc 420


aacatctttgcatttctgagttttcacttgtaatcataggttttcccaaattattagaat 480


gtctataccttagctgttttactagaatgatttatgctagtatagtcacttgtttagaag 540


tcggaaaaagatcattttttctttttagaaattactaagctctgttgtactacagctgat 600


cc 602
<210> 51
<211> 1653
<212> DNA
<213> Human
<400>
51


acgtccggggaggggccaggtgagcggcagacccggcacgcaggtgggggccggcggggt 60


ccgtggccagagctgcagagagacaaggcggcggcggctgctgtgctgggtgcagtgagg 120
1


aagaggccctcggtggtgcccatggctggccaggatcctgcgctgagcacgagtcacccg 180


ttctacgacgtggccagacatggcattctgcaggtggcaggggatgaccgctttggaaga 240


cgtgttgtcacgttcagctgctgccggatgccgccctcccacgagctggaccaccagcgg 300


ctgctggagtatttgaagtacacactggaccaatacgttgagaacgattataccatcgtc 360


tatttccactacgggctgaacagccggaacaagccttccctgggctggctccagagcgca 420


tacaaggagttcgataggaaagacggggatctcactatgtggcccaggctggtctcgaac 480


tccaagctcaagcgatcctcccacctcagcctcccaaagtactgggattacaggtacaag 540


aagaacttgaaggccctctacgtggtgcaccccaccagcttcatcaaggtcctgtggaac 600


atcttgaagcccctcatcagtcacaagtttgggaagaaagtcatctatttcaactacctg 660


157/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
agtgagctcc acgaacacct taaatacgac cagctggtca tccctcccga agttttgcgg 720
tacgatgaga agctccagag cctgcacgag ggccggacgc cgcctcctac caagacacca 780
ccgccgcggc ccccgctgcc cacacagcag tttggcgtca gtctgcaata cctcaaagac 840
aaaaatcaag gcgaactcat cccccctgtg ctgaggttca cagtgacgta cctgagagag 900
aaaggcctgcgcaccgagggcctgttccggagatccgccagcgtgcagaccgtccgcgag960


atccagaggctctacaaccaagggaagcccgtgaactttgacgactacggggacattcac1020


atccctgccgtgatcctgaagaccttcctgcgagagctgccccagccgcttctgaccttc1080


caggcctacgagcagattctcgggatcacctgtgtggagagcagcctgcgtgtcactggc1140


tgccgccagatcttacggagcctcccagagcacaactacgtcgtcctccgctacctcatg1200


ggctttctgcatgcggtgtcccgggagagcatcttcaacaaaatgaacagctctaacctg1260


gcctgtgtcttcgggctgaatttgatctggccatcccagggggtctcctccctgagtgcc1320


cttgtgcccctgaacatgttcactgaactgctgatcgagtactatgaaaagatcttcagc1380


accccggaggcacctggggagcacggcctggcaccatgggaacaggggag cagggcagcc1440


cctttgcaggaggctgtgccacggacacaagccacgggcctcaccaagcc taccctacct1500


ccgagtcccctgatggcagccagaagacgtctctagtgttgcgaacactc tgtatgtttc1560


gagctacctcccacacctgtctgtgcacttgtatgttttgtaaacttggc atctgtaaaa1620


ataaccagccattagatgaattcagaaccttct 1653


<210> 52
<211> 846
<212> DNA
<213> Human
<400>
52


gtataaggtccacaccccgggagctgagtgattgcagaaactggccttccatctctctca 60


gacaccaagctgcagatccaggcttttctgggaaagtgaggccaccatggctctggagaa 120


gtctcttgtccggctccttctgcttgtcctgatactgctggtgctgggctgggtccagcc 180


ttccctgggcaaggaatcccgggccaagaaattccagcggcagcatatggactcagacag 240


ttcccccagcagcagctccacctactgtaaccaaatgatgaggcgccggaatatgacaca 300


ggggcggtgcaaaccagtgaacacctttgtgcacgagcccctggtagatgtccagaatgt 360


ctgtttccaggaaaaggtcacctgcaagaacgggcagggcaactgctacaagagcaactc 420


cagcatgcacatcacagactgccgcctgacaaacggctccaggtaccccaactgtgcata 480


ccggaccagc ccgaaggaga gacacatcat tgtggcctgt gaagggagcc catatgtgcc 540
158/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
agtccacttt gatgcttctg tggaggactc tacctaaggt cagagcagcg agatacccca 600
cctccctcaacctcatcctctccacagctgcctcttccctcttccttccctgctgtgaaa660


gaagtaactacagttagggctcctattcaacacacacatgcttccctttcctgagtccca720


tccctgcgtgattttgggggtgaagagtgggttgtgaggtgggccccatgttaacccctc780


cactctttctttcaataaaacgcagttgcaaacaataaaaaaaaaaaaaaaaaaaaaaaa840


aaaaaa 846
<210> 53
<2l1> 2566
<212> DNA
<213> Human
<400> 53
ggcacgagtt gtgctcctcg cttgcctgtt ccttttccac gcattttcca ggataactgt 60
gactccaggcccgcaatggatgccctgcaactagcaaattcggcttttgccgttgatctg120


ttcaaacaactatgtgaaaaggagccactgggcaatgtcctcttctctccaatctgtctc180


tccacctctctgtcacttgctcaagtgggtgctaaaggtgacactgcaaatgaaattgga240


caggttcttcattttgaaaatgtcaaagatataccctttggatttcaaacagtaacatcg300


gatgtaaacaaacttagttccttttactcactgaaactaatcaagcggctctacgtagac360


aaatctctgaatctttctacagagttcatcagctctacgaagagaccctatgcaaaggaa420


ttggaaactgttgacttcaaagataaattggaagaaacgaaaggtcagatcaacaactca480


attaaggatctcacagatggccactttgagaacattttagctgacaacagtgtgaacgac540


cagaccaaaatccttgtggttaatgctgcctactttgttggcaagtggatgaagaaattt600


cctgaatcagaaacaaaagaatgtcctttcagactcaacaagacagacaccaaaccagtg660


cagatgatgaacatggaggccacgttctgtatgggaaacattgacagtatcaattgtaag720


atcatagagcttccttttcaaaataagcatctcagcatgttcatcctactacccaaggat780


gtggaggatgagtccacaggcttggagaagattgaaaaacaactcaactcagagtcactg840


tcacagtggactaatcccagcaccatggccaatgccaaggtcaaactctccattccaaaa900


tttaaggtggaaaagatgattgatcccaaggcttgtctggaaaatctagggctgaaacat960


atcttcagtgaagacacatctgatttctctggaatgtcagagaccaagggagtggcccta1020


tcaaatgttatccacaaagtgtgcttagaaataactgaagatggtggggattccatagag1080


gtgccaggagcacggatcctgcagcacaaggatgaattgaatgctgaccatccctttatt1140


tacatcatcaggcacaacaaaactcgaaacatcattttctttggcaaattctgttctcct1200


159/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
taagtggcatagcccatgttaagtcctccctgacttttctgtggatgccgatttctgtaa1260


actctgcatccagagattcattttctagatacaataaattgctaatgttgctggatcagg1320


aagccgccagtacttgtcatatgtagccttcacacagatagacctttttttttttccaat1380


tctatcttttgtttccttttttcccataagacaatgacatacgcttttaatgaaaaggaa1440


tcacgttagaggaaaaatatttattcattatttgtcaaattgtccggggtagttggcaga1500


aatacagtcttccacaaagaaaattcctataaggaagatttggaagctcttcttcccagc1560


actatgctttccttctttgggatagagaatgttccagacattctcgcttccctgaaagac1620


tgaagaaagtgtagtgcatgggacccacgaaactgccctggctccagtgaaacttgggca1680


catgctcaggctactataggtccagaagtccttatgttaagccctggcaggcaggtgttt1740


attaaaattctgaattttggggattttcaaaagataatattttacatacactgtatgtta1800


tagaacttcatggatcagatctggggcagcaacctataaatcaacaccttaatatgctgc1860


aacaaaatgtagaatattcagacaaaatggatacataaagactaagtagcccataagggg1920


tcaaaatttgctgccaaatgcgtatgccaccaacttacaaaaacacttcgttcgcagagc1980


ttttcagattgtggaatgttggataaggaattatagacctctagtagctgaaatgcaaga2040


ccccaagaggaagttcagatcttaatataaattcactttcatttttgatagctgtcccat2100


ctggtcatgtggttggcactagactggtggcaggggcttctagctgactcgcacagggat2160


tctcacaatagccgatatcagaatttgtgttgaaggaacttgtctcttcatctaatatga2220


tagcgggaaaaggagaggaaactactgcctttagaaaatataagtaaagtgattaaagtg2280


ctcacgttaccttgacacatagtttttcagtctatgggtttagttactttagatggcaag2340


catgtaacttatattaatagtaatttgtaaagttgggtggataagctatccctgttgccg2400


gttcatggattacttctctataaaaaatatatatttaccaaaaaattttgtgacattcct2460


tctcccatctcttccttgacatgcattgtaaataggttcttcttgttctgagattcaata2520


ttgaatttctcctatgctattgacaataaaatattattgaactacc 2566


<210> 54
<211> 555
<212> DNA
<213> Human
<220>
<221> misc_feature
<222> (9). (10)
<223> n is a, c, g, or t
<400> 54
160/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tttttattnn ttcagttctg ggtctataga aacccagggg gattttcatt tgctacaaca 60
gattcccttctaataaaatgcactggcaaggtgaccagtgagtgacccaatgtctggttg 120


ggaaatctctctctgaacttcttgctgttggacctaaaatgtggatgtaaattggatcac 180


agctggtttggcattgaaaaaaatacatacacaacaaacaattacaacttctttatatgg 240


cagtttttactgggtgtctaatactctctttactgtctcaagtggaagtccaaacaaatt 300


tcatttttgtagtaaaaaatctttatttccaaaatgatttgttagccaaaagaactataa 360


accacctaacaagactttggtaagaaagagacttgatgcttcttataaattccccattgc 420


aaacaaaaaataacaatccaacaagagtcatgttacccattcttagccattaacctggtt 480


ttaagtctccaaaatcaggattttaaaatgtacccaactgggaccaaatacaaacatgag 540


acactagggtggctt 555


<210> 55
<211> 1984
<212> DNA
<213> Human
<400>
55


ggatccagagatttagattttttataagctttcctgccaccgaaacgggtgtttgggacc 60


tcacgaggccctgttcattcttcgtcgctgcgctccccactctgtactggatgcatttac 120


tgacgttgttgtctccgtccccagagtatgaacccccaaggtgactcatgcagctgtggg 180


tgcccggcatacagcatggtgactggaatggatgagcacccaataaacatttgttgcagg 240


aatgcaggaggacgggcaggccagcaagcaggctgcctggtttttcccacatgggctttt 300


ctgggaaagaagagcttctatttttggaaagggctgctatgattgagaaaagttcatggc 360


agcaaaaaaaggacagacgtcgggagggaaacactcctagttctcccagacaacacattt 420


tttaaaaagactccttcatctctttaataataacggtaacgacaatgacaatgatgatta 480


cttatgagtgcggctagtgccagccactgtgttgtcactgggcgagtaatgatctcattg 540


gatcttcacggtgggcgtgcggggctccagggacagcctgcgttcctgggctggctgggt 6,00


gcagctctcttttcaggagagaaagctctcttggaggagctggaaaggtgcccgactcca 660


gccatgctggcgctactgtgttcctgcctgctcctggcagccggtgcctcggacgcctgg 720


acgggcgaggactcggcggagcccaactctgactcggcggagtggatccgagacatgtac 780


gccaaggtcacggagatctggcaggaggtcatgcagcggcgggacgacgacggcacgctc 840


cacgccgcctgccaggtgcagccgtcggccacgctggacgccgcgcagccccgggtgacc 900


ggcgtcgtcctcttccggcagcttgcgccccgcgccaagctcgacgccttcttcgccctg 960


161/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gagggcttcccgaccgagccgaacagctccagccgcgccatccacgtgcaccagttcggg1020


gacctgagccagggctgcgagtccaccgggccccactacaacccgctggccgtgccgcac1080


ccgcagcacccgggcgacttcggcaacttcgcggtccgcgacggcagcctctggaggtac1140


cgcgccggcctggccgcctcgctcgcgggcccgcactccatcgtgggccgggccgtggtc1200


gtccacgctggcgaggacgacctgggccgcggcggcaaccaggccagcgtggagaacggg1260


aacgcgggccggcggctggcetgctgcgtggtgggcgtgtgcgggcccgggctctgggag1320


cgccaggcgcgggagcactcagagcgcaagaagcggcggcgcgagagcgagtgcaaggcc1380


gcctgagcgcggcccccacccggcggcggccagggacccccgaggcccccctctgccttt1440


gagcttctcctctgctccaacagacaccttccactctgaggtctcaccttcgcctctgct1500


gaagtctccccgcagccctctccacccagaggtctccctataccgagacccaccatcctt1560


ccatcctgaggaccgccccaaccctcggagccccccactcagtaggtctgaaggcctcca1620


tttgtaccgaaacaccccgctcacgctgacagcctcctaggctccctgaggtacctttcc1680


acccagaccctccttccccaccccataagccctgagactcccgcctttgacctgacgatc1740


ttcccccttcccgccttcaggttcctcctaggcgctcagaggccgctctg'gggggttgcc1800


tcgagtccccccacccctccccacccaccaccgctcccgcggcaagccagcccgtgcaac1860


ggaagccaggccaactgccccgcgtcttcagctgtttcgcatccaccgccaccccactga1920


gagctgctcctttgggggaatgtttggcaacctttgtgttacagattaaaaattcagcaa1980


ttca 1984


<210> 56
<211> 1621
<212> DNA
<213> Human
<400>
56


ggcacgaggggacagctcctgcctcccgcagggcccacctgtgtcccccagcgccgctcc60


acccagcaggcctgagcccctctctgctgccagacaccccctgctgcccactctcctgct120


gctcgggttctgaggcacagcttgtcacaccgaggcggattctctttctctttctctttc180


tcttctggcccacagccgcagcaatggcgctgagttcctctgctggagttcatcctgcta240


gctgggttcccgagctgccggtctgagcctgaggcatggagcctcctggagactgggggc300


ctcctccctggagatccacccccagaaccgacgtcttgaggctggtgctgtatctcacct360


tcctgggagc cccctgctac gccccagctc tgccgtcctg caaggaggac gagtacccag 420
tgggctccga gtgctgcccc aagtgcagtc caggttatcg tgtgaaggag gcctgcgggg 480
162/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
agctgacgggcacagtgtgtgaaccctgccctccaggcacctacattgcccacctcaatg540


gcctaagcaagtgtctgcagtgccaaatgtgtgacccagccatgggcctgcgcgcgagcc600


ggaactgctccaggacagagaacgccgtgtgtggctgcagcccaggccacttctgcatcg660


tccaggacggggaccactgcgccgcgtgccgcgcttacgccacctccagcccgggccaga720


gggtgcagaagggaggcaccgagagtcaggacaccctgtgtcagaactgccccccgggga780


ccttctctcccaatgggaccctggaggaatgtcagcaccagaccaagtgcagctggctgg840


tgacgaaggccggagctgggaccagcagctcccactgggtatggtggtttctctcaggga900


gcctcgtcatcgtcattgtttgctccacagttggcctaatcatatgtgtgaaaagaagaa960


agccaaggggtgatgtagtcaaggtgatcgtctccgtccagcggaaaagacaggaggcag1020


aaggtgaggccacagtcattgaggccctgcaggcccctccggacgtcaccacggtggccg1080


tggaggagacaataccctcattcacggggaggagcccaaaccactgacccacagactctg1140


caccccgacgccagagatacctggagcgacggctgctgaaagaggctgtccacctggcga1200


aaccaccggagcccggaggcttgggggctccgccctgggctggcttccgtctcctccagt1260


ggagggagaggtggggcccctgctggggtagagctggggacgccacgtgccattcccatg1320


ggccagtgagggcctggggcctctgttctgctgtggcctgagctccccagagtcctgagg1380


aggagcgccagttgcccctcgctcacagaccacacacccagccctcctgggccagcccag1440


agggcccttcagaccccagctgtctgcgcgtctgactcttgtggcctcagcaggacaggc1500


cccgggcactgcctcacagccaaggctggactgggttggctgcagtgtggtgtttagtgg1560


ataccacatcggaagtgattttctaaattggatttgaattcggaaaaaaaaaaaaaaaaa1620


a 1621


<210> 57
<211> 2755
<212> DNA
<213> Human
<400>
57


cctacccgcgcgcaggccaagttgctgaatcaatggagccctccccaacccgggcgttcc60


ccagcgaggcttccttcccatcctcctgaccaccggggcttttcgtgagctcgtctctga120


tctcgcgcaagagtgacacacaggtgttcaaagacgcttctggggagtgagggaagcggt180


ttacgagtgacttggctggagcctcaggggcgggcactggcacggaacacaccctgaggc240


cagccctggctgcccaggcggagctgcctcttctcccgcgggttggtggacccgctcagt300


acggagttggggaagctctttcacttcggaggattgctcaacaaccatgctgggcatctg360


163/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gaccctcctacctctggttcttacgtctgttgctagattatcgtccaaaagtgttaatgc420


ccaagtgactgacatcaactccaagggattggaattgaggaagactgttactacagttga480


gactcagaacttggaaggcctgcatcatgatggccaattctgccataagccctgtcctcc540


aggtgaaaggaaagctagggactgcacagtcaatggggatgaaccagactgcgtgccctg600


ccaagaagggaaggagtacacagacaaagcccatttttcttccaaatgcagaagatgtag660


attgtgtgatgaaggacatggcttagaagtggaaataaactgcacccggacccagaatac720


caagtgcagatgtaaaccaaactttttttgtaactctactgtatgtgaacactgtgaccc780


ttgcaccaaatgtgaacatggaatcatcaaggaatgcacactcaccagcaacaccaagtg840


caaagaggaaggatccagatctaacttggggtggctttgtcttcttcttttgccaattcc900


actaattgtttgggtgaagagaaaggaagtacagaaaacatgcagaaagcacagaaagga960


aaaccaaggttctcatgaatctccaaccttaaatcctgaaacagtggcaataaatttatc1020


tgatgttgacttgagtaaatatatcaccactattgctggagtcatgacactaagtcaagt1080


taaaggctttgttcgaaagaatggtgtcaatgaagccaaaatagatgagatcaagaatga1140


caatgtccaagacacagcagaacagaaagttcaactgcttcgtaattggcatcaacttca1200


tggaaagaaagaagcgtatgacacattgattaaagatctcaaaaaagccaatctttgtac1260


tcttgcagagaaaattcagactatcatcctcaaggacattactagtgactcagaaaattc1320


aaacttcagaaatgaaatccaaagcttggtctagagtgaaaaacaacaaattcagttctg1380


agtatatgcaattagtgtttgaaaagattcttaatagctggctgtaaatactgcttggtt1440


ttttactgggtacattttatcatttattagcgctgaagagccaacatatttgtagatttt1500


taatatctcatgattctgcctccaaggatgtttaaaatctagttgggaaaacaaacttca1560


tcaagagtaaatgcagtggcatgctaagtacccaaataggagtgtatgcagaggatgaaa1620


gattaagattatgctctggcatctaacatatgattctgtagtatgaatgtaatcagtgta1680


tgttagtacaaatgtctatccacaggctaaccccactctatgaatcaatagaagaagcta1740


tgaccttttgctgaaatatcagttactgaacaggcaggccactttgcctctaaattacct1800


ctgataattctagagattttaccatatttctaaactttgtttataactctgagaagatca1860


tatttatgtaaagtatatgtatttgagtgcagaatttaaataaggctctacctcaaagac1920


ctttgcacagtttattggtgtcatattatacaatatttcaattgtgaattcacatagaaa1980


acattaaattataatgtttgactattatatatgtgtatgcattttactggctcaaaacta2040


cctacttctttctcaggcatcaaaagcattttgagcaggagagtattactagagctttgc2100


cacctctccatttttgccttggtgctcatcttaatggcctaatgcacccccaaacatgga2160


164/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aatatcaccaaaaaatacttaatagtccaccaaaaggcaagactgcccttagaaattcta2220


gcctggtttggagatactaactgctctcagagaaagtagctttgtgacatgtcatgaacc2280


catgtttgcaatcaaagatgataaaatagattcttatttttcccccacccccgaaaatgt2340


tcaataatgtcccatgtaaaacctgctacaaatggcagcttatacatagcaatggtaaaa2400


tcatcatctggatttaggaattgctcttgtcatacccccaagtttctaagatttaagatt2460


ctccttactactatcctacgtttaaatatctttgaaagtttgtattaaatgtgaatttta2520


agaaataatatttatatttctgtaaatgtaaactgtgaagatagttataaactgaagcag2580


atacctggaaccacctaaagaacttccatttatggaggatttttttgccccttgtgtttg2640


gaattataaaatataggtaaaagtacgtaattaaataatgtttttggtaaaaaaaaaaaa2700


aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaa 2755
<210> 58
<211> 2553
<212> DNA
<213> Human
<400>
58


ctaaaggccttgcacaacatcagagagttcatactggagagaaccttacacatttcacga60


gtatggaaagacctttgctcaaaattcagcccttgtaatgcataaggcaattcatactgg120


aaagaaaccttacacatgtaatgaatgtggcaaggtttttagtagaaaagcacaccttgc180


atgtcatcatagacttcatactgtctaaggtttctaatcaacaatcaaaccttgcacaac240


atcagagagtttatactggagagaaaccttacaagtgtaatgagtggggcaaagccttaa300


gtgggaagtcgtcacttttttatcatcaagcaatccatggtgtagggaaactttgcaaat360


gtaatgattgtcacaaagtcttcagtaatgctacaaccattgcaaatcactggagaatcc420


ataatgaagacagatcttacaagtgtaataaatgtggtaaaattttcagacatcgatcat480


atcttgcagtttatcagcgaactcatactggagagaaaccttacaaatatcatgactgtg540


gcaaggtcttcagtcaagcttcatcctatgcaaaacataggagaattcatacaggagaga600


aacctcacaagtgtgatgattgtggcaaagtcttgacttcacgttcacacctcattagac660


atcagagaatccatactggacagaaatcttacaaatgtcttaagtgtggcaaggtcttca720


gtctgtgggcactccatgcagaacatcagaaaattcatttttgagataactgttccaaat780


acagtgactatagaagatcataaagctttaattgacattagagccaaataggcattgact840


tgagattgagttgacttaaccttgagtttaagaattaatttacattaaagtgtttatgtt900


aagaagattgggccaggtgggattacaggcgcgagcaccgcgcccggcccctaagttaat960


165/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
atttcaaacaatcgaaggtaaaacaacatattgtgttgggccacctgtactgaacgctga1020


atcgtttttcctcttaagttgaaaatggttttaatgcaaagcgcctttttttgagcaggt1080


agagtcacgcatccggcaggcggggcgagctcccctctgtctggggcagggtgggggaga1140


ggggcagggacctcggtaaaggggtggagtggcgcgctggttgccgcgggcactggcaat1200


tagaagggattattaaactaagcaaggtcctgggttgtttgagtggataatggaaactga1260


aaggtgacgtgcaaaactgcctattactcccaggagtggaggataatttcatatttcatg1320


gaaataaactcagggcccggagcggtggctcacacctgtaatcccagcactttgagaggc1380


caaggagggaggatcgcttaagcccaggaattcgaaatcagcctaggcaacatagtaaga1440


cctcatctctactaaaaataaaaaaaaacagccaggtgtgttagtccacacctgtggtcc1500


cagctgcctcagcttcccgagtagctgggattacaggtatgaaccactatgcccggctaa1560


ctttgttttttttttttagaaattaaaccttttttcagcttaatgacccaggggtgtatt1620


tttgaaggacttgggagctctctttgaaaggcaaacaacaagggaaacagtacctttatc1680


tcagtaggaaattaaataattcaaacatcaaataacttcaatttaaggctatggactttg1740


agataattctgagccttgagaggaatgtggtcaggcaacctgagtccagtggaatgcagg1800


tgcaacttctaagagttttcctgtaagtaattaagaagactaagtagccccagagataag1860


acctcctcggatcattgtcccttcttatgtagtgataaagtaaccttccttgaagtgtat1920


ctatccgtaatcaatcaagttgctgcagcctatgcactggcccagaataaaaaacgtggt1980


gattctgctaaagcttctctgtctttccctgtgtgtgaaatcttaacgtctctacttggg2040


aacgctgatcccattcatttagagttgatgtttccacgtggctatttccaagctttgcct2100


tcaaataaattctgtacttaatcatatattctaaattttattatttactgctgacatcag2160


tttctgtcggattgtaggagcctcaccagagagggcccctgtcgccatgttgtaaaactc2220


acacttgccaaaagttgtgggttagggtttctccccctccctcaggatgacgctagttag2280


ctgacacagatggtcacctccattaccaagtagagtcaggatgaactatgtgtgactgtt2340


caactatgtgtcctcttccctgaggactgattagtgtttatcttgaaaacatgtccttaa2400


tgggttgtatagaacactgaagcatctgatttcaaactcttagctcttttcctctatttc2460


ccatcacattctggtctaaggcttatttattaataaaatgatttttatttctttaaacaa2520


aaaaaactttagagcacactggggtaccggatc 2553


<210> 59
<211> 452
< 212 > DI~iA
166/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
<213>
Human


<400>
59


gcggccgcgttgatccacagggcgctgttcagaaagcccaggaaagcaaagagccagtga60


agcctggggggctggctgtcagatgtggcaaaaaaggtcactgaagccaaggctgtgcct120


gcgatcaccaccacgacccagacgggaacgaggccgcctatctcatagacaccataggtc180


cccgactgcagggtcaggaccacaaccagggggctgataaccagatgcagacagttgagg240


ggccgtttccagttctggtcatccttgtccgggtccacgacggggactgtgaggagcagc300


aggaactccacaggcagcttgaacaccttgagggctttccagtatgctgatttccttctc360


cacttcatgtaatccaggggattgagggcccggaccaggatctgagccgtggtctcctgg420


tagaagaacagcggccggtactcatcaccgto 452


<210> 60
<211> 1130
<2l2> DNA
<213> Human
<400>
60


ggcccttagagtcttggttgccaaacagatttgcagatcaaggagaacccaggagtttca60


aagaagcgctagtaaggtctctgagatccttgcactagctacatcctcagggtaggagga120


agatggcttccagaagcatgcggctgctcctattgctgagctgcctggccaaaacaggag180


tcctgggtgatatcatcatgagacccagctgtgctcctggatggttttaccacaagtcca240


attgctatggttacttcaggaagctgaggaactggtctgatgccgagctcgagtgtcagt300


cttacggaaacggagcccacctggcatctatcctgagtttaaaggaagccagcaccatag360


cagagtacataagtggctatcagagaagccagccgatatggattggcctgcacgacccac420


agaagaggcagcagtggcagtggattgatggggccatgtatctgtacagatcctggtctg480


gcaagtccatgggtgggaacaagcactgtgctgagatgagctccaataacaactttttaa540


cttggagcag caacgaatgc aacaagcgcc aacacttcct gtgcaagtac cgaccataga 600
gcaagaatca agattctgct aactcctgca cagccccgtc ctcttccttt ctgctagcct 660
ggctaaatctgctcattatttcagaggggaaacctagcaaactaagagtgataagggccc720


tactacactggcttttttaggcttagagacagaaactttagcattggcccagtagtggct780


tctagctctaaatgtttgccccgccatccctttccacagtatccttcttccctcctcccc840


tgtctctggctgtctcgagcagtctagaagagtgcatctccagcctatgaaacagctggg900


tctttggccataagaagtaaagatttgaagacagaaggaagaaactcaggagtaagcttc960


tagaccccttcagcttctacacccttctgccctctctccattgcctgcaccccaccccag1020


167/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ccactcaact cctgcttgtt tttcctttgg ccataggaag gtttaccagt agaatccttg 1080
ctaggttgat gtgggccata cattccttta ataaaccatt gtgtacataa 1130
<210> 61
<211> 3323
<212> DNA
<213> Human
<400>
61


tgcttcataaaatttacctaagcaagtggtcttgcttgcctcaaatccaagcagtcttga60


acacttggaggcaattaatgagtatatcttagtcaaaagaattgttggagctttttatta120


aagctgcagtttcagttctgcttttggggaattgtgctatgaaagcagctgccaaaataa180


gctcatttattttcttcaatcccactcagtgctcagtcactatattctgtttcctttttt240


tttttcaagttgcatatttggtttccccttatgattgggaaagatgaattttcagcagaa300


aacagtgtttgttcactttcaaagagtgatagtttctaaaacatttagagcaataaatat360


tcatcagaggtaccaagtaagccagcagaagagttaagggttagagaaatcccttatttc420


atgtcttgactctaaaatgatcaaagtacttttccttgtaatgtggatttcttcttatgc480


ggatatgcaaaaacttcagttatacgtagtaatgctagcaggtaattttagtggacattt540


tataacaactgtcactttgttttgccacatgtagagtttgttcagctattttccagatat600


ctccccacaaaaggaggcaaagggtaccagcttttcaatgagcattacctattacttggc660


aaagatgatgaagactctattaatagttcatttgataaatgttgacataaccaacaatag720


agattaggaagttagttttaagaaatcaatagcatatagacattaccctcatggagtttg780


tattctactacttgaactgattgtagctataaaagcatagttagatagctgaatagttag840


atcataagcaaagaaggccagaacacatctcttatcaagaaatcaatgaatagtttatct900


catttttaaagcaactttatccttctttaattccttcctttcttctagtgcaaaactact960


taataaggttggtgtttaggttagtgttcacaccattcctcatctggtgtgaattacctt1020


ctctttctttactatttactaccaacctagtacatgtgttgactgaattcttttcaaaca1080


atgttgagttatcatggtgcacctaataaattaacaccacagattacagcatccttgctg1140


attttctcagcaaagccagattagatggaaataaacaaagaaaatgatcctagagtgaat1200


ttttctagaaaatatctattatgaaccatgctgtttaaagtattagcttgaaggtgatgg1260


atccagctattcagaaaataactttcatataaccatgattttgcacagtatgaggtctta1320


aatgtgtggaaagagataaattttttatcattaccacaaaccccttttaaagattcaaag1380


gtggaagaaagtgatttattttttctcttcagcatacatatataaaagacttgtcagatg1440


168/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tttaatttggggaggttgataatgaaacatatcaacagagtatagtagttatagtagtgt1500


ttgtgggtaaataatttcctggggtcagacatatataaacatatttgcttcaaaatgata1560


aaggcatgaaatcagtcttaaaaattgaaatgggggtgatgggggagaaaaagaagaaca1620


aatttgaagtgccctttcaaatctgctggatacaagtattgaagttttaagtcatcttat1680


tctgtctgaaagtgtatttttcattctacaatagacccaatcaacaagacgtataacttg1740


agttgcatgatgttcagtttatgtaatctactgttgggatggtaagaattgatgtaggct1800


gtggtgtaagaatgaattaaaatatagtttcactggcttttctctacatatccactatca1860


caatggctaggtttcctgttgctcactgttggattctggagaaaaatttaatgaaagatg1920


atatcagagg aagaataagt ggaggtagag aagaaaggag tgatagagga ggggaaaaaa 1980
acaaaacata tttttgtgtt atccaaagga gctttttcct tattctgtca agcattgaga 2040
tcttcttcag ctttcaatgt agttgctaaa tacaaataat gctactaggt agtgactaaa 2100
tatagcaaac acttcatcag atattagaat taggtcacac tattgaggtt ataatctgaa 2160
ggttgtgtta catagaaacc actttagatt attatcaact tgggctaggc tttattttat 2220
aatagcatag taagtaatat ctattgtgtc atttcttcaa ccattttatt ctaagatcca 2280
tgaagcttct tgaggccaaa taaaataata agtttagaca agaagtagat tgtgactttt 2340
tttcccttag agatactatt tactatctcc tatcctgata ggtggaaggt ttactgaatt 2400
ggaaattggt tgactattag tttttaacta aaatgtgcaa taacacattg cagtttcctc 2460
aaactagttt cctatgatca ttaaactcat tctcagggtt aagaaaggaa tgtaaatttc 2520
tgcctcaatt tgtacttcat caataagttt ttgaagagtg cagattttta gtcaggtctt 2580
aaaaataaac tcacaaatct ggatgcattt ctaaattctg caaatgtttc ctggggtgac 2640
ttaacaagga ataatcccac aatataccta gctacctaat acatggagct ggggctcaac 2700
ccactgtttt taaggatttg cgcttacttg tggctgagga aaaataagta gttcgaggaa 2760
gtagttttta aatgtgagct tatagataga aacagaatat caacttaatt atgaaattgt 2820
tagaacctgt tctcttgtat ctgaatctga ttgcaattac tattgtactg atagactcca 2880
gccattgcaa gtctcagata tcttagctgt gtagtgattc ttgaaattct ttttaagaaa 2940
aattgagtag aaagaaataa accctttgta aatgaggctt ggcttttgtg aaagatcatc 3000
cgcaggctat gttaaaagga ttttagctca ctaaaagtgt aataatggaa atgtggaaaa 3060
tatcgtaggt aaaggaaact acctcatgct ctgaaggttt tgtagaagca caattaaaca 3120
tctaaaatgg ctttgttaca ccagagccat ctggtgtgaa gaactctata tttgtatgtt 3180
169/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gagagggcat ggaataattg tattttgctg gcaatagaca cattctttat tatttgcaga 3240
ttcctcatca aatctgtaat tatgcacagt ttctgttatc aataaaacaa aagaatcctg 3300
ttaaaaaaaa aaaaaaaaaa aaa 3323
<210> 62
<211> 737
<212> DNA
<213> Human
<400>
62


gggaatgccctaacaacacccatgcttgtgttgctgggagctgacattcaagaaaagtgc60


attaaaaattccttgagaaggcatattcttttgagagccgtaaatgaaaagtgcattcac120


ggagaacatgctcctttgttgtgagaggaaagaaaggactgttgttgcctttaaggaaca180


ggtttcccagttccccggaatgtcagggtcacatgaggaatgggtgagcacttagggcca240


agattgtcgtgtgcttggcccggcagcttctctctaagtgacctctccagcatcactctg300


tgccagtgctcatatctgaggccacttgagtgtcacgaggcagagcctggaaacattagc360


tttggaaaccgttccttcctttttatgtggaggaaagtaaggtttcacaagacacctaag420


ctggacatggtgatgtgccacttggatagttcccaaaagcagaaagcagcaggacatccc480


agtaccccacttctccgtgccgtgtactttcagggaggttctcgaaagctagcttcttta540


ccgatgatttgtctatgtactggttatggtggaaaaccttgcatttattacctggtccta600


tctcagagtcttctattcagcattcaatatgacttctaatgcttctaattggactgtatg660


gacagagaaccggtttgtcattcacgggccgcggatataatcagagcctggaatccgcca720


aaaggtcggtgccggat 737


<210> 63
<211> 3780
<212> DNA
<213> Human
<400> 63
tactggacaa acatttcctc caaggacaca gctctctgcc tccatgtcac cacctttgaa , 60
ggactgactg attccctcgg ctggtgccag tgcctgctcc tgccatgggg cccgcgggga 120
gcctgctggg cagcggacag atgcagatca ccctgtgggg aagtctggca gctgtcgcca 180
ttttcttcgt catcaccttc ctcatcttcc cgtgctctag ttgtgacagg gaaaagaagc 240
cgcgacagca tagtggggac catgagaacc tgatgaacgt gccttcagac aaggagatgt 300
tcagccgttc agttactagc ctggcaacag atgctcctgc cagcagtgag cagaatgggg 360
cactcaccaa tggggacatt ctttcagagg acagtactct gacctgcatg cagcattacg 420
170/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aggaagtccagacatcggcctcggatctgctggattcccaggacagcacagggaaaccaa480


aatgtcatcagagtcgggagctgcccagaatccctcccgagagcgcagtggataccatgc540


tcacggcgagaagtgtggacggggaccaggggctggggatggaagggccctatgaagtgc600


tcaaggacagctcctcccaagaaaacatggtggaggactgcttgtatgaaactgtgaagg660


agatcaaggaggtggctgcagctgcacacctggagaaaggccacagtggcaaggcaaaat720


ctacttctgcctcgaaagagctcccagggccccagactgaaggcaaagctgagtttgctg780


aatatgcctcggtggacagaaacaaaaaatgtcgtcaaagtgttaatgtagagagtatcc840


ttggaaattcatgtgatccagaagaggaggccccaccacctgtccctgttaagcttctgg900


acgagaatgaaaaccttcaggagaaggaagggggagaggcggaagagagtgccacagaca960


cgaccagtgaaactaacaagagatttagctcattgtcatacaagtctcgggaagaagacc1020


ccactctcacagaagaagagatctcagctatgtactcatcagtaaataaacctggacagt1080


tagtgaataaatcggggcagtcgcttacagttccggagtccacctacacctccattcaag1140


gggacccacagaggtcaccctcctcctgtaatgatctctatgctactgttaaagacttcg1200


aaaaaactccaaacagcacacttccaccagcagggaggcccagcgaggagccagagcctg1260


attatgaagcgatacagactctcaacagagaggaagaaaaggccaccctggggaccaatg1320


gccaccacggtctcgtcccaaaggagaacgactacgagagcataagtgacttgcagcaag1380


gcagagatattaccaggctctagcaacccagaagacaaccctgggtagcctgtgatcagt1440


gtctggagacgtttcttctgtggaagagaagaagtgacacaaacctatacttcatatgct1500


gctttagtcacctgaagatggttggagaggccctgtcgactgttctcccagttgttcagt1560


ttctgagacagagaggtacggactaggctgcacctgagtgtgcccctgcctgccagatgg1620


acaggtacacccaagcacatctccctgctgcaccctcaccacccacaaaagatcccagct1680


gtcagtggtctcatctcattagtgaggaaagccaagctgtatggaaaagctgcactcacc1740


aaggaccacaatgcccccggcctaaagtactgccattcagaaaagcaggtttttcttcct1800


ctctttccttttctctgtctgctactgactttaaggctttttcccccttgaaatgtccag1860


attcctgtggttcatcccaaggaaattttcacacaaagcttggcctttgccctcaatata1920


ggtgttttaggatggtgacaaaccatggctgctgctttctgcccagctcgccagtcctcc1980


ccaaagagttgcgcatcagcacctggggatctggaccctgcgggtgaagggatggggagg2040


gacgtccctggagtctcttctgtctttgttccttcttattttggcattcgatatcagcag2100


cctctccccaaagtacttgaagtcagttttagatgctttattttatttttctagtcaaaa2160


171/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
acgtgtttcccccagtgtttgaaaactcgtccgaatcttttcagtattttccatgagtat2220


tgtggtacttctagacttgtttaagcccagaactcattccttcaaaacagagagccttaa2280


tctttatgttgggacacagaccacatatttggacggcagccatgcatccatcgctgaagg2340


gctgtggacatgaatgtgtatttcccatggtctccgctgcccacaccaacagtgtggcat2400


ctcataagttaactgctaccctaaggtaatctaagattaaaatgtaaacatttatttttg2460


ttatgtaagtttataagatgttttatgttcaatgcctaatttctcaaaagtgccagaaaa2520


aaatgtatattagctattttgattttatgtacaatgatttatactctccttttgaaaaga2580


taccataaagcacataagctagatcactacaaggagctgttatcttttttctaatcaagt2640


gtttaaaacactgatggtttttaaagactcacctttttaaatggtacttggagctcctga2700


ttcaaattacctagaccccctagagaaataaatggaatatacataaataatcattttcag2760


tggtttatggtgggcaatattgcaatatttgaaatggtaaaaatggaaagaagaacaaaa2820


tatgatgagaggtggctgtgaattataaacctcataaaagtgtcataattccattaaggt2880


ttaattatattttttcagaaaacagtgatgaattctgtagtccagtgcttgccaatgcaa2940


attgcctattggaatcttcttcctatattttacaaacatcagtggctgaaatagctcaga3000


gtaagagctcagcctggtttgaatttaatcatctctttagatcttataaggccagcatta3060


ggaaacttgttcacttttcattttcaaaggagcctagttgaagtgctattatgagtgtgg3120


gctatggaaagacagcttttcctacactgataaagaaaaaaaatgaggaaattatttcat3180


ccccttgtgacatctgtgactttttggatttaataatcttgctgtttttcctctttatga3240


caaagaatataattgggaggatgaagtgtcttaaaaattgtagagaccagctcactggaa3300


tgtttttccatccctgtattcatggcttgactttgtgactgctctacactgcatgtctga3360


cattgcagagtgagctatgttgaggtaaactggttggttgtcattattttgcaatcagcc3420


tggtctctcccatgaagatgtcgtgtgcataagcacaatcatcactgattagaagatcac3480


agcagaatacccttggattagagagaagttcgtaccttgcatttctctgaattctagtct3540


ctcataagcactgctttgctggatgattttcactgctttgtgttaatgactttgagcgat3600


ctctcacatgatggggttctttagtacatggtaacagccatgtcatcttacacacctagc3660


attgtgaatgctgtagtgacatcctttataggcaccttacagctcaaaacttttgtttca3720


tttcatgccttacttatcaaaaaggcaggaaagtaggtatgatctctaaagtaaaaaaaa3780


<210> 64
<211> 437
<212> DNA
<213> Human
172/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
<400> 64
gtgatggtgg gtttttgttt tattttttat aaaacacttg cactcaagaa catacaaaca 60
gtggccaccaatccccacccctggggctccggggagcaccatggcttgtttgtggctgtt120


ttcctctgtcccttccctggcatctggtgccagagggcaggtgcgggggtcctggggcggl80


gtggaatttgtacagcactttcatggggagatggtcacaagaaaggaaaccaggacaaga240


taaggactaagtctagggcacccacaaagatggcagacgaagcccatgaaagggcctgcg300


acagagtgaagagacggatgggcctgcgttggcctcagctagctctggaggctctgtggg360


ggaggggcaggtgggccttgcagtcaggattcggtaattacactttgctcacgggtagca420


ccttcggagtcctcctg 437


<210> 65
<211> 566
<212> DNA
<213> Human
<400> 65
tacgttttat caactgccaa gatcctttat tttttccagg ccccttcctg cccactccac 60
atcggggcagctccagcataagggagatgacatgatgaaggggctaagagtagggcctgg120


ccagcatccactgagggcccaaccagggaacagttgctagccgctctcttccatgcagct180


ggagcactagcaaggccttccagaggctcccagggcgacctccacatcactcccgcttgt240


ctctgccctccagggtgctccgggcctcctctccctgtgtaccctagaggtgtgagggcc300


acagtcctcctcaggtgaacctccctccccaagcccagggccctagcacaggctgcagtt360


ggacggcttcgagctgcggctctgggcctgctgccgctggtattctgcctcactggctga420


cagtgcttgtgctaaagctaggtcttcttcctcctgacaacttggaaactggggtttggg480


ttctgccagggacatttccagggcccctgcagagttcatcctcactcaggccatttgcaa540


gaatcactgg aggggctgtc agaagg 566
<210> 66
<211> 566
<212> DNA
<213> Human
<400> 66
ttttttttga gcaaagagct ttttattcaa agaaagaggc aaattgcacc caatctctct 60
ccctgtaaga tctcatctgg ttttgacatc agttgcaatg ctttcagtct gaggctaagc 120
aaaatgttat gctgtgaatg gtcaccacag agagaccact gtgttgctgg tgtggggagg 180
cgaggctcag ggttggacag gttaattacc tacataaccc tggctgtggc ccagcccagc 240
173/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
acctcccaaaacagggactgacatggctgaggtctaccttggagatggggtcagtgaaga300


ggggaggcagggtcagcctctgtgcaagtaaaatgccccctcaccccagccttcctttcc360


agagcaaccaatctgaaaacagaattgcctttggggctggtgttgtacctctgctttcag420


gccaagatggattccctagaagaggagtttgaagcccaatgtgcaaggacatttctcaag480


ggccatgtggttttgcagacactgctgtcctcaggcctgaactcaccatggaaacccatg540


tcagcaaacagtgaccagcaaatcct 566


<210> 67
<2l1> 3510
<212> DNA
<213> Human
<400>
67


agaagccgttcagatgtgagaactgcaatgagcgcttccagtacaagtaccagctgcggt60


cacacatgagcatccacattggccacaagcagttcatgtgccaatggtgcggcaaggact120


tcaacatgaagcagtacttcgatgagcacatgaagacccacacaggagagaagccgtaca180


tctgcgagatctgtggcaagagcttcaccagccggcccaacatgaagcggcaccggcgca240


cgcacacgggcgagaagccgtacccgtgcgacgtgtgtggccagcgcttccgcttctcca300


acatgctcaaggcccacaaggagaagtgcttccgcgtcagccacaccctggccggcgacg360


gcgtccccgctgccccaggcctgcccccaacccagccccaggcgcacgcactgcccctgc420


tcccggggctgccccagaccctgccgcccccgccccacctgccgcccccgcctccgctct480


tccccaccactgccagccccggcgggaggatgaacgccaacaactagctgccgagctgca540


cccgtgcacccgctggggcctggagtcagggcccactccaggagggacccactgccttcc600


cggggagcacagtagtgcgggcctgggccctgctccacctccagaagtggctggatgtac660


cctgcctgaggccccgacgaggaggggtatgcaggctggcaggccccagagctggtggag720


ggcatctcactcccaagtgccccccctttctgtgactccttgaagcctttactttttttt780


ttttttggaagtgaaggaaaaagaaactatttacagcactcccctccaggtgaggggggt840


gctgggggtctgcagcagaaagaaaggggcctgggcagcaggtgtggccagtccctctgc900


caaggcctgtgccagaggggttggccagttggagcctgggtcagcctcagcagcctatcc960


ccatgtcctctatgcccctaatttgcttcctcatcttggagggtttggggagaagttggc1020


gtgccacccccacaacccctgaggaggtgtagacccagtctgagagccgcaagcactgag1080


gcagggcctgagactggacctgggtgagcgtggggggtggagggtggcgaggtgcggaga1140


ctgcagaccagtgcttcactgtgtggagtggggcaggcaggggctggaccccagggactt1200


174/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gccttcccca cccactctgc tgccagcagg cccagggatc cctgacctgc accaggtggc 1260
accaagggtc ctgagtcctg gagatgtccc cagaagctgc tgtgcctcac agcgctgtga 1320
gccagaccct ccttgggcag acaggctgac tggcagcacc agctttgggg gcagagtcct 1380
aggatgaggc ttgggcagtg ctggtagggt ttcaaggtgc tattagtggg gcaggggcag 1440
ggcggctgct cacagagcac cccagttcct caccagctac tctggccata tatcccacac 1500
cagaaggaac aagtgtggct gtgtccatct ctgctccccc aaaggcccgc tctaggcctt 1560
atCCtCCCtC taggtCCtgC cacaacctgt ccctggctgg ctccagcgtc ctcgtccctc 1620
ctgggcctgt gcaccggtgg gtggggcgcc catagcactg ccggtaaagg agcctgcatg 1680
ttcaggcccc tcgggggatt ggggggactg gggaggcgca gcctagaccc aattgcttgc 1740,
ccccatgagg ctagcactaa taggaaaccc ttttttgttg tcatttaatg tctttattcc 1800
tgcctttaat atggggagga aggttccata agctacatgt ttcctagtta agctctttcc 1860
tattgtgttt atacagtttt gtttgttata ctctttgcac cttaaacccc caccactccc 1920
cgacactatt gccttcccag catggctgga gtgggaagag gcttgggccc cgggggaatg 1980
gttaggggga ctgaacccct ctgaccttat gaggcccatg gcactggggc agggagctgg 2040
ggacatttta atcatcaata aacgaagcac tttattctgt acagatttgg gcaggcccaa 2100
ggtgcccgag tgatctgagg atttataatc caagccacac caccctggtt gttctctggg 2160
cttggagggt acagtgccag cagcttcctt gcccaattga tgttggagct gtagacgtac 2220
gctcaggcgc tcctgctgtc ctgggggaga gaaggttcgc ccctccccga ggaagaaggc 2280
ttctggtcag gacccccacc ccaaggctgg ggactccagg ctcctgcttt actgtagctc 2340
tttttcttcc ttgcactcct tgatctttgg gcttccgtga tgtcctcagg gtccccccct 2400
ccctgttgct atttttaatc tctagtccca gtgcctggca gctctttgga gctggctcac 2460
attttcccaa aaaaaagttg atctctccca gtgggctgta ggcagggtcc tccatgggtt 2520
tccaaccccc atcactggca ccaggatctc ccacaggcac tggtggtgtc atcacctgct 2580
ggccccacta cagcctgagt aggcctgagt ggccgtggcc aggctgagac ctgtcaggcc 2640
atactgacaa gcagaggtca gagacactgg tggggagctg gcaatgaaac cctgtcctgg 2700
gacatgggtt tcatgttctt gtacacttcc cctctgggat caggtgaggg gtccagacag 2760
ctgaccagac agcttgacag ctggtcaaga cggtcacggg agctctaggt gggcacaacc 2820
aacccctctc ctgggaggcc cctgccccac tggggatagg agcctgtgtc cctggtgcta 2880
agcactctct tcacttgggc cattgttggt gggggctcct ttccggccag accacaaggc 2940
175/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
cagaagcaat aatggcacct cagcagttcc agtatggata ggggttactg ttttactagc 3000
ttttacatct ttttatttaa aacaaaacaa cacaaaaaaa caatgtgccc ccagatgtca 3060
gaatgaggcgactagggcaccatactcactttccagggctgggggaagggggacgcagga3120


tcatcccctcccaaggagatctgtgggggtcccaccgtccatctggacttctcagcctgt3180


ttggctagaactcaggcctggagtctgggtctgccccctccccggctccttggggctctc3240


tggtctcaggccagctggcgatgggtggctagagtgatgaactcaagccctgtggccaca3300


gttctgggagccttcaaccctggctcatgctgccatagtctccacggtgcccttcacaga3360


gggcttggtagtggcagaatggccatgcccaggtgtgtgttgagaccattgacaactgct3420


cgtgtacaggcaccccacagccccagagcatggggcacagcaggcatgcgagtgagagga3480


tgaaggggaataaagtcagtacaactcgtg 3510


<210> 68
<211> 2800
<212> DNA
<213> Human
<400>
68 ggggcactgaggcctccccacctcagaacaacagcggcagtagttctcct60
gcctcccccc


gtcttcaccttccgccacccgcttctgtcatctggtggcccccagtccccactccgagga120


tccacaggctccctgaagtcttccccgtccatgtcccatatggaggccctgggcaaggcc180


tggaaccggcagctcagccgtcccctctcccaggctgtgtcattcagcaccccctttggc240


ctggacagcgacgtggatgtcgtcatgggagaccctgtgctcctccgctctgtgagctcg300


gacagcctgggccccccgcgtcccgcgccggccaggacccccacccagccacccccggag360


cctggtgacctgcccaccatcgaggaagctctgcagatcatccacagtgccgagccccgg420


ctcctcccagatggggcggccgacggcagcttctacctccactcccctgaggggccctcc480


aagccatccctggcctccccctacctgcccgaggggacctccaaaccactgtccgacagg540


cccaccaaagcaccagtgtacatgccacaccccgagaccccctcgaaaccatctccctgt600


ctggtgggggaggcatcgaaaccgccagccccatccgaggggtccccgaaggcggtggct660


tcgtccccagcagccaccaactccgaggtgaaaatgaccagctttgcagaacgcaagaaa720


cagctggtgaaggcagaggctgaggccggagcggggtcccccacgtccactccggccccg780


ccggaggccctgagctcggagatgagtgagctcagcgcccggctggaggagaaacgcaga840


gccatcgaggctcagaagcgacggattgaggccatattcgccaagcaccgccagcggctg900


ggcaaaagcgccttcctgcaggtgcagccgcgggaagcctctggggaggcggaagcagag960


176/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
gcggaggagg ccgattccgg tccagtccct ggtggggagc ggcccgcagg cgagggccag 1020
ggtgagccaa cctcacggcc caaggcagtg accttctcgc cagacctggg cccggtgccc 1080
cacgaggggc tgggggaata caatcgagcg gtcagcaagc tgagtgccgc cttgagctcg 1140
ctgcagcggg acatgcagag gctcacggac cagcagcagc ggctcctggc cccgcccgag 1200
gcccccggat ccgccccacc acctgctgcg tgggtcatcc ctggccccac gacggggccc 1260
aaagctgcat cccccagccc cgcccggcga gtcccggcca cccggcgcag ccctgggccc 1320
~gggcccagcc agtcaccccg cagcccgaaa cacacgcggc cagcggagct gcggctggca 1380
cccttgacca gggtgcttac gccaccccac gacgtagaca gcctccccca cctgcgcaag 1440
ttctcgccga gccaggtgcc cgtgcagacg cgctcttcca tcctcctggc ggaggagacg 1500
ccccccgagg agccagccgc ccggccgggc ctcatcgaga tcccgctggg cagcctggca 1560
gatcccgccg ccgaggacga gggagacggg agccccgctg gtgctgagga ttccttggag 1620
gaggaggcgt cttcggaggg ggagccccgg gtggggctgg ggttcttcta caaggatgaa 1680
gacaagcctg aggacgagat ggcccaaaag cgggccagcc tgctggagcg gcagcagcgg 1740
cgagcagagg aggcgcggcg gcgcaagcag tggcaggagg tggagaagga acagcggagg ; 1800
gaggaggccg cgaggctggc ccaagaggag gccccgggcc cagccccgct tgtgtccgca 1860
gtcccgatgg cgactccagc ccctgctgcc cgggctccag ccgaggagga ggtgggcccc 1920
cggaaggggg acttcacgcg gcaggagtac gagcgccggg cccagctgaa gctgatggac 1980
gacctcgata aggtgctgcg gccccgggct gcggggtccg ggggtccagg tcggggcggg 2040
cggagggcca cccggcctcg ctcgggttgc tgtgacgact cagccctggc acgaagccca 2100
gcccgcggcc tgctgggctc tcggctgagc aaaatctatt cccagtccac cctgtcactg 2160
tccactgtgg ccaacgaggc ccacaataac ctcggggtga agaggcccac gtctcgggct 2220
ccctccccgt caggtctcat gtccccaagc cgcctgcctg gaagccgcga acgggactgg 2280
gaaaatggca gcaatgcctc ctccccagcg tcagtgcccg agtacacagg tccacggctg 2340
tacaaagaac ccagcgccaa gtccaacaag ttcatcatcc acaatgccct atcacactgc 2400
tgcctggcgg gcaaggtgaa cgaaccgcag aagaatcgca ttctggagga aattgagaaa 2460
agcaaggcca accacttcct gatcctcttt cgcgactcga gctgccagtt ccgggcgctc 2520
tacacgctgt cgggggagac agaggagctg tcgcggctgg cagggtatgg gccccggacc 2580
gtcacgcccg ccatggtgga aggcatctac aagtacaact cggaccgcaa gcgcttcacc 2640
cagatccccg ccaagaccat gtccatgagc gtcgatgcct tcaccatcca gggacacctc 2700
tggcagggca agaaacccac cactcccaag aagggcggcg gcacccccaa atagccccac 2760
177/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ccgggcggtc cacgggccgg gccctgtgtg ctgcggccgc 2800
<210> 69
<211> 1634
<212> DNA
<2l3> Human
<400> 69
aaaggtaaga gcactttatt cttatttgaa ccacactgta ttgttgatta ccgagtgtga 60
aggtagtatg ttcagagtct tgttttatgc ctttgtagct gtgttgccag catttgaagg 120
taactcctcc acataagcgg caggaaaatg gccttttttc ccattcaaag atccaaacca 180
ccatccttct tcttttttct cgtgtataat cacaatgtca cccttttcca aattcaactc 240
atcatcttgcctggcttgaaaagaatacaaggccttgcaaagtctgctgctgagctgggc300


tgcaccaggggctggagttgaagaacctggattgctctgcccaccagaagatgccttgct360


cacaatattctctaatctcttcattaaaaaaggccgagatattttcacatagctatgagt420


atgctccttttccctccacctgaagatggaattactacaaggatggctgggttgaggtct480


ttgctcaagttctgctaacattgatgacagtttgtaggagttcgcttccaaaaggtctag540


tttcaaattgttctcatccattaacgctgctgtgtctttctggctctttgcatcagagaa600


ggaggaggtgctggagtacgttttaagcattcgttccaggccttccttgtcttttgaggc660


tttttcaatgtctctctgcagtctcaataattttggttttagtaaagactttcgtctctc720


tttatccattgcactgttaggatcttcttcaaagtaatccgttaacaggaactcagattt780


gttttctgtagataaaattgcagtttcttccattacagcctggatatctttttcaatgtc840


aatcttgctgatggcacagtgaatctgcgtgtggcatgtggtcagggtttggccaaaaag900


agaaatatgttggctgtactggtttaagttattgcataaaagttgaattctttccttctc960


cagctccagaatgctctggtagcagttctctagtgtgttttcccatttcagtctggtaga1020


ataacccgccatgtttttttggtagtaattttcatcttccttttccaacttttcagttga1080


ttttgtcagtttattgaggagcttccgcttctccttctcagtcatagattgcttggagct1140


ttctacaagctggaaaagtgcttcatgtttcttggtactaaccattaatttcttcttggc1200


cttaatttgctgattccagttgctaatgacaagatttgctgtcttttcaacttcattgtc1260


aagtgattttctcttcttctcttgtacatttaggacttgataagtcggttttattgcttc1320


caattcaattgctttgccaagtttttgatgcaggtccgctgtggatttcattccctctga1380


ggcccaggcccaggcactgctaacacaactttttctcgtgttctgtaatgctttgctcag1440


cttgcttgccagtttctgaagtcctttggcatagctaatttccaggtttgccctttgctg1500


178/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aagaacagat gtgacctgtt tgcagaaatt ctctccattt tgagaaaact cctttaggtt 1560
cttgtatact ttattatacg gacaatctgt cagtgggtcc ctcatgttga aatgtgtctg 1620
gcttttgtcc tttc 1634
<210> 70
<211> 774
<212> DNA
<213> Human
<220>
<221> misc_feature
<222> (465)..(465)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (509)..(509)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (617)..(617)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (636)..(636)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (667)..(667)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (693)..(693)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (740)..(740)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (762) . . (762)
<223> n is a, c, g, or t
<400> 70
accaaaccaa atcattttat tgtgcaattt ccttctacca gaaaattact aaaaatataa 60
atattaactc tctaaaaaat actcagaata gatctgtaat cttcctcctc ctcctccgaa 120
179/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ctggagccaatcttcttctttaaacgctgatggattgcatacatgtatgtcttccatatc180


agccacatacacaacattcagatacacttccctctgtgcagggggatacaccagcctcct240


gccaggttctggaagctcaccttataatctaccaggataaagctgtgtgctgagtaggag300


gttatggtggggttggggagtaacaaggagataaaagaccttgtggtcccaacttcctta360


tgtggacagagaagataggtcctttactcctcctcattaccctgccctctcatggactgg420


gctaactgaaggccaagctcccagagaagctggactcactgtgtnggattactgagggtg480


tggctgccaggctacagtcacaggaaggncagactgttgagatggacatggaaaccaggt540


gaggcttggatggaaagctggtctgggccaagggctctggcaggatgagtagtaagctgt600


ttcctggctgggctttnggcagcccctagaccctangcaccaggtactatgtgcagcatc660


ttaaganccagacaccagtcttcagagagcctnccgaggtagccgcaacattcctgcagc720


aggggacgggcaggttgtangcagttagattggagccaggtnccatggcactgt 774


<210> 71
<211> 578
<212> DNA
<213> Human
<400> 71
tttttttttt tttttttaca tgcaatacca caaatttatt ataatacaca gggaaaaaca 60
aactcaaactttgacaacatccacagaatgttccagtctttaaaaagttagcagaaataa120


agggtaatggaaagaatataatctcgtaattttatacttaaggctgtaaatggcaaagtc180


ccatagatatttaaaaatctatatttgtatttatttataatatagatataggccctcaag240


gattcatagagatttatgtaataaactagattttggtactatttattttgttgttgttgt300


tgcttgttaggtaagcaaacccaaacaaattaagtcctgaaaagtgggatgaaatcccaa360


aggaactctatgagaccacacagaactcttttaataaatatggcccatacaaattccata420


tccagtgaaaatcattttgatccacaatcatgttgatgtttctatggaggatacttctag480


cagctgtgatttcttttgtagcattctggctctccacttctattcatataattgagtatg540


tgttttattacatgttagcttataggcaagttaaacat 578


<210> 72
<211> 475
<212> DNA
<213> Human
<220>
<221> misc_feature
<222> (285)..(285)
180/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (361)..(361)
<223> n is a, c, g, or t
<400>
72


gggtttgcacagtttattaagataatcaatcaatttcttaagttattcctttgttaacca60


gacagcatctctggagagaaaatgcactctctgtgtagatacataaaaatacatcagtca120


ttttgcccctcctggatgtgaacggaatctcccctcctcacctccacagagggagctcaa180


gccccagggaaccttcccctccccttttatgcattaccaggggagtggcaggggcagccc240


ccaactgtggagtgcattcaggtctgaggggggaggaaggctcanaggggcatctcccca300


gcaccctgccacagtgctggcttctggggtgtttgttcagcggcctgctgggctgcccca360


ngctgggggctcccccagctccccgtgcatcctggcttgttccacggagccctgagccaa420


gtctttgtctggctcatgttcctctcacaacatcccacaggcaggggtgagcctg 475


<210> 73
<211> 512 '
<212> DNA
<213> Human
<400> 73
catgtaaaactgacttttattacaattaaaaaagaacaaagacaatttgataagtgcctt60


taattacaacatacctgctatttacatgtaatcatacttttatatatagcttgaataagt120


tttattacatgtaaactataagatattacaagttaaactccagtcttttctggatattca180


attgaaatactactggcagaaacatacagaaaacaaatacccatttcagttcctcaggta240


ccattactggttgaatgatcaagatctggccacagaagagaagtggaaatatgcatcaaa300


acaaaacttattcttaacatgactaacagtattgttatttaaaccctaaacataattaat360


aattggatcattaaaaacacatcttcaatttatatagcacctttcttccgaagagttgaa420


agcattcgtgcttatctctattatttcgtttgtccccataacatctctatgaggtaggca480


atggttagta tcattatccc cattttgtat at 512
<210> 74
<211> 668
<212> DNA
<213> Human
<400> 74
tttcaaaacc agcaaaaatt aaatttaatt gggctcaagt ctgggcagtt tgtccttcct 60
caggaccagc cgtcagcagt ccctgacgaa agcaccccat tctctccaca gacagctggt 120
181/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tccaaaaggaccctctgaggctggtcttccgggtaggatgtgctgtgggagggttctgtt180


tccgaggaggagaggcgcgacacagcgtgcaaggacctgcagcaccttccacgcagcacc240


ccctgctcctcctcctcagcccctgccgggctctgactcctaaagtaaggcaggagcttc300


ttcaggcccctggctgaggaagagccacagccaccctaaaatggcttcgggggcatgcag360


ccctccatctccagcagctctggccatccctcgtatttgttggtgtctgggctgttcttt420


aagaactgctcaaaggggctgttacccctgaggtctttggctcctatgaagacccagctg480


tcccggaagcccagttgttttgcgtaggaactccccaagtcagagaagagtttcctgctt540


tcatcgatcattttggtcgctggatcgtcgtaggaggccaccaacaccagtgcaccccgc600


ggaaatatcttatggaatttcactaggtgcataacttctcctaagtgcatgtcaaatgcc660


tgctggcg 668


<210> 75
<211> 568
<212> DNA
<213> Human
<400>
75


aaggaataaggtgaatttttattaagtgaaaaaaatcaataacaatataggaatgatcac60


atctatacaaatacattgctacatttctacatataaaatgtataggaaaaagtctgaaag120


aatgcacaccaaattattctgtttttaggaaaagcagtaggattggtcagggcatggaat180


gtcggctaagtgaagtgagatttaaaatttttattctacatgattttctagtgttgggaa240


tttttgacagtgagcatacatgcacttattacttgcataattctgaaaactattttaaaa300


acaacagagaatatatgaaagtctattggtgtatacagcattaatagtagtgaaagttta360


acagaaaagatctgaaaatctcccaaagttatatagaaacagatctagctgacacactgt420


gtacctagaaatgattttggatctcttcacagagacccctatcccaccaacctccaatcc480


tcccaccatacattgatccctttctatctgcttggatcattagctgtaaatttaacttcg540


aaaaacaaagtacgtttaatcattgtac 568


<210> 76
<211> 491
<212> DNA
<213> Human
<220>
<221> misc_feature
<222> (371)..(371)
<223> n is a, c, g, or t
182/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
<220>
<221> misc_feature
<222> (394)..(394)
<223> n is a, c, g, or t
<400> 76
ttagattgaa gaaaacataa cgtttaattc tcagaaacaa atgcaagcct cggtccaagt 60
cttccttcccaaacctttgtcatttagggattgagaagctgagttgggtgaaaggttgaa120


tagaaaacaaaaaggaaagctagaaacacgctgagctcatggagatgcagcttcttctgt180


agctcctaaaggcccagctgaggtatcatctaatgagaattctctctatgccaggcactg240


cgctaagattttcacatcattaaccaatgtgagttttaggcaaccccgaagcaggcagtc300


tgttcatcccaattgcagctgaggaaacaggggtgaggtgaggccaagcagctgggccca360


agggtcccctncctgggtaagtgggcacagctgncagccctgccagggtggggtcctgct420


aaccaagccggcgttttcttgtcaccatgccgtattcgccttcccgtactatcaaaatgt480


acttatccaat 491


<210>
77


<211>
2437


<212>
DNA


<213>
Human


<400>
77


tcggatccactagtaacggccgccagtgtgctggaattcgcggccggtcgacccaccacc 60


atgaggtcctgcctgtggagatgcaggcacctgagccaaggcgtccagtggtccttgctt 120


ctggctgtcctggtcttctttctcttcgccttgccctcttttattaaggagcctcaaaca 180


aagccttccaggcatcaacgcacagagaacattaaagaaaggtctctacagtccctggca 240


aagcctaagtcccaggcacccacaagggcaaggaggacaaccatctatgcagagccagtg 300


ccagagaacaatgccctcaacacacaaacccagcccaaggcccacaccaccggagacaga 360


ggaaaggaggccaaccaggcaccgccggaggagcaggacaaggtgccccacacagcacag 420


agggcagcatggaagagcccagaaaaagagaaaaccatggtgaacacactgtcacccaga 480


gggcaagatgcagggatggcctctggcaggacagaggcacaatcatggaagagccaggac 540


acaaagacgacccaaggaaatgggggccagaccaggaagctgacggcctccaggacggtg 600


tcagagaagcaccagggcaaagcggcaaccacagccaagacgctcattcccaaaagtcag 660


cacagaatgctggctcccacaggagcagtgtcaacaaggacgagacagaaaggagtgacc 720


acagcagtcatcccacctaaggagaagaaacctcaggccaccccaccccctgcccctttc 780


cagagccccacgacgcagagaaaccaaagactgaaggccgccaacttcaaatctgagcct 840


183/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
cggtgggatt ttgaggaaaa atacagcttc gaaataggag gccttcagac gacttgccct 900
gactctgtga agatcaaagc ctccaagtcg ctgtggctcc agaaactctt tctgcccaac 960
ctcactctct tcctggactc cagacacttc aaccagagtg agtgggaccg cctggaacac 1020
tttgcaccac cctttggctt catggagctc aactactcct tggtgcagaa ggtcgtgaca 1080
cgcttccctc cagtgcccca gcagcagctg ctcctggcca gcctccccgc tgggagcctc 1140
cggtgcatca cctgtgccgt ggtgggcaac gggggcatcc tgaacaactc ccacatgggc 1200
caggagatag acagtcacga ctacgtgttc cgattgagcg gagctctcat taaaggctac 1260
gaacaggatg tggggactcg gacatccttc tacggcttta ccgccttctc cctgacccag 1320
tcactcctta tattgggcaa tcggggtttc aagaacgtgc ctcttgggaa ggacgtccgc 1380
tacttgcact tcctggaagg cacccgggac tatgagtggc tggaagcact gcttatgaat 1440
cagacggtga tgtcaaaaaa ccttttctgg ttcaggcaca gaccccagga agcttttcgg 1500
gaagccctgc acatggacag gtacctgttg ctgcacccag actttctccg atacatgaag 1560
aacaggtttc tgaggtctaa gaccctggat ggtgcccact ggaggatata ccgccccacc 1620
actggggccc tcctgctgct cactgccctt cagctctgtg accaggtgag tgcttatggc 1680
ttcatcactg agggccatga gcgcttttct gatcactact atgatacatc atggaagcgg 1740
ctgatctttt acataaacca tgacttcaag ctggagagag aagtctggaa gcggctacac 1800
gatgaaggga taatccggct gtaccagcgt cctggtcccg gaactgccaa agccaagaac 1860
tgaccggggc cagggctgcc atggtctcct tgcctgctcc aaggcacagg atacagtggg 1920
aatcttgaga ctctttggcc atttcccatg gctcagacta agctccaagc ccttcaggag 1980
ttccaaggga acacttgaac catggacaag actctctcaa gatggcaaat ggctaattga 2040
ggttctgaag ttcttcagta cattgctgta ggtcctgagg ccagggattt ttaattaaat 2100
ggggtgatgg gtggccaata ccacaattcc tgctgaaaaa cactcttcca gtccaaaagc 2160
ttcttgatac agaaaaaaga gcctggattt acagaaacat atagatctgg tttgaattcc 2220
aggatcgagt ttacagttgt gaaatcttga aggtattact taacttcact acagattgtc 2280
tagaagacct ttctaggagt tatctgattc tagaagggtc tatacttgtc cttgtcttta 2340
agctatttga caactctacg tgttgtagaa mactgataat aatacaaatg attgttgtcc 2400
atggaaaggc aaataaattt tctacagtga aaaaaaa 2437
<210> 78
<211> 582
<212> DNA
184/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
<213> Human
<400>
78 aattattatttatttcaataagactattgcgaggcattaaaaaaactaaa60
ttccagatca


tagtaatattacaaaatctatatacttgcacatttagtatttgtcaatgtgccagaggtt120


ttcttcatgaaatttgacttctttgaagtgaaggcttttttctatcatctcttatagctc180


tgactgaataagtcttaatgctttcttcatgttttctatcaataggggtaaatcccgagg240


cttatatgtgtacaatctgttagagtatcttccagctatgtcagctctaactgttaaaga300


agggtctacaaacatgattctaggcacatattgcccatcaggtgataaattcttatcagt360


ggtttcatgcataaggtttagcatgatgaacttattctgagccatttcttgtatttcttc420


attttgggcaaatactttctttagtgcttgagagtattgacaatcctccaggtgatgaat480


aaccattaatggcttcttacttttttgagcataaaagagaccttgctcataagtttgtac540


ccaagagatggcatctacccatcctcttgagagtgactgagg 582


<210> 79
<211> 511
<2l2> DNA
<213> Human
<400> 79
ttgaaagcct ttacatttat tgaagagcgg acatatgttt gcaaatcaca gtgtgcatgg 60
gcatgcatta catggttcat aatgctattc caattaggct tttcatagtg ccttctcata 120
acgtcctttaaaaaaaataataactgaaagggaaaagaaagtgtcaattgcaattacatt180


tacaaaaccaaactgctgctttcaattagagtgaatctgtgcttcgctactcagatatac240


acatgtagattttccaaggcccatgcacacacttctgtaggggcagaaattttctatgaa300


taatggctttagcaacccgaatagtatctctaaacattgacaagcttggggaacagggca360


acaagtgcaatgaacaatacaatttctaacgtttgtcccagtcaacataccactttgccc420


tggagatatttaacacagcatttcatttttggaatgataagggataattcatctaattaa480


gggtattatacagaatatacctataaaagac 5ll


<210> 80
<211> 987
<212> DNA
<213> Human
<400> 80
gtgatgatcg acatttgaat ctctttgccc tttccaacgg ctatggcatc aggttctaaa 60
ataagctcgt aatttttcct gttattttaa taatatggaa atattagcat agtgtttctt 120
185/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ttgatagtga tagactataa tccatattta aattttatag.agaagaaatt ttattgtact 180
gtgatgtaga tatttattat ccaggtaagg atttgcccgg tgtgtatttt ttacaattga 240
gacattttac tttaatcttt aacaaaaaat gcattaaaaa cacactcaaa aaaaaacaaa 300
aaaaaaaaaaaaagacaacccaaacggggggggaaaaaagaggtgattggcaccctttat 360


cacgaaaatcttcctgcgggcggccctctaataaccagtcttctggaacaactgtgccca 420


aaccgaggtgtcgctctttaaaataggcgtggtctcccaccatatctaacactcaaatgg 480


cgccgcctcttctcaaaagaacccacaaatatgtgtgccgaccaagagttaaaaaacccg 540


ccttgcgttggacggggcggacattatcttggattggcaccaacactattaaaagaggcg 600


atgcgacacccaaccccgattaattggcagcagacagaaatcctttctcaactagtatag 660


aaaactgttgtggccctccaccacacaaaaggacgaatcctacccaactaatgtattagc720


tcctctccagtgtgaacaatatactaatctggatgcgcccacacccaagctggttagcta780


acacaaacaccagggagggaagacacacgcattttgtaacacaaatagatctaatattag840


actcgtgccgtataacatcggacactaatctctagcaccagcgggcgtcgactgtaatta900


tgtcccgccactgctgctgttcgtcggcatgttatcatgccccacgctctctgtgatcct960


acacgagagggatcaccccacgcttat 98~


<210> 81
<211> 483
<212> DNA
<213> Human
<400>
8l


ctgttcaaaaaaggttttatccaaaaaagttaatcaagacaagcaacagatactgcaaag 60


cattatatacagcaccatagtccaggggccaaagaaatcaggaggggctgggcagtagag 120


gaattccatatattaatgaatgtgagattaagtatagagtgaagacattaacacacaatt 180


ctaatttctgttaggcagaatgctcccctaccctgatgccacagcctttcacgtttccta 240


aaccctagtaacctctgatctccatctgcctcatcaacacgtcaccaccctttgctcttc 300


ttccaattagtcacatgttggctgaatttatttcactccagtactttaggaccttgacag 360


acaaatcgattacaaggtcaattcccaggatttcttcagggtgtgttcaggagtgcagat ~
420


gttctttggatgacctttctactaaattagacctctgaaggagaaagctacttgccagag 480


get 483
<210> 82
<211> 552
<212> DNA
186/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
<213>
Human


<400>
82


tttttttaccacctagaaataaacattatattttcctctgatatgtaggtaagaacttca 60


aatataagacataatttaaaagtttataattgacatagtcagggattataaataatatca 120


cacaaaataagctcttaatgcaagaaatgaatctccaggatagatcatactaatctatcc 180


aatccagccctctgttctgaaagcagcacatgaaaaggcagagaaagaaaaataatctct 240


acgacctggcctgttaaacatgtatttatttcctgagtaactattaggtgctagctgtaa 300


tgggctattcagtggaggacagtggtcaaagcctcttatgatgtatggcagatgccagaa 360


agatatgaaagatgtgatggtacaaaaaaggaagttggagtcacatccagccacaggact 420


aactaagcctctttggggcaggagactttggaagtgttgaaggagagtagaatctattca 480


gaaagaaacaactgggggcaggtccttccagtctgaatgaagattaactaggcgtaatgt 540


aactggcatcat 552


<210> 83
<211> 505
<212> DNA
<213> Human
<400> 83
gactgtagaaggaaagcattttattgcaaataactaatagttacaaaagcactttttaaa 60


tgttattattagatgttaagccgaaaatctagaaactaacatttacccaggttacaaaat 120


aagagcttcatatttttcaaagtctctaagggtaaggtacatccccagataaaatgagta 180


taggccagtctcctttggctttgtggattctttccaaaaattttccagactatttagctt 240


tccttgtgtagttacagctcaaattagaaactgaagaaacagcaagtggccaggcagggt 300


agaaagcaaataaactgagctacctgtgcctttttccaaatcagtatatgtgcttggctc 360


ctgaaaaaaaaaattctgatatgtaggcattctcattacttagtgagatattagtgaaga 420


cctttcaacgtataacacacagtaactgttgcatagttttaataaacacttgaattttcc 480


aggaatgtga ctgctgtgta aatca 505
<210> 84
<2l1> 671
<212> DNA
<213> Human
<400> 84
gcggccgcgg ctgcggcggc agcagcactg gctgggtctg gctgcacagc aatggggctg 60
atcatgtgct ccactgtgtg gattttgcca tcttcaatca ttttaggggc tggagctgct 120
187/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ggaaacatggaatactgagccccaatggcagggatggctactgtaccaggtttaatggca 180


actgggttgacggtagggatttccaaattcggcaccagttcatatcctttttcttgctgc 240


tttcctttcccttcatgatatcggctatatataccacggccagcagaatatcccccgagg 300


taggaacccctaggccctggggctctgttgccagctgcacctcgccctcggcctcttatg 360


ctgcctgctttcacaaagtagtccctgttgggcccaatgagcgcgttgtaggggtagccg 420


tagtaggccagtgtgtaggggtcgcaggagtacacgtagctgggctgctgcgctgcctca 480


gccgcgccgccgcccctggctgccttctggtagcgcgagtactgctccttgtccacgggc 540


ttggccagcgtgacctccaggcacgagccctccagctcagtgccggttgagttgttcatg 600


gcatgcacggcatcctcgcggctggtgaagtgcacggaggcgtaggtccggatcttcttg 660


acgcgctcca c 671
<210> 85
<211> 563
<212> DNA
<213> Human
<400> 85
tttttttttt atatctgtta taagcttttt cttttttaga atttaagctt atgagtttat 60
ctacgcccactatattcataattacagttttatatctgcatacaaaagctatgtaaaaat 120


ccatttttcccaaatatacaaattttttttggatagtttaaaacattttgatcacagatt 180


tcaacagagttttaggctgaaaaaaatatcaccatctagcaatatcacttaacactgttt 240


gcaaaacacaaatcttccaatgactgtaaatctttttctattctgtagtatttttctgat 300


tctcagggcatgaaaacattatgggaaaaaaaaggattttctacgaagaaagcatggaga 360


actaatttggctctatggtcaaattaaaaatgccaagttaataagggagaaccaaaagaa 420


agaagtggcataatgtcacatcagctcattcatgccctgataatttctgtatcaacaata 480


catatgtaaagtgtctccttttgtcttacattgtgctccataatttacatgagtattatc 540


tgcatcctgaggaggacagattt 563


<210> 86
<211> 545
<212> DNA
<213> Human
<400> 86
ttattaggga ttcctgccac cttattaaca tataaaacaa tctggatgtt gacatagaaa 60
tgcaaatttc actatacaaa ggtaaggctc caagcacagt aacatggccc ccatatcttt 120
agtatttcaa tgaaataaac ttattgggga ttcaccccga gttgtgttta taaatattag 180
188/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
acaaaccaca aaatatattc caaatacata acattttaca atatttttca agcacagaca 240
aatacatact ttactttacc tacattgttt tcatgatcca acttgcatta gcactaaagg 300
caatattgtg tgtgtatatg tatttgccat atgtgtgtgt gtattatata tatttattta 360
tatccacaaa tgtacactca gtggcattta tggaaaattt aaccctttca ggctgtgggt 420
tttacccacc atagtatctg agagggagaa gaaccaataa tacatctcaa attcctcaat 480
tagggcaaaa taagcacaat tatgcatgag gggcatatat gttgtgtcta ttcaaagaca 540
cacat 545
<210> 87
<211> 464
<212> DNA
<213> Human
<220>
<221> misc_feature
<222> (28)..(28)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (276)..(276)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (422)..(422)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (463)..(463)
<223> n is a, c, g, or t
<400> 87
gcagcgtttg tccctgggca tgtgatgngg agtcctgggc acatcgagat gctttacttc 60
tttctttcga cctcttaaaa aactaaacca agccaaacca caaaggaaat ctgcacaact 120
taagagaaac ttgaaaggga tcgtgtaact actagtttgt actaagtttt tttcaagaaa 180
gggaaacaaa tttatatata tatatatata tatatatatg tgcaatatat ttttacactg 240
tgtgattaac attagggagt actgagtgca tcactntatc agtgtgacgg gtgatgtcca 300
cgtcatggct gttctgactc tgaaagccac ttctgctgat gtctaaaccg cactcaccgc 360
ggacgtccgg ggttgtggtg gccctgctgt gcctcctgca ggtgagaggt gtggtgttgc 420
cngttggact tgctgttgag cctggttgca aacctgtagt gana 464
189/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
<210> 88
<211> 611
<212> DNA
<2l3> Human
<400>
88


tttgctaaaaatttaccaaaatagtttgaacacataaaaatatttttaaaaaaacagaac60


caaaaacccagcataaatttagttgtataggcattggttagaggacactgttttcactaa120


ggattatattcaacaactttctcttgagttgttactaaaattctgattctgaaccttata180


gcttataatggtgccaactattagaaatgggaaaatctaattcagtccaatgtaacatgt240


attatgatataatagatgaagggtatgtctacactataataaaaaataaacatatttttg300


gttatttaaagaccatcttcctaacctgtaactaaaataactgtatttgatttaaactta360


tttaagtgcagtgaattatggaaagctaacttaaaggtttgaataatcaattatgagtaa420


ggaacacctg ttgacagccc cgtgaccctt cagaaccagg catttgctga aaaaaagaaa 480
tcactagcat tgaatatagc ccttagtcac gtgagagatt aacttcatga gcaacccagc 540
atgtagagga tgaggtggac tttcccagcc acccactcct tgaggggaca gtagtattca 600
tagtgaaact g 611
<210> 89
<211> 515
<2l2> DNA
<213> Human
<400> 89
tttaacagta aaatttattt ttatttttgc atattctcaa atacacattt acaatagtat 60
cacacttcct atatgaattc ttcatagtta ttttaagtat tttacaattt gtacagagga 120
agggacatac aatatctaat aggctatttt tcaaccaaat aataatttat gtccttgtaa 180
gattttgtac ctctttaaaa ctttcaactt caacatccac ttttttagct ttgctaatca 240
aattaagaattaaaaccagcctgcaaataataacagtatataacattaagcacaatttca300


tttctttctttatacaaatgttctatatttacttgaccaaatgcttaattaccttttaaa360


ggtttcaataccgtggttaaaaacaaaacaactgtgtatacctccagactatatgaaaaa420


tatgaaatatgtaaagtgtcacgttttttaccttagtttatttttaaaagataaatagct480


aactatctgtattaattttaaagaatgttttaaaa 515


<210> 90
<211> 535
<212> DNA
<213> Human
190/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
<220>
<221> misc_feature
<222> (422)..(422)
<223> n is a, c, g, or t
<220>
<221> misc_feature
<222> (424)..(424)
<223> n is a, c, g, or t
<400>
90


gaattctccttaatagttatgtgcaaacaggatgctcgaccctaagtgaattttagtgca 60


gcctcaggccaatcttggtcctgggagtgggcagggttcccagaagaacgagtctggttt 120


ctgaggctgtagaagggagccggaagcccctcaacttgatcacggtgagaacacagggag 180


cctttggagaagctattcagccactgtagttaagagctcctgttctgatccagggagacc 240


tgggttcaagtcctgactcagccacttcctagttgtgtgagtttcagaaaaaaaatcact 300


tcacctcttagaacgcaatttcagcttctgtaacaatctctaggttaggagggagtgggg 360


cgggtgagggcggggaggggagaggaaaaaaaaacacaacaatctctatgtggtttaagg 420


gnangggggttaaatgagatgatcatgacaatgcctatagaagtgctgggagtatgaaag 480


ctggaacagccctgtgagctttgtgtcgttgtccgatttttgataagggcaaata 535


<210> 91
<211> 535
<212> DNA
<213> Human
<220>
<221> misc_feature
<222> (97) .(97)
<223> n is a, c, g, or't
<220>
<221> misc_feature
<222> (322)..(322)
<223> n is a, c, g, or t
<400>
91


tttttttttttttttttacaatttaaacaagaggattcactggtttgaaaaaaaggtttg60


aaaatcaggaaagctaaacaaaagtcattttacatantggagaaactgagacccatatgt120


gtaaatggcttcccaaggtcacagtggtgtcagtggcagagctggtactgtaccaggctg180


cctggatcatagactgatgtttttgccaagaccagccgaaatgttcctctcaggaggtgg240


caggtgggggtggagtgccaggaaggcactgtccaaagaagtgggttaaggtcacagcct300


191/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
cccggctccc aaggaccccc tngagaacag ttgctttgga aaggtcactc agatgtgaac 360
cagaggcttg aggttttgga gtggaaaggg gcagggtaag gaagaataga gtaggaggag 420
ggcgggggac agggattcat cctccaggtt cctcacaccc ccactgggag cagcgccccc 480
accccaagca cctgatttca aagtctcccc tccactgaag ggaggggcaa aggga 535
<210> 92
<211> 548
<212> DNA
<213> Human
<400>
92


accttcttaactatgagattattacaaatatatttttacaaatacaaaaaactgaagtac 60


agagaggctaagttaatttctccaaggtcccacagcaagtaactgcagaagggcaaagca 120


aaaataggacaacacatgtaggcaataccaagcagttcttgtggcagcaactggaaacct 180


tttggagacaccattctgcatttcgttgtagtcatacacaaaaccctagttatgtatcca 240


tgcttctttctcataatgccaaagtggcactattctaatttactaacaaggttttctaaa 300


aactacccaaattattgaggtgtttttgctcacttcttcccattagaataaatgtagaca 360


ataagaaacgcatgagggatgacatagtcctccatcaaatctgtcctttcacacaagaga 420


tggcatggtgtagtgtagcagaatcatgagctgccaggaaattatgaattctgattcctc 480


cagctgagtctttgaaaaagtccagatgagaaacacttccatcctgatgctgaagcaagg 540


agaatgtc 548
<210> 93
<211> 481
<212> DNA
<213> Human
<400>
93


tttacattgttattaccactttatttatttcctgatatcgactagataattacatgtccc60


atcactctcccacatgggccatacaatggcttgagctgcatcattttgtaaattcctcaa120


gcttctctactggtacacatattaccctagcctatgtttctgagatgccttagtgaaagt180


tgattttctttctatgtcttctcagggaaaacgacttctgctttcacacttactggagat240


gggagatgagtggcactggcaattcacaccctgaaccttcagcttcacaacaaaatcgtt300


tgtgaggccaaaggaatcaagacagcagagctcaaagcagggccagaaggtgcagggggg360


accacattggcgggtctcgctcagggacacgatggcgtcattgtaacagcactgctccaa420


ggggttgtagatcttgtctccacacctgggtgccggctggcacagccatggttctgagcc480


481
192/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
<2l0> 94
<211> 4021
<212> DNA
<213> Human
<400>
94


taacgaacgtgtgagagatctacttcggcggaagtcatctaaaaccttcaatttgagagt60


ccgtgagcatcccaaagaaggcccttatgttgaggatttatccaaacatttagtacagaa120


ttatggtgacgtagaagaacttatggatgcgggcaatatcaaccggaccaccgcagcgac180


tgggatgaacgacgtcagtagcaggtctcatgccatcttcaccatcaagttcactcaggc240


taaatttgattctgaaatgccatgtgaaaccgtcagtaagatccacttggttgatcttgc300


cggaagtgagcgtgcagatgccaccggagccaccggggttaggctaaaggaagggggaaa360


tattaacaagtcccttgtgactctggggaacgtcatttctgccttagctgatttatctca420


ggatgctgcaaatactcttgcaaagaagaagcaagttttcgtgccttacagggattctgt480


gttgacttggttgttaaaagatagccttggaggaaactctaaaactatcatgattgccac540


catttcacctgctgatgtcaattatggagaaaccctaagtactcttcgctatgcaaatag600


agceaaaaacatcatcaacaagcctaccattaatgaggatgccaacgtcaaacttatccg660


tgagctgcgagctgaaatagccagactgaaaacgctgcttgctcaagggaatcagattgc720


cctcttagactcccccacagctttaagtatggaggaaaaacttcagcagaatgaagcaag780


agttcaagaattgaccaaggaatggacaaataagtggaatgaaacccaaaatattttgaa840


agaacaaactctagccctcaggaaagaagggattggagttgttttggattctgaactgcc900


tcatttgattggcatcgatgatgaccttttgagtactggaatcatcttatatcatttaaa960


ggaaggtcagacatacgttggtagagacgatgcttccacggagcaagatattgttcttca1020


tggccttgacttqgagagtgagcattgcatctttgaaaatatcggggggacagtgactct1080


gatacccctgagtgggtcccagtgctctgtgaatggtgttcagatcgtggaggccacaca1140


tctaaatcaaggtgctgtgattctcttgggaagaaccaatatgtttcgctttaaccatcc1200


aaaggaagccgccaagctcagggagaagaggaagagtggccttctgtcctccttcagctt1260


gtccatgaccgacctctcgaagtcccgtgagaacctgtctgcagtcatgttgtataaccc1320


cggacttgaatttgagaggcaacagcgtgaagaacttgaaaaattagaaagtaaaaggaa1380


actcatagaagaaatggaggaaaagcagaaatcagacaaggctgaactggagcggatgca1440


gcaggaggtg gagacccagc gcaaggagac agaaatcgtg cagctccaga ttcgcaagca 1500
ggaggagagc ctcaaacgcc gcagcttcca catcgagaac aagctaaagg atttacttgc 1560
193/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ggagaaggaaaaatttgaagaggagaggctgagggaacagcaggaaatcgagctgcagaa 1620


gaagagacaagaagaagagacctttctccgcgtccaagaagaactccaacgactcaaaga 1680


actcaacaacaacgagaaggctgagaagtttcagatatttcaagaactggaccagctcca 1790


aaaggaaaaagatgaacagtatgccaagcttgaactggaaaaaaagagactagaggagca 1800


ggagaaggagcaggtcatgctcgtggcccatctggaagagcagctccgagagaagcagga 1860


gatgatccagctcctgcggcgtggggaggtacagtgggtggaagaggagaagagggacct 1920


ggaaggcattcgggaatccctcctgcgggtgaaggaggctcgtgccggaggggatgaaga 1980


tggcgaggagttagaaaaggctcaactgcgtttcttcgaattcaagagaaggcagcttgt 2040


caagctagtgaacttggagaaggacctggttcagcagaaagacatcctgaaaaaagaagt 2100


ccaagaagaacaggagatcctagagtgtttaaaatgtgaacatgacaaagaatctagatt 2160


gttggaaaaacatgatgagagtgtcacagatgtcacggaagtgcctcaagatttcgagaa 2220


aataaagccagtggagtacaggctgcaatataaagaacgccagctacagtacctcctgca 2280


gaatcacttgccaactctgttggaagaaaagcagagagcatttgaaattcttgacagagg 2340


ccctctcagcttagacaacactctttatcaagtagaaaaggaaatggaagaaaaagaaga 2400


acagcttgcacagtaccaggccaatgcaaaccagctgcaaaagctccaagccacctttga 2460


attcactgccaacattgcacgtcaggaggaaaaagtgaggaaaaaggaaaaggagatttt 2520


ggagtccagagagaagcagcagagagaggcgctggagcgggccctggccaggctggagag 2580


gagacattctgcgctgcagaggcactccaccctgggcacggagattgaagagcagaggca 2640


gaaacttgccagtctgaacagtggcagcagagagcagtcagggctccaggctagcctgga 2700


ggctgagcaggaagccctggagaaggaccaggagaggttagaatatgaaatccagcagct 2760


gaaacagaagatttatgaggtcgatggtgttcaaaaagatcatcatgggaccctggaagg 2820


gaaggtggcttcttccagcttgccagtcagtgctgaaaaatcacacctggttcccctcat 2880


ggatgccaggatcaatgcttacattgaagaagaagtccaaagacgccttcaggatttgca 2940


tcgtgtgattagtgaaggctgcagtacatctgcagacacgatgaaggataatgagaaact 3000


tcacaatggcaccattcaacgtaaactaaaatatgagctgtgtcgtgacctcctgtgtgt 3060


cctgatgccagagcctgatgccgctgcctgcgctaatcatcccttgctccagcaagatct 3120


ggttcagctttctcttgattggaaaacagaaatccctgatttagttttgccaaatggagt 3180


tcaggtgtcatccaaattccagactaccttggttgacatgatttactttcttcatggaaa 3240


tatggaagtcaatgtcccttccctggcagaagttcagttactgctctacacaacagtgaa 3300


194/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
agtcatgggtgactctggccatgaccagtgccagtcgctagtccttctgaacacccacat3360


tgcactggtgaaggaagactgtgttttttatccacgcattcgatctcgaaacatacctcc3420


tccgggtgcacaatttgatgtgatcaaatgccatgctttaagtgaattcaggtgtgttgt3480


tgttccagaaaagaaaaatgtgtcaacagtagaactagtcttcttacagaaactcaaacc3540


ttcagtgggttccagaaatagtccacctgagcaccttcaggaagccccaaatgtccagtt3600


gttcaccaccccattgtatcttcaaggcagtcagaatgtcgcacctgaggtctggaaact3660


tactttcaattctcaagatgaggctctttggctaatctcacatttgacaagactctaagg3720


aggagacttttaaagatgcactacatgttttttgagatcattaataaaataagcattgtg3780


aaaacagtcaaggcaatatgaatatctccgtgtagctaattgaattggaactggaaaaat3840


gcagacctctaaaattgaaaatgtaactattttaaatatctacaataaaataaaaacagc3900


taatagcagagccccaatgaaatatctttatcatcaccttgcttcattttcttgaaactc3960


aggcttgtaaatttgtgcctgcttcattatttgtgaggtgattaaagcatttctgattgt4020


t 4021
<210>
95


<211>
2917


<212>
DNA


<213>
Human


<400>
95


tgtcagtaccacacctgttacgaggtttcctgagagtagcaccccttccataccatctgt60


ttacaccagcatgtctatgaccactgcctctgaaggcagttcatctcctacaactcttga120


aggcaccaccaccatgcctatgtcaactacgagtgaaagaagcactttattgacaactgt180


cctcatcagccctatatctgtgatgagtccttctgaggccagcacactttcaacacctcc240


tggtgataccagcacacctttgctcacctctaccaaagccggttcattctccatacctgc300


tgaagtcactaccatacgtatttcaattaccagtgaaagaagcactccattaacaactct360


ccttgtcagcaccacacttccaactagctttcctggggccagcatagcttcgacacctcc420


tcttgacacaagcacaacttttaccccttctactgacactgcctcaactcccacaattcc480


tgtagccaccaccatatctgtatcagtgatcacagaaggaagcacacctgggacaaccat540


ttttattcccagcactcctgtcaccagttctactggtgatgtctttcctgcaacaactgg600


tgctgtatctacccctgtgataacttccactgaactaaacacaccatcaacctccagtag660


tagtaccaccacatctttttcaactactaaggaatttacaacacccgcaatgactactgc720


agctcccctcacatatgtgaccatgtctactgcccccagcacacccagaacaaccagcag780


195/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aggctgcact acttctgcat caacgctttc tgcaaccagt acacctcaca cctctacttc 840
tgtcaccacc cgtcctgtga ccccttcatc agaatccagc aggccgtcaa caattacttc 900
tcacaccatcccacctacatttcctcctgctcactccagtacacctccaacaacctctgc960


ctcctccacgactgtgaaccctgaggctgtcaccaccatgaccaccaggacaaaacccag1020


cacacggaccacttccttccccacggtgaccaccaccgctgtccccacgaatactacaat1080


taagagcaaccccacctcaactcctactgtgccaagaaccacaacatgctttggagatgg1140


gtgccagaatacggcctctcgctgcaagaatggaggcacctgggatgggctcaagtgcca1200


gtgtcccaacctctattatggggagttgtgtgaggaggtggtcagcagcattgacatagg1260


gccaccggagactatctctgcccaaatggaactgactgtgacagtgaccagtgtgaagtt1320


caccgaagagctaaaaaaccactcttcccaggaattccaggagttcaaacagacattcac1380


ggaacagatgaatattgtgtattccgggatccctgagtatgtcggggtgaacatcacaaa1440


gctacgtcttggcagtgtggtggtggagcatgacgtcctcctaagaaccaagtacacacc1500


agaatacaagacagtattggacaatgccaccgaagtagtgaaagggaaaatcacaaaagt1560


gaccacacagcaaataatgattaatgatatttgctcagacatgatgtgtttcaacaccac1620


tggcacccaagtgcaaaacattacggtgacccagtacgaccctgaagaggactgccggaa1680


gatggccaaggaatatggagactacttcgtagtggagtaccgggaccagaagccatactg1740


catcagcccctgtgagcctggcttcagtgtctccaagaactgtagcctcggcaagtgcca1800


gatgtctctaagtggacctcagtgcctctgcgtgaccacggaaactcactggtacagtgg1860


ggagacctgtaaccagggcacccagaagagtctggtgtacggcctcgtgggggcaggggt1920


cgtgctgatgctgatcatcctggtagctctcctgatgctcgttttccgctccaagagaga1980


ggtgaaacggcaaaagtacagattgtctcagttatacaagtggcaagaagaggacagtgg2040


accagctcctgggaccttccaaaacattggctttgacatctgccaagatgatgattccat2100


ccacctggagtccatctatagtaatttccagccctccttgagacacatagaccctgaaac2160


aaagatccgaattcagaggcctcaggtaatgacgacatcattttaaggcatggagctgag2220


aagtctgggagtgaggagatcccagtccggctaagcttggtggagcattttcccattgag2280


agccttccatgggaactcaatgttcccattgtaagtacaggaaacaagccccgtacttac2340


caaggagaaa gaggagagac agcagtgctg ggagattctc aaatagaaac ccgtggacgc 2400
tccaatgggc ttgtcatgat atcaggctag gctttcctgc tcatttttca aagacgctcc 2460
agatttgagg gtactctgac tgtaacatct atcaccccat tgatcgccag gattgatttg 2520
gttgatctgg ctgagcaggc gggtgtcccc gtcctccctc actgccccat atgtgtccct 2580
196/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
cctaaagctg catgctcagt tgaagaggac gagaggacga ccttctctga tagaggagga 2640
ccacgcttca gtcaaaggca tacaagtatc tatctggact tccctgctgg cacttccaaa 2700
caagctcaga gatgttcctc ccctcatctg cccgggttca gtaccatgga cagcgccctc 2760
gacccgctgt ttacaaccat gaccccttgg acactggact gcatgcactt tacatatcac 2820
aaaatgctct cataagaatt attgcatacc atcttcatga aaaacacctg tatttaaata 2880
tagggcattt accttttggt aaagaaaaaa aaaaaaa 2917
<210> 96
<2l1> 138251
<212> DI~7A
<213> Human
<400>
96


gatcaaaagatgctcatcaaaagctctgagctttcctgagtgctaacaggaaacatccag60


catcactggtctctccaaggctgcaggtgtctttgcccatagtgcctgttttgtgtcagg120


gaaagaatcaacctgggagccaagcccaggaatcaggatgaccaagacatactggacaag180


gaaggaacaaacccatccaaggacactcaaggacaaatcaagcaaatgaatttaagggag240


acctgctcatggtctgctttgctgctcagcatggctgggaggcacagtggaagatcatgc300


atccttcccctgggactcctctgccagagcctgagagctttctcctgcacacaggctagg360


ggtagggcagttggaattgatccatgccttctagctagactgtgggtcccctcagtcttg420


ggcatggtgacagcccagcatcagacagaggtcagtatcaaactagaaaatttaataaat480


gctgtcagatttgtagacccaagaaaatataaactgccaatcacggaggaaaaaaatctc540


tcaatgatcttatctttatatgattcccttgctgcctggagattgacatttccttgggga600


taatctggtcataggattggtgaaggtggaagggaggcaacctccgaaggtggggccctc660


tgctcacctgggacagggggggcctgaggtaggtgtctgtgtgggctgggcaggaggatg720


ggagcagtgcttctagatgtttccactttctcctcattagataataatgaatgggtgatt780


tccctagtcactgcagtgtgaggaaatctacaaaattaatttcacaatacactttacagg840


ataggtggagaaacacatgaagcacaactgcagtgggttataaaaaatggcctttcgagt900


tgagcagtaaattcgttcaagcagccattctgaaggacaaactggctctgtatttaacag960


gggcattccagcacttctctagctactgggttgacaatgactcaccaaagcctctggtag1020


ccaccacaggacgcccagagcacgttttaaagctgaacaccaaactgcggacttcgggag1080


taagtgaactgactggtttttattttgttttactgcttttaacattacagtgactgttac1140


aggttccagcaggataactgggtggaaatgagtttggtttcacttagtctctctaaagag1200


197/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
aaagcaagttggtagactaatacctaataaaagcaaagctgccaacaattgaaattgcct1260


gggctgctctgtgtgtcccacatgcatgggtgtgggtgccagtgtgtgtgcgtgtgtgca1320


tgcatgtgcatgtgtgttgggatagagtggcaagaaaatgggaaataataagaatgttca1380


gtccatagcccttcattataaaaaggtgagctgtaataaatactagtgccacatttagcc1440


aaaactttactccagccaaaggtgatattttcatgataacatcctgtgattgctttgttc1500


ttcgtcttttatgttcttcctagatgggctcagaacatacaagaattaagtacacatctt1560


attttccagtgataatgctaccggcaaattctgttgtttgtataaacatcagccatgttt1620


atataactaaactagtgttttgttttgtcaattcagcaagaaattagaccacatggtggc1680


ttaatgctgcattgatttggctatcaatttgttttcacttttctgcaaaatatttaatac1740


attattaaattgaattatgctgatgccacagttgttcttatctcaattgtcttaaaattc1800


atttaatttttttttcctttcgtttcattattcaaattttaacttcagttctcaacattt1860


tatctgatggaagagatggagtccattactaaggactccattgtgctccatcatgccaga1920


gttgtaaaatagatcttttaaaggaaatttactgtgatttttttctatttaagagcttcc1980


tctccagttgagcatgtaagaaaattataccaggagaatacagtaaactctatgaggcaa2040


gctataaacatgtaggattgtgattagggctggttctccttctagagacatggtaggatt2100


gcaatttcataccatccttgaagttagagagagccacttgactcatttagccaatgaact2160


gtgagcagaatgacatgtcacttccagcagaagctttaagaatctgagagacattcatac2220


gttttccatgtgctgtagccttatacccaaagcctgggtcccaagtgaccatgacaggca2280


gagctccctgttgagccacagagatttagagaatggctgttaacacagcataatccagcc2340


catcctgactaatctgatattaacatgtataataaagaattctatcaatgctgagggaag2400


atgattagttaaggtcctaggttgcaagtctcaaaacctcttctaaggattgtagacagg2460


aaattaaatgacttctagtccctagagttcccaatctcctaccatcccatcctaatatga2520


cagaagtaattcctgagttgcttctgaaaccagagcttccctcagaacccttagcctgcc2580


agatggcttcttggagagccctcactcacttttctccttctgctattgctgctcattcat2640


tccagcttttaaaaattcatctttatccaggaacctcgcttctagaaaagtcatacaggt2700


gcttccaggaggctacatgggcacccatatttttctagccactttcattagaccaatgca2760


gcagagaagaaaagcctcaataattattatgacatggcatgttaggataccaagtaaatt2820


gcatttgtaaaatgtgattttctgttggtgttcacttcggctctactgacatttggtaag2880


tattattgactgactgactaactaatgtggtcattagtcttcataaagaaaggctctcta2940


198/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
caaaaacggagggatgccctttttctggcatttaatacgtaagaaattgcctccgataga3000


aaccagagttgcctgattactatcagcacaggagaaatgtattaatgtgcctttctagta3060


acaggtttttagaaagtcaaatataaacaaatctgtctatttgtgtgtgtgcatgtggta3120


gtggggagggaagaaaaaaggagggggagagaaagagaaataagaaccaagtttattata3180


ctgtattcagggggaaaacattttcccaaggttctaacagaagagcaaagtgccactgtc3240


aatagcctcagtagtgttagggttgcttttatgtatttatttatttacttatttatttat3300


ttttcctttttttttcctttctctttttttcttcttttttttttttttggacagagtctc3360


acactgtcgcctgggctggagtgcattggcgcaatcttgactcactgcaacttctgcctc3420


ccaggttcaagtgattctcctgcctcagccgcccaagtagctgggattacaggtgtctgc3480


caccgtgcctagataatttttttatatttttagtagagatgaggtttcactatgttggcc3540


acgctggtctcaaactcctgacctcatgatccacccacgttggcctcccaaagtgctggg3600


attacaggcgtgagccaccgcccctggccaggattgcttttatagccagtcttcaggtgc3660


ccactgtaggaacaatgtcatttagccctcgggattattctgtgccaaatatggataatg3720


actaatattcaacacagatattctcagctcagaagagcaattagcaaattcataaattaa3780


gtgcttgcttcctttttagtcaaatacaaacatttgttaaaagatattattttgctttac3840


actttttctctcagaaataaacagatgcttgaattcccacagtgctgcttgagcctcaca3900


ccatgtcatcctgccaggcacccagatccagttctagagtttcacatgatcatgagtgtt3960


ggttaataagtcactgtgaactgggaggggagatttttcaggagtgccacagggctctcc4020


ctttaatcacatacactccctgctttcattggaaagtgtataatgatgtcagagtgcccc4080


agaatggagctagttggaagactgccgtcatagggatgccttagtgaattaatcaggttt4140


taatttctggctctcaactttgtagatgtaaaagttgatttatcaatatgtgagaaagga4200


tgaatctttctgaaggttatgtcatcacactcactaagcacacagagaataatgtctaga4260


atctgagtgccatgttatcaaattatactgagactcttgcagtcacacgggctgacatgt4320


aagcatcgcctgcctagtacagactctccctgcagatgaaattatatgggatgctaaatt4380


ataatcagaacaatgtttggtgagccaaaactacaacaagggaagctaattggatgaatt4440


tataaaaatatacctcagccaaaatagcttaattcagtctcccttatcataaggatactc4500


ttgcctaaag ggacagtaat attaaagaca ctaggaataa cctctgtact ttggacagta 4560
gacctgcata gcccattagg cctcaatgaa gtcttatgca agaccagaag ccaatttgcc 4620
attttaaggt gattctccat gtttctgctc taactgtgct tcacaatact caagacactg 4680
aatcaggatg tttcctggag tgcagggagc tgtccgtgtt actgagcagt tctcagcaac 4740
199/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
acaaagatcctactgactcctcatcagacttctttctcactggaattttacacctgggct4800


gttaacaccaggccaggtcaaattcaaaggagagaaaaaagctcattatgaagggtaaaa4860


tccaaaacactgtgcataaagatatgtgtgcacaatttttatacataaagatttcataaa4920


gccaaagcatcaggaaatgaaaagagatacagaaagaaaaatgatggtaaatgagacatt4980


aatttacccttctaatctctatcacagcaaaaaggtaattaaaaaatctatatgaggacc5040


aaaaaatacacaaagactatgtagcaaagcctatagcctgaaaaagtaaacattgaaatt5100


tgtatgtccataaaatgtttacaaaattcagtacatattacacaccccaccctaaaaaca5160


tctaagcaaa gtagagaatg tagaaatgct acagattata ttctctgatt atgacacaac 5220
aaaactagaa attacagcat ggaaatttaa aagctttctc ttaaataatt ctatgtcaaa 5280
aagaaatccaggccgggtacagtggctcatgcctgtaattccagtactttgggaggccaa5340


ggtgggcaggtcacttgaggtcaggagttcaagaccagcctcgtcaacatggcgacaccc5400


tgtctctactaaaaatacaaaaattagctgggcctggtggcgcatgcctgtaatcccagc5460


tacttaggaggctgaggcaggagaattccttgaacccagaaggtggaggttgcagtgagc5520


tgagattgcaccactgcactccagcctaggtgacacagcaagactctgtcaaaaaaaaaa5580


aaaaaagaaatccaaataaaatttccagaatatgtggaaaatagtgccaataaaaatatt5640


acacatgtgtaatcccagcattttgagatgccaaggtggcaggatcacttgagaccagga5700


gttcgcaaccagcctggacaacatagggagactccatctccacacacgccaaaaaaaaat5760


tttaaatagccaggtatagtggtacttcttgtaatcccatctacttgggaggctaaggtg5820


ggagaatcacccaacctcaggagttcagggcttcagcaagccatgatcatatcactgcac5880


tccagcctcagcaacagagcaagatcctatctcaaaaaaaaaaaaaaaatcacatgtggg5940


aaatagctatagcacaataaaaataaatgtattaagtatgaacaacaaaaaagctagtaa6000


aggttgaacaacaactatccttaggaaagtggaaataatgtgttaataaatatgaaagca6060


ggctaggcacggtgactcacatctgtaatcccagcactttgggaggctgaggcaggcaga6120


tcacctgaggtcaggagttccagaccagcctggccaacatggtgaaatcttgtctctcct6180


acaaatacaaaaactagccaggcttggttgcgcactcctgtaattccagctacttgggag6240


gctgaggcaggagaatctcttgaacctgagaggcagaggttgcagtgagccaagatcatg6300


ccactgcactccaactggggcaacagagtgacactccatctcaaaataaataaataagaa6360


agcagaaactaataaattagaaaacagaaacatagaactaatttataaatcaaagcacta6420


tgccttgaaaagagggagaaaaattgtgaattaaggaagggaagagatggttggagagga6480


200/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ggtgggagaaggcagagataattgaaggagcaaaagcatctggagaagcaaagccactga6540


aagatgaacagggctctgaaagaaatgcttgattgctatcttttcaaatgactgcagttc6600


ccagtgacatcatttttctcctccctggaagtctgaggggcagttcacttatctactccc6660


CtCCCCtaCtcctcaccccacactcaaaacctgtctatgctcctttcattctcatatgac6720


agatttcagatggcattcttatttccctgatttctttttgagatagcttgcatttcccta6780


ctctatataaagccaccgtttatcaaatgcctacatggaccaagcagtccacaagggctt6840


cacagacagttttactaaactcatgccaaaactttcaggttttatagataaagatctata6900


ccttatagataaaggtatctataaggtatagataaaggtaaggtatctataccttataga6960


taaagaaattgaagcttatagagtttaagtaatgttcccaaagcctcgtggctagtaatt7020


caaacctaatttctgcctactccaaagtctatttttcctcatgatactatactgcctctc7080


catggataaagacagagatcacatattaataaaatttgcacaaagtcggcaaattgttga7140


aagggaaggctaagatgactaataaaatcaagagccagatgatctcaacaacctgaaata7200


actggctgacaaccaatttgaataactccctgcgggtgaagttcaaagtactatttgggg7260


tttttttttaagtttggctgggtgcagcggctcacgcctgtaatccaagcacttagggaa7320


gccaaggtgggtggatcatgaagtcaggagttgaagaccagcccggtcaacatggtgaaa7380


ccccatctctactaaaaataaaaaattagccgggcctgctggtggatgcctgtagtccca7440


gctacgcgggaggctaaggcaggagaatcgcttgaacccaggaggtggaggttgcaggga7500


gccgagatcgcaccactgcactccagcctgggtgacagggcgagattccgtctcaaaaaa7560


taaaataaaataaaataaaaaataaaagtttgatatattcagaatcagggaggtctgttg7620


ggtgcagttcatttgaaaaattcctcagcattttagtgatctgtatggtccctctatccg7680


tcagggtcctagcaggaaattgttgcactctcaaaggattaagcagaaagagtttaatga7740


agggtctctttccagggttaagggaactgctagggtttggatatttgaccactccaaact7800


catgttgaaatgtgatccccattgttggaggtgggacctaatgggaggtgttttggtcct7860


gagtgtggacctctcacgaatgtcttggtgccatccaagtgagatcttgctcgctctttt7920


tttctttttgagatgtagtttcactcttgctgcccaggttggaatgtagtggtgcgatct7980


tggctcactgcaacatccacctcacgggttcaacccattctcctgtgtcagcctccagag8040


tagctaggattacaggtacccaccactatgcccagctaatttttggtatttttagtagag8100


acggggtttcaccatgttggccaggctggtctcaaactcctgacctcaggtgatccacct8160


gcctcggcctcccaaagtgctgggattacaggcgtaagccaccgtgcctacctagttcta8220


gctctcttaattcccacaagagctggttgttaacaagagcctggtacaaacccctctctc8280


201/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ttgccacgtg atctctgcac atgccagctt cccttcccct tctgccatga gtggaaacag 8340
actaaagccc tcaccagaag caaatggtgg caccatcctt cttgcacacc ttcagaactg 8400
tgaaccaaat aaacctctct tctttaaaat tattcagcct ctggtattcc tttataacaa 8460
cacacacaca cacacacaca cacacacaca cacgcaaaag cagactaaaa caggaactaa 8520
ttagaaatgg tgatgcaccg agggattggc accgaggctc cccaacagga actgaggcca 8580
tggatagaag gacacattca tgttattttt ttctaatggt taagtaatta tttgctctta 8640
ctctcaaaat ttctgccaag gcctcccatg gaccaaactc aactagaatc taggaagcag 8700
agaacctgag tgttgcattc agcagaagtc agcttcctag ggaatattgc aggaagggtg 8760
aaggtagaga atctggtggg gaagcaagca aatgcccatc acatgcactt tcctccaaca 8820
gagcgactca gatgctataa aacttgctaa cgcagtctca gggtctgatc acagtaacat 8880
acaatccagg ttttaatcat cagaaatcgc agtcctattg tcttctgcac agacccaaac 8940
acacttggag gtcatgttca atatgaatac ctcacagaga aggaaattta cacacgagaa 9000
gtacatctgc agaaagccag ctggcatgtc aaccattcga aaactcagga tgttcgggat 9060
aaagaagact caggaagaca agtatgaagc ataatctgtg acattattga tatcttcctg 9120
atatcaataa tattgatatc ttcctgatat caatattatt gatatcttcc tgaagaacat 9180 ,
aattcctgcc taccatcaac aagcatcaat actttctacc agctattctc aaccctcatc 9240
atcggaagag acagacactg actgtgtcaa agtattagtc ccatcattca gcaattaact 9300
ttagctcaat gcttcaaaaa ttcttcaggc cctgtgtaat ttcagctatg tacattaatg 9360
atgagtaccc atacaaccat tctgtttctt attttcagta ccatatttaa taaatatcag 9420
ttattcaata ctttatttag acattttgtt agattgtttt gaccaatgaa gtctaatcta 9480
aatgttctga gcatgttcaa agtaagctag gctaacctat aatttttggt gtgctaaatg 9540
catttttaac ttatgatatt ttcagtttac gggggtttgt tgggacataa cttcatcata 9600
catcaaggag catctgtata tgggatatag ttaaagcagt gatcagagga aaatctatag 9660
ccttaacaca tttattaata aaagtgtagg aattaaatta tcagctgaaa aatgtaaaaa 9720
gtatctaaaa gagtaagcag aaagtacaag aaagaaccca tagtagaaaa aagtgaaaat 9780
taataaaata agaagccaaa aaacagatca aatcagtaaa ccaaaaatct tgttctttaa 9840
acaaatcaac aaagttgaca aaaaattaga tcttttaatc atgaataaaa aaagagaaag 9900
cacaaaaatg aataaggaat ggtgagagaa ataactattg ataatcagca aataaaaaat 9960
cattaaaaac aatgttgttc acatctatga aaaacattga aagctagagg gaatgggtaa 10020
202/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ttttccagaa aaatacaatt caccacaatt gacttcaaaa aaaaaaaaaa agaagtacag 10080
cacttatgtg agcaatttcc atagagaaat acagttgtca tggaattata acacacacac 10140
aaacactagg tttagatgtt ttcacagaga attccaccaa acctttagaa atcagatcat 10200
ccaaaggcaa attaacaacc ctcagccatt tgaggcaaaa tattacaatt gaggcaagat 10260
atactgtact gaaaacttga ggaaaaagca ggagagaaag ttcctttggg aaattcgaat 10320
actcaaaagt gcttacatac aatgaaaaat ttggaaatcc ataagcatgg ccaaggtggg 10380
acacatgctc agaaaaggcc tgagaagaca ctaataactc acctttagta attcctaggc 10440
tcacagcaag aaaaaatgaa ggctaaggca gaattatata tggctccact aagtgttgag 10500
ggagccccaa tacagagtca gtaagcaaag tctgggagat gtttttcata tttttttctt 10560
ttttggctcc ttgcagtcaa ggaaatcatt tttaaatcac taaatgctaa atgaacacaa 10620
gctaaaggaa ccgagccgcc ttcaaacatc aaacataaaa aagaatgcag atattacaaa 10680
accagtttac aaaagttact aaacaaataa aaactacatc ccacagtggg taacaaaaat 10740
aaccttgaag aagggaaaaa tttggtttcc agaataaaca cattataata tccaaaatgc 10800
ccagttttca acaaaaatta agaagcatgc aaataaacac aaaactatgg cccatttaca 10860
gaagaaataa atgagactct ccctgagtaa gcagatattg gaaatattcg acaaaaactt 10920
tatataactg tcttaaataa acttaaagag ctaaagaaac ccaagagaat gacatataaa 10980
taaataagaa atatgaattt tttaaaaggt acaaaaaaat tctgaggctg aaaagtacaa 11040
taactaatta aaaagttact ttttacttag ggttccaata gaagatttga gcagctggaa 11100
aaaagaatca gtgaacttga tagatcaagt gaaatgattc agtctgaaga gcaggaaaat 11160
gaaagaatga caacaaaaaa gaatagagcc taaagacctg tgtaacaaca tcaagaatgc 11220
ctacatacag aatcctggtg gggagtgagg ggcaggaaga ctatttgaag aaatgtgttt 11280
gaaagcttcc caaatttcac taaaaacaaa tatatacatt caaaaagctc agtgcacttc 11340
atcaaggaaa tatacaaaga tattcacacc aagacacact atgtttcaaa ttgtcaaaag 11400
gcaaagcgaa tgtttgaaag cagcaagaga aaggcaacgc gtcatttaca aaggatcctc 11460
aataagtttg acagcagata gtgcattata atccatggat gccagaagag cttaggaaaa 11520
aggcaatgca tcatttacaa aggatcctca gtaagtttga cagcagagag ctcattataa 11580
accatgggtg ccagaagagc ttagaatgac attttaaagt tctgaaagaa aaaaacactg 11640
tcaaccaaaa attctgtaac ttggaagatg ccccttcaag tattaaggat aaattacaca 11700
ttcccagatt aaaaaaaaaa gagagagaga aagagaaaga aagaaagaag agagagaaag 11760
aaagggagag aaagaaaaag aaagaaagaa agaaagaaaa agaaagaaag aaagaaagaa 11820
203/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
agaaagaaag aaagaaagaa aaagaaagaa aagaaagaaa gaaaagcaag caagctttaa 11880
aagttcatgt ttggtaggct gtacttcaag atacactttt aaaaaaaaag actccttcag 11940
atacaaacta aaaaacacta gaaagtaact caaaaccaca taaagaaata actccagtaa 12000
ggataactac ataggtaaat ataaaagcaa ttatcatatt ttttgtaagt ctttttaaat 12060
attctatatg ttttaaaaca aatgtgtaaa ataatgacta taaatctatg ttaatgaagc 12120
atgatgtata aagatgtggt ttgtgaaatt accaacataa agaaattcat aggaaactaa 12180
ataataatag agattttgta tactattgaa gttgtttcaa tttattctaa attgttccaa 12240
attaagaatg ttaattgtaa atccccatgg taaccactaa gttaatatct tttgaaaata 12300
cagaaaagga aagcagaggg taaacacagt gatatgctac aaaatagcaa ctaaacacaa 12360
aagaaggcga taattgagga aattaggaac aaaggaggta taagacatac agaaaacaaa 12420
agcaaaatgg taggagtaag cccctcttta tcagtaatta cattaaatac aaatgaatta 12480
aactctccaa tccaaagaaa cagattgaca gaatggattt ttaaaaaatg atccaactat 12540
attgtccacc agatactcac tttagatcaa aatacacaat gagttgaaat gaaaggatgg 12600
gagaaaatat tccatgtaag taataaccaa aggagatctg aggcaaatat acttatatca 12660
gacaaaatag actttaagtc aaaaactgtt acaaaataca aagaacagta tatattgatt 12720
tcaaaattaa acaagaagat ataacaatta taaatatatg tacaccaact aacagggctc 12780
caaaatatat aatgtaacca ttgagagaat taaagggaga gacagacaat tccacgaaaa 12840
ttgttgggca ttttaaaacc caactttaat aaaggacaaa acatccagag caaatatcaa 12900
gggaggaatt agaggatttg aataaaacta taagcaataa ctatagataa cacttctctc 12960
aaaaactgca gaatacacat tcttctcaag tgaacatgga acattctcca gcacagatga 13020
tatgttaggc cataagataa gctcaataaa cttaaaaaga ttgaaatcat gcaaagtatc 13080
ttcactgacc acaatggaat gaaataagat atcaataaca aaaggaaaac tagaaaattt 13140
acaaatattt ggaaattaaa caacacagta tttaccaacc aatgaatcaa agaacaaatc 13200
atgagggaaa ttagaaaatg tttagagacg attgaaaaca aagatataac aagatgggtg 13260
tgatatatca aaagcagtgc tcagagttgt aacacctaca ttttaaaaaa gaaacatgtc 13320
aaatcaataa ccaaacttta ctcaataaat cataaaagga agagcaaaca aaatccagag 13380
ctagcagaag gaaggaaata aagattagag cagagataaa tgaaattgag aattaaaaaa 13440
ttatacagag atcaacaaaa ctaaaagttg gttcttttaa aatatcaata aaattaatat 13500
acttttacat agactaagca aaacatctct attcagctga cttttttttt tacaagggag 13560
204/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
ccaacattat tcagtgggga ataatagctt tttcaacaaa aagtgctggg aatactgaat 13620
attcatatgc aaaaaaaatg aagctggacc cctacctcac attatataca aaatctagat 13680
tggatcaata atgtaaatat acgagtgaaa accatacatg cttagaagaa aacatggaaa 13740
taaaacattg ctgtggattg gcaatgcatt cttagataat acaccaaaaa tacaagcatg 13800
aaacaaacaa atgtagccaa aatgtaccag aatctgaaaa catgtattat ctataaagaa 13860
ttagagggga atttggtgaa agaaatatgg gagaatggga tattgctctg tgaatgcttt 13920
tgtgcataat tgtacatttt taattaagtt aatcttttac actctcaaag tgtgatatta 13980
agcaagcaaa gataagttat tacaagactc taaaaccgaa tgcaatgaga aacaagtgaa 14040
tccaaatata tttcaaatga atgaatgaca taatcaaact taaggggaaa ataataatta 14100
atctgattaa tttttgactg ttctcttatt tcaaattgac ttttgaacat actttgacta 14160
catactattg cttgaaaaaa taaaatatct gcaaaaaatt attaaatctt catgatagga 14220
ttttttcttt ttatattagt ataaatataa caattctgaa acaaatgtat gtgcattgta 14280
agattaagcc aatgagtaaa tattaatata tttgtattgc tagaacccca gattctcact 14340
gtgaaaggac agagatacag atatggaata agacaaggaa agaagcagcc cactgagtta 14400
cattagaatc agtattatca acataaataa gcaatgtgct ctctcacatg ctctttcctt 14460
ctcttaaaaa atatataata tgtacttatt atatattata tgcatagaca cacgtgtgtc 14520
tatacatatc ctacatgtac atattgagga ttaacaggtg ctagtagaaa atattaactt 14580
tctttgtatt aacaggtgtt agtagaaagt agtagtaggt gctaagataa aagccataat 14640
taaacctcct ggtgaatgaa cacaccatca cctacaatct taccaaaaat agaatcaagc 14700
acgtgtccta gtcaaacctc tggattcaac tgtcatttgg ataaaacgca aaggatagtg 14760
aaaatgtcga tcttcactga gagtctcacc agcaaaattc acagtgtgga caccaagtga 14820
caaaaatccc aaatttttca acaaatatat tgtatgggaa agaaaacttt gaaaagaaac 14880
ctgtatgtta gaaggcattt taaaaacacg acaaatgaaa acaaatgggc aagactaaat 14940
catagtgtct tggaatgcat gcatgaagga cacagccgtg aaaatgcaag gacgcctcta 15000
ctggaacagt catgtttatc gtcacttttc aggagaaagg tggctgcagt tgaggagagt 15060
cacatgcttc agggctggca aagtcctata tcttgactta tgtgatgatt acagggatgt 15120
ttacaaaaat caaactataa gtttgttttg tgccatgttt tgtattgtgt gtgtgtgtgt 15180
tttgtttttc aacttaaaaa taaataaaat caaaaccaag gcttcattat caagtagcac 15240
aaagtctcca atctataacc tcctttgtct ggatatctgc atttaactac cattgccaga 15300
gctaatcctg acaatgcatt catattttta acactgaaac acagtaaaca gggaaaattt 15360
205/439



CA 02512536 2005-06-30
WO 2004/063709 PCT/US2004/000368
tgctcctcta aaacagggca tcttcaggca atcagaacaa ctcagaaagt ttctgtctgt 15420
tgcataaaac tcccctgtgc aaagagttac acaaaatgct gtcatagtaa aggtagttaa 15480
ctaacggcac taattgttct tgggcagtgg ccaagtggaa cttcagagac ctggcattgc 15540
caaccagaaa tcaattgtca tgggaattgt ctcctggaat cactttggtt gtcccagggt 15600
aacgcaggga aagtggttaa tgggtcactt cggggtggca tcttcatcag taaatcacat 15660
ttactttctc ctactaagaa ttttattttt ggccatgaag ccaaaagtca gctcttaaat 15720
aacaagggaa gcaaataatc attgaataaa aatagcagaa agaaaaagct gtgcaaagaa 15780
atttatgttt ttaatttgtt atatatgtat atttttatca tactttaagt tctagggtac 15840
atgtgcacaa tgtgcaggaa taaaatttat gtttttaaaa tttattctac attatgaatt 15900
ctacattaga aaaataaacc atagcctcat cacaggcact taaatacact gaagctgcca 15960
aaacaatcta tcgttttgcc tacgtactta tcaacttcct catagcaaac tgggagaaaa 16020
aagcaatgga atgaataaaa tgatagccac aaaaatcaag gtgggagaaa tacttattat 16080
atgtccataa aaaattttaa ttaatgcaaa gtattaacat caatgattgc agtaatacag 16140
atcttacaaa tgatagtttt agtctgaaca ggactatcca aaagttaatt ttctatagta 16200
acagttttta aataaaatat caattcctga aacacataaa atggtccatg agtatacaac 16260
gagtgaaaaa aaacaaattc agagcaaaga taaattaaga agtatctaat attcaaacat 16320
agtcaaagag agggagattt ctggataatc acttaaaccc atggttaaac ataaatgcac 16380
atatgttaat gtttactgaa taacttatct gtgccaagtg gtgtattaat gattcatttt 16440
tatttttcac taaatctttt ctctaaagtt ggtgtagcct gcaactaaat gcaagaaatc 16500
tgacctagga cctgcacttc ttaccatttt gctcatattt attccctgtg catttttgta 16560
acatgtatat gttatatata tagaaagaga gagaggcaga gatggaaagt aatttatgga 16620
gtttgatgtt atgtcagggt aattacatga ttatataatt aacaggtttc tttttaaatc 16680
agctatatca atagaaaaat aaatgtagga atcaagagac tcattctgtc catctgtgat 16740
agttccatca tgatactgca ttgtcaagtc attgctccaa aaatatggtt tagctcaaca 16800
ctgagtgact ataggaaacc agaaaccagg ctgggcgcta aagatgcaaa gatgaatgag 16860
acatcatctc tgccgtccaa aagcttactg tctagtggga gagttacaca cgtaaggaca 16920
gtaatctaat aagagctaat aagtgaaaac taagataaat taataataca agattacagg 16980
gaaggtttcc aaagtcaatg aggcctcaaa tgaatcttga aagtgtgcaa ggattaacca 17040
aatgaagaaa tgtgtaagtt tttcaaacaa aaaggaacag catgagcaaa tgcaaggagg 17100
206/439




DEMANDE OU BREVET VOLUMINEUX
LA PRESENTE PARTIE DE CETTE DEMANDE OU CE BREVET COMPREND
PLUS D'UN TOME.
CECI EST LE TOME 1 DE 2
CONTENANT LES PAGES 1 A 281
NOTE : Pour les tomes additionels, veuillez contacter le Bureau canadien des
brevets
JUMBO APPLICATIONS/PATENTS
THIS SECTION OF THE APPLICATION/PATENT CONTAINS MORE THAN ONE
VOLUME
THIS IS VOLUME 1 OF 2
CONTAINING PAGES 1 TO 281
NOTE: For additional volumes, please contact the Canadian Patent Office
NOM DU FICHIER / FILE NAME
NOTE POUR LE TOME / VOLUME NOTE:

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date Unavailable
(86) PCT Filing Date 2004-01-08
(87) PCT Publication Date 2004-07-29
(85) National Entry 2005-06-30
Dead Application 2010-01-08

Abandonment History

Abandonment Date Reason Reinstatement Date
2009-01-08 FAILURE TO REQUEST EXAMINATION
2009-01-08 FAILURE TO PAY APPLICATION MAINTENANCE FEE

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Registration of a document - section 124 $100.00 2005-06-30
Application Fee $400.00 2005-06-30
Maintenance Fee - Application - New Act 2 2006-01-09 $100.00 2005-06-30
Maintenance Fee - Application - New Act 3 2007-01-08 $100.00 2006-12-13
Maintenance Fee - Application - New Act 4 2008-01-08 $100.00 2007-12-20
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
BRISTOL-MYERS SQUIBB COMPANY
Past Owners on Record
AMLER, LUKAS C.
JANUARIO, THOMAS
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Cover Page 2005-10-11 1 49
Abstract 2005-06-30 2 104
Claims 2005-06-30 1 44
Drawings 2005-06-30 3 111
Description 2005-06-30 283 15,193
Description 2005-06-30 235 8,075
Representative Drawing 2005-10-07 1 19
Description 2006-06-01 250 14,432
Description 2006-06-01 211 7,786
Correspondence 2006-05-12 1 28
PCT 2005-06-30 2 53
Assignment 2005-06-30 8 259
Prosecution-Amendment 2006-05-12 1 60
Prosecution-Amendment 2006-06-01 250 14,376
Prosecution-Amendment 2006-06-01 137 3,362

Biological Sequence Listings

Choose a BSL submission then click the "Download BSL" button to download the file.

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.

Please note that files with extensions .pep and .seq that were created by CIPO as working files might be incomplete and are not to be considered official communication.

BSL Files

To view selected files, please enter reCAPTCHA code :